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Chapter 1: Introduction 
 
Mental health problems such as depression and anxiety disorders are common, with 
a general understanding that one in six people in their lifetime are likely to suffer with 
a mental health problem at some point, and can be particularly debilitating affecting 
employment, relationships and general quality of life (1). The cost to society is difficult 
to estimate, however health economic analyses describes how investing in treating 
mental illness with therapy pays for itself by an increase in people working, and 
reducing the cost to the welfare state. (2,3) The evidence base for efficacy of 
psychological interventions in common mental disorders such as depression and 
anxiety is well-established, however less is known about how to implement them in 
local service contexts. In addition, the notion that severe and complex should require 
a more intensive treatment perpetuates service model design and clinical guidance, 
yet there is a growing body of evidence of the efficacy of low intensity interventions. 
The Stepped Care model is a framework of organising a range of treatment and 
intensity and is recommended by The National Institute for Health Care Excellence. 
(NICE).  However, there appears limited evidence regarding the effectiveness of a 
stepped care model, different interpretations of what stepped care actually means in 
routine practice, and even more uncertainty as to whether outcomes are affected by 
one type of stepped care model compared to others.  
The Improving Access to Psychological Therapies (IAPT) programme in England 
aims to implement psychological therapies for common mental disorders such as 
depression and anxiety on a large scale, and broadly takes a stepped care 
approach.  Its goals are major clinical benefits, but also economic benefi ts in terms 
of return to work. The collation of standardised minimum dataset collection of 
information is mandatory, providing information such as patient demographics, 
categorisation of referred problem, psychological severity measures administered 
every treatment session, type of treatment delivered, number of treatment sessions 
and use of psychological measure scores to measure clinical outcomes such as 
recovery. Such detailed information across many services nationally provides for the 
first time a comprehensive picture of people with common mental health problems, 
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treatments delivered, and the possibility of exploring what works, particularly in 
routine practice service delivery. The service delivery model of therapies appears to 
be heterogeneous across the country, particularly in terms of different versions of 
stepped care. The study site is an IAPT service which has implemented a range of 
initiatives to improve outcome, one of which is a move from a stratified, allocated 
model of stepped care, to a progression model of delivery. This service development 
has created a naturalistic opportunity for measuring how this service change is 
associated with outcomes, particularly for those scoring higher on psychological 
measures, indicating severity of problem. This project aim was to explore the impact 
on clinical outcomes moving from one service delivery model (allocated) to another 
(progression) and therefore there were two main research questions for this study: 
1. What is the relationship between clinical outcomes of depression and anxiety and 
service delivery model for adults treated in and IAPT service?  
2. What is the relationship between the clinical outcomes for moderate to severe 
anxiety and depression, and service delivery model?  
Baseline variables such as gender, ethnicity, disability and employment status were 
also analysed to explore any relationship with outcome and model.  
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Chapter 2: Background & Context 
 
There is a substantial body of research regarding the efficacy of effectiveness of 
psychological interventions, arguably the largest being in the modality of Cognitive 
behavioural therapy (CBT), particularly with regard to common mental health 
problems, anxiety and depressive disorders, which has led to several clinical 
guidelines. (4-11) In particular with over forty years of research on psychotherapy for 
depression, it is of note that a recent network meta-analysis comparing seven 
different psychotherapeutic approaches found that there was no significant 
difference in effectiveness between any of the types of therapy (12). Despite an 
extensive body of research which informs national guidelines and influences how 
mental health treatment is delivered, there remains a lack of evidence regarding 
what specifically works for whom. Psychotherapy trials are often underpowered to 
demonstrate clear findings, and there is no clear superiority between modality of 
therapies and clinical outcomes (12, 13). In addition such questions relating to the 
efficacy of specific interventions, little evidence exists to guide clinician and 
managers on regarding service design and delivery, and how this may impact on 
clinical outcome.  
Traditionally therapeutic intervention has been informed by professional training and 
latest research, emphasis on types of therapy on offer varied locally, with service 
design being much more locally defined within mental health and psychology 
services. The design and introduction of the national programme in England of 
Improving Access to Psychological Therapies (IAPT) was a comprehensive attempt 
to increase the number of professionally qualified therapists nationally, thereby 
increasing the availability of talking therapies, through a structured training 
programme and new service design. Its predicted benefits are the reduction of the 
cost of prescribed medication, and the reduction of the state welfare cost with more 
people previously unemployed or on sickness benefit, able to return to work through 
an improvement or recovery of their mental health. (11, 14) 
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2.1 Definition of stepped care  
Of historical importance is a review and discussion paper (MAPLE) by Lovell & 
Richards (15) predating the recommendation of the stepped care model by NICE; in 
many ways was an early proposal of a version of stepped care. The authors outline 
the problems with traditional Cognitive Behavioural Therapy delivery, and propose a 
solution which is multi access points and levels of entry for CBT services (MAPLE) 
as a service delivery model with what looks like an early version of stepped care. It is 
of particular importance to highlight the issues the authors identified with traditional 
therapy delivery which were time wasted through clients not attending, these 
sessions are wasted. In terms of dosage, session length is traditionally 50-60 
minutes planned around therapist convenience and traditional, however there no 
evidence of optimal session time. The authors also discuss a “negatively accelerated 
dose affect curve”, which questions whether the traditional number of sessions 
offered (NICE 12-20 sessions dependant on disorder) is actually needed by all or 
majority of patients. The “efficacy of brief vs intensive therapy” is also explored, and 
the argument is outlined that brief and low intensity interventions are effective for a 
larger patient group than is traditionally treated, and therefore a system which 
favours these as a first line treatment, with a step up to multi strand / complex 
treatment if no progress at this level is recommended. (15) 
 
A further paper (16) proposed a version of stepped care for depression, with the 
comparison with the stepped care treatment of physical disorders, alcohol use and 
the psychological treatment of some anxiety disorders. In 2005 NICE issued 
guidelines regarding the implementation and practice for treating depression with a 
stepped care approach. Pilling & Harvey (17) describe how this stepped care 
approach for depression draws on “chronic disease management models and the 
principles that the most cost-effective and least intrusive treatment should be offered 
first.” A more stratified/allocated model of stepped care is presented, with description 
regarding which types of treatment should be offered depending on severity of 
patient presentation.  
However this does not necessarily control the problems that are outlined in the 
MAPLE paper of the issues regarding length of time, and the “negatively accelerated 
dose affect curve”. It is likely that given that the current NICE guidelines recommend 
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higher step intervention for moderate and severe presentations that this is what 
services and therapists would offer, even on first access to treatment, as there is the 
implication within this guidance that this is the correct treatment. However it still 
remains, that we do not know that anything up to 20 sessions of 60 minutes of a 
talking therapy is the best course of action.(15) In the same year as the NICE 
guidelines for stepped care for depression, a narrative literature review was 
published regarding stepped care and psychological therapies, stating that the 
clinical effectiveness of therapy is well evidenced but identified that there is a gap of 
knowledge and evidence regarding efficiencies and cost, relating to models of 
delivery. (18) 
This review explains the definition of stepped care, with key features being 
described, such as ‘least restrictive’ – defining this as less intensive treatment, and 
‘self-correcting’ meaning the system has mechanisms to change the treatment, i.e. 
‘step up’ if the least restrictive treatment is not achieving results. They describe that 
low intensity interventions that are CBT informed e.g. problem solving and stepping 
up to CBT are compatible, there is a suggestion that a stepped care system could be 
used involving a number of different levels and types of therapy. (18) 
 
Suggestions are made regarding how many steps, and also how decisions may be 
made regarding stepping up, they discuss some of the advantages and 
disadvantages of individual clinical decisions, and the complexity of this. As is also 
described in the MAPLE paper (15), “there is a general perception that minimal 
interventions are best restricted to less severe disorders, although the evidence for 
this is not definitive.”  The narrative review (18) considers that cost effectiveness is not 
a straightforward process it is also suggested that early intensive treatment may be 
more cost and clinically effective for complex presentations.  
 
The narrative review (15) explores 3 key assumptions regarding issues with stepped 
care at the time of writing.  
a) Lower intensity interventions can achieve similar clinical outcomes to that of 
traditional therapy for a proportion of clients. 
b) Low intensity interventions enable efficiencies of resources. 
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c) Low intensity interventions and stepped care are acceptable to patients and 
clinicians.  
 
Therefore at this point although there are huge similarities with the definitions and 
explanations of stepped care amongst NICE guidelines and the research, there is 
clearly a difference in terms of interpretation of when least intrusive intervention 
principle is applied and how lower intensity interventions are delivered. The NICE 
guidelines recommended a version of stepped care that although it advocates the 
principle of least intrusive intervention, it appears to emphasise apparent severity of 
presentation influencing where in the stepped model someone begins to access 
treatment, therefore appearing to be more of a matched care, allocated model. This 
is not the same as the apparent position with evidence in the literature emerging 
demonstrates the validity of a more ‘progressive’ or pure model of stepped care, 
which emphasise lower intensity interventions in the first instance, even with severe 
presentations.   
For the purpose of this study, clarity and reference here on, the definition of the 
different models of stepped care are as such: Patients that are allocated to an 
intervention based on their level of need which is predominately psychological 
measure and clinician judged, where least intrusive intervention may be low or high 
intensity, depending on presentation is defined as allocated or matched care. This is 
delivered by a stratified model of stepped care or could be in a mixed model where 
some are allocated and those that do not recover from low intensity are stepped up. 
A progressive or pure stepped care model is where all patients are treated with the 
least intrusive low intensity intervention first, and stepped up to a higher intensity 
intervention at the end of the first if not recovered.   
Published studies have sought to demonstrate the efficacy of stepped care 
compared to treatment as usual, but have not compared different versions of 
stepped care, with the exception of two, which will be discussed alongside the  
context of IAPT, and the within the literature review.  
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2.2 Historical context to IAPT development 
Mental health service community provision is generally divided into primary and 
secondary care, operating a stratified stepped care approach based on complexity, 
severity chronicity and risk. Stepped care has been a system model in operation for 
around 10 years, and was viewed as a potential solution to the longer standing issue 
of lack of numbers of qualified therapists and poor access to treatment. (16,18) 
Stepped care continues to be presented by NICE as the service model of delivery for 
psychological therapies. In the stepped care model presented in the NICE guidance 
(9) (figure 1) there are both suggestions regarding type of intervention to a particular 
severity of presentation, with an allocated matched care approach but also an 
element of progressive stepped care, to step up from lower intensity interventions if 
there is no improvement. Thus the current NICE guidelines appear to advocate a 
mixed model of delivery.   
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Figure 1: Stepped-care model showing steps 1 to 4 for people with common mental health disorders (NICE 2011) 
 
Step 4: 
Depression: severe and complex depression; risk 
to life; severe self -neglect.  
Generalised anxiety disorder : complex treatment 
– refractory GAD and very marked functional 
impairment, such as self -neglect or a high risk of 
self-harm 
Panic disorder, OCD and PTSD: severe disorder 
w ith complex co morbidities, or people w ho have 
not responded to treatment at steps 1-3 (see note 
1 below ) 
Step 3: 
Depression: persistent subthreshold depressive 
symptoms or mild to moderate depression that has not 
responded to a low -intensity intervention; initial 
presentation of moderate or severe depression  
Generalised anxiety disorder : with marked functional 
impairment or that has not responded to a low -intensity 
intervention 
Panic disorder: moderate to severe 
OCD: moderate or severe functional impairment  
PTSD: moderate or severe functional impairment  
Step 2: 
Depression: Persistent subthreshold depressive symptoms or 
mild to moderate depression 
Generalised anxiety disorder 
Panic disorder: mild to moderate 
OCD: mild to moderate 
PTSD: mild to moderate 
Step 1: 
All disorders: know and suspected presentations of common mental 
health disorders 
Depression: highly specialist treatment, such as 
medication, high intensity psychological 
interventions, combined treatments, multiprofessional 
and inpatient care, crisis services, electroconvulsive 
therapy  
Generalised anxiety disorder : Highly specialist 
treatment, such as complex drug and/or 
psychological treatment regimens; input from multi-
agency teams, crisis services, day hospitals or 
inpatients care 
Panic disorder, OCD and PTSD: (see note 1 below ) 
Depression: CBT, IPT, behavioural activation, 
behavioural couples therapy, counselling*, short-term 
psychodynamic psychotherapy*, antidepressants, 
combined interventions, collaborative care**, self -help 
groups. 
Generalised anxiety disorder : CBT, applied relaxation, 
drug treatment, combined interventions, self -help groups. 
Panic disorder: CBT, antidepressants, self -help groups. 
OCD: CBT (including ERP), antidepressants, combined 
interventions and case management, self -help groups. 
PTSD: Trauma-focused CBT, EMDR, drug treatment. 
All disorders: Support groups, befriending, rehabilitation 
programmes, educational and employment support 
services; referral for further assessment and 
interventions. 
Depression: Individual facilitated self -help, computerised CBT, 
structured physical activity, group-based peer support (self-
help) programmes**, non-directive counselling delivered at 
home***, antidepressants, self -help groups. 
Generalised anxiety disorder and panic disorder: Individual 
non-facilitated and facilitated self-help, psycho educational 
groups, self -help groups. 
OCD: Individual or group CBT including ERP (typically 
provided w ithin step 3 services; see note 2 below ), self -help 
groups. 
PTSD: Trauma-focused CBT or EMDR typically provided w ithin 
step 3 services; see note 2 below ). 
All disorders: Support groups, educational and employment 
services; referral for further assessment interventions.  
Step 1: 
All disorders: know and suspected presentations of common mental 
health disorders 
Note 1: The NICE guidance on panic disorder (CG113) and OCD (CG31) uses dif f erent models of  stepped care to the step 4 model used in the NICE guidance on 
depression (CG90, CG91)  and generalised anxiety  disorder (CG113). 
The NICE clinical guidance on PTSD (CG26) does not hav e the stepped care model. People with panic disorder, OCD or PTSD that has not  responded to 
treatment at step 1-3, or who hav e sev ere disorders and complex co-morbidities that prev ent ef f ective management at steps 1-3, should receiv e specialist serv ices 
at step 4, according to indiv idual need and clinical judgement. The principle interv entions at step 4 are similar to those listed f or depression and generalised anxiety  
disorder; with the exception that electroconv ulsiv e therapy  is not indicated.  
Note 2: The NICE clinical guidance on OCD (CG31) recommends that people with mild to moderate OCD receiv e indiv idual or group based CBT. The NICE clinical 
guidance on PTSD (CG26) recommends that people with mild to moderate PTSD receiv e trauma-f ocused CBT or EMDR. These interv entions may  ty pically be 
commissioned f rom, and prov ided by , trained, high intensity  therapy  staff in step 3 serv ices.  
*Discuss with the person the uncertainty  of  the ef f ectiveness of  counselling and psy chody namic psychotherapy in treating depression.  
** For people with depression and a chronic phy sical health problem.  
*** For women during pregnancy  or the post natal period.  
Key: CBT – Cognitiv e behav ioural therapy ; ERP – exposure and response prev ention; EMDR – ey e mov ement desensitisation and reprocessing; OCD – 
obsessiv e compulsiv e disorder; IPT – interpersonal therapy ; PTSD – post traumatic stress disorder. 
 
Focus of Intervention Nature of Intervention 
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GP’s would usually be the first point of contact prior to all steps, intervention 
provision from community mental health teams for steps 1-3 delivered at a primary 
care level, and 3-4 at a secondary care level. For patients with common mental 
health problems, prior to 2008, provision for talking therapies was scarce and 
sporadic, (19) and therefore the privilege of the more complex and chronic patient, but 
only with a long wait of several months. Patients with common mental health 
problems would be managed by GP’s with prescribed medication, patients with more 
chronic problems managed by primary care mental health teams or secondary care 
services for the more risky or complex presentations. (19) However the size and cost 
of mental health problems is an increasing concern. “Mental ill-health accounts for 
over a third of all illness in Britain and 40 percent of all disability..... one in six 
working adults (16 percent of the population) at any one time are suffering from 
clinical depression and/or anxiety disorders.” (19) A proposal to the government 
described the link between poor mental health and unemployment, and suggested 
that by increasing numbers of qualified therapists and targeting therapy to more 
people with mild to moderate mental health problems, this would increase the 
numbers moving into employment, thus reducing the cost to the welfare state. (3) 
2.3 IAPT development 
During 2006 – 2007, pilot sites tested out different service model and therapy 
delivery (20, 21) and produced good results regarding volume, throughput and clinical 
outcomes. In 2008, the 3 year roll out of a large national programme called 
Improving Access to Psychological Therapies (IAPT) commenced. It aimed to 
transform and improve the psychological therapies provision. “The Improving Access 
to Psychological Therapies (IAPT) programme is concerned with raising standards of 
recognition of, and treatment for, the mass of people who suffer from depression and 
anxiety disorders. The programme is at the heart of the Government’s drive to give 
greater access to, and choice of talking therapies to those who would benefit from 
them.” (19). IAPT was designed to be aimed at those patients that rarely accessed 
talking therapies, the mild to moderate range of common mental health problems, 
previously managed within primary care settings largely by GP’s and medication, 
with sporadic potential involvement with a practice counsellor or the primary care 
mental health team. IAPT was seen as an opportunity to transform how services 
were delivered, and be paid for, by acting as long term prevention to more serious 
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mental health problems. This should also reduce demand and cost on secondary 
care services, and with a reduction of medication cost in the long term be more cost 
effective for primary care. It was also viewed as part of the solution to rising number 
of unemployed and the cost to the benefits system with numbers of people 
unemployed for long periods of time claiming mental health problems prevented 
them from working.  
Through increasing the numbers of qualified therapists with a large scale training 
programme, increasing the low intensity workforce and emphasised the principle of 
least intrusive intervention, IAPT aims to increase the numbers accessing a talking 
therapy.  
A comprehensive and detailed monitoring and evaluation system of individual sites 
and generally the IAPT programme nationally are in place. “Detailed outcome 
monitoring and ongoing evaluations of the programme are considered an integral 
part of IAPT”. (11) Each assessment and therapy session delivered is expected to 
collect a minimum data set (MDS), comprising of a number of psychological 
measures and employment and benefit status. These data are evaluated locally and 
nationally against specific key performance indicators (KPI’s), as set by the national 
IAPT team. (22) Essentially all IAPT sites have to submit data to the national IAPT 
team regarding a number of key areas; access; with numbers of referrals and 
throughput with numbers entering into treatment, effectiveness and efficiency with 
numbers that receive treatment within a specific timescale, and numbers of those 
moving towards employment as well as effectiveness regarding clinical outcomes in 
terms of attainment of a recovery rate target.  
The definition of recovery is through the use of particular psychological measures. All 
IAPT sites are required to use these. PHQ-9 (23) measuring mood and GAD-7 (24) 
measuring anxiety are used in every clinical session and the scores at the first and 
last sessions are used to measure recovery. Patients must score above clinical 
caseness at first session on at least one measure, and below caseness on both 
measures at the last session to count as recovered in the IAPT data returns for the 
KPIs. (caseness = 10 on PHQ9, 8 on GAD7). (22) 
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2.4 Low intensity psychological therapies  
Traditional psychological therapies are delivered face to face with the patient, and 
usually sessions last 50 minutes to an hour, with a varying range of session 
frequency and dosage recommendations depending on therapy type, and threshold 
level of presentation. As mentioned previously, evidence suggests that no one type 
of therapy is superior. (12). The most improvement in CBT takes place in the earliest 
sessions, and therefore it can be considered that the whole traditional treatment 
package has parts that are not necessary and ineffective for clinical gain. 
Unfortunately not enough is known about which components of therapy are effective 
for whom, and there is a need for research to focus on the “mechanisms for change”. 
(25) 
Scogin et al (16) discuss the benefits and the potential problems with using a stepped 
care model with depression; however this is in the context of 2003, with only 
bibliotherapy and pharmacotherapy being the advocated evidenced based low 
intensity interventions. As discussed previously the range and the evidence of the 
effectiveness of low intensity interventions has grown since.  
Scogin expresses concerns that “severe consequences could occur if severe 
depressive symptoms (including suicidal ideation) are not promptly addressed with 
more intensive treatments.”  At the time of Scogin’s publication there was little 
evidence to support the efficacy of low intensity treatments with more complex 
presentations, however as mentioned previously the recent meta- analysis found 
severely depressed patients could benefit from low intensity interventions at least as 
much as those severely depressed. (26) 
It could be argued that in the case of severe depression that impairs daily 
functioning, low intensity treatment or single strand therapy such as basic behaviour 
activation delivered frequently may be all that this kind of patient can tolerate and 
engage with initially rather than a complicated cognitive orientated formulation. 
Indeed the recommended models of depression for high intensity treatment, 
including the Beckian Cognitive Behavioural Therapy (CBT) advocate increased 
behaviour activation initially. Therefore high intensity treatment includes a low 
intensity style component. Less ‘complex’ therapies such as single strand treatments 
e.g. behaviour activation, and low intensity interventions potentially may offer insight 
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into what are the mechanisms for change, solutions to the unnecessary dosage 
highlighted by Lovell and Richards (15) and are possibly more cost effective. 
Behaviour Activation as a stand-alone single strand therapy for depression has been 
found to be effective. (27,28) Low intensity interventions such as internet or telephone 
based CBT, and guided self-help are psycho- educative in nature, brief, with usually 
between four to eight sessions, and have demonstrated their effectiveness. For 
instance, Hammond et al (29) found low intensity telephone CBT based intervention to 
not be inferior compared to face to face CBT, except with those with more severe 
illness, where traditional CBT was superior. However a meta-analysis of 16 studies 
looked at the effectiveness of low intensity interventions on more severe depression.  
It found that more severely depressed patients can gain at “least as much clinical 
benefit” as those with less severe presentations. (26) Further research (13) support this, 
and suggests there is a cost benefit, “These treatments have been found to be 
effective in the treatment of depression, with comparable effect sizes as face-to-face 
therapies, while needing fewer resources”. Certainly the evidence makes low 
intensity treatments attractive economically and clinically, achieving the same 
outcome with less resource, and within a context of a stepped care model, provides 
support regarding the principle of least intrusive intervention first.  The national IAPT 
programme provides a workforce and clinical delivery framework which advocates 
the use of low intensity interventions, and recommends a stepped care approach in 
line with the NICE guidelines. (19)  
 
2.5 A brief overview of delivery models of stepped care 
Mental health psychological services treatment delivery in the UK is generally 
informed by NICE guidelines. As discussed previously the current NICE guidelines 
offer a mixed stratified matched and pure stepped care model, for depression 
advocating least intensive treatment first, with some variation for some anxiety 
disorders, and some exceptions e.g. PTSD where current recommendations suggest 
step 3 interventions as a first line treatment. ( figure 1). Bower and Gilbody (18) neatly 
describe the definition of stepped care, clarifying that the principle of ‘least restrictive 
treatment’ is often defined as the minimum dosage and treatment intensity required 
for the most optimal outcome, Bower et al (26) further suggest that “it is legitimate to 
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include low intensity interventions in the first step of a stepped care system and to 
encourage most patients to use them as the initial treatment option, even when the 
initial severity of depression is high.”  
As discussed previously, the development, definition and inclusion of stepped care 
within NICE guidelines occurred prior to the development of IAPT. Simultaneously 
there appears to be an expansion of the definition, with a number of slightly different 
models of delivery, all being described as stepped care.  
There appears to be a version of stepped care, which has different layers of 
intensity, however patients are allocated directly to a step, for a treatment where the 
intensity of treatment matches the intensity of complexity and severity. This is a 
stratified matched or allocated model of stepped care. A second version is where the 
least intrusive intervention principle is applied more stringently, and patients are 
treated at the lowest step first, then ‘stepped up’ if needing more intensive treatment. 
This is true, or pure stepped care.  
Some literature also includes the collaborative care model as a version of stepped 
care. Collaborative care is usually defined as multi component, with a number of 
professionals around the patient, e.g. “a medical doctor, a case manager (with 
training in depression and anxiety), and a mental health specialist such as a 
Psychiatrist”. (30). This kind of arrangement would usually be seen in secondary care, 
over a longer period of time than primary care delivered brief therapy. Given that “a 
key aspect of collaborative care is ‘case management’ (Gilbody 2003a)” (30), this 
places collaborative care usually in the threshold level of secondary care mental 
health provision. Some models of collaborative care are delivered with a variety of 
threshold levels for mental health and comorbid with other problems, for instance 
and long term physical conditions (LTC) such as Asthma, or Diabetes. A meta-
analysis found collaborative care to be an affective model of care with LTC and 
depression. (31) “The collaborative care model is based on the principles of chronic 
disease management applied to conditions such as Diabetes.” (30) Here the physical 
problem is chronic and longstanding; however the mental health problem may only 
require brief therapy. It is primarily targeted to patients with specific physical care 
management needs; therefore the focus of the model delivery is this, with the mental 
health treatment as a component, rather than the main focus. Collaborative care may 
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contain the points of treatment review and adjustment, and a component of step up 
or sideways, fitting with the broad definition of the stepped care model, however as 
delivery is not necessarily comparable in terms of focused problem, threshold level 
of mental health problem and treatments offered, there is a counter argument 
regarding validity of comparison with other stepped care models.  
 
Excluding the literature focusing on collaborative care, models of treatment delivery 
appear broadly differentiated as allocated /stratified or pure stepped care (18, 32) 
Whilst there has been some attempt within the literature to define more clearly what 
stepped care service delivery actually means, It would appear that both in policy and 
routine practice there are different interpretations being delivered and the evidence 
of the effectiveness of these various interpretations is limited.   
One RCT study in the Netherlands aimed to compare different service models of 
matched care and stepped care, defining the latter “in a stepped care model all 
patients start with an evidence-based treatment of low intensity as a first step”. (33) 
Interestingly its first step of treatment is either brief therapy, which broadly appears 
to compare with the guided self-help low intensity intervention in England, and CBT 
sessions equivalent to high intensity step 3 treatment in the U.K, particularly within 
an IAPT service. This Randomised Controlled Trial (RCT) set in routine practice, and 
although found in favour both clinically and cost effectively for the stepped care 
model, unfortunately the study did not find statistical significance, suffered with a 
large number of drop-outs, and lacked power.   
An observational study (32) (which is critiqued within the literature review, section 4) 
attempts to analyse different models in routine practice in 4 different services. 
Unfortunately large levels of missing data and lack of availability of clinical outcome 
data meant that it was difficult to reach any conclusion. However this study highlights 
that the “variation in models was significant”, and that service design appears to be 
responsive to resource capacity, different local definition of need or interpretation of 
the NICE guidelines. The study (34) suggests that whilst a combination of “stepping 
and stratification is likely to be required, the relative importance of the two different 
mechanisms was not explicit in the NICE guidelines.” It further states there is limited 
literature pertaining to the evaluation of effectiveness of the stepped care approach, 
and “significant questions remain about implementation”, although goes on to define 
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the difference between ‘stepped’ and ‘stratified’ in line with Bowers and Gilbody (18), it 
states that it is not explicit in the NICE guidelines the important difference between 
the two. This is the fundamental problem with interpretation of the guidelines and 
implementation in routine practice. 
Furthermore, most literature is prior or leading up to the development of IAPT, 
therefore are more general to mental health teams, psychology services and 
collaborative care. Most are consistent with the idea that stepped care values the 
idea of low intensity and least intrusive intervention, and the stepped care model is 
‘self-correcting’ in that where patients fail to progress they are stepped up. (18, 32) 
However what is also describes is the notion of targeting the ‘right’ treatment that 
achieves the most benefit. (32) 
Whilst in theory, combining the two principles may be desirable, they could be 
contradictory, as still not enough is known about what components of treatment are 
most beneficial and works with whom in stepped care. (32) The idea of choosing the 
right treatment is limited, and surely if enough was known about what constitutes the 
right treatment for each patient, the mechanism of self-correction with the stepped 
care model, i.e. stepping up with failure to progress, would not be necessary, and 
simply the stepped care model of implementation would be a stratified one.  
Returning to point about not enough is known about what works with whom, (32) it 
could be reasonable to assume that there are numbers of patients that present as 
severe and complex that are allocated and may receive more dosage of treatment 
than they really need, simply because they are allocated that level of stepped care 
treatment.  This was indicated within the MAPLE paper (15) as an argument for an 
increase of use for low intensity treatments and a pure model of stepped care.  
If not enough is known about what works for whom then there is a question about 
how allocation of treatment is decided. If therapists follow the NICE guidelines and 
specific disorder model treatment plan of recommended number of treatment 
sessions, this will average 12-16, depending on disorder treated regardless of 
individual patient dosage need. Nice guidelines describe the allocation of increased 
intensity and dosage of treatment delivered by more specialist staff, matched to the 
increased severity, complexity, chronicity and risk of patient presentation. (10) 
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Within IAPT, the psychological measures used that measure frequency of symptoms 
are self-reporting, therefore open to some level of personal interpretation and 
therefore variation. Alongside an assessment, the clinician is likely to use this 
information to inform the decision regarding complexity and severity. Again this is 
subject to personal interpretation and variation, within services, and across the 
country. 
Other elements that may inform decision to step up is dosage of treatment, and more 
subtle and less tangible factors regarding therapist, i.e. inexperience or lack of skill 
or knowledge with particular disorders, interpersonal processes, i.e. the 
communication, connection and relationship between patient and therapist, and 
generally therapist bias. This notion suggests a possibility in a system of matched 
care open to the influence of therapist decision, personal preference of the therapist 
may be one of the driving factors to allocation of intensity of treatment, rather than 
specifically what may be needed.   
NICE guidelines are developed through a consideration of evidence, and in practice 
the equation of complex and severe needs more complex and intensive therapy 
would appear logical. This is what is recommended within the NICE stepped care 
guidelines.  However this may cause a pragmatic and resource problem, if a service 
receives the majority of their referrals that fall into the more severe, complex, chronic 
and risky presentations, then by this equation more patients would be allocated to 
higher intensity interventions. Given the findings of the Layard’s (3) Department of 
Health (DOH) report it would appear that this was indeed the case that led to long 
waiting times for patients accessing a talking therapy. A wish to tackle this problem is 
the principle of the national IAPT programme.  
More specific to IAPT, a review of the national IAPT first year implementation and 
explore differences in stepped care treatment levels in terms of which patients are 
most likely to receive a high intensity treatment. (21) Findings were that higher PHQ9 
or phobia scores are slightly more likely, with higher GAD 7 and women more likely. 
Older patients are more likely to have some treatment but less likely high intensity or 
CBT.  Clark (14) reviews the progress of the national IAPT programme in its third year 
at the time of publication. It makes reference to a Department of Health (DOH) report 
that states the majority of patients are receiving NICE compliant treatment, if the 
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psychological measures score profiles of other IAPT services are similar to this study 
sites, then one could assume that the majority of services are using an allocated and 
stratified model. However a prospective study of the IAPT pilot sites by Richards & 
Borglin (34) discusses that most patients are treated through low intensity 
interventions, and a smaller number are stepped up to high intensity.  Therefore it 
does not appear clear whether there is consistency amongst the IAPT sites 
nationally regarding a definition and implementation of a stepped care model. 
Neither does there appear to be consistency in the literature regarding the decision 
mechanisms for stepping up, whether it be clinician judgement, psychological 
measures score thresholds, types of disorder, failure to reach agreed goals, or 
patient choice. (34) 
There appears to be an assumption that the basic definition outlined by Bowers et al 
(18) and Richards et al (32), is implemented according to both the literature, NICE 
guidelines and in routine practice. There are a number of questions and gaps of 
evidence within the literature: not enough is known about which treatments work best 
for whom, and how many treatment sessions should be delivered. Which then does 
question the efficacy of a matched care model, and perhaps this is more directed by 
therapist preference and the notion that complexity and severity should always be 
treated with high intensity therapy. Not enough is known about the optimal 
implementation model of stepped care, the number of steps and the best range of 
treatment, and optimal step up choice points. (32) 
These pose problems for routine practice, where services are responsible and 
accountable for the safe care and treatment of often vulnerable people, and are 
charged with the task of improving patient’s mental health difficulties and wellbeing. 
For services such as IAPT’s delivering psychological therapy to achieve those aims, 
and publicly measured on their performance of such, this is a particular area of 
interest to know what works and how it needs to be delivered.  
There are many factors involved in potential analysis of what works for whom, with a 
few mentioned briefly above however this is beyond the scope of this study. In the 
absence of comprehensive evidence about the efficacy of components of therapy, 
mechanisms of change, intensity and dosage of treatment, that can inform and direct 
decisions without bias regarding allocation of treatment to a specific patient, if a 
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service delivery model can improve outcomes then this is worth considering until 
such time bespoke treatments are able to be developed.  
This study site is a large IAPT service within the North East of England, and through 
its move from one type of delivery model to another has provided an opportunity to 
explore the impact of different stepped care models of delivery.  
2.6 Research study rationale 
Although research demonstrates the effectiveness of psychological therapies with 
common mental health problems, as briefly mentioned earlier, there is no superiority 
between modalities of therapy. (12, 13) Furthermore we do not understand what 
components of therapy are the most effective and whether this varies by the patient 
presentation. There is perhaps an assumption pervading routine practice that the 
more complex and severe the presentation of a patient, the more intensive and 
complex the therapy, with a larger number of sessions is needed, when we do not 
understand optimal dose or intensity levels for different patients.  There is some 
evidence within the literature that low intensity interventions can be as effective as 
high intensity regardless of complexity and severity (27) and are potentially more cost 
effective. There appears to be different interpretations of how to define and 
implement a stepped care model, and this may dictate the emphasis on throughput 
to low or high intensity interventions, yet there is not enough known about how 
particular interpretations and implementations of stepped care and therefore service 
design can impact on clinical outcomes. Specifically there is a gap in evidence 
regarding the efficacy of an allocated model compared to a progression model of 
stepped care, and a possible continued belief perpetuated in routine practice 
individually and systemically that severe presentations should only be treated with a 
high intensity therapy. Through a change in model delivery, the study site as 
described in more detail in section 5.5 provides a unique opportunity to explore some 
of these issues.  
This study firstly set out to explore the current literature regarding the evidence for 
the efficacy of stepped care, and secondly through an observational cohort design 
analysed the clinical outcomes with two variations of stepped care as delivered over 
a 4 year period by an IAPT service. By also isolating those scoring moderate to 
severe allows exploration of association of severity, outcome and model, to explore 
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the anecdotal notion that those with severe presentations would have poorer 
outcomes if treatment was not matched.  
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Chapter 3: Literature review search strategy 
 
An initial exploration of the literature was undertaken to scope the evidence of the 
key issues surrounding the research question, and indeed if there were any studies 
that specifically relate to the question of comparing patient outcomes with different 
models of stepped care delivery. This initial exploration informed and refined the 
study aim, to explore what impact, if any change in service delivery design has on 
clinical outcome.  
In order to benchmark any results of a particular study, a review of relating RCT’s, 
any other studies, and any other relevant literature is undertaken.  In order to fully 
appraise the literature relating to system design, a full systematic review and meta-
analysis where possible would be conducted, however to do so falls outside of the 
practical limitations of this project. In order to retain the rigour of such approaches 
key elements of a review have been incorporated into this study’s literature review. 
Systematic searches were conducted across four databases most likely to include 
research relating to the study question.  
The Cochrane handbook for systematic reviews (35) describes the purpose and 
method of a systematic review to answer a research question, with the collation of 
“all empirical evidence that fits pre-specified eligibility criteria”, in an attempt to 
minimize bias uses clear methods. Systematic reviews reduce the risk of bias in 
research findings by following a transparent approach to study identification, 
assessment and data extraction. Following the PICO approach, population, 
intervention, comparison, outcomes sets out this out in a methodological clear 
manner. (37) It is also important is to decide whether only published studies will be 
included  and what kind, e.g. RCTs, qualitative research, and whether there will be 
studies in any language accepted or if restrictions will apply.  
3.1 Population 
In order to minimise any selection bias the criteria should be wide enough to include 
enough studies, but specific enough to ensure validity and relevance within the 
scope of the research. For instance the research area concerns an adult population, 
and generally adult is defined as over 18 years of age. However in terms of mental 
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health service criteria there is a grey area with regards to the age definition and type 
of service. For instance there would appear a general custom and practice for Child 
and Adolescent Mental Health Services (CAMHS)  to deliver services to those up to 
aged 16, or 18 where they are in full time education or in the looked after system 
with the Local Authority. Early Intervention with Psychosis teams generally see 
patients from aged 14 – 35. How stepped care is delivered if at all may differ 
between children’s and adults services, and also the nature of interventions within 
children’s service model delivery may be different to adults therefore providing too 
many variables for the scope of this study. The range of disorders are usually 
separated by severity for service delivery organisation, e.g. primary care for common 
mental health problems, secondary care for more severe, perhaps at risk of harm to 
self or others or needing care co-ordination (a package of other services involved co-
ordinated by a lead professional) and tertiary services offering more long term 
involvement, or short or long term hospital care.  The range of literature that covers 
all levels may be broad and variable. Also specific disorders may have differing 
levels of intervention and therefore not directly comparable. IAPT services are 
offered to people aged 16+ and there is no upper age limit. In terms of the validity of 
the results of this study it is important for the population group within the literature e 
to be similar. Therefore the population to be targeted in this review is adults with 
common mental health problems (anxiety or depression) treated within psychological 
therapies services.  
3.2 Intervention and Comparison 
“The second key component of a well-formulated question is to specify the 
interventions of interest and the interventions against which these will be compared 
(comparisons). In particular, are the interventions to be compared with an inactive 
control intervention (e.g. placebo, no treatment, standard care, or a waiting list 
control), or with an active control intervention (e.g. a different variant of the same 
intervention, a different drug, a different kind of therapy)?” (35)  
The literature pertaining to the effectiveness of psychological therapies is well 
evidenced and the intervention under consideration here is not a specific type of 
therapy, but a model of delivery of psychological therapies.  
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The main model of delivery is stepped care, defined by Bowers et al (26), NICE (10) 
and Richards et al (32) however within the literature there are a variety of models of 
care provision that may have a stepped care component, be a component of stepped 
care, another term of description, or a different model of delivery for comparison. 
Therefore initial searches covered all known terms and phrases that are relevant to 
the question, for instance ‘stepped care’, ‘allocated care’, ‘matched care’, 
‘collaborative care’, and ‘stratified care’.  
3.3 Outcomes 
RCTs remain the gold standard with the regards to reliability of evidence, In RCT’s 
treatment protocols are followed to ensure that the core components of treatment are 
the same to ensure standardisation and validity of outcome. Confounding variables 
are acknowledged and if possible controlled, in an attempt to ensure the results are 
reliable. However although widely acknowledged that RCT’s are of the highest 
standard with regards to accepted reliability of evidence this method of study is not 
without its flaws. (36) RCT’s are a deductive method, which supports the notion of gold 
standard, as demonstrable causality is better than degrees of association. Generally 
what the outcomes of RCTs demonstrate is that the results are applicable to the 
population criteria of the RCT, there is potentially an issue with external validity, 
unless it is demonstrated that the study sample is indeed representative of the 
general population. However the very nature of the RCT, controlling variables will 
mean that the study sample is likely to be narrower in clinical presentation compared 
to a routine practice population.  They can be challenging to deliver, in terms of 
recruitment of participant numbers to ensure the study has enough power for valid 
results, and It may not be replicable in routine practice, through specific variables not 
able to be isolated, for example patients with co-morbidity.  There are other methods 
to evaluate and examine data within routine clinical practice, one of the most 
common criticisms of observational studies is that they risk bias with the over 
estimation of treatment effects and therefore are less valid, however one review 
found that “the results of  well-designed observational studies (with either a cohort or 
a case control design) do not systematically over-estimate the magnitude of the 
effects of treatment as compared with those in a randomised controlled trial on the 
same topic.”(37)  The benefits of observational studies are that they are more 
applicable to routine practice, as it demonstrates outcomes within settings with a 
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number of variables, and therefore could be viewed as more realistic. Given the 
context of this study taking place in routine practice it is absolutely valid to review 
studies whose methods may be more comparable, other than RCT’s.  
The Cochrane Handbook states “Review authors should consider how outcomes 
may be measured, both in terms of the type of scale likely to be used and the timing 
of measurement. Outcomes may be measured objectively (e.g. blood pressure, 
number of strokes) or subjectively as rated by a clinician, patient, or carer (e.g. 
disability scales). It may be important to specify whether measurement scales have 
been published or validated. When defining the timing of outcome measurement, 
authors may consider whether all time frames or only selected time-points will be 
included in the review.” (35)  
In the mental health field, outcome of intervention delivery may be multi -faceted, with 
observable, measurable aspects which may be open to interpretation, bias and 
confounding variables. For instance clinician’s observations and patient verbally 
reporting an improvement in symptoms are valid to those individuals, however 
subjective in terms of whether that demonstrates an intervention to be effective and 
generalizable to a wider population.  
The outcome of interest for this study is the effectiveness or the results of 
implementation of a particular service delivery design. Therefore literature of interest 
will be in the first instance systematic reviews and published RCT’s regarding the 
effectiveness of stepped care delivery of psychological therapy with anxiety and 
depression. “By providing a reliable synthesis of the available evidence on a given 
topic, systematic reviews adhere to the principle that science is cumulative and 
facilitate decisions considering all the evidence on the effect of an intervention”. (37) 
Secondly given that the method of this study is observational, any observational 
studies regarding the efficacy of stepped care were also included.  
3.4 Inclusion and exclusion criteria 
Using the PICO approach, studies included were those published in English, 
systematic reviews and meta-analyses, randomised controlled trials, and 
observational studies in routine practice. Participants were adults with mental health 
problems treated in a psychological therapy service, within a stepped care service 
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design. Models of service design were searched for using the following ‘stepped 
care’, ‘allocated care’, ‘matched care’, ‘collaborative care’, and ‘stratified care’ . The 
focus of studies included had to be regarding the effectiveness of the stepped care 
model.  
The Cochrane library search of systematic reviews 
anxiety or anxious "stepped care" or "collaborative care" or "stratified care" or 
"matched care" by record title. 
Table 1: Initial search inclusion criteria using a PICO approach 
 
 
Search terms Filters Limits Results
Manual 
Filter
Results Duplicates
Unique 
results
1994-2014, 
systematic 
reviews,
Depression, 
anxiety and 
neurosis group
(mental health) 
OR anx* OR 
depress* AND 
therap* AND 
(matched care) 
AND effect* OR 
impl*
119 3 3 0
(mental health) 
OR anx* OR 
depress* AND 
therap* AND 
(allocated care) 
AND effect* OR 
impl*
119 3 3 0
(mental health) 
OR anx* OR 
depress* AND 
therap* AND 
(stratified care) 
AND effect* OR 
impl*
119 3 3 0
(mental health) 
OR anx* OR 
depress* AND 
therap* AND 
(collaborative 
care) AND effect* 
OR impl*
130 3 3 0
3
(mental health) 
OR anx* OR 
depress* AND 
therap* AND 
(stepped care) 
AND effect* OR 
impl*
Title, 
abstract, 
keywords
119
By title and 
abstract 
using 
inclusion /  
exclusion 
criteria
3
38 
 
As well as systematic reviews searched for through the Cochrane database, several 
other established health databases, psycINFO, MEDLINE, CINHAL, and EMBASE 
were also searched using similar key terms, adjusting where necessary according to 
the specific coding nature of that database. (Table 1).  
The searches altogether returned 152 papers. Duplicates were removed, and the 
manual filter was applied. Through my professional qualification and experience 
working within the field I am aware that the research in the area of the effectiveness 
of psychotherapy with anxiety and depression is broad and extensive, and 
particularly rich in terms of evidence pertaining to Cognitive Behavioural Therapy. 
The study question does not relate to contrasting and comparing different types of 
therapies for mental health problems, and is beyond the limitations of this study to do 
justice to this topic. The question relates to the effectiveness of a particular service 
delivery model.  
There is a variety of definition and implementation of service delivery model in 
routine practice, the focus of this project is the exploration of definition of “stepped 
care” and its evidence of effective implementation in routine practice. Initial searches 
included collaborative care, and resulted in a number of trials, and one Cochrane 
systematic review (32) that focus specifically on the delivery of collaborative care. The 
literature regarding collaborative care was analysed briefly to ascertain its relevance 
to this study. There are a number of studies that focus on the delivery of 
collaborative care based on a psychotherapy model and Archer et al (30) demonstrate 
the effectiveness of collaborative care in improving Depression. One of the 
difficulties is that the collaborative care is often delivered within or around a stepped 
care model, therefore is it quite difficult in this case to identify either as a separate 
model of delivery. Whilst this is a similar case for stratified or matched care models 
i.e. services are likely to be describing their model of delivery as stepped care but 
more likely to be delivering  a combination of that and matched or stratified. As 
described previously to be able to differentiate between studies and identify those 
that are based on a psychotherapy stepped care model, and delivered within a 
threshold level of primary care is a systematic review in itself.   
Collaborative care is certainly a model that is well evidenced regarding depression, 
and there is certainly a need to increase and review the evidence for collaborative 
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care with LTC and mental health problems, and anxiety (30) but this is beyond the 
scope and specific focus of this study. 
Given its main focus is either at a secondary care threshold level or the physical 
problem is the identifier for this model of care, this legitimises collaborative care to 
be excluded from the main literature review for this study.  
Removing any results that covered collaborative care, adding together papers 
already obtained by the author prior to the commencement of this study, and 
subsequent papers published after the time of the initial database searches, brought 
the total meeting the criteria of the search question to 8 papers.  
Two of those are systematic reviews (38, 39) and between them included within the 
review a number of studies identified as relevant to this research question and 
included in the 8. (20, 33, 34, 40) Therefore to avoid duplication this study will not 
undertake an analysis of those papers but concentrate on the analysis of them within 
the systemic reviews. Richards & Borglin (34) was not included in the van Straten (39) 
review as it did not fit the criteria of being an RCT. The Richards et al (32) paper did 
not feature within the Firth (38) review, and it is not clear why given it is an 
observational study exploring the effectiveness of stepped care in routine practice, 
and the authors’ inclusion of other observational studies. The paper is highly relevant 
to this study; therefore it is included in the literature review. This then brings the total 
number of papers for the context of the specific question around effectiveness of 
stepped care service delivery, to 4, to be reviewed in the next chapter. 
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Figure 2: A search strategy diagram  
 
 
 
Records identified through 
database searching. 
(n=401) 
Additional records identified 
through other sources. 
(n=3) 
Records after duplicates 
recorded. 
(n=152) 
Records screened. 
(n=152) 
Records excluded. 
(n=144) 
Full text articles assessed for 
eligibility. 
(n=8) 
Full text articles excluded 
1 not RCT. 3 included in 
systematic reviews. 
(n=4) 
Studies included in qualitative 
synthesis. 
(n=4) 
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Chapter 4: Literature review findings 
 
The studies were reviewed using either the CASP cohort study checklist (41) or the 
PRISMA checklist for systematic reviews. (42)  
4.1 Delivering stepped care: an analysis of implementation in routine 
practice 
David A. Richards, Peter Bower , Christina Pagel, Alice Weaver, Martin Utley, John 
Cape, Steve Pilling,  Karina Lovell, Simon Gilbody,  Judy Leibowitz, Lilian Owens, 
Roger Paxton, Sue Hennessy, Angela Simpson , Steve Gallivan, David Tomson and  
Christos Vasilakis. (2012)(32) 
Findings 
Part of a larger project aiming to “develop a decision and modelling aid for services 
designing stepped care organisational systems.” , this is an observational study 
using data of patients in 4 different routine health settings operating stepped care 
models, with an analysis of the proportion of patients accessing treatment, at which 
‘step’ and the transitions between steps.  
The study found that the interpretation of the NICE guidelines for stepped care was 
implemented with large variation across all 4 sites, with a particular difference with 
the ratio of low or high intensity treatments received by differing proportions of 
patients across all the sites.  
Analysis 
The study positively met the criteria outlined in CASP for all 12 questions apart from 
question 6 regarding follow up of participants, which was not relevant in this 
instance. Consideration of quality, validity and bias of results and methodology as 
outlined in CASP are further outlined.  
The context and rationale for evidence based practice for psychological therapies 
with anxiety and depression is briefly acknowledged, and the authors highlight that 
the stepped care model within NICE guidelines was not based on the same rigorous 
evidence synthesis. Therefore this study poses the question regarding the evidence 
for stepped care aiming to answer the following questions:  
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“1. What different models of stepped care are implemented in practice? 
1. How do patients access and flow through the different models? 
2. What proportion of patients are managed at each step, and what proportion 
‘stepped up’?”  
The authors state that there was no analysis of outcomes, and acknowledge this is a 
limitation to the findings, however identify that outcome data across all sites was 
extremely limited, and not routinely collected by information systems or clinicians, 
which as the authors acknowledge is a great concern. Although the use of 
psychological measures is not the only way to assess presentation and progress, 
they can aid clinical judgement and decision making, and if tested as highly reliable 
and valid can give some objective perspective which is easier to quantify for 
research purposes.  
In the setup of this study, the authors were involved in a ‘consensus workshop’ in 
which they provided facilitation to the services to build their version of a stepped care 
approach. The authors state there was no influence regarding new service design, 
however the methodology of this is not outlined in detail, nor any mention of a 
qualitative study method which would discuss the concept of impartiality, or influence 
and whether there is such an occurrence through any interaction from the 
researchers regarding the service model design.  
Essentially the data regarding the patient care pathway flow is analysed, and the 4 
sites compared. The method of data analysis was using categorical data and 
continuous data as means, and standard deviations. (32) There were a large number 
of patient cases excluded from the results due to missing data, however throughput 
data of nearly 8000 cases was reported on.  The authors acknowledge that the time 
limitations of the project meant that there was no endpoint data, which is 
disappointing as there is a need to evidence the clinical effectiveness of a stepped 
care process. The population characteristics analysis shows one particular site 
ranking high on the Index of Multiple Deprivation, as there is no analysis of the 
clinical information it is not known whether the level of mental health problems differ 
from the other sites, which is possible given the evidence link between poverty and 
mental ill health. (43) 
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All four sites had different referral and assessment management systems, with 
different types of professionals assessing, all which potentially effects patient flow, 
and clinical decision making. Essentially the models of delivery were either stratified 
with a matched care/allocated system or stepped care. One site deployed a much 
larger amount of resource of experienced staff to assessment to support allocation to 
the ‘right’ treatment level, however this resulted in the service not being able to meet 
the demands at a high intensity level and therefore patients were shifted to low 
intensity interventions. It is disappointing that there are no clinical outcomes to 
compare all the sites, however in particular it would have been interesting to see the 
outcomes of those assessed as in need of high intensity, but treated with low 
intensity.  It is indicated in this study that a stratified (allocated) model of delivery 
appears more likely to have a large volume of patients allocated to high intensity 
treatment, and a stepped care model will likely have the inverse. The authors 
acknowledge the limitations of the study, particularly with regards to missing data 
and inability to analyse clinical outcomes.  There is a comment on the possibility of 
clinician bias, with “triage or assessment by a professionally qualified workforce may 
lead to more people receiving high intensity”, which then may then also be reinforced 
by service design and policy. The issue of heterogeneity of interpretation and 
implementation of stepped care is discussed and the authors highlight that the NICE 
guidelines do not provide a “formal blueprint for the organisation and delivery of 
services” which may contribute to the variability of stepped care definition and 
practice implementation.  
 
4.2 Service use, drop-out rate and clinical outcomes: A comparison 
between High and Low intensity treatments in an IAPT service 
Stella W.Y.Chan &  Malcolm Adams (2014) (44) 
Findings 
Using routine care data from an IAPT service, this is a small sample study 
comparing low and high intensity treatments, analysing outcomes and drop out rates.  
Using a between groups design, it takes a small sample of 100 cases from an 
original dataset of 15,082.  
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It finds that there is no difference between groups regarding dropout rate, a level of 
% difference between groups in terms of recovery rates – 50% high intensity, 55.3% 
low intensity, however no significant statistical difference.  
Analysis  
The study positively met the criteria outlined in CASP for all 12 questions apart from 
question 6 regarding follow up of participants, which was not relevant in this 
instance. Consideration of quality, validity and bias of results and methodology as 
outlined in CASP are further outlined.  
The study sets the scene of the national picture in terms of recovery rates averaging 
at 42% as reported by the “latest national evaluation study”. This the authors are 
referring to an evaluation of the first year of roll out published by NEPHO, 2010, and 
although the authors also acknowledge other studies that present variable recovery 
rates, it would have been useful to have comment on the potential variable that may 
affect recovery rates, such as different time frames of studies with different groups of 
staff that in later periods may have more experience. This study sample is drawn 
from a dataset covering a time period of nearly 3 years, which includes the first year 
of IAPT roll out where potentially a larger number of therapists were in training, and 
then in subsequent years may be more experienced. With 100 cases samples from a 
3 year timeframe, it would have been helpful if there was an explanation of the level 
of competency or experience of therapists delivering which may have an impact on 
outcomes.  
The study begins with a large dataset, 15,082 cases, which would be a healthy large 
number to analyse. Firstly the authors state that each client contact was recorded as 
a separate entry, which is true for most health databases, however they state this 
then gave 88,072 entries to analyse, which they state is too large and this is the 
rationale for a much smaller sample of 100 cases. It is difficult to understand this as 
data extraction regarding outcome and drop out could have been extracted through a 
cohort of cases which could have been on a case basis rather than individual clinical 
contact entry. This cohort could be smaller than the whole dataset, but larger than 
100 to ensure generalizability. The authors state that they arrived at the sample size 
using a general statistics principle; however “a formal power calculation was 
impossible due to the unavailability of relevant data in the existing literature.”  It is 
unclear as to what the authors are meaning here and an assumption can only be 
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made that they are referring to the fact that IAPT is relatively new, there isn’t enough 
studies, particularly randomised controlled trials with which to base a prediction of 
effect size. However there is an abundance of studies that explore the efficacy of 
CBT, and more lately low intensity interventions, both of which occur in this study 
therefore this information could have informed the consideration of a formal power 
calculation. 
Secondly the authors state that the intensity level of which cases received treatment 
was not explicit in the original dataset, and in order to remedy that they separated 
cases out into low and high intensity according to the pay band of the therapist 
delivering treatment. This is a reasonable step to take, however again it indicates 
potentially issues in the services clinical recording system design regarding input of 
information that can be collated. Both the issue of service system design and 
therefore data input accuracy and validity issue and the lack of formal power 
calculation weaken the results.  
The authors also go onto acknowledge limitations with the randomisation procedure 
where they did not control the higher probability of certain cases more likely to be 
selected through their greater number of contacts. Whilst more sessions of therapy 
does not necessarily mean a better outcome, the fact that this variable is not 
controlled means that the higher recovery rate may have been influenced by the 
number of treatment sessions.  
There are other variables that would have been useful to have explored. The authors 
explain the context of the service with the standard description of the IAPT criteria as 
generally those with mild to moderate symptoms of anxiety or depression, and 
operate a stepped care model, describing the usual definition of low intensity to the 
majority, with step up for those not making progress, and also the exception of those 
clinically judged to be more severe being offered a higher step in the first instance. 
The authors rationalise their purpose for this study from the findings in Gyani, 
Shafran, Layard and Clark (11) where it is suggested that “services that made better 
use of stepped care produced better outcomes, and further estimated that an 
improvement on the “step- up” rate could potentially increase the recovery rate to as 
high as 54%”, further stating that as there are large variability amongst the IAPT 
services reviewed here, it is important to research the differences between high and 
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low intensity treatments within the same service. This is worthy of exploration, which 
the study does, however the step-up issue is not explored fully. There is no 
explanation of the ratio of those receiving low intensity to those receiving high 
intensity in the first instance, so there is no way of knowing if indeed the majority of 
referrals to this service do in fact receive a low intensity intervention in the first 
instance, or whether this may be the broad description and expectation of the service 
however in reality severity of presentation and clinician interpretation may impact on 
the actual proportion receiving low or high interventions. As this is not discussed, 
appear to be considered or controlled in the methodology, this may also have an 
impact on the types of cases used study sample, and therefore may affect the 
results. As previously mentioned, the intensity of treatment received was not 
documented, nor was the ratio of step up from low to high, where longer dose of 
treatment is received and the presentation likely to be complex, and less likely to 
recover. The authors do discuss how this may have ‘dragged’ down the recovery 
rate in high intensity, stating that lack of ‘stepping up’ data meant an inab ility to test 
this possibility. The authors describe in their methodology how they use pay bands of 
clinician treating to differentiate cases into low and high intensity, therefore it should 
have been possible to undertake an analysis of sample groups clinical recording 
entries which could have given information about which type of clinician was treating 
each patient at the commencement and end of treatment, and where it differed this 
should be able to identify those cases that have stepped up.  
The authors describe a standard definition in IAPT of stepped care to indicate how 
cases are ‘allocated’ to each step, however there is no analysis of score by step, 
therefore it is not clear whether score severity correlates with this definition.   
What is really interesting, in light of the above is there is no difference in the two 
groups, low or high intensity with baseline scores for all cases. Therefore the 
reasons for allocation in the first instance to a high intensity treatment must be 
dependent on something other than scores, which are self-reporting and therefore an 
element of subjectivity, however other information and clinician judgement are the 
deciding mechanisms in the allocation of intensity of treatment, however these 
factors are not controlled in this study and therefore it is unknown whether those 
cases receiving low intensity treatment differed with complexity or co-morbidity which 
may impact on outcome of treatment.  
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An important summary of this study is that it found that high intensity deliver more 
treatment sessions, but the recovery rate is lower than those treated at low intensity, 
and yet there was no difference between the groups in the baseline psychological 
measures, questioning whether score severity can be an indicator of step intensity 
needed. The authors acknowledge this surprising finding and that it is possible that 
both groups could contain similar presentations, which could imply that “high 
intensity does not offer additional benefits.” Conversely it is also possible that 
although no difference in scores, clinical presentation was different and the high 
intensity group more complex and chronic. Further analysis of such would be useful.  
In summary, the results could be generalizable to the clinical population of IAPT and 
show some consistency with efficacy of step 2 interventions as demonstrated in 
other research. (26) However there are indications of possible issues with the service 
data collection design and the study methodology- some of which is acknowledged 
by the authors, which may question the reliability of the results.  
4.3 Stepped care treatment delivery for depression: a systematic review 
and meta-analysis 
A.van Straten, J. Hill, D.A. Richards, and P. Cuijpers. 2014 (39) 
Findings 
This is a robust review of 14 studies, (n=5194, 2560 in stepped care) of which 10 are 
used in a meta –analysis (n =4580, with n= 2243 in stepped care).  
7 studies are regarding the delivery of a collaborative care model, 6 studies are 
regarding an increasing intensity of stepped care with just 2 studies with progressive 
intensity of stepped care.  
The review finds that stepped care has a moderate effect on depression with the 
progressive intensity doing significantly worse.  
Analysis 
This systematic review positively met all the criteria of the PRISMA checklist apart 
from there was no information regarding any protocol and registration or funding.  
Whilst the methodology of this review is of high quality, the definition of stepped care 
for this review and therefore the inclusion criteria is by the authors’ 
acknowledgement arguably too wide and so it does raise issues regarding validity of 
comparison of studies with extreme heterogeneity of treatment delivery organisation.  
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However there is a dearth of studies regarding stepped care, and given the 
demonstrable difference with interpretation and implementation of stepped care in 
the previous study (32) of which one author is also involved in both studies, it is also 
an understandable point to include other treatment delivery systems such as 
collaborative care to compare a wider range of delivery systems.  
 
The validity was assessed using the Cochrane handbook criteria, and 2 reviewers 
undertook a quality assessment of each study independent of each other most 
studies were rated of good quality.  Publication bias was also tested, and none 
found. The meta-analysis included between-group effect sizes, and sensitivity 
analyses, where a study reported more than one outcome, effect sizes were also 
pooled, and heterogeneity tested.  
 
The authors define the inclusion criteria as quite wide ranging, covering adults, with 
a diagnosis or symptoms scoring above a threshold for depression, ‘stepped care’ as 
one of the trial groups, includes a psychological therapy, availability of more than 
one treatment that ‘step up’ based on ‘systematic clinical evaluation’ at a specific 
time point. It also included studies with physical and psychiatric co-morbidity.  This 
wide definition resulted in the inclusion of a number of IMPACT American trials, 
IMPACT being a model of delivery akin to collaborative care. The definition also 
included pharmacological treatment, and ‘step up’ was loosely defined as an 
adjustment in treatment. There was heterogeneity between studies regarding 
number of steps, types of treatments offered and length of intervention.  
 
The 7 collaborative care studies and one other, involving psychological treatment 
and anti-depressant medication had no progression of increasing therapeutic 
intensity, rather there were review points and treatment adjustment. Whilst the 
authors found that stepped care had a moderate effect on depression, the 2 
progressive stepped care studies demonstrated a worse effect than those without a 
clear intensity order. However the authors do acknowledge that with only 2 studies 
the results need to be treated cautiously, and perhaps consideration needs to be 
given to the fact that one of these studies was underpowered, (40) and the other relied 
in two levels on anti-depressants as well as a psychological talking therapy and 
results may be more reflective on the variability of effect of pharmacotherapy over 
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the long term if discontinued or not adhered to. (45) The study found that the stepped 
care 6- month effect size was similar to collaborative care as found in the Cochrane 
review. (30) 
 
The authors do acknowledge that their definition of stepped care is “debatable”. 
There is already a systemic review on collaborative care, (30) and therefore arguably 
no need for another. Although a more strict inclusion criterion would have resulted in 
a smaller systematic review, even this would have demonstrated a wide range of 
heterogeneity. As it is with the inclusion of collaborative care and also studies that 
include physical conditions, the heterogeneity is extreme, and arguably either 
weakens the findings, or demonstrates the perspective that stepped care definition is 
open to wide interpretation. They do suggest that more studies of ‘true’ stepped care 
need to be undertaken.  
 
The authors also reviewed the cost analyses where available, and found that there is 
an indication that stepped care interventions might be more cost effective, however 
there are still huge gaps in the evidence, recommending that stepped care and 
matched care, or high intensity only need comparison and cost effectiveness 
measured.  
 
4.4 The clinical effectiveness of stepped care systems for depression in 
working ages adults: A systematic review  
Nick Firth, Michael Barkham, Stephen Kellett. 2015. (38) 
Findings 
This systematic review analyses a total of 14 studies to evaluate the evidence of the 
effectiveness of a stepped care system for depression with adults.  
There are 9 randomised controlled studies, 1 quasi-randomised comparison study, 
and 3 uncontrolled prospective cohort studies. The number of patients per study 
range from 18-7859, (mdn = 430). 
Recovery rates for depression are between 50%-60% in stepped care, and 
“equivalence to usual care is suggested by comparison studies.”, however the 
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evidence in some studies suggesting the superiority of stepped care, the authors find 
to be inconclusive.  
Analysis 
This systematic review positively met all the criteria of the PRISMA checklist apart 
from there was no information regarding any protocol and registration or funding.  
The authors use a published quality checklist which is suitable for RCT’s and non-
randomised studies, they did not rate any of the studies as excellent, and found all 
the RCTs to be good quality, of the non-randomised studies two were found to be 
fair, and two poor quality. The authors discuss and critique the variety of quality, 
underpowered studies and missing data, lack of comparators, and variety in results 
reporting and acknowledge that this made “comparisons or meta-analysis more 
difficult.”  The authors also acknowledge that the inclusion of non-randomised 
controlled trials could be seen as inferior to a review of RCT’s only, however justify 
the inclusion “in order to gather a wide, evidence base and to enable to realities of 
clinical practice to be closely reflected.”   
The studies included are also those that focus on comorbidity with physical 
conditions, e.g depression and cancer or diabetes, and also use of 
pharmacotherapy.  
The authors differentiate service delivery models by defining stepped care models as 
intervention systems, and usual care or other care systems as comparison systems.  
The authors discuss the demographics of the study samples, mentioning 
employment rates being low in those reporting, acknowledging selection biases 
within the studies may have influenced this, and causal factors are also considered, 
e.g. co-morbid physical conditions, and socioeconomic factors. There are further 
variations between the studies regarding ethnicity and nationality and gender, i.e 
range for male participants between 0-56% between 13 studies.  
Clinically a variety of different diagnostic measures are used amongst the studies, 
but most are considered appropriate.  
Of particular interest is the analyses of two studies (20,34) that evaluate IAPT sites, 
the authors score these both fair in quality, however neither of these studies focus 
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specifically on the effectiveness of the stepped care system, although both are 
concerning the evaluation of IAPT pilot sites, where the stepped care system is 
assumed.  
Those studies that undertook follow-up demonstrated mixed results, with two 
demonstrating significance for stepped care at 6-18 months which then varies at 24 
months, however the van Straten et al’s study (33) did not have the power “detect the 
significance of trends in favour of stepped care that were observed.” 
Although the authors view the 11 studies that compare stepped care with other 
service models as “tests of the efficacy of stepped care”, there are some issues with 
the results in some, Seekles et al (40) is underpowered, this systematic review 
questions the results for depression with an 86% comorbidity rate, and it also has 
high attrition rates.  
Although the authors methodology is sound, and they acknowledge the issues 
regarding the variability of study methodology making a comparison and meta-
analysis difficult there is no discussion regarding the variability between all studies 
regarding patient complexity, and in particular the potential impact of co-morbidity on 
outcomes.  
Unsurprisingly the authors found the studies stepped care systems to be 
heterogeneous, with a variety in types of treatment and timing of step up, and 
clarification of rationale for step up. The authors also acknowledge the difficulty in 
understanding effect, as confounding factors of implementation could impact on 
effect, for instance with a mixed model delivery of collaborative and stepped care, is 
difficult to ascertain the effect attribution to each element.  
The author acknowledges limitations of the review from both a difficulty with the 
literature itself, and also some methodological weakness.  
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4.5 Summary of literature review 
The review of the literature finds stepped care to appear effective however there are 
methodological issues amongst the studies within the systematic reviews, and both 
find a wide range of heterogeneity regarding definition and implementation of 
stepped care, which further raises questions, and potentially weakens study results.  
The Richards et al (32) study is of particular relevance to this study, firstly with the 
methodology of an observational design, and secondly comparing four different sites 
defining and delivering their interpretation of stepped care. This is an important point, 
as it demonstrates the wide range of interpretation of the NICE guidelines, of which 
there is a commonality with all the studies within this review, and particularly 
regarding the heterogeneity of stepped care implementation.  
The Chan et al (44) study is included because of its attempt to compare two clear 
steps in an IAPT service, therefore comparable to this study site, and attempts to 
offer analysis of clinical effectiveness of a fundamental design of a stepped care 
system, rather than comparing to specific psychological treatments.  
As discussed there appears to be service data recording issues, a small sample 
(n=100) is used, and there are a number of confounding variables. One fundamental 
issue that impacts on the findings of this study is no explanation or consideration of 
ratio of step up, and it is not clear whether the service system is using a pure model 
of stepped care, or a matched care, or if the sample selection was a mixture or 
distinctly separate low and high? Whether if high they had previously received low 
intensity as this could impact on outcomes.  
The study does find proportionally in favour of low intensity treatment in terms of 
clinical outcomes, although there is no statistical difference. Due to the lack of clarity 
of model it is difficult to directly compare results to this study however some 
inferential observations can be made.  
The two systematic reviews have six studies in common, with all but two of these the 
focus is co-morbid depression with a physical condition. Methodological issues are 
found by both reviews, demonstrating the difficulty with measuring effectiveness of 
stepped care provision, even with randomised controlled trials. Both demonstrated a 
wide range of heterogeneity, which raises two possibilities, either the research 
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inclusion criteria were too wide, and this in itself widens the definition of stepped care 
or it demonstrates that the stepped care guidance or at least the interpretation of 
guidance implementation in routine practice is varied.  
Firth et al (38) discuss three key areas of heterogeneity, there is a large variation of 
sample demographics amongst the studies, “marked variation in the effectiveness of 
“usual” care”, and considerable variation between the stepped care systems 
themselves, all of which mean that comparison and demonstration of model 
effectiveness is difficult, which is the conclusion of both the systematic reviews, with 
the generalizability limited. (39) 
Both systematic reviews conclude that stepped care appears to be effective; 
however both raise issues regarding the comparators “usual care”. Firth et al (38) 
discuss lack of clarity as to whether usual care interventions are the same as those 
delivered in the stepped care systems, stating that it is unlikely, and therefore there 
is a possibility of effectiveness achieved through the treatment interventions 
themselves rather than the delivery model. Van Straten et al (39) discuss further, 
stating that four of the reviewed studies appear to have care as usual “probably more 
closely resembled ‘no care’.”, therefore demonstrating that stepped care was more 
effective than no care. This also supports Firth’s (38) notion that any effectiveness 
could be achieved through the actual treatments delivered rather than any influence 
of model delivery.  
At best the literature proposes that a stepped care model is effective, however it is 
not clear whether the model itself makes a difference or whether effectiveness is 
achieved through evidence based treatments alone, regardless of model delivery. 
Both systematic reviews recommend future research should compare stepped care 
to matched care, or against high intensity treatment, where the treatment is the same 
in different models. Furthermore the literature demonstrates variety of interpretation 
of what is stepped care, thus weakening any finding in support of stepped care as a 
delivery model, and as van Straten et al (39) recommend there is a need to further 
test the effectiveness of different variations of stepped care in terms of cost, 
acceptability and clinical outcomes.  
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Chapter 5: Specific study context 
 
Drawing the main points in previous sections together, psychotherapy is effective in 
treating anxiety and depression disorders, CBT in particular is recommended, 
however it is not superior to any other intervention, including low intensity 
treatments. There is an absence of clear evidence regarding the specifics of what 
best works for whom, which would be needed for the efficacy of a matched care 
model. The literature review finds that generally the model of stepped care is 
effective however implementation in practice and indeed in some studies show 
variation of definition of stepped care. Similarly guidelines appear to describe a 
mixed model of allocated/matched care and pure/progressive stepped care. 
Outstanding is a need to compare more specifically matched care and pure stepped 
care.  
This study aims to explore the question regarding effectiveness in routine practice of 
different models of stepped care and if a service design impacts on clinical 
outcomes.  
5.1 The study site 
The study site is a large IAPT service covering the areas of Durham and Darlington, 
a large geographical area combined of rural and suburban, small villages and larger 
towns, with both areas of affluence and deprivation. The Census 2011 population 
count for persons aged 16+ living in County Durham Darlington was: 510,615.  It is 
estimated that 65,561 of this population will have a mental health problem. The 
National Key Performance indicators for IAPT require IAPT sites to have 15% of the 
population with common mental health problems to enter treatment. (46) For the study 
site this is 9,834 per year.  
This study site was a ‘third wave’ site meaning it was part of year 3 of the national 
roll out of IAPT sites. This has meant the service has benefited from lessons learnt 
from previous waves, however has had shorter time to develop and embed as a new 
service before increases in national performance targets, such as the move  in 2013 
from 45% to 50% recovery rate key performance indicator.  This may have impacted 
on progress and target achievement of the service.  
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5.2 Author’s involvement 
The author is currently the Clinical Lead for the study site, and has also previously 
worked as a senior therapist in another IAPT site. The role of Clinical Lead is 
primarily to provide clinical governance, linked with improving clinical performance 
which includes exploring and implementing those evidenced based components 
which may improve a patients experience and ultimately clinical outcome. The author 
is also involved in a regional forum where learning and practice is shared between 
the IAPT services across the North East region. From personal observations it would 
appear that there is some variation across the North East of England regarding 
definition and implementation of stepped care, and it would therefore be reasonable 
to assume that this variation is replicated nationally.   
 
5.3 Staffing profile of service 
The study site was organised through a combination of configuration of the previous 
primary care mental health teams and recruitment on a large scale for trainees. 
Some of the previous primary care staff was trained as Psychological Wellbeing 
Practitioners, (PWPs) and high intensity therapists in the year prior to local roll out, to 
ensure there was a sufficient number of qualified therapists. None the less during the 
first year of operation, approximately two thirds of the workforce were in training, 
which naturally impacted on throughput and recovery rates, with trainees operating 
with lower caseloads due to university attendance and demands, and as learning 
how to delivery therapy, it is natural to expect that their recovery rates of their cases 
would improve over time alongside their competence levels. “The trainees’ 
knowledge of CBT, ability to conceptualize, and actual therapy skills significantly 
improved over time.” (47) The numbers of trainees within the workforce decreased 
over years 2 and 3, however year 2 saw some trainees taking longer to complete 
their training than was predicted. Subsequently the two local University training 
providers have lengthened their High Intensity training course from 12 to 18 months. 
Given the potential propensity of any improvement in clinical outcomes being 
affected by skill and competence development over time, this condition will need to 
be considered.  
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With a large service it is a natural occurrence to experience a turnover of staff, which 
did occur over the same time period. This could impact on turnover and outcomes 
with loss of skilled therapists, recruitment timescales causing reduced capacity, and 
replacement staff taking time to acclimatise to service culture and processes may 
affect the build-up of productivity. Replacement staff may not be at the same skill 
and competence level as their predecessor and again this may have an effect either 
way on productivity and outcomes. During the latter half of the 4 year time period 
analysed, the service undertook a staffing configuration. The workforce profile at 
commencement was 70% high intensity therapists and 30% low intensity as 
specified in the original service specification set out by commissioners. However with 
the volume of referrals at over 10,000 per year, and building waiting lists, the 
introduction of a progression model of stepped care re-emphasised the focus on step 
2 interventions. Shorter dosage lengths of treatment compared to High Intensity was 
hoped to increase the volume patients treated, would improve turnover and meant 
that more step 2 therapists were needed. The service therefore decided to not 
replace like for like, and as high intensity staff left they were replaced with low 
intensity workers. A further variation of this was that due to the difficulty in recruiting 
qualified PWPs and often vacancies being too far away from the university course 
commencement to recruit trainee PWPs, the service created Therapy Support 
Workers. (TSW) These posts are trained in house to deliver only screening and 
remote treatment interventions (Computerised Cognitive Behavioural Therapy 
CCBT, and Telephone Guided Self Help TGH). Both treatment interventions are 
standardised computer programmes or workbook module manual guided and the 
function of the worker is to provide support as the patient works through the 
intervention, and to risk assess each week. However the TSW posts were a new job 
description and competence level at recruitment was more or less similar to trainee 
PWPs, but without the support of University training in psychological interventions.  
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5.4 Performance management 
Historically mental health psychological therapy services have perhaps delivered 
therapy according to the individual clinicians training and experience, and 
understanding of evidence based practice informed by NICE guidelines. Increasingly 
there is a move towards a culture of evidenced based service delivery and cost 
effectiveness, meaning increased data collection analysis and monitoring, linked with 
funding arrangements. The national IAPT programme is possibly the largest reform 
of psychological therapy service delivery, and brought with it the change in culture 
where services are expected to demonstrate their effectiveness and are measured 
across a number of areas, as described previously. The KPI achievements of each 
IAPT service are published via a publicly accessed health database, the Health and 
Social Care Information Centre (HSCIC), and therefore this in itself is a performance 
management strategy using competition to influence potential improvement. “There 
is considerable evidence that the publication of provider performance measures 
leads to improved performance.” (48) Certainly it could be argued that some of the 
KPI’s place a perverse incentive to design systems a particular way or accept 
unsuitable patients to increase numbers. For instance, the definition of completed 
treatment is two or more sessions, a service could maximise its attainment of high 
numbers for this target by accepting unsuitable patients and ensuring they have 2 
sessions. The potential negative consequence of this is that it takes up unnecessary 
resources and may reduce service capability of achieving the target for proportion 
recovered. Perhaps one of the more fundamental changes that brought performance 
measurement more to the forefront for the clinician was the requirement within IAPT 
to collect psychological measures every single session. Previously, psychological 
measures were traditionally collected by the clinician at the beginning, middle and 
end of therapy. Unfortunately when trying to monitor effectiveness, this would have 
resulted in a large amount of incomplete data, as it is fairly common that patients do 
not necessarily receive the total dosage of treatment that is recommended by NICE, 
with patients not attending a last session. Administering measures every session 
means that this data is collected regardless of when or how the treatment ends.  
Anecdotally, clinicians in this service initially were concerned that administering 
measures every session would be detrimental for treatment, the patient would be 
reluctant to complete so frequently, and would perhaps refuse. In reality this has not 
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been the case, with the vast majority of patients happy to complete every session 
when it is explained that this is part of the treatment, and can help both clinician and 
patient to track progress. The service began to develop and implement performance 
management strategies. This began with explaining and showing the information 
about the KPI’s with all staff, to encourage understanding and dialogue in team 
meetings about the service performance and how clinical delivery was linked with 
achieving targets. This strategy was informed by the principle of target achievement 
is everyone’s responsibility. Alongside the KPI reports, using the electronic 
database, the service developed a number of throughput and outcome monitoring 
reports, in the form of scorecards for both of teams within the service and of 
individual clinician. These reports formed a framework of performance management, 
which set out the frequency of reports, how they were to be used, and also the 
benchmark of minimum standards regarding throughput, efficiency, engagement and 
outcomes that individuals and the whole service needed to achieve, in order to 
maximise the ability to meet the KPIs. One of the main aspects was that each 
clinician would receive their monthly scorecard, showing them their months 
performance in terms of efficiency, throughput, engagement and outcomes, and that 
this would be discussed with their team manager in supervision, with the aim that 
this would encourage personal ownership of performance, reflection and a proactive 
attitude to engaging in improving where needed or maintaining good performance. 
“Individuals will respond to performance measures in ways that maximise their own 
utility or benefit.” (49) So the values that are triggered to improve performance may be 
different with each member of staff, for instance a more altruistic therapist may be 
motivated through the goal of seeing patients recover, whilst some may be more 
motivated through competition with other colleagues.  Similarly to the reaction of 
clinicians to the introduction of the progression stepped care model, many clinicians 
initially found this performance management culture new and different, and for some 
perhaps challenging. The emphasis of performance management strategies began 
to occur towards the end of the first year of delivery, and steadily increased to the 
point the scorecards given to individual therapists by the end of year 4. Whilst this 
can be seen as developing at the same time as the change in model delivery, they 
evolved over time rather than being a whole set performance management 
strategies introduced at a specific time. This makes it extremely difficult to control as 
a variable and measure the impact. Equally there is little research that explores the 
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effectiveness of such within the health care field, “the kind of academic rigour that 
has been applied to evaluation of performance management in the training field has 
not yet occurred in health.” (49) Therefore it is difficult with no benchmark to even 
estimate the potential influence of performance management on outcomes. Given 
the likelihood of performance management strategies having negative or no impact 
for some therapist’s behaviour and outputs, it could be argued that these would 
balance out any potential positive effect. Therefore although possible, it is likely at 
best performance management strategies would have an extremely small direct 
causality on any improving rate of clinical recovery in this study site.  
5.5 Delivery of stepped care – service variation of model 
There are a number of variations of phrase that describe models of stepped care in 
the literature, stratified, matched/ allocated and stepped, or progression. As 
described previously, for the purposes of this study I will define an allocated model 
as that which allocates a particular treatment /step based on the assessment of the 
patient’s complexity and severity, including psychological measure scores. A 
progression model is one in which a patient will be allocated onto the lowest 
treatment/step and ‘progress’ upwards to receive more intensive treatments 
depending on need and lack of significant improvement/recovery. Locally, within this 
study site the ‘progression model’ of stepped care means most patients receive a 
step 2 intervention as their first part of treatment, regardless of severity or 
complexity. If at completion of this step 2 treatment the patients presentation 
warrants further treatment they are then stepped up to the most appropriate type of 
therapy the service offers, or referred on to different services.  
The study site began operation in its first year with an allocated model. However 
began the introduction to a progression model during the latter of year 2. Initially this 
was to pragmatically address unacceptable waiting times, an underuse of step 2 
practitioners, and to put into practice the notion that it was clinically better and safer 
to offer patients some initial generic treatment that may help to reduce and stabilise 
symptoms., rather than complex patients sit on a waiting list for some length of time 
with no intervention and their presentation possibly worsening. Further benefits were 
to identify and manage any risk at the earliest point. 
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Cost effectiveness is an increasingly important issue in the delivery of psychological 
service, and as described previously one of the compelling arguments supporting the 
IAPT model is the projected zero cost due to the eventual reduction of welfare 
provision through the improvement of mental health and the subsequent increase of 
people entering into paid employment. (3) 
Increasing the use of step 2 interventions to treat more patients is inevitably more 
cost effective in comparison to the equivalent use of step 3 due to the difference in 
the pay scales of low and high intensity staff respectively, commencing on above 
£21,000 for bottom band 5, and up to £41,000 for top of band 7 for qualified staff on 
NHS bandings (Agenda for Change bandings 2014. (www.nhscareers.nhs.uk)). 
Added to the lower salary cost issue, by the nature of the difference between the 
dosage each intervention offers,  4-8 low intensity compared to 12-16 high intensity, 
resulting in higher volume and shorter throughput, means that the cost of delivery is 
further reduced proportionally for numbers of patients receiving step 2 interventions. 
However cost effectiveness should not be at the detriment of clinical outcomes, and 
therefore if on balance low intensity interventions can be compared and achieve 
similar clinical outcomes to more traditional high intensity interventions, with the 
same type of patients, then the cost effectiveness consideration becomes more 
valid.  
Service model change was introduced through initial meetings with staff, to discuss 
the problems with underuse of step 2, and a large waiting list at step 3. It was here 
that the majority of staff expressed the belief that where they perceived patients to 
have a more complex presentation, the higher the scores on the psychological 
measures, those patients should be matched to a step 3 high intensity treatment. 
Staff understood the concern regarding leaving people on a waiting list with no 
treatment at all, and understood the rationale of offering people some treatment 
quickly may be better than nothing at all. The pure definition of stepped care was 
explained, and the service model introduced where patients would receive a brief 
step 2 low intensity intervention in the first instance, and if they had not recovered at 
the end then they would be stepped up to high intensity treatment. The focus of this 
was not about treating complexity and severity with step 2 interventions, more that 
they would be offered as the first part of a package of treatment, and recovery from 
them alone would be a positive consequence if it was achieved.  The change from a 
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more traditional allocated stepped care model to the progression model was a 
culture shift for staff within the service, which appeared difficult for some. The 
rationale was discussed in several staff meetings, and operational policies and 
procedures amended to promote adherence to the changed model delivery.  
The study site operates through two main hubs, where referrals, triage and 
telephone assessments occur. Although the service operates with standardised 
policies and systems across both hubs, observations and discussions with staff 
indicated that there appeared a difference in culture, clinical decision making, and 
mostly a continuation in one hub area of the allocated model, rather than 
progression, despite a service directive to operate a progression model. This meant 
proportionally more patients were being allocated straight to step 3 from assessment 
rather than step 2. The rationale anecdotally given by individual staff and through 
discussions in team meetings were that the more complex and severe the patients 
presentation, the more likely they would be allocated straight to step 3, despite a 
much longer waiting list. There was a consistent belief expressed that only a high 
intensity therapist with their qualification and experience would be able to achieve a 
positive outcome with complex and severe presentations.  
However it was observed that in the hub where the progression model was operating 
more consistently, (hub A) waiting times were decreasing, as more patients were 
being seen, and monthly recovery rates were consistently improving.  
Hub A also received more robust performance management of staff in comparison to 
the other, and therefore it could be speculated that the increase in recovery rates 
could be due to performance management, or the use of the progression model or a 
combination of both. Although there were different starting points to these service 
operational delivery factors, the use of the progression model took time to fully 
embed in hub A, and at this point both this and the performance management aspect 
were in operation, therefore It would be useful to know what the impact on clinical 
outcomes would be without one of these factors.  
In the second hub (hub B) both the progression model and the performance 
management strategies took much longer to embed, and different starting points for 
both factors, however at the end of year 3 performance management strategies were 
also not as fully embedded as in hub A. this provides an opportunity to undertake a 
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comparative analysis with the data, raising a question as to whether hub A ’s 
outcomes would have been similar to hub B if the two factors were in the same stage 
of development, and indeed provides some useful information in relation to the 
research questions.   
5.6 Patient presentation 
IAPT was expected to improve access to a talking therapy for those patients with 
mild to moderate presentations, previously thought to been managed at a GP level 
through medication or not accessing any help. Through the abili ty to self-refer, it was 
hoped that IAPT would encourage those who didn’t want to speak to their GP to 
access a service. Through the collection of demographic information, and self-
reporting scores on psychological measures, there is now a large data set of a 
number of years locally and nationally which is used to report on the key 
performance measures, and attainment of national targets.  Locally within this study 
site patients aged 16+ are referred or self-refer to this IAPT service who have a 
common mental health problem – anxiety or depression disorders, are not acutely at 
risk to themselves or others, and not in need of care co-ordination.   
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Chapter 6: Methodology 
 
Comparison of progression and allocated service delivery models for adults 
with common mental health problems in a North East IAPT service.  
The Project aim was to explore the impact on clinical outcomes moving from one 
service delivery model (allocated) to another (progression) and therefore there were 
two main research questions for this study. 
6.1 Research questions 
1. Is there a relationship between outcomes and service delivery model?  
2. How does a service model impact on outcomes for severe and complex 
presentations?  
With several sub questions that would inform the findings of the main questions: 
 
-Is there a significant association between the outcomes on PHQ-9 and the stepped 
approach (allocated or progression model)? 
-Is there a significant association between the outcomes on GAD 7 and the stepped 
approach (allocated or progression model)? 
-Is there a significant association between the outcomes on PHQ-9 and any of the 
baseline factors such as age, gender, employment, and disability? 
-Is there a significant association between the outcomes on GAD 7 and any of the 
baseline factors such as age, gender, employment and disability?  
6.2 Ethics 
A study proposal outlining the methodology, and that the retrospective data would be 
anonymised at source. Was submitted to Durham University ethics committee and 
Tees Esk and Wear Valley mental health trust Research and Development 
Department (R&D) for approval, discussed at the Trust’s Quality Assurance group, 
and was subsequently agreed by all.  
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6.3 Background data preparation 
The study site uses an N3 secure internet supported clinical database called IAPTus. 
It is a bespoke system that is designed specifically for IAPT services, with the 
background reporting set up to meet the national key performance indicators, 
therefore providing some level of consistency in nationally reported data. At a local 
level it is also bespoke with the system set up visually to replicate the care pathways 
and the patient journey through the organisation. It is designed to allow staff to input 
narrative clinical recording of each treatment session, supervision sessions, as well 
as psychological measures and the demographic information about patients.  
At the study site, the service routinely collects and stores the psychological 
measures information, patient demographics and recording of clinical notes on a 
secure electronic data base. This is part of the IAPT national delivery and evaluation 
of performance against key performance indicators. Therefore 4 years of data exists 
already within the study site, with high levels of completion for severity ratings and 
outcomes which are linked to key performance indicators for the service.  The 
psychological measures are taken at every therapy session. (22) 
6.4 Data Description 
The data used in this project was a sample of the routine data collected by the 
service as described above.  
The first and last PHQ9 and GAD 7 scores of each patient whom entered and 
completed treatment within a 4 year timescale were extracted. Completed treatment 
was defined in the same way as the National IAPT KPI (patients who have received 
2 treatment sessions or more) rather than the discharge reasons as defined by 
individual therapists, which may vary the numbers depending on definitions used.  
The patients and their first and last scores will be separated into bands of severity as 
defined by the national IAPT Data Handbook. (22)  
Information can be collated and extracted from IAPTus either in raw data form to 
transpose onto excel or through a number of mandated and self-customised reports. 
As well as the data returns for the national reports on the key performance 
indicators, the service has a performance management framework which regularly 
analyses several reports to aid service and individual staff improvement. This service 
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information had not been analysed statistically prior, in the manner in which this 
study set out to do.  
The service began live operation on 18/10/210. For the purposes of this study raw 
data over a four year period (Nov 1st 2010-31st October 2014) were extracted from 
IAPTus, this was done through a serious of steps given the size of the dataset and 
the nature of some of the extraction has to be done separately. The service received 
10, 313 referrals in year 1, steadily rising to 11,573 in year 4. This resulted in 43,464 
patient referred and details recorded on the clinical database over the designated 
time period. 
Table 2: Referrals per year into service 
 
 
Patients that had completed a treatment with this time period were then selected. 
The definition of completed treatment used for initial data extraction was the same as 
the national KPI’s, that where a patient has received two or more treatment sessions. 
Whilst there may be some question regarding the validity of the treatment that is only 
two sessions, the actual numbers of patients this applies to is predicted to be 
relatively small, and those receiving a low intensity intervention which is 
predominately psycho-education in nature may only need this level. A further aspect 
Year One Year Two Year Three Year Four
Referrals 10313 10347 11231 11573
Dropped Out Prior to Screening 2548 2505 1987 1844
Non Engagement 2017 2099 1554 1413
Declined Treatment 84 95 148 131
Not Suitable for Service 253 203 228 263
Referred On 194 108 57 37
Dropped Out at Screening 1428 1615 1957 2002
Non Engagement 533 638 799 820
Declined Treatment 232 280 364 404
Not Suitable for Service 316 316 386 366
Referred On 347 381 408 412
Dropped Out Prior to Treatment 1189 1702 1103 1053
Dropped Out After One Session 1128 1531 1153 1327
Completed Treatment 1893 4291 5394 5145
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to the validity of using the KPI definition of completed treatment is that the results of 
this study can be compared to current and future national IAPT data, and other 
studies of IAPT sites.  
The number of patients selected using the completed treatment KPI, and therefore 
the data set for this study is 16,723.  
Demographic data for these patients were extracted, alongside  the disorder 
presented at referral point, what step they entered and left treatment, the 
geographical locality area within the service patch the patients GP is (then grouped 
into the 2 hubs), number of sessions and first and last outcome measures.  
Where possible and appropriate, numerical information was also grouped, for 
instance age was grouped into government statistics age bandings, and the 
psychological measures PHQ9 and GAD7 scores were grouped into the pre-defined 
bandings of presentation severity according to score. (22)  
Data from a third measure, the work and social adjustment scale (WSAS) which 
reports on patient perception of how their current problems affect their functioning in 
several areas was also extracted to provide further outcome commentary.  
The outcome information was collated in several ways; actual total score, caseness 
(first treatment), below caseness (last treatment), recovery, and reliable 
improvement, reliable deterioration and no improvement. The definition of recovery is 
through the use of particular self-reporting psychological scales. All IAPT sites are 
required to use these.  
6.5 Psychological measures 
The PHQ-9 is a nine question scale that measures depression symptoms frequency 
scoring from 0, “not at all bothered by the problem”, to 27 “bothered nearly every 
day”. The reliability and validity of The PHQ-9 in terms of measuring depression is 
good. (23) The GAD-7 is a seven question scale that measures the frequency of 
anxiety symptoms scoring from 0-21. The reliability and validity of the GAD-7 in 
terms of measuring general anxiety symptoms is good, and satisfactory with more 
specific disorders such as social phobia, or obsessive compulsive disorder. (22,24) The 
scales are used in every clinical session and the scores at the first and last sessions 
are used to measure recovery. IAPT data returns for the KPIs stipulate that recovery 
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is defined as patients scoring above clinical caseness at first session on at least one 
measure, and below caseness on both measures at the last session to count as 
recovered. (caseness = 10 on PHQ9, 8 on GAD7). Reliable improvement is defined 
as a reduction on PHQ-9 as equal to six points or more, and equal to 4 points or 
more on the GAD-7. (22,23,24) The WSAS is a five item questionnaire which measures 
how much the mental health problem (anxiety or depression) impacts in areas of life; 
work, home management, close relationships, private leisure and social leisure 
through a rating scale of 0-8, measuring the impairment in that area. 0 equals no 
impairment and 8 indicate very severe impairment. The total score measures overall 
functional impairment, with 0-10 showing subclinical impairment, 10-20 functional 
impairment; 20-30 moderate impairment and 30+ severe impairment. (22, 50) The 
WSAS results are only analysed in this study within the descriptive analysis, and not 
included within the further statistical tests as it is not used within the recovery 
outcome calculations within IAPT.  
6.6 Cohort design 
Within routine practice it is not often or practical to set up a randomised controlled 
study of types of service design and delivery. This study site provides a unique 
opportunity to observe the impact of moving from one delivery model to another. This 
study used the method of an observational cohort design, with retrospective data 
taken from routine practice in an IAPT site. Given the nature of the question related 
to comparing slightly different service delivery designs it would have been extremely 
difficult to undertake an RCT, with regards to size, commissioning arrangements, to 
name but a couple of aspects. As described in section 5.5, the pragmatic decision to 
change and improve service efficiency and organise a system so that it delivered a 
more pure version of stepped care provided the opportunity to explore and compare 
the outcomes of each method of delivery.  
As described section 5.5 the service changed from a more allocated model to a 
progression stepped care model approximately 18 months from the commencement 
of the IAPT service. Although procedurally was implemented and communicated to 
staff at this point, it is recognised that this took time to take effect, and there was a 
need for several methods of communication to ensure this was fully implemented. 
Also, treatment lifespan can take on average 6 months at step 3 or high intensity, 
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therefore patients allocated straight to treatment at step 3 at the 18 month mark of 
service existence, may not be completed treatment until near the 2 year mark.  For 
these reasons it is arguably acceptable to separate the cohort by the two year mark, 
taking years 1 and 2 as the allocated model cohort, or the baseline comparison 
measure, and years 3 and 4 as the progression cohort, or the experimental group.  
However one of the hub areas did not fully adopt the progression model for another 
year, so a further method of defining the cohorts and undertaking analysis of each to 
compare with the first method is to separate using the North and South hubs. As 
described earlier, the South hub took approximately a further year to fully implement 
the progression model, and therefore comparing by area, would be interesting to see 
if there is any difference in the outcomes of each area, and also compared to the first 
cohort design.  
One of the fundamental concerns from clinicians regarding the progression model is 
that patients with severe presentations would not improve without receiving a high 
intensity intervention from the outset. By comparing the outcomes of those scoring 
moderate to severe at entry point in the allocated model to the progression model 
will provide some observation of service design on outcome effect. Therefore to 
explore the above described issues, cohorts were designed as shown in the 
following table:  
Table 3: Cohorts as defined by service delivery 
 
 
Whole service All 4 
years data
Years 1 & 2 Years 3 & 4
North Years 1 & 2 Years 3 & 4
south Years 1, 2, 3 Year 4
Sensitivity group 
(from whole service)
Year 2 Year 4
Cohorts
Allocated 
delivery
Progression 
delivery
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Lastly a further cohort was isolated from years 2 and 4 to test the relationship 
between severity of baseline scores and outcomes. The participants scoring 
moderate to severe on both psychological measures in each year were grouped.  
6.7 Statistical analysis 
SPSS version 20 was used for all statistical analysis.  
To answer the research questions initial descriptive analyses was undertaken, cross 
tabulations and chi square tests undertaken to explore the relationship between 
certain factors and the outcomes. Logistical regression was then undertaken to 
further analyse the predictive effect of certain factors on outcomes.  
Firstly a descriptive analysis of the outcomes was performed by calculating 
percentages of patients at each level of the outcome by year and first/last outcome. 
Basic description of the outcomes and age were based on mean plus standard 
deviation and median plus interquartile.  Cross tabulations and chi square were used 
to explore associations with baseline factors a series of tests on each cohort 
investigating the relationship between model and outcome, and also controlling 
baseline variables, gender, ethnicity, disability and employment status.  
 
The value of p is set at 0.05 in terms of significance for all tests. The Hosmer- 
Lemeshow goodness of fit test is used to test model fit in logistic regression as 
SPSS does not give any other alternative. (51) 
 
Primary analysis included a sub cohort isolating the participants who scored 
moderate to severe at entry and their outcomes, by service model. Secondary 
analyses of the same tests for were performed on further sub-cohorts as a sensitivity 
analysis. Testing years 2 and 4 only, was undertaken to remove any impact and 
variability on data output of the practical issues around first year system set up and 
the effect of adjusted and improved procedures regarding clinical database input. 
Year 3 was removed because of any potential effect of unclear model delivery 
across the whole data set due to the lower adoption of the progression model in the 
South (hub b).   
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Regression is a statistical technique used to predict or explain the relationship 
between independent variables and the outcome variable. It essentially creates an 
estimation of how a set of predictors (independent variables) affect an outcome 
(dependent variable), and through correlation can show the strength and direction of 
the association between one variable and another. Given the change from one 
delivery model to another was completed over a time period, the sensitivity cohort 
contains ‘clean’ data in terms of model delivery. Therefore logistical regression was 
used with this cohort to explore the relationship with model type, (allocated or 
progression), baseline factors, (gender, disability, employment and age), discharge 
reasons and first psychological scores (PHQ9, GAD7) on likelihood of outcome. 
(Recovery, reliable improvement, no change. reliable deterioration). The dependent 
variable – recovery outcome was turned into a binary variable, so the main logistical 
regression was recovered versus non-recovered.  
 
Regressions were performed on cohorts of model type, those patients who had been 
treated in the allocated, and those treated in progression to explore the predictive 
effect of baseline factors, discharge reasons and first scores, and also the cohort of 
the sensitivity analysis group, (years 2 & 4), exploring the relationship between 
outcomes and model type, baseline factors, discharge reasons and first scores.  
Further regressions were used on cohorts of each psychological measure’s initial 
score severity group, to explore the relationship between outcomes and model type, 
baseline factors and discharge reasons, and also included the other psychological 
measures initial scores.  
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Chapter 7: Results 
 
7.1 Descriptive analysis 
The participant dataset consisted of 16,723 patients referred and completed 
treatment as described above. The demographic data was analysed by the 
respective cohorts, there was no overall discernible difference of participant 
characteristics by cohort therefore in general the descriptive analysis does not 
distinguish by cohort, but any difference is noted below. (Appendices 3&4) 
Participants at entry level and steps 
Where participants enter treatment demonstrably changes as the years progress, 
and as the progression model is implemented, there is an observable increase in 
numbers that enter step 2 initially, rising from 54% in year 1, to 88% by year 4.  
 Table 4: Steps at first session 
 
Conversely there is a decrease in numbers entering straight into high intensity 
treatment, where although the number completing treatment is hugely different 
between years 1 and 4, the number entering straight into high intensity treatment in 
year 4 falls to below that of year 1. Proportionally to the total number of participants, 
each year, the difference is considerable, with 29.5% in year 1, enter step 3 initially, 
and by year 4 it is 7.6%.  
 
 
 
Low 
Intensity
1020 53.90% 2993 69.80% 4207 78.00% 4535 88.10% 12755 76.30%
High 
Intensity
559 29.50% 992 23.10% 818 15.20% 392 7.60% 2761 16.50%
Not Stated 314 16.60% 306 7.10% 369 6.80% 218 4.20% 1207 7.20%
Total 1893 11.30% 4291 25.70% 5394 32.30% 5145 30.80% 16723 100.00%
Year Three Year Four TotalYear One Year Two
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Figure 3: Step intensity at first session 
 
Distribution of participants by entry scores  
Analysis of the entry scores across the years (Appendix 5) indicates that apart from 
year one, severity of score distribution remains fairly static within the groups. There 
is no difference in the mean and standard deviation (SD) of the scores for years 2, 3, 
& 4.  
Table 5: Entry score analysis 
 
From year 2 onwards a mean of 59.1% of participants score moderate to severe on 
PHQ9, and a mean of 52% score severe on GAD7, with functioning as measured on 
WSAS presenting a similar picture.  
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
Year One Year Two Year Three Year Four
Low Intensity High Intensity
Measure 
range
Mean SD Median IQR
PHQ9 0-27 15.4 6.3 16 9
GAD7 0-21 13.9 5.1 15 8
WSAS 0-40 19.8 10.4 20 14
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Figure 4: Scores at first session 
 
Referred problem  
A consistent pattern was observed across years 1 to 4 with the presentations of 
Depression, Generalised anxiety disorder (GAD), or mixed Anxiety and Depression. 
Depressive episode is consistent across the years with a 23% average. Other 
presentations occurred in much smaller numbers, and are consistent across the 
years with some minor fluctuations.  
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Figure 5: Referrals by disorder 
With GAD there is a decrease in years 3 & 4, of 8% and 14% from years 2, 
conversely there is an increase for mixed anxiety and depression from years 1 – 
26.8% to 39.6 % in years 4. There are some notable differences in proportion of the 
main 3 categories within the geographical or service model cohorts.  In terms of 
entry scores norm and range, the only outliers are the comorbid with alcohol scoring 
highest on PHQ9, and specific phobias scoring lowest on GAD7 and WSAS, which is 
not unexpected as it is likely that the participants will be managing their anxiety 
through avoidance of the specific trigger of that phobia. However this data should be 
treated with caution given the decision regarding which label the ‘problem’ fits is 
based on a varied level of information and not always at the same stage in the 
pathway, and therefore no further analysis was undertaken on the referred problem 
due to the question regarding validity. 
Ethnicity  
A descriptive analysis of participants demographics (appendix 3) show that ethnicity 
is predominantly White British, cohort comparison does show a difference in % 
reported depending on model however this will be due to improved reporting in later 
years and therefore is not considered to necessarily show an increase in other ethnic 
groups given the extremely low numbers or zero in categories other than White 
British. (Appendix 4). There are some marginal differences in norms of entry scores 
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for different ethnic origin, however of particular note is how the White and Asian 
group score much lower than others across both PHQ9 and GAD7 but not WSAS, 
and the white and black African, any other mixed background and African all score 
much higher on PHQ9, less so on WSAS, and the only group with difference in 
GAD7 is the African scoring higher, and Caribbean scoring lower.  
 
 
Figure 6: Ethnicity and initial scores boxplots 
 
However numbers are very small in each of the mentioned categories and therefore 
cannot be generalised necessarily to that category population. No further tests were 
performed using the category of Ethnicity, as there would be no statistical validity.  
Gender  
The ratio of gender is consistent across all 4 years, even with a rise in referral and 
completed treatment numbers, with 36 -37% male, and 61-63% female. There is no 
gender difference in the norm of entry score. (Appendix 3). 
Disability  
There is some small variation of around 1% of those disabled in the cohort 
comparison; all cohorts show there are more participants who have a disability in the 
progression model. There is no difference with disability and GAD7 scores, but some 
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difference with PHQ9 and WSAS, where those registered as not disabled entry 
scores norm are slightly lower.  (Appendices 4, 24) 
Age  
There is a similar consistency of age across the years, with most participants falling 
within one of , the 3 middle age bands – 25-34, 35-44, and 45-54, and distribution 
across these quite even, There are 2 notable exceptions, a decrease of 3% in year 4 
in the age band 55-64, of which there is no obvious explanation, and there is a rise in 
the participant numbers across the age band 18-24 in years 3 and 4, by 3 % each 
year.  
 
Figure 7: Referrals by age 
 
 
The interquartile range is 21, with a mean age of 42.3. Standard deviation (SD) is 
13.9, which further corroborates the age distribution.   
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Table 6: Age distribution 
 
There are clear outliers with the whole group with the age groupings 16-17, and 85-
94 in terms of PHQ9 scores with the range and the norm in the latter age bands 
showing as considerably less than middle age bands. However numbers are small, 
16-17 n=3, 85-94 n=35, and therefore not necessarily representative.  
 
Figure 8: Age and PHQ initial scores 
Comparing this to the other psychological measures, the score /age norm pattern on 
the WSAS appears similar to the PHQ9, with a drop in the norm of entry scores 
measuring functioning in the latter age bands; the range for the upper age bands 
remains similar to others. However the anxiety norm on GAD 7 remains evenly 
distributed, with demonstrably smaller range in scores in the age groups 16-17, and 
85+, it implies a lower severity of depression and better perceived functioning in 
older people. However again numbers are small, and may be different if there were 
more participants within these age groups, and should be treated with caution. 
(Appendix 23). 
 
 
Mean SD Median IQR
Age 42.3 13.9 42 21
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Employment 
Employment status no real difference with first score norms, apart from the retired 
group which scores remarkably lower, corresponding with the age distribution. There 
are two distinct groups where the scores in each of this group are similar. The first 
group contains employed, students, homemaker and retired, and the second group 
unemployed, sick, not claiming benefits and not working and voluntary work. The 
participants scores across the categories in the first group score lower than the 
second for PHQ9, implying that the second group experience more severe 
depression. (Appendix 26). 
Outcomes 
The spread of participants by score was calculated with the median and interquartile 
range for entry and outcome scores, the difference can be observed in figure 9, with 
a median outcome below caseness on both PHQ9 and GAD7 measures. (Appendix 
6).  
 
Figure 9: Range of scores between first and last treatment session  
 
In terms of last scores with demographic categorical factors there was no difference 
for norm distribution for gender, and both measures and both norms achieved below 
caseness. In terms of disability, non-disabled distributed with a norm below 
caseness for both PHQ9 and GAD7, was on the cut-off line for disabled with Gad7 
and was above caseness for disabled with PHQ9, so although the norm on last 
PHQ First PHQ Last GAD First GAD Last W&SAS First W&SAS Last
IQR1 11.5 2.5 11 2 13 4
Median 16 8.0 15 7 20 12
IQR3 20.5 13.5 19 13 27 20
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score for those registered disabled is higher than those not disabled, the norm does 
show a good drop in outcome scores compared to initial. For those employed, 
students, homemaker, no benefits or not working, or retired the norm is below 
caseness on PHQ9 and GAD7. For those unemployed, sick or disabled or in 
voluntary work, the norm for both PHQ9 and GAD7 was not below caseness in 
outcome scores. Ethnic groups that did not achieve norm below caseness were any 
other mixed, white and black Asian, African. On phq9. For gad 7 those not achieving 
a norm below caseness were African, any other mixed, White and black African, 
Caribbean, with White and Asian and Chinese on borderline. However as described 
previously, numbers are so low that this result should not be treated as 
generalizable. The distribution of last scores by age on both PHQ9 and GAD7 show 
that the norm falls below caseness for all age groups, with  particularly lower scores 
in the older age groups (65+), following the pattern demonstrated with the initial 
scores. (Appendices 28, 29,30). 
Table 7: Outcomes per year, area and model 
 
 
Table 7 shows the % of participants meeting certain outcomes as defined by the 
national IAPT key performance indicators, by whole service and split by geographical 
hub, and also indicated by model type.  
Year One Year Two Year Three Year Four
Whole Service 42.1% 41.2% 42.1% 50.4%
North 44.7% 42.0% 43.0% 51.1%
South 38.5% 39.9% 40.8% 49.7%
Whole Service 23.0% 25.8% 25.8% 22.6%
North 23.0% 25.2% 25.1% 21.9%
South 23.1% 29.9% 26.7% 23.5%
Whole Service 28.3% 27.9% 27.3% 23.1%
North 26.0% 28.1% 26.5% 22.9%
South 31.5% 27.4% 28.3% 23.2%
Whole Service 6.6% 5.1% 4.8% 3.9%
North 6.3% 4.7% 5.3% 4.1%
South 7.0% 5.7% 4.2% 3.6%
*Values in white represent allocated model, values in grey represent the progression model.
No Change
Reliable Deterioration
Recovery
Reliable Improvement
80 
 
Recovery rates only differ slightly in the first 3 years, with a clear increase by year 4, 
of 8% in whole service and in both hubs. There is also a marked drop in the % of no 
change, and reliable deterioration, the latter particularly with the progression model.  
Dosage of treatment 
There appears no difference in the average dosage of treatment between cohorts, as 
can be observed in table 8.  
Table 8: Average number of sessions per cohort 
 
Of particular note is the number of participants in the stepped up category, where the 
dosage increases by 2 sessions in the progression model compared to the allocated 
in the north area, and by 1 session in the south area.  
Discharge reasons comparison 
It can be observed that as the rate of completed treatment significantly rises, the 
dropout rate is also reduced, settling at consistently in years 3 and 4 at 19.5%.  All 
cohorts show more participants completed treatment and less drop out in the 
progression model, although the difference in the South area is only 1%, compared 
to 6% in the North. (Appendix 7). 
 
 
 
 
 
Step 2 Only Step 3 Only Stepped Up Stepped Down Total
Average no of Sessions 4.8 9.2 10.9 6.8 5.7
Number of patients 58.7% 27.3% 12.3% 1.8% 100.0%
Average no of Sessions 4.9 10.2 12.8 6.5 7.1
Number of patients 64.2% 10.8% 23.4% 1.6% 100.0%
Average no of Sessions 4.8 9.5 10.6 6.4 6.3
Number of patients 63.5% 23.2% 12.3% 0.9% 100.0%
Average no of Sessions 4.8 10 13 6 7.2
Number of patients 64.0% 9.1% 25.5% 1.4% 100.0%
Average no of Sessions 4.9 9.4 11.6 7.2 6.8
Number of patients 56.7% 25.2% 15.4% 2.7% 100.0%
Average no of Sessions 4.8 10.7 12.7 6.7 7
Number of patients 67.3% 8.8% 22.8% 1.1% 100.0%
North
Allocated
Progressive
South
Allocated
Progressive
Whole
Allocated
Progressive
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Relationship between categorical variables - Cross tabulations and chi square 
Table 9 provides a summary of the chi square results of the baseline factors and 
outcomes, which are presented in further detail below.  
Table 9: Chi square summary results of each cohort group. Baseline variab les and recovery outcomes 
 
Cross tabulations and chi square tests on age and gender showed that there is an 
association between age and gender; X2 (9, n=16,718)=130, p= ˂ 0.001, with the Chi 
square test meeting the assumptions of 20% or less having an expected count less 
than 5. The younger aged bands show significantly in favour of women, with a 
particular change between the proportional differences of gender in the age bands 
45-54, 55-64, returning to the previous margins until the age band 85-94 where the 
proportion of gender is almost equal, as is demonstrated in table 10. (Appendices 
11,12).  
 
Figure 10: Age distribution by gender 
Count Chi Square Sig Count Chi Square Sig Count Chi Square Sig
Recovered 6809 64.164 p<0.001 3958 41.811 p<0.001 2809 19.199 p=0.014
Reliable Improvement 3761 37.743 p<0.001 2090 25.422 p=0.001 1646 19.117 p=0.008
Non Recovered 4028 41.98 p<0.001 2251 22.495 p=0.004 1741 31.442 p<0.001
Reliable Deterioration 737 15.174 p=0.019 428 6.56 p=0.255 304 3.277 p=0.773
Recovered 6808 0.893 p=0.345 3958 1.279 p=0.258 2808 4.591 p=0.032
Reliable Improvement 3760 0.967 p=0.325 2089 0.065 p=0.799 1646 1.144 p=0.285
Non Recovered 4026 0.015 p=0.903 2250 0.304 p=0.581 1740 0.011 p=0.917
Reliable Deterioration 737 0.387 p=0.534 428 0.01 p=0.920 304 0.312 p=0.577
Recovered 6809 54.053 p<0.001 3958 50.334 p<0.001 2809 7.086 p=0.008
Reliable Improvement 3761 64.726 p<0.001 2090 58.854 p<0.001 1646 1.482 p=0.224
Non Recovered 4028 63.683 p<0.001 2251 37.839 p<0.001 1741 6.611 p=0.010
Reliable Deterioration 737 10.686 p=0.001 428 9.089 p=0.003 304 0.872 p=0.350
Recovered 6774 58.27 p<0.001 3933 51.08 p<0.001 2799 20.903 p=0.002
Reliable Improvement 3743 28.512 p<0.001 2081 29.929 p<0.001 1637 2.092 p=0.911
Non Recovered 4002 42.227 p<0.001 2238 39.213 p<0.001 1728 16.447 p=0.012
Reliable Deterioration 726 118.435 p=0.428 423 3.131 p=0.680 298 1.091 p=0.955
South Cohort
Age
Gender
Disability
First 
Employment 
Status
Whole Cohort North Cohort
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Cross tabulations and chi square tests on age and disability showed that there is an 
association between age and disability; X2 (9, n=16,723) = 486, p=˂0.001, however 
the chi square test did not meet the assumption of less than 20% having an 
expected count less than 5, with an actual of 25%. However these are in the age 
categories 16 -17 and 95+ with the participants n=4, therefore unlikely to affect the 
significance. There is an observable rise in proportion of those disabled by age 
group which appears to correspond with the general age distribution, i.e. a peak in 
the age categories 45-54, and 55-64. (Appendices 15,16). 
Cross tabulations and chi square tests on age and employment showed that there is 
an association between age and employment; X2 (63, n=16,613) =14520, p=˂0.001, 
however the chi square test did not meet the assumption of less than 20% having an 
expected count less than 5, with an actual of 40%. Apart from the perhaps 
questionable number of participants in the age groups 25-34, 35-44, that fall into the 
retired category, n=5, zero value in certain categories would be expected, i.e. the 
zero count in the range of categories other than retired for the 75+ age groups. 
(Appendices 13,14). 
The results show that in the first two age groups the larger proportion are students, 
the middle groups there are more employed and the older age groups retired, all 
which would be expected. 
Cross tabulations and chi square tests on gender and disability showed that there is 
an association between gender and disability; X2 (1,n=16,718) =31.7, p=˂0.001, with 
the Chi square test meeting the assumptions of 20% or less having an expected 
count less than 5. Proportionally to the total number of men, more males register 
disabled compared to the proportion of women. (Appendices 17,18).  
Cross tabulations and chi square tests on gender and employment showed that 
there is an association between gender and employment; X2 (7, n=16,608) = 552, 
p=˂0.001, with the Chi square test meeting the assumptions of 20% or less having 
an expected count less than 5. More women than men are employed, and 
unemployed, although the proportion of men unemployed is larger than the 
proportion of women, a much larger number of the student category are women at 
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70.8% compared to men 29.2%. a larger proportion of men than women are in the 
category of sick or disabled, and a huge number of homemakers are women 90.8% 
compared to men. (Appendices 19, 20). 
Cross tabulations and chi square tests on disability and employment showed that 
there is an association between disability and employment; X2 (7, n=16,631) = 1081, 
p=˂0.001, with the Chi square test meeting the assumptions of 20% or less having 
an expected count less than 5. Proportionally of those registered with a disability the 
larger group are unemployed (29.1%), or sick or disabled (31.6%), or retired 
(16.2%). (Appendices 21, 22).  
7.2 Analysis of outcomes by model  
Firstly the original cohorts allocated and progression defined by years, secondly the 
model (allocated versus progression) by area, north then south, was analysed in 
terms of association between model and outcomes, association between baseline  
factors, model and outcomes, and logistic regression to test for any significant 
association.  Finally a further sensitivity analysis was applied.  
None recorded, missing data, and non caseness at first score were removed to avoid 
false skew.  
Table 10 is a summary of all cohorts chi square results by outcome, showing 
statistical significance with across all cohorts and recovery, a weaker significance for 
reliable improvement across all cohorts, and no significance in the south or the 
sensitivity analysis cohorts for reliable deterioration.  
Table 10: Chi square summary results of each cohort, by outcome 
 
 
Count Chi Square Sig Count Chi Square Sig Count Chi Square Sig Count Chi Square Sig
All Recovery 
Outcomes
15335 38.552 p<0.001 8727 14.825 p=0.002 6500 56.904 p<0.001 8578 80.021 p<0.001
Recovery v Non 
Recovery
15335 31.279 p<0.001 8727 13.76 p<0.001 6500 53.473 p<0.001 8578 78.608 p<0.001
Reliable Improvement 
v Non Recovery
8526 4.394 p=0.036 4769 1.029 p=0.310 3691 2.511 p=0.113 4733 1.354 p=0.245
Reliable Deterioration 
v Non Recovery
8526 4.675 p=0.031 4769 0.025 p=0.874 3691 2.145 p=0.143 4733 0.275 p=0.600
Outcomes
Whole Cohort North Cohort South Cohort Sensitivity Analysis
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Allocated v progression (whole cohort)  
Cross tabulations and chi square tests on outcome group by model show that there 
is an association between outcome and model, X2 (3,n=15335) =38.5, p = ˂0.001, 
with more participants attaining recovery in progression model than allocated, both in 
number and in proportion to the total number of participants. There is no discernible 
difference in reliable improvement or reliable deterioration between models. 
Proportionally there are more participants not recovered in allocated model. (table 
11, appendix 32).  
Table 11: Cross tabulation of recovery and model by whole cohort 
 
 
Tests were then undertaken separating the dataset as recovered versus all other 
outcomes by model. Cross tabulations and chi square tests show an association 
between outcome and model, X2 (1,n=15,335) =31.2, p=˂0.001, with larger 
proportion of participants recovering in the progression model, and more not 
recovering in allocated. (Appendices 33, 34). 
The outcome group reliable improvement was then isolated in a similar way (with the 
recovery group omitted for this calculation). Cross tabulations and Chi square tests 
show an association between this outcome and model, X2 (1, n= 8526) = 4.39, 
p=0.036, with a 2% difference in favour of the progression model, and just under 2% 
proportionally are more likely to not make improvement in the allocated model. The 
association between reliable improvement and model is weaker than that of recovery 
outcome. (Appendices 35,36). The same was undertaken for reliable deterioration, 
cross tabulations and Chi square tests show a weaker association between this 
Allocated Progressive
Count 2323 4486 6809
% within Model 41.40% 46.10% 44.40%
Count 1401 2360 3761
% within Model 25.00% 24.30% 24.50%
Count 1570 2458 4028
% within Model 28.00% 25.30% 26.30%
Count 311 426 737
% within Model 5.50% 4.40% 4.80%
Count 5605 9730 15335
% within Model 100.00% 100.00% 100.00%
Total
Model
Total
Recovery
Recovered
Reliable 
Improvement
Non Recovered
Reliable 
Deterioration
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outcome and model with X2 (1, n=8526) =4.67 p = 0.03, only 1.4% proportionally 
more reliably deteriorated in the allocated model, and 1.4% more did not recover in 
the progression model. (Appendices 37,38).  
 
Analysis of score severity and outcome by model 
To observe the outcomes of participants in the upper end of severity scores the 
variables were isolated where first scores show moderate to severe or severe on 
PHQ9 and moderate or severe on GAD7.   
Table 12 shows the chi square summary results for each cohort group, by moderate 
to severe scores and outcome. Each severity groups results are detailed below. 
Table 12: Chi square summary results of each cohort group, isolating moderate and severe scores, by outcomes 
 
 
 
Cross tabulations and Chi square tests were undertaken on the higher PHQ9 groups 
and show an association between score severity, outcome and model.  Severe 
PHQ9 showed X2 (3, n=4986) = 17.0 p = ˂0.001, with participants scoring severe a 
larger proportion recovered in the progression model, a larger proportion did not 
recover in the allocated model, and there was no discernible difference with reliable 
improvement or reliable deterioration. Moderate/severe PHQ9 showed X2 (3, N= 
4754) =20.7, p=˂0.001, with participants scoring moderate to severe a larger 
proportion recovered in the progression model, however a larger proportion attained 
reliable improvement or did not recover in the allocated model, and no real difference 
with reliable deterioration. (Appendices 39,40). 
Count Chi Square Sig Count Chi Square Sig Count Chi Square Sig Count Chi Square Sig
Severe PHQ Levels 
and Recovery 
Outcomes
4986 17.063 p=0.001 2785 10.045 p=0.018 2169 19.927 p<0.001 2776 27.208 p<0.001
Moderate to Severe 
PHQ Levels and 
Recovery Outcomes
4754 20.649 p<0.001 2754 9.529 p=0.023 1967 21.663 p<0.001 2664 30.142 p<0.001
Severe GAD Levels 
and Recovery 
Outcomes
8567 25.034 p<0.001 4850 13.408 p=0.004 3659 32.372 p<0.001 4759 40.753 p<0.001
Moderate GAD Levels 
and Recovery 
Outcomes
4694 16.351 p=0.001 2682 3.388 p=0.336 1977 29.624 p<0.001 2639 24.841 p<0.001
Sensitivity Analysis
Severity of Levels
Whole Cohort North Cohort South Cohort
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Cross tabulations and chi square tests were undertaken on the higher GAD7 score 
groups and showed an association between severity, outcome and model. The 
GAD7 severe group showed X2 (3, n=8567) = 25.0, p=0.001, with the severe group 
the largest proportion to recover was in progression than allocated, and conversely a 
larger proportion not recovering in allocated than progression. The margins of 
proportional difference with reliable improvement and reliable deterioration were 1% 
or less. The Moderate GAD 7 group showed significance with X2 (3,n=4694) =16.3, 
p=˂0.001, with the largest proportion of participants recovered in the progression 
model, and less than 1% difference between models for reliable improvement or 
reliable deterioration. (Appendices 41,42). 
Analysis of outcomes and drop outs 
The data was isolated in terms of reasons for discharge from the service, as 
stipulated by the individual clinician to observe any difference in those ‘dropping out’ 
of treatment earlier than scheduled, by model.  
There was a correlation in result with the discharge reason completed treatment and 
outcome, showing an association with model, with again around a 5% proportional 
difference in favour of the progression model for those recovered. There is a 
difference between the KPI defined completed treatment outcomes and therapist 
defined discharge reasons. (Appendix 7).  
The group ‘dropped out’ showed some association with X2 (3, n=3342) =12.3, 
p=0.006, with those in the allocated the largest proportion to have recovered despite 
dropping out, yet those in the progression model  and attained reliable improvement 
were the largest proportion to have dropped out. There was no difference in the 
dropout rates by model for those not recovering or deteriorating. (Appendices 132, 
133). 
Analysis of baseline factors, outcomes and model for whole service data 
Cross tabulations and chi square tests were undertaken on baseline factors, 
outcome groups and model.  
Age 
There is an association between outcomes, age and model, those recovered showed 
X2 (9, n=6809) = 64.1, p=˂0.001, where the age groups 18-24, and 35-44 the larger 
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proportion to recover were in the progression model, and 45-54 in the allocated 
model. Those that reliably improved showed X2 (7, n=3761) =37.7, p=˂0.001, where 
again the 18-24 group the larger proportion to improve was in the progression model, 
however in the 35-44, and 45-54 groups proportionally the largest to improve were in 
the allocated model, with there being no difference in other age groups. The 
association for non-recovered showed X2 (8,n=4028)=41.9, p=˂0.001, where in the 
18-24 group the largest proportion to not recover was in progression model, however 
in the 25-34, and 55-64 groups the largest proportion to not recover were in the 
allocated model. The association is a weaker one for reliable deterioration with 
X2(6,n=737)=15.1, p=0.019 , where reliable deterioration occur in a larger proportion 
in the progression model for 18-24s, but for the next 2 age groups it occurs in the 
allocated model, with no difference from 45+. (Appendices 43, 44). 
Gender 
There is no association and no difference in the cross tabulations for gender and 
outcomes, although cross tabulations show a reliable deterioration is proportionally 
larger for males in the allocated model and for females in the progression model, p= 
˃0.5, therefore there is no association.  (Appendices 45, 46). 
Disability 
There is an association between all outcomes, disability and model. For those 
recovered with X2 (1,n=6809)=54.0, p=˂0.001, reliable improvement 
X2(1,n=3761)=64.7, p=˂0.001, non-recovered X2 (1,n=4028)-63.6 p=˂0.001, and 
reliable deterioration X2 (1,n=737)=10.6 p=0.001. Proportionally more registered 
disabled achieve all outcomes in the progression model than the allocated. 
(Appendices 47, 48) 
Employment 
There is an association between all outcomes and model except reliable 
deterioration. For those recovered, X2 (7,n=6774)=58.2, p=˂0.001, with no difference 
in all categories apart from a larger proportion  of unemployed in the allocated 
model, and a larger proportion of sick or disabled in progression. For reliable 
improvement, X2(7,n-3743)=28.5 p=˂0.001, with homemaker, employed and 
unemployed all having larger proportion in the allocated, but again sick or disabled 
have a larger proportion in the progression model. For non-recovered, X2 
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(5,n=726)=4.90, p=0.428 where no difference by model for some categories apart 
from a larger proportion for unemployed in the allocated model, and for students and 
sick or disabled a larger proportion in the progression model. (Appendices 49, 50). 
North allocated v north progression  
Cross tabulations and chi square tests on outcome group by model show that there 
is an association between outcome and model, X2 (3,n=8727) =14.8, p = ˂0.05, with 
more participants attaining recovery in progression model than allocated, both in 
number and in proportion (4%) to the total number of participants, There is no 
discernible difference in reliable improvement or reliable deterioration between 
models. Proportionally there are more participants not recovered in allocated model. 
(Appendices 51, 52). 
Tests were then undertaken separating the dataset as recovered versus all other 
outcomes by model. Cross tabulations and chi square tests show an association 
between outcome and model, X2 (1,n=8727) =13.7, p=˂0.001, with larger proportion 
of participants recovering in the progression model, and more not recovering in 
allocated. No correlation and no proportional difference between models were found 
for neither reliable improvement nor reliable deterioration. (Appendices 53, 54). 
Analysis of score severity and outcome by model 
To observe the outcomes of participants in the upper end of severity scores the 
variables were isolated where first scores show moderate to severe or severe on 
PHQ9 and moderate or severe on GAD7.   
Cross tabulations and Chi square tests were undertaken on the higher PHQ9 groups 
and show an association between score severity, outcome and model.  Severe 
PHQ9 showed X2 (3, n=2785) = 10.0 p = ˂0.05, with participants scoring severe a 
larger proportion recovered in the progression model, (difference of 5% between 
models), a larger proportion did not recover in the allocated model, (again difference 
of around 5% between models) and there was no discernible difference with reliable 
improvement or reliable deterioration. Moderate/severe PHQ9 showed X2 (3, 
n=2754) =9.52, p=˂0.05, with participants scoring moderate to severe a larger 
proportion recovered in the progression model, (6% difference between models) 
however a larger proportion attained reliable improvement or did not recover in the 
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allocated model, and no real difference with reliable deterioration. (Appendices 
59,60).  
Cross tabulations and Chi square tests were undertaken on the higher GAD7 score 
groups and showed an association between severity, outcome and model. The 
GAD7 severe group showed X2 (3, n=4850) = 13.4, p=0.05, with the severe group 
the largest proportion to recover was in progression than allocated (5% difference 
between models), and conversely a larger proportion either reliably improving or not 
recovering in allocated than progression. Reliable deterioration was less 1% 
proportional differences. The Moderate GAD 7 group showed no significant 
correlation, although there were proportional differences of 3% more recovered with 
the progression model and the same difference with more non-recovered with the 
allocated model. (Appendices 61,62).  
Analysis of outcomes and drop outs 
The data was isolated in terms of reasons for discharge from the service, as 
stipulated by the individual clinician to observe any difference in those ‘dropping out’ 
of treatment earlier than scheduled, by model.  
There was a correlation in result with the discharge reason completed treatment and 
outcome, showing an association with model, with again around a 4% proportional 
difference in favour of the progression model for those recovered. There is a 
difference between the KPI defined completed treatment outcomes and therapist 
defined discharge reasons.  
The group ‘dropped out’ showed some association with X2 (3, n=1965) =12.4, 
p=˂0.05, with those in the allocated the largest proportion (about 5% difference 
between models) to have recovered despite dropping out, with a larger proportion of 
non-recovered in the progression model. (Appendices 134, 135). 
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Analysis of baseline factors, outcomes and model 
Cross tabulations and chi square tests were undertaken on baseline factors, 
outcome groups and model.  
Age 
There is an association between outcomes, age and model, those recovered showed 
X2 (9, n=3958) = 41.8, p=˂0.001, where the age groups 18-24, the larger proportion 
to recover were in the progression model, and 45-54 in the allocated model. Those 
that reliably improved showed X2 (7, n=2090) =25.4, p=˂0.001, where again the 18-
24 group the larger proportion to improve was in the progression model as well as 
the 25 -34, however in the 35-44, and 45-54 groups proportionally the largest to 
improve were in the allocated model, with there being no difference in other age 
groups. There was a very weak association for non-recovered, and no correlation for 
reliable deterioration. (Appendices 63, 64). 
Gender 
There is no association and no difference over 2% in the cross tabulations for gender 
and outcomes. (Appendices 65, 66). 
Disability 
There is an association between all outcomes, disability and model. For those  
Recovered with X2(1,n=3958)=50.3,p=˂0.001, reliable improvement 
X2(1,n=2090)=58.8, p=˂0.001, non-recovered X2 (1,n=2251)37.8 p=˂0.001, and 
reliable deterioration a weaker association X2 (1,n=428)=9.08 p=˂0.05. 
Proportionally more registered disabled achieve all outcomes in the progression 
model than the allocated. (Appendices 67, 68)  
Employment 
There is an association between all outcomes and model. Those recovered, X2 
(1,n=3933)=51.0, p=˂0.001, with a larger proportion  of employed and unemployed 
in the allocated model, and a larger proportion of sick or disabled in progression. For 
reliable improvement, X2(1, n=2090)=58.8 p=˂0.001, with unemployed having larger 
proportion in the allocated,  however sick or disabled and students have a larger 
proportion in the progression model. For non-recovered, X2 (1,n=2251)=37.8, 
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p=˂0.001 where no difference by model for some categories apart from a larger 
proportion for unemployed in the allocated model, and for students and sick or 
disabled a larger proportion in the progression model. There is a weaker association 
for those reliably deteriorated, X2 (1, n=428)=9.08, p=˂0.05, with larger proportions 
of employed and unemployed in the allocated model, and larger proportions of sick 
or disabled in the progression model. (Appendices 69,70).  
South allocated v south progression 
Cross tabulations and chi square tests on outcome group by model show that there 
is an association between outcome and model, X2 (3,n=6500) =56.9, p = ˂0.05, with 
more participants attaining recovery in progression model than allocated, with a 
proportional difference of 9.6% between models, proportionally more there were 
reliable improvement ,reliable deterioration and not recovered in allocated. ( table 13, 
appendix 72). 
Table 13: Cross tabulation of recovery and model in the south 
 
 
Tests were then undertaken separating the dataset as recovered versus all other 
outcomes by model. Cross tabulations and chi square tests show an association 
between outcome and model, X2 (1,n=6500) =53.4, p=˂0.001, with larger proportion 
of participants recovering in the progression model, with a proportional difference of 
over 9% and more not recovering in allocated. No correlation was found for reliable 
improvement nor reliable deterioration, however there was some proportional 
difference between models. (Appendices 73,74 ). 
Allocated Progressive
Count 1764 1045 2809
% within Model 40.10% 49.70% 43.20%
Count 1153 493 1646
% within Model 26.20% 23.50% 25.30%
Count 1253 488 1741
% within Model 28.50% 23.20% 26.80%
Count 228 76 304
% within Model 5.20% 3.60% 4.70%
Count 4398 2102 6500
% within Model 100.00% 100.00% 100.00%
Total
Model
Total
Recovery
Recovered
Reliable 
Improvement
Non Recovered
Reliable 
Deterioration
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 Analysis of score severity and outcome by model 
To observe the outcomes of participants in the upper end of severity scores the 
variables were isolated where first scores show moderate to severe or severe on 
PHQ9 and moderate or severe on GAD7.   
Cross tabulations and Chi square tests were undertaken on the higher PHQ9 groups 
and show an association between score severity, outcome and model.  Severe 
PHQ9 showed X2 (3, n=2169) = 19.9 p = ˂0.001, with participants scoring severe a 
larger proportion recovered in the progression model, (proportional difference of 6% 
between models), a larger proportion did not recover in the allocated model, 
(proportional difference of around 7% between models) and there was no discernible 
difference with reliable improvement or reliable deterioration. Moderate/severe PHQ9 
showed X2 (3, n=2169) =21.6, p=˂0.001, with participants scoring moderate to 
severe a larger proportion recovered in the progression model, (10% proportional 
difference between models) and a larger proportion attained reliable improvement,  
reliable deterioration or did not recover in the allocated model.(Appendices 79,80).  
Cross tabulations and Chi square tests were undertaken on the higher GAD7 score 
groups and showed an association between severity, outcome and model. The 
GAD7 severe group showed X2 (3, n=3659) = 32.3, p=˂0.001, with the severe group 
the largest proportion to recover was in progression than allocated (nearly 9% 
proportional difference between models), and conversely a larger proportion not 
recovering in allocated. Reliable improvement and reliable deterioration were less 
1% proportional difference between models. The Moderate GAD 7 group showed  X2 
(3, n=1977) =29.6, p=˂0.001, with the largest proportion to recover in the 
progression model, with  over 13% difference between models. Larger proportions 
were in the allocated model for reliable improvement, reliable deterioration and non-
recovered. (Appendices 81,82). 
Analysis of outcomes and drop outs 
The data was isolated in terms of reasons for discharge from the service, as 
stipulated by the individual clinician to observe any difference in those ‘dropping out’ 
of treatment earlier than scheduled, by model.  
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There was a correlation in result with the discharge reason completed treatment and 
outcome, showing an association with model, with a larger proportion recovered in 
the progression model, and the larger proportion reliably improved and non-
recovered in the allocated model. There is a difference between the KPI defined 
completed treatment outcomes and therapist defined discharge reasons.  
There was no correlation with dropped out of treatment and outcome, however there 
was some proportional differences between models. (Appendices 136, 137).  
Analysis of baseline factors, outcomes and model 
Cross tabulations and chi square tests were undertaken on baseline factors, 
outcome groups and model.  
Age 
There is an association between outcomes, age and model, those recovered showed 
X2 (8, n=2809) = 19.1, p=˂0.05, where the age groups 18-24, 25-34 the larger 
proportion to recover were in the progression model, and 55-64in the allocated 
model. Those that reliably improved showed X2 (7, n=1646) =19.1, p=˂0.05, where 
again the 18-24 group the larger proportion to improve was in the progression model 
55-64 proportionally the largest to improve were in the allocated model, with there 
being no difference in other age groups. Non-recovered showed X2 (7, n=1741) 
=31.4, p=˂0.001, with larger proportions in the progression model for 18-24, and 35-
44, and larger proportion in the allocated model for 25-34, 45-54 and 55-64. There 
was no correlation for reliable deterioration. (Appendices 83, 84). 
Gender 
There is a weak association for recovered with X2 (1,n=2808)=4.59,p=˂0.05, with 
proportionally more females in progression and more males in allocated. There are 
no further associations with gender and type of outcome. (Appendices 85,86).  
Disability 
There is some association between some outcomes, disability and model. For those 
Recovered with X2(1,n=2809)=7.08,p=˂0.05, with proportionally more registered 
disabled recover in progression model. For those non recovered X2 (1,n=1741)=6.61 
p=˂0.05, with proportionally more non recovered in the progression model. There 
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was no association between reliable improvement or reliable deterioration and 
model. (Appendices 87, 88). 
Employment 
There is some association between some outcomes and model. Those recovered, 
X2(6,n=2799)=20.9, p=˂0.05, with a larger proportion  of unemployed in the allocated 
model, and a larger proportion of employed, homemaker and sick or disabled in 
progression although the proportional differences are small. For non-recovered, X2 
(6,n=1728)=15.8, p=˂0.05 with larger proportions in employed, unemployed and 
homemaker in allocated, and a larger proportion of students and sick or disabled in 
the progression model. There is no association for reliable improvement, or reliable 
deterioration and model. (Appendices 89, 90).  
Sensitivity analysis 
Years 2 and 4 data was isolated to remove the possible effect on results of service 
development in year 1, and service model changeover in year 3, and the same tests 
undertaken.  
Cross tabulations and chi square tests on outcome group by model show that there 
is an association between outcome and model, X2 (3,n=8578) =80.0, p = ˂0.001, 
with a larger proportion recovering in year 4, and the larger proportion for all other 
outcomes in year 2. (Appendices 91, 92) 
Tests were then undertaken separating the dataset as recovered versus all other 
outcomes by model. Cross tabulations and chi square tests show an association 
between outcome and model, X2 (1,n=8578) =78.6, p=˂0.001, with larger proportion 
of participants recovering in year 4, and a larger proportion not recovering in year 2. 
(Appendices 93,94). No correlation was found for reliable improvement or reliable 
deterioration. (Appendices 95, 96, 97, 98). 
Analysis of score severity and outcome by model 
To observe the outcomes of participants in the upper end of severity scores the 
variables were isolated where first scores show moderate to severe or severe on 
PHQ9 and moderate or severe on GAD7.   
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Cross tabulations and Chi square tests were undertaken on the higher PHQ9 groups 
and show an association between score severity, outcome and model.  Severe 
PHQ9 showed X2 (3, n=2776) = 27.2 p = ˂0.001, with participants scoring severe a 
larger proportion recovered in year 4, a larger proportion did not recover in year 2) 
and there was no discernible difference with reliable improvement or reliable 
deterioration. Moderate/severe PHQ9 showed X2 (3, n=2664) =30.1, p=˂0.001, with 
participants scoring moderate to severe a larger proportion recovered in year 4, 
(10% proportional difference between years) and a larger proportion attained reliable 
improvement, reliable deterioration or did not recover in year 2. (Appendices 99, 
100). 
Cross tabulations and Chi square tests were undertaken on the higher GAD7 score 
groups and showed an association between severity, outcome and model. The 
GAD7 severe group showed X2 (3, n=4759) =40.7, p=˂0.001, with the severe group 
the largest proportion to recover was in year 4 than allocated (over 8% proportional 
difference between years), and conversely a larger proportion of Reliable 
improvement, reliable deterioration,  and not recovering in year 2. The Moderate 
GAD 7 group showed  X2 (3, n=2639) =24.8, p=˂0.001, with the largest proportion to 
recover in year 4, with  over 10% difference between years. Year 2 has the larger 
proportions for reliable improvement, reliable deterioration and non-recovered. 
(Appendices 101, 102).  
Analysis of outcomes and drop outs 
The data was isolated in terms of reasons for discharge from the service, as 
stipulated by the individual clinician to observe any difference in those ‘dropping out’ 
of treatment earlier than scheduled, by year.  
There was a correlation in result with the discharge reason completed treatment and 
outcome, showing an association with model, with a larger proportion recovered in 
year 4, and the larger proportion in all other outcomes in year 2. There is a difference 
between the KPI defined completed treatment outcomes and therapist defined 
discharge reasons. There was no correlation with dropped out of treatment and 
outcome, however there was some proportional differences between models. 
(Appendices 138,139).  
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7.3 Logistic regression 
A logistic regression was used with the years 2 and 4 data, (n = 8524) to firstly 
investigate the relationship of a number of independent variables including the type 
of model delivery (allocated or progression), and likelihood the outcome of recovery,  
Logistic regression was also used with the years 2 and 4 data, with the cohorts 
grouped by model type, allocated (year 2) and progression (year 4), and the baseline 
factors added as independent variables to test the relationship  with all outcome 
categories, recovery, reliable improvement, no change and reliable deterioration.  
Further logistic regressions were used isolating the psychological measures score 
severity groups, and exploring the relationship between outcomes and the model 
type, and baseline factors.  
 
Years 2 and 4 together cohort 
The first logistic regression was used with years 2 and 4 data together. Table 14 
shows that the data were shown to fit the model using the Hosmer and Lemeshow 
test (p ˃ .05). The logistic regression model was statistically significant, with X2(25) 
=3555.72, p ˂ .001. The model explained 45.6% of the variance in the recovery 
outcome. (Using Nagel-kerke’s R2) and correctly classified 76.5% of the cases. 
Sensitivity was 79.8%, specificity was 73.7%. The positive predictor value 
was 72.1% and the negative predictor value was 81%. 
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Table 14: Years 2 & 4 logistic regression tab le 
 
 
The logistic regression analysis (table 14) showed that there no statistical 
significance for gender or disability, however there was statistical significance for six 
of the predictor variables, model type, age, employment PHQ 9 initial scores, GAD 7 
initial scores and discharge reason. 
Patients in the progression model were more likely to recover than in the allocated 
model, (Wald statistic (1) =  57.075, p˂ .001, odds ratio 1.53,  lower CI =1.368, upper 
CI =1.705).  
Lower Upper
Model(1) 0.424 0.056 57.075 1 0 1.527 1.368 1.705
Gender(1) -0.024 0.058 0.176 1 0.675 0.976 0.872 1.093
Disability(1) -0.025 0.11 0.053 1 0.818 0.975 0.787 1.209
Age 30.314 5 0
Age(1) 0.089 0.113 0.628 1 0.428 1.093 0.877 1.364
Age(2) 0.227 0.117 3.772 1 0.052 1.255 0.998 1.578
Age(3) 0.287 0.119 5.835 1 0.016 1.332 1.056 1.681
Age(4) 0.176 0.127 1.905 1 0.167 1.192 0.929 1.53
Age(5) 1.01 0.208 23.504 1 0 2.745 1.825 4.129
Employment 160.801 5 0
Employment(1) -0.725 0.073 99.336 1 0 0.485 0.42 0.559
Employment(2) -0.259 0.129 4.06 1 0.044 0.771 0.599 0.993
Employment(3) -0.895 0.091 96.315 1 0 0.409 0.342 0.489
Employment(4) -0.488 0.119 16.762 1 0 0.614 0.486 0.775
Employment(5) -0.73 0.181 16.297 1 0 0.482 0.338 0.687
PHQ 151.663 4 0
PHQ(1) -0.159 0.224 0.502 1 0.479 0.853 0.55 1.324
PHQ(2) -0.661 0.211 9.815 1 0.002 0.516 0.342 0.781
PHQ(3) -1.034 0.21 24.188 1 0 0.356 0.235 0.537
PHQ(4) -1.339 0.213 39.578 1 0 0.262 0.173 0.398
GAD 124.811 3 0
GAD(1) 0.057 0.244 0.055 1 0.815 1.059 0.656 1.709
GAD(2) -0.455 0.236 3.738 1 0.053 0.634 0.4 1.006
GAD(3) -0.914 0.235 15.166 1 0 0.401 0.253 0.635
Discharge 1548.424 5 0
Discharge(1) -2.774 0.085 1061.675 1 0 0.062 0.053 0.074
Discharge(2) -2.434 0.206 138.909 1 0 0.088 0.059 0.131
Discharge(3) -2.122 0.123 300.067 1 0 0.12 0.094 0.152
Discharge(4) -3.434 0.217 251.076 1 0 0.032 0.021 0.049
Discharge(5) -1.329 0.14 89.779 1 0 0.265 0.201 0.349
Constant 2.181 0.328 44.166 1 0 8.853
Step 1a
a. Variable(s) entered on step 1: Model, Gender, Disability, Age, Employment, PHQ, GAD, Discharge.
B S.E. Wald df Sig. Exp(B)
95% C.I.for EXP(B)
98 
 
In the age category, the age 18-24 group was the reference. Only the groups 44-54 
and 65-74 showed a significant relationship with the recovery outcome, with patients 
aged 44-54 1.33 times more likely to recover than the group 18-24, (p=0.016). The 
65-74 group were 2.75 more likely to recovery than the 18-24 group. (p=˂ .001).  
In the employment category, employed was the reference. All groups showed 
significance, although the student group was an extremely weak one, (p=0.44). 
However the relationship for all groups was negative, therefore unemployed, 
students, sick and disabled, homemaker and retired were less likely to recover than 
employed.  
With the psychological measures, the reference was the minimal group for both. For 
PHQ9 scores the moderate, moderate/severe and severe groups were statistically 
significant and all showed a negative relationship with the recovery outcome, and all 
were less likely than the minimal group to recover.  
For GAD7 scores all groups apart from the mild group had a negative relationship 
however the mild group was not significant. The moderate and severe group had a 
negative relationship with the recovery outcome, i.e. less likely to recover than the 
minimal group, with statistical significance. 
For both psychological measures the results show that the higher the initial score 
group, the less likely that patient was to recover.  
For discharge reasons, completed treatment was the reference group. All discharge 
reasons were statistically significant, and all groups had a negative relationship with 
the recovery outcome, therefore only those with completed treatment as a discharge 
reason were likely to recover.  
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Allocated model 
Logistic regression was used with the cohort of patients that had been treated in the 
allocated service model. (year 2), n= 3875. Regressions were undertaken with each 
outcome group as a binary, i.e. recovered versus non recovered, reliable 
improvement versus none, etc.  
 
Recovered outcome (Appendix 104) 
The data were shown to fit the model using the Hosmer and Lemeshow test (p ˃ 
.05). The logistic regression model was statistically significant, with X2(24) =146.089, 
p ˂ .001.The model explained 41.3% of the variance in the recovery outcome. (using 
Nagel-kerke’s R2) and correctly identified 75.1% of the cases outcomes. The model 
successfully identified 72.6% that recovered (sensitivity value), and 76.9% that did 
not recover specificity value). The positive predictor value was 72.76% and the 
negative predictor value was 76.9%. 
With age the only group that showed statistical significance was the 65-74 group, 
with an odds ratio of 3.56 times more likely to recover than the reference group 18-
24. However the confidence intervals range is rather large. (lower CI =1.979, upper 
CI= 6.416). 
With employment, the groups unemployed, sick and disabled, homemaker and 
retired were statistically significant, and all less likely to recover than the reference 
group, employed. 
The groups in the PHQ9 scores that were significant were the moderate, 
moderate/severe and severe, and all were less likely to recover than the reference 
group minimal.  
The only group in the GAD7 scores that was significant was the severe, with a weak 
significance, p=.039, and less likely to recover than the reference group minimal.  
All discharge reasons were significant, and all were less likely to recover than the 
reference group completed treatment.  
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Reliable improvement outcome (Appendix 105) 
The data were shown to be a poor fit with the model using the Hosmer and 
Lemeshow test (p = .005). The logistic regression model was statistically significant, 
with X2(24) =363.745, p ˂ .001. The model explained 13.1% of the variance in the 
reliable improvement outcome, (using Nagel-kerke’s R2) and correctly classified 
73.8% of the cases. Sensitivity was 0.1%, specificity was 99.7%. The positive 
predictor value was 0.099% and the negative predictor value was 0.34%. 
Only the 65-74 age group showed a weak significance (p= 0.020), and were less 
likely than the reference group 18-24 to attain reliable improvement.  
In the PHQ9 scores category, the groups moderate/severe and severe were 
significant, with moderate/severe 5.09 times more likely and severe 5.42 times more 
likely to attain reliable improvement that the reference group minimal.  
Similarly with the GAD7 category, the groups moderate and severe were significant, 
with moderate 6.27 times more likely and severe 12.11 times more likely to attain 
reliable improvement than the reference group minimal.  
With the discharged reasons category only the dropped out group was significant, 
and 1.30 times more likely to attain reliable improvement than the reference category 
completed treatment.  
No change outcome (Appendix 106)  
The data were shown to fit the model using the Hosmer and Lemeshow test (p ˃ 
.05). The logistic regression model was statistically significant, with X2(24) =661.319, 
p ˂ .001. The model explained 22.6% of the variance in the no change outcome, 
(using Nagel-kerke’s R2) and correctly classified 75.1% of the cases. Sensitivity was 
39.5%, specificity was 88.8%. The positive predictor value was 39.54% and the 
negative predictor value was 88.8%. 
With the age category the only group to show significance was the 65-74 group, who 
were less likely than the reference group 18-24 to attain no change outcome.  
101 
 
Three groups in the unemployed category were significant, with unemployed 1.638 
times more likely, sick and disabled 1.877more likely and retired 1.990 times more 
likely to attain a no change outcome compared to the reference group employed.  
There was no significance with any of the psychological measures scores.  
All discharge reasons were significant, with dropped out 5.29 time more likely, not 
suitable 5.06 times more likely, declined 3.95 times more likely and  referred on 6.25 
times more likely than the reference group completed treatment to attain a no 
change outcome.  
Reliable deterioration outcome. (Appendix 107) 
The data were shown to fit the model using the Hosmer and Lemeshow test (p ˃ 
.05). The logistic regression model was statistically significant, with X2(24) =273.458, 
p ˂ .001. The model explained 20.5% of the variance in the reliable deterioration 
outcome, (using Nagel-kerke’s R2) and correctly classified 94.9% of the cases. 
Sensitivity was 2%, specificity was 99.9%. The positive predictor value was 2% and 
the negative predictor value was 0.11%. 
Two groups in the employed status category were significant, with unemployed 2.16 
times more likely and sick and disabled 2.57 times more likely to attain a reliable 
deterioration outcome compared to those employed.  
Only the moderate and severe groups in GAD7 psychological measures showed 
significance, with both less likely to attain reliable deterioration than the reference 
minimal group.  
All discharge reason groups were significant, with dropped out  4.85 times more 
likely,   not suitable 15.97 times more likely , declined treatment  5.52, 4 time more 
likely , and referred on 10.79 times more likely to than those completed treatment to 
have reliably deteriorated.  
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Progression model 
 
Logistic regression was used with the cohort of patients that had been treated in the 
progression service model. (year 4), n=4649. Regressions were undertaken with 
each outcome group as a binary, i.e. recovered versus non recovered, reliable 
improvement versus none, etc.  
Recovered outcome (Appendix 108) 
The data were shown to fit the model using the Hosmer and Lemeshow test (p ˃ 
.05). The logistic regression model was statistically significant, with X2(24) 
=2128.826, p ˂ .001. The model explained 49% of the variance in the recovery 
outcome. (using Nagel-kerke’s R2) and correctly classified 78.4% of the cases. 
Sensitivity was 85.6%, specificity was 71.2%. The positive predictor value 
was 85.57% and the negative predictor value was 28.75%. 
There was no significance for gender, disability or age categories.  
All employment status groups were significant, with a negative relationship therefore 
all were less likely than the reference employed group, to attain a recovery outcome.  
With the PHQ9 scores, the moderate, moderate/severe and severe group all showed 
significance, although the moderate group was extremely weak, p = .044. All groups 
had a negative relationship therefore all were less likely than the reference group 
minimal to attain a recovery outcome.  
With the GAD7 scores the moderate and severe groups showed significance, with a 
negative relationship therefore both were less likely than the reference group 
minimal to attain the recovery outcome.  
All discharge reasons showed significance, with a negative relationship, therefore all 
were less likely than the reference group completed treatment to attain recovery.  
Reliable improvement outcome (Appendix 109) 
The data were shown to fit with the model using the Hosmer and Lemeshow test (p ˃ 
.05). The logistic regression model was statistically significant, with X2(24) =566.554, 
p ˂ .001. The model explained 17.5% of the variance in the reliable improvement 
outcome,(using Nagel-kerke’s R2) and correctly classified 77.3% of the cases. 
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Sensitivity was 4.4%, specificity was 98.7%. The positive predictor value 
was 4.36% and the negative predictor value was 1.30%. 
There was a weak significance (p= 0.033) for the unemployed group, with an odds 
ratio of 1.24 times more likely to attain reliable improvement outcome than the 
reference group employed.  
With the PHQ9 scores, there was statistical significance with the moderate, 
moderate/severe and severe groups, with moderate 3.77 times more likely, 
moderate/severe 5.39 times more likely, and severe 7.14 times more likely to attain 
reliable improvement outcome compared to the reference group minimal.  
Only the severe group in the GAD7 scores showed statistical significance, and was 
9.03 times more likely to attain reliable improvement outcome than the minimal 
group.  
The discharge reason category had 2 statistically significant groups, with dropped 
out  1.62 times more likely, and declined 1.86 times more likely to attain reliable 
improvement than the completed treatment group. 
No change outcome (Appendix 110) 
The data were shown to be a poor fit to the logistic model using the Hosmer and 
Lemeshow test (p = 0.041). The logistic regression model was statistically significant, 
with X2(24) =1051.175, p ˂ .001. The model explained 30.6% of the variance in the 
no change outcome, (using Nagel-kerke’s R2) and correctly classified 78.7% of the 
cases. Sensitivity was 40%, specificity was 90.4%. The positive predictor value 
was 39.96% and the negative predictor value was 9.57%. 
The age group 25 -34 showed statistical significance, with a negative relationship, 
where they were less likely to attain a no change outcome than the reference group 
18-24.  
3 employment status groups showed significance, although homemaker was weaker 
with p = .036. unemployed was 1.60 times more likely, sick and disabled 1.88 times 
more likely and homemaker 1.44 times more likely to attain a no change outcome 
than the employed group. 
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There was no significance with the PHQ9 scores, however all groups in the GAD7 
category showed weak significance, with mild 3.14 times more likely, moderate 3.26 
times more likely, and severe 3.16 times more likely to attain a no change outcome 
than the minimal group.  
All discharge reasons showed statistical significance, with dropped out 9.84 times 
more likely, not suitable 8.95 times more likely, declined 7.61 times more likely, and 
referred on 12.07 times more likely, to attain a no change outcome compared to 
those completed treatment.  
Reliable deterioration outcome. (Appendix 111)  
The data were shown to fit the model using the Hosmer and Lemeshow test (p ˃ 
.05). The logistic regression model was statistically significant, with X2(24) =371.762, 
p ˂ .001. The model explained 27.3% of the variance in the reliable deterioration 
outcome, (using Nagel-kerke’s R2) and correctly classified 99.9% of the cases. 
Sensitivity was 3.3%, specificity was 99.9%. The positive predictor value 
was 4.39% and the negative predictor value was 0.13%. 
Two groups within the employment status category showed statistical signi ficance, 
with unemployed 2.65 times more likely, and sick and disabled 2.55 times more likely 
to attain a reliable deterioration outcome than those employed.  
All PHQ9 groups showed significance, with a negative relationship, all groups 
(moderate, moderate/severe, severe) were less likely to attain a reliable deterioration 
outcome than those in the minimal group.  
Both moderate and severe groups in the GAD7 category showed statistical 
significance, with a negative relationship. Both were less likely to attain a reliable 
deterioration outcome than those in the minimal group.  
All discharge reasons showed significance, with dropped out 13.38 times more likely, 
not suitable 10.59 times more likely, declined 8.68 times more likely, and referred on 
24.90 likely to be reliably deteriorated than those completed treatment.  
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Psychological measures Initial score severity - PHQ9  
 
Logistic regressions were used with the cohort of patients that either scored 
moderate, moderate/severe or severe on the initial scores of PHQ9. Regressions 
were used for each outcome group as binary. The relationship with baseline factors, 
discharge reasons and GAD7 severity was also tested.  
PHQ9 moderate 
PHQ9 moderate – recovery outcome ( Appendix 112) 
With a cohort of n= 2053, the data were shown to fit the model using the Hosmer and 
Lemeshow test (p ˃ .05). The logistic regression model was statistically significant, 
with X2(21) =686.495, p ˂ .001. The model explained 38.3% of the variance in the 
recovery outcome (using Nagel-kerke’s R2), and correctly classified 76.4% of the 
cases. Sensitivity was 88.5%, specificity was 59.8%. The positive predictor value 
was 88.46% and the negative predictor value was 59.77%. 
This group showed statistical significance and were 1.28 times more likely to recover 
in the progression model.   
There was no difference with gender, although those with a disability appeared 1.19 
times more likely to recover than those without, it was not statistically significant. 
Two age groups showed significance, with the 55-64 group 1.76 times more likely, 
and the 65-74 group 2.75 times more likely to recover than the reference group 18-
24. Four employment status groups were significant, with unemployed, sick and 
disabled, homemaker and retired all less likely to recover than employed. Those with 
moderate or severe GAD7 scores as well as moderate PHQ9 were less likely to 
recover than those with additional mild GAD7 scores. All discharge reasons were 
less likely to recover than those completed treatment.  
PHQ9 moderate – reliable improvement (Appendix 113 ) 
The data (n= 2053) were shown to fit the model using the Hosmer and Lemeshow 
test (p ˃ .05). The logistic regression model was statistically significant, with X2(21) 
=256.272, p ˂ .001. The model explained 21.3% of the variance in the reliable 
improvement outcome (using Nagel-kerke’s R2), and correctly classified 86.53% of 
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the cases. Sensitivity was 1.4%, specificity was 99.8%. The positive predictor value 
was 1.73% and the negative predictor value was 99.77%. 
There was no significance regarding model type for this outcome and appears there 
is no difference. There were only 3 groups in the discharge category  showing 
significance, with dropped out 2.42 times more likely, declined 2.09 times more 
likely, and referred on 2.33 times more likely than the completed treatment group to 
attain reliable improvement. 
PHQ9 moderate – no change (Appendix 114 ) 
The data (n= 2053) were shown to fit the model using the Hosmer and Lemeshow 
test (p ˃ .05). The logistic regression model was statistically significant, with X2(21) 
=288.478, p ˂ .001. The model explained 20.5% of the variance in the no change 
outcome (using Nagel-kerke’s R2), and correctly classified 80.4% of the cases. 
Sensitivity was 19.1%, specificity was 96.4%. The positive predictor value 
was 19% and the negative predictor value was 96.4%. 
This group was more likely to achieve a no change outcome in the allocated model.  
The age groups 45-54 and 65-74 were less likely to have no change than the 18-24 
group. The sick and disabled were 2.48 times more likely, and the retired 2.68 times 
more likely to not change than the employed group. The dropped out group were 
6.27 times more likely, declined 4.43 times more likely and the referred on group 
5.93 times more likely than the completed treatment group to not change from their 
initial scores.  
PHQ9 moderate – reliable deterioration (Appendix 115 ) 
The data (n= 2053) were shown to fit the model using the Hosmer and Lemeshow 
test (p ˃ .05). The logistic regression model was statistically significant, with X2(21) 
=210.327, p ˂ .001. The model explained 25.4% of the variance in the reliable 
deterioration outcome (using Nagel-kerke’s R2), and correctly classified 93.7% of the 
cases. Sensitivity was 6.7%, specificity was 99.7%. The positive predictor value 
was 6.7% and the negative predictor value was 99.73 %. 
There appeared no difference in terms of model type and this outcome. The 
unemployed group were 2.70 times more likely, and the sick and disabled 2.81 times 
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more likely than the employed group to reliably deteriorate. Those with additional 
moderate or severe GAD7 were less likely to reliably deteriorate. The dropped out 
group were 9.59 times more likely, not suitable 26.96 times more likely and referred 
on 8.98 times more likely than the completed treatment group to reliably deteriorate.  
PHQ9 moderate/severe  
PHQ9 moderate/severe  – recovery (Appendix 116) 
The data (n= 2617) were shown to fit the model using the Hosmer and Lemeshow 
test (p ˃ .05). The logistic regression model was statistically significant, with X2(21) 
=911.303, p ˂ .001. The model explained 39.4% of the variance in the recovery 
outcome (using Nagel-kerke’s R2), and correctly classified 74.1% of the cases. 
Sensitivity was 83.1%, specificity was 67.1%. The positive predictor value 
was 83% and the negative predictor value was 67%. 
The moderate/severe group were shown to have statistical significance (p ˂ .001) 
with the model type, and 1.79 times more likely to recover in the progression model. 
There was no significance for gender and disability and appeared no difference. The 
age group 65-74 showed significance, (p=0.014) and were 2.55 times more likely to 
recovery than the 18-24 group. Unemployed and sick and disabled were less likely to 
recover. There was no significance with additional GAD7 scores. The discharge 
reasons were all significant, will all less likely to recover than the completed 
treatment group.  
PHQ9 moderate/severe  – reliable improvement (Appendix 117 ) 
The data were shown to be a poor fit with the model using the Hosmer and 
Lemeshow test (p =0.033). The logistic regression model was statistically significant, 
with X2(21) =129.272, p ˂ .001. The model explained 7% of the variance in the 
reliable improvement outcome (using Nagel-kerke’s R2), and correctly classified 
73.5% of the cases. Sensitivity was 0.1%, specificity was 100%. The positive 
predictor value was 0.14% and the negative predictor value was 0%. 
The model type was significant, (p ˂ .001), with this group less likely to reliably 
improve in the progression model.  
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With additional severe GAD7 scores there was statistical significance where they 
were 11.91 times more likely to reliably improve. The dropped out group were 1.62 
more likely , and declined 1.49 times more likely to reliably improve than the 
completed treatment group, although the declined group was a weak statistical 
significance at p=0.44.  
PHQ9 moderate/severe  – no change (Appendix 118 ) 
The data were shown to fit the model using the Hosmer and Lemeshow test (p ˃ 
.05). The logistic regression model was statistically significant, with X2(21) =502095, 
p ˂ .001. The model explained 26% of the variance in the no change outcome (using 
Nagel-kerke’s R2), and correctly classified 76.8% of the cases. Sensitivity was 
35.4%, specificity was 90.2%. The positive predictor value was 35.4% and the 
negative predictor value was 90.2%. 
There was no significance in terms of model type.  
Aged group 25-34 showed a weak significance (p=0.046), and less likely to not 
change than the 18-24 group. Unemployed were 1.75 times more likely, sick and 
disabled 1.84 times more likely and home maker 1.55 times more likely (weak 
significance p =0.036) to not change than the employed group. All discharge reasons 
were significant, with all more likely to not change than the completed treatment 
group.  
PHQ9 moderate/severe – reliable deterioration (Appendix 119 ) 
The data were shown to be a poor fit with the model using the Hosmer and 
Lemeshow test (p =0.035). The logistic regression model was statistically significant, 
with X2(21) =185.344, p ˂ .001. The model explained 21.5% of the variance in the 
reliable deterioration outcome (using Nagel-kerke’s R2), and correctly classified 95% 
of the cases. Sensitivity was 0.8%, specificity was 99.8%. The positive predictor 
value was 0.14% and the negative predictor value was 99.75%. 
The model type showed a weak significance, (p=0.032) and less likely to reliably 
deteriorate in the progression model.  
Two employment status groups showed significance, with unemployed 1.99 times 
more likely and sick and disabled 2.31 times more likely to reliably deteriorate than 
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the employed group. The additional severe GAD7 scores were significantly less 
likely to reliably deteriorate. The discharge reasons were all significant and all more 
likely to reliably deteriorate than the completed treatment group.  
PHQ9 severe 
Phq9 severe- recovery (Appendix 120 ) 
The data were shown to fit the model using the Hosmer and Lemeshow test (p ˃ 
.05). The logistic regression model was statistically significant, with X2(21) = 
1088.246, p ˂ .001. The model explained 44.9% of the variance in the recovery 
outcome (using Nagel-kerke’s R2), and correctly classified 79.4% of the cases. 
Sensitivity was 61.2%, specificity was 87.1%. The positive predictor value 
was 61.18% and the negative predictor value was 87%. 
The model type was significant, (p ˂ .001) with recovery for severe PHQ9 scores 
1.606 times more likely in the progression model.  
The 65-74 age group showed significance and were 3.79 times more likely to 
recover than the 18-24 group.  Unemployed, sick and disabled, homemaker and 
retired were all significant and less likely to recover than the employed group. The 
discharge reasons were all significant and all less likely to recover than the 
completed treatment group.  
PHQ9 severe- reliable improvement (Appendix 121 ) 
The data were shown to fit the model using the Hosmer and Lemeshow test (p ˃ 
.05). The logistic regression model was statistically significant, with X2(21) =66.702, 
p ˂ .001. The model explained 3.2% of the variance in the reliable improvement 
outcome (using Nagel-kerke’s R2), and correctly classified 64.7% of the cases. 
Sensitivity was 1.2%, specificity was 99.1%. The positive predictor value 
was 1.19% and the negative predictor value was 99.14%. 
There was no significance and no difference with model type.  
The 65-74 group were less likely than 18-24 group to reliably improve, and the 
retired group 1.85 times more likely to reliably improve than the employed group. 
There was no significance with the additional GAD7 scores, and completed treated 
was the most likely discharge reason.  
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PHQ9 severe- no change (Appendix 122 ) 
The data were shown to fit the model using the Hosmer and Lemeshow test (p ˃ 
.05). The logistic regression model was statistically significant, with X2(21) =737.800, 
p ˂ .001. The model explained 31.5% of the variance in the no change outcome 
(using Nagel-kerke’s R2), and correctly classified 73.9% of the cases. Sensitivity was 
59.3%, specificity was 81.2%. The positive predictor value was 59.3% and the 
negative predictor value was 81.17%. 
The model type was significant with no change less likely to occur with the 
progression model. 
Those scoring severe and with a disability were 1.38 times more likely to have no 
change. 3 groups in employment status were significant, with unemployed 1.95 times 
more likely, sick and disabled 2.03 times more likely, and homemaker 1.72 times 
more likely than those employed to have no change.  All discharge reasons were 
significant, with dropped out 8.04 times more likely, not suitable 8.90 times more 
likely, declined 6.36 times more likely and referred on 11.63 times more likely to be 
discharged with no change than those completed treatment.  
PHQ9 severe- reliable deterioration (Appendix 123 ) 
The data were shown to fit the model using the Hosmer and Lemeshow test (p ˃ 
.05). The logistic regression model was statistically significant, with X2(21) =737.800, 
p ˂ .001. The model explained 31.5% of the variance in the reliable deterioration 
outcome (using Nagel-kerke’s R2), and correctly classified 73.9% of the cases. 
Sensitivity was 1.5%, specificity was 100%. The positive predictor value 
was 1.53% and the negative predictor value was 100%. 
The model type was not significant.  
The unemployed group was 2.78 times more likely, sick and disabled 3.26 times 
more likely, and homemaker 3.16 times more likely to reliably deteriorate than the 
employed group. Only the additional GAD7 severe scores were significant with these 
less likely to reliably deteriorate. All discharge reasons were significant, with dropped 
out 9.37 times more likely, not suitable 20.68 times more likely, declined 6.04 times 
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more likely, and referred on 17.11 times more likely to be reliably deteriorated than 
the completed treatment group.  
Psychological measures Initial score severity – GAD7 
 
GAD7 moderate  
GAD7 moderate – recovered (Appendix 124 ) 
The data were shown to fit the model using the Hosmer and Lemeshow test (p ˃ 
.05). The logistic regression model was statistically significant, with X2(22) =92.790, 
p ˂ .001. The model explained 40.6% of the variance in the recovery outcome (using 
Nagel-kerke’s R2), and correctly classified 76.5% of the cases. Sensitivity was 
87.1%, specificity was 63.4%. The positive predictor value was 87.1% and the 
negative predictor value was 63.37%. 
The model type was significant (p ˂ .001) with the GAD7 moderate group 1.49 times 
more likely to recover in the progression model.  
The 35-44 group was 1.56 times more likely, 44-54 group 1.66 times more likely and 
the 65-74 group 4.03 times more likely to recover than the 18-24 group. 
Unemployed, sick and disabled, homemaker and retired were all significantly less 
likely to recover than the employed group. With additional PHQ9 scores the 
moderate/severe and severe group were both significantly less likely to recover. All 
discharge reasons were less likely to recover than the completed treatment group.  
GAD7 moderate – reliable improvement (Appendix 125) 
The data were shown to fit the model using the Hosmer and Lemeshow test (p ˃ 
.05). The logistic regression model was statistically significant, with X2(22) =158.098, 
p ˂ .001. The model explained 10.3% of the variance in the reliable improvement 
outcome (using Nagel-kerke’s R2), and correctly classified 84.4% of the cases. 
Sensitivity was 0%, specificity was 100%. The positive predictor value was 0% and 
the negative predictor value was 100%. 
The model type was significant with those scoring moderate GAD7 less likely to 
reliably improve in the progression model.  
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With additional PHQ9 scores, the moderate group were 4.40 times, moderate/severe 
9.66 times, and severe 15.11 times more likely to reliably improve. The dropped out 
group were 1.57 times, declined 1.77 times, and referred on 1.70 times more likely to 
reliably improve than the completed treatment group.  
GAD7 moderate – no change (Appendix 126 ) 
The data were shown to fit the model using the Hosmer and Lemeshow test (p ˃ 
.05). The logistic regression model was statistically significant, with X2(22) =397.927, 
p ˂ .001. The model explained 21.9% of the variance in the no change outcome 
(using Nagel-kerke’s R2), and correctly classified 78.3% of the cases. Sensitivity was 
24.9%, specificity was 93.9%. The positive predictor value was 24.87% and the 
negative predictor value was 93.85%. 
The model type was significant with a no change outcome less likely in the 
progression model.  
All age groups were significantly less likely to have a no change outcome than the 
18-24 group. Unemployed were 1.52 times, and sick and disabled 11.77 times more 
likely to not change compared to the employed group. Dropped out were 6.67 times, 
not suitable 3.48 times, declined 4.15 times and referred on 5.62 times more likely to 
not change than the completed treatment group.  
 GAD7 moderate – reliable deterioration (Appendix 127 ) 
The data were shown to fit the model using the Hosmer and Lemeshow test (p ˃ 
.05). The logistic regression model was statistically significant, with X2(22) =256.609, 
p ˂ .001. The model explained 25.1% of the variance in the reliable deterioration 
outcome (using Nagel-kerke’s R2), and correctly classified 93.5% of the cases. 
Sensitivity was 1.8%, specificity was 99.8%. The positive predictor value 
was 1.8% and the negative predictor value was 99.83%. 
The model type was not significant.  
Men were less likely to reliably deteriorate than women. The Unemployed were 3.67 
times, sick and disabled 4.19 times, and retired 3.90 times more likely to reliably 
deteriorate than the employed group. With additional PHQ9 scores, the moderate, 
moderate/severe and severe group were significantly less likely to reliably 
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deteriorate than the minimal group. The dropped out were 10.08 times, not suitable 
26.48 times, declined 5.83 times and referred on 18.26 times more likely to reliably 
deteriorate than the completed treatment group.  
GAD7 severe 
GAD7  severe– recovered (Appendix 128 ) 
The data were shown to fit the model using the Hosmer and Lemeshow test (p ˃ 
.05). The logistic regression model was statistically significant, with X2(22) 
=1805.039, p ˂ .001. The model explained 43% of the variance in the recovery 
outcome (using Nagel-kerke’s R2), and correctly classified 76.8% of the cases. 
Sensitivity was 73.3%, specificity was 78.7%. The positive predictor value 
was 73.27% and the negative predictor value was 78.74%. 
The model type was significant with those in the progression model 1.55 times more 
likely to recover than in the allocated model.  
65-74 group were 2.49 times more likely to recover than the 18-24 group. All 
employed groups were less likely to recover than the employed. Additional severe 
PHQ9 scores were less likely to recover, and all discharge reasons were less likely 
to recover than the completed treatment group.  
GAD7  severe– reliable improvement (Appendix 129) 
The data were shown to fit the model using the Hosmer and Lemeshow test (p ˃ 
.05). The logistic regression model was statistically significant, with X2(22) =100.910, 
p ˂ .001. The model explained 2.9% of the variance in the reliable improvement 
outcome (using Nagel-kerke’s R2), and correctly classified 66.5% of the cases. 
Sensitivity was 0.2%, specificity was 99.7%. The positive predictor value 
was 0.24% and the negative predictor value was 99.68%. 
The model type was not significant.  
65-74 group were less likely to reliably improve compared to the 18-24 group. With 
additional PHQ9 moderate/severe scores they were 2.71 times more likely, and the 
severe group 3.22 times more likely to reliably improve than the minimal PHQ9 score 
group. Dropped out were 1.41 times, and declined 1.32 times more likely to reliably 
improve than the completed treatment group.  
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GAD7  severe– no change (Appendix 130 ) 
The data were shown to fit the model using the Hosmer and Lemeshow test (p ˃ 
.05). The logistic regression model was statistically significant, with X2(22) 
=1175.417, p ˂ .001. The model explained 31% of the variance in the no change 
outcome (using Nagel-kerke’s R2), and correctly classified 75.8% of the cases. 
Sensitivity was 51.3%, specificity was 85.6%. The positive predictor value 
was 51.27% and the negative predictor value was 85.58%. 
The model type was significant with the progression model less likely to have a no 
change outcome with this group.  
Unemployed were 1.78 times, sick and disabled 2.04 times, homemaker 1.81 times 
and retired 1.76 times more likely to not change compared to the employed group. 
There was no significance with PHQ9 scores. The dropped out group were 8.20 
times, not suitable 8.42 times, declined 6.93 times and referred on 10.93 times more 
likely to not change than the completed treatment group.  
GAD7 severe– reliable deterioration (Appendix 131 ) 
The data were shown to fit the model using the Hosmer and Lemeshow test (p ˃ 
.05). The logistic regression model was statistically significant, with X2(22) =197.330, 
p ˂ .001. The model explained 21.5% of the variance in the reliable deterioration 
outcome (using Nagel-kerke’s R2), and correctly classified 97.8% of the cases. 
Sensitivity was 0%, specificity was 100%. The positive predictor value was 0% and 
the negative predictor value was 99.97%. 
The model type was significant, with this group less likely to reliably deteriorate in the 
progression model.  
The unemployed were 2.26 times more likely to reliably deteriorate than the 
employed. The additional severe PHQ9 group were significantly less likely to reliably 
deteriorate. The dropped out group were 6.48 times, not suitable 9.06 times, 
declined 9.62 times and referred on 12.93 times more likely to be reliably 
deteriorated.  
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7.4 Summary of results 
The descriptive analysis shows a normal distribution of the clinical population of this 
study site, regarding demographics and psychological measures. Chi square tests 
show a significant association between recovery and all cohort groups, including the 
sensitivity analysis of isolating years 2 and 4.  
Score severity impact 
The association between the two psychological measures and the outcomes in the 
logistic regression results show that compared to moderate to severe in one and 
minimal in another, if there are moderate to severe scores in one and the other, the 
recovery outcome is less likely, interestingly the reliable deterioration outcome is 
also less likely but the reliable improvement outcome is more likely. Therefore 
confirming a clinical picture that a combined higher initial score on both measures is 
less likely to achieve recovery, but may reliably improve.  
Allocated versus progression model 
Moving to a progression model increases the dosage of treatment sessions for those 
stepped up, compared to an allocated model by 1-2 sessions. As the rate of 
completed treatment rises, the dropout rate is reduced, with a larger difference in the 
North between models. Basic calculations demonstrate that the recovery outcome 
demonstrably increases in year 4 compared to others, with a comparable decrease 
in reliable improvement, no change, and reliable deterioration. Of particular note, is 
the difference of recovery percentage in the South, between years 3 and 4, when in 
year 4 the progression model is fully embedded.  
Table 15: Mean recovery outcome, by model and by cohort 
 
Allocated Progression
Whole service 41.4 46.1
North 42.8 46.9
South 40.1 49.7
Sensitivity analysis
(Yrs 2&4)
39.6 49.2
Recovery rate (mean %)
Cohort 
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The above table 15 demonstrates a 4-10% mean difference in reliable recovery 
outcome attainment in favour of the progression model, with chi square tests 
demonstrating statistical significance. (p=˂0.001).  
The results demonstrate the progression model achieves more recovery, between 4-
10%, and is statistically significant. Further analysis with logistic regression of years 
2 and 4 showed that patients were 1.527 times more likely to recover in the 
progression model than the allocated model.  
 
Table 16: Logistic regression of years 2 & 4 cohort recovered outcome 
 
Note: Allocated model is the reference, therefore figures shown are the values for the progression 
model compared to the allocated model 
Score severity and model type 
For both psychological measures the logistical regression shows that the higher the 
initial score group, the less likely that patient was to recover, and this applies in both 
the allocated and the progression model. The analysis of the end scores for 
moderate to severe PHQ9 and GAD7 showed that there is a 5% mean difference in 
favour of the progression model, with chi square tests demonstrating statistical 
significance. . (p=˂0.001). 
Table 17: Mean below caseness end score attainment of participants with moderate / severe entry scores and by 
model 
 
According to the cross tabs and chi square tests the progression model does not 
adversely affect those who score moderate to severe at entry to treatment, 
conversely more (5%) achieve below caseness on each measure in a progression 
model. Further with the years 2 and 4 cohorts, the progression model achieves a 
mean recovery that is 10% more than allocated. Comparing the model type logistic 
regression results, although both models allocated or progression show that the 
Upper Lower
Recovered 0.424 0.056 57.075 0 1.527 1.368 1.705
SE Wald Sig. Exp(B)
95% C.I. for EXP(B)
B
Measure Allocated Progression
PHQ9 24.90% 29.30%
GAD7 31.20% 36.00%
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PHQ9 moderate to severe groups are less likely to recover than the minimal group, it 
likely to recover than the progression.  
 
Table 18: Summary of logistic regression for PHQ9 severity groups and outcome 
 
Note: the reference group is the minimal score group, therefore the figures shown are the values of 
each severity group compared to the minimal group.  
 
This is a similar result with the reliable improvement outcome where it appears that 
participants in either model are more likely to reliably improve than the minimal 
groups however the odds ratio is better in the progression model. A no change 
outcome appears more likely in the progression model, and a reliable deterioration 
outcome more likely in the allocated model.  
The regressions using the score severity cohort groups show a clear result in terms 
of recovery, where moderate, moderate/severe and severe all showed significantly 
more likely to recover in the progression model. 
The results for the GAD7 moderate to severe groups are less clear cut, they appear 
least likely to recover or reliably improve in the progression model when compared to 
the GAD7 minimal group, however the isolated score groups regressions showed 
that both moderate and severe groups were more likely to recover in the progression 
model.  
 
 
Upper Lower
Recovered 0.244 0.111 4.850 0.280 1.277 1.027 1.587
Reliable Improvement -0.016 0.141 0.012 0.912 0.985 0.747 1.298
No Change -0.249 0.121 4.218 0.040 0.780 0.615 0.989
Reliable Deterioration -0.069 0.200 0.119 0.731 0.933 0.630 1.382
Recovered 0.584 0.098 35.493 0.000 1.794 1.480 2.174
Reliable Improvement -0.346 0.093 13.743 0.000 0.708 0.589 0.850
No Change -0.128 0.105 1.486 0.223 0.880 0.717 1.081
Reliable Deterioration -0.440 0.205 4.619 0.032 0.644 0.431 0.962
Recovered 0.474 0.105 20.472 0.000 1.606 1.308 1.972
Reliable Improvement -0.054 0.082 0.431 0.512 0.948 0.808 1.112
No Change -0.311 0.094 10.886 0.001 0.733 0.609 0.882
Reliable Deterioration -0.196 0.282 0.485 0.486 0.822 0.473 1.427
Moderate
Moderate / 
Severe
Severe
B SE Wald Sig. Exp(B)
95% C.I. for EXP(B)
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Table 19: Summary of logistic regression for GAD7 severity groups and outcome  
 
Note: the reference group is the minimal score group, therefore the figures shown are the values of 
each severity group compared to the minimal group.  
Compared to the minimal group, the moderate recovers better in the allocated 
model, for severe both recover however the odds ratios are higher in the allocated 
model. Regressions using score severity cohorts showed the moderate group less 
likely to reliably improve in the progression model. Also the progression model 
appears to be more likely to have no change, however the results are either less 
distinct or not significant for reliable deterioration and moderate or severe GAD7 
scores.  
Therefore compared to their minimal groups both PHQ9 and GAD7 moderate to 
severe groups are more likely to recover in an allocated model. However the 
regressions of the moderate to severe scores cohorts showed that PHQ9 scores and 
GAD7 moderate to severe groups are all more likely to recover in the progression 
model than the allocated model. The progression model is also more likely to 
achieve more reliable improvement for PHQ9 moderate to severe; however for 
GAD7 the likelihood for reliable improvement is better in the allocated model. 
Discharge reasons 
The discharge reasons analyses shows statistical significance that completing 
treatment is more likely to have a recovered outcome. Proportionally there is no 
difference between the model type and dropout rate, Although in the separate model 
type regressions, the odds ratios are more in the progression model for all the 
discharge reasons, this includes the completed treatment reason also. As there has 
not been a specific regression grouping discharge reasons to test the predictability of 
model type, it can only be said that the odds ratios are higher in the progression 
model for all discharge reasons. In terms of the score severity groups, the more 
Upper Lower
Recovered 0.400 0.099 16.165 0.000 1.491 1.227 1.812
Reliable Improvement -0.250 0.115 4.739 0.029 0.778 0.621 0.975
No Change -0.258 0.106 5.887 0.015 0.773 0.628 0.952
Reliable Deterioration 0.049 0.180 0.075 0.784 1.051 0.738 1.496
Recovered 0.436 0.076 33.002 0.000 1.546 1.333 1.794
Reliable Improvement -0.101 0.064 2.504 0.114 0.904 0.798 1.024
No Change -0.234 0.075 9.672 0.002 0.791 0.683 0.917
Reliable Deterioration -0.532 0.218 5.944 0.015 0.587 0.383 0.901
Severe
SE Wald Sig. Exp(B)
95% C.I. for EXP(B)
Moderate
B
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severe the initial scores the more likely they would be discharged as dropped out, 
not suitable or referred on.  
Therefore a conclusion can be made that overall proportionally there is no difference 
in dropout rate with model type. Compared to the allocated model, the progression 
model achieves 10% more, and there is a statistically significant likelyhood of 
recovery for both measures and more reliable improvement for PHQ9 moderate to 
severe groups, however it appears to need to offer an average 1-2 more sessions 
overall to patients that are stepped up.  
Baseline factors impact 
Descriptive analysis shows that proportionally there are more younger women than 
men, with the difference in gender decreasing as the age bands rise. There is a rise 
in proportion of registered disabled within the 45-54, and 55-64 age bands, with a 
larger proportion being male.  
Chi square tests show there is no significant association between cohorts, outcomes 
and gender, which is also confirmed by the logistic regression where there was no 
significance and odds ratios similar across both models. The only anomaly within this 
was that the GAD7 moderate group showed that men were less likely to reliably 
deteriorate than women. Generally, overall however, gender does not have an 
influence on any outcome.  
There is a significant association between disability and all cohorts and outcomes, 
apart from the South, where there is a weaker association for recovery, and non-
recovered, and no association for reliable improvement and reliable deterioration. 
However logistic regression showed no significance and odds ratios were similar 
across both models. The only anomaly was that the PHQ9 severe group with a 
registered disability were more likely to have a no change outcome. However in 
general a registered disability does not have any influence on outcomes.  
Chi square tests show a significant association between all cohorts, outcomes and 
age, although the South has a weaker association with all outcome areas and is not 
significant for reliable deterioration. Regression showed that the 18-24 group does 
not do as well as the others, with a distinct poorer recovery than other age groups in 
the GAD7 moderate group. However the age group that showed significance across 
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all areas in logistic regressions was the 65-74 group. This group, and  across all 
score severity groups appeared more likely to recover in the allocated model, 
however they are also more likely to reliably deteriorate too, and less likely to attain 
no change or reliable improvement in the allocated model.  
Chi square tests showed there is a significant association for employment status, 
outcomes and all cohorts. Logistic regression showed a clear result that the 
employed group are more likely to recover, and appeared more so in the progression 
model. The logistic regression tests showed that in terms of model type the 
unemployed, sick or disabled, homemaker and retired appeared to do better in a 
progression model, but are less likely to recover. In particular the unemployed or sick 
or disabled, are more likely to not change or reliably deteriorate (there was only a 
small difference between models), and the more severe the PHQ9 and GAD7 scores 
were the more likely these outcomes would occur. Given the result that a registered 
disability does not appear to influence outcome, an assumption could be made that it 
is the more general self-reporting sick or perceived disability that impacts on 
outcomes. The retired group appeared more likely to recover, reliably improve or not 
change in the progression model, This is an interesting result considering the age 
group 65-74 are more likely to recover in the allocated model, it may be that there 
are more patients from the younger age groups that fall into the retired group 
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Chapter 8: Discussion 
The two key research questions were regarding the impact of different stepped care 
models on outcomes, and also how moderate to severe presentations may impact 
on outcomes, and whether there was a difference for these in terms of model design 
and outcome. The results show that the progression model achieves better 
outcomes, consistently across the different cohorts including the sensitivity analysis, 
with a 10% proportional difference, and statistical significance of 1.53 times more 
likely for recovery than the allocated model. Furthermore, the patients with initial 
scores in the moderate to severe on both psychological measures are all shown with 
statistical significance to recover, and the moderate to severe PHQ9 groups are 
shown to be more likely to reliably improve, in the progression model, compared to 
the allocated model. One of the ‘costs’ of attaining better outcomes does appear to 
be an increase of 1-2  treatment sessions for patients stepped up in the progression 
model,  
Subsidiary research questions were whether any baseline factors such as patient 
characteristics had any relationship with the outcomes. The results show that gender 
and registered disability do not make a difference, but employment status does have 
a relationship, with being employed more likely to recover, and being unemployed, 
sick or disabled, a homemaker or retired was associated with a less likely to 
recovery outcome. The only age group to show a significant relationship with 
recovery was the 65-74 group.  
There are, as with any study, limitations with the methodology, and given the 
observational nature of the study, the associations demonstrated within the results 
do not prove causality, there are potentially confounding factors that are uncontrolled 
which may also have a relationship with the outcomes.  A more detailed discussion 
of the meaning of the results is presented, with limitations of the methodology and 
the study, and future recommendations.   
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8.1 Descriptive analysis 
No further analysis on the variable categories Ethnicity or referred problem was 
undertaken due to low numbers in categories other than White British, and a lack of 
confidence in the data regarding referred problem, as there was a concern this may 
give false meaningful results.  
In terms of Ethnicity, the data is not as robust. The service was quite poor in the first 
few years at collating and recording this particular information as can be seen by the 
amount of ‘not stated’ in the first 2 years, subsequently decreasing considerably in 
the next 2 years as systems were improved to ensure this data was collected. Year 4 
data regarding ethnicity gives a more accurate picture of the ethnic representation of 
the participants, over 93% recorded as White British, and less than 1% in each of 
any of the other categories, and 4% not stated. Compared to the national picture this 
study appears to have a much lower representation of ethnic groups other than 
White British, with 80.5% of the general population recorded as White British. (52) It is 
possible that the clinical population is more skewed where ethnic minority groups 
may be less likely to access services, there was an under –representation of other 
ethnic groups reported in the year one evaluation of IAPT (11), and certainly an 
analysis of IAPT data nationally indicates this may be the case with 89% of those 
accessing treatment recorded as White British. (53)  Although the results show some 
interesting distribution in the entry scores, with African and white and black African 
scoring significantly higher on PHQ9 than others, the sample size is too small (total 
n=9) to be generalizable or valid for further analysis.  
The ‘coding of referred problem’ occurs at triage stage, which is based on varied 
levels of information depending on whether it is a brief letter from the GP, or an initial 
discussion between the patient and a clinician, where it is a self-referral, of which the 
service has seen a steady increase. IAPT services generally collect this information, 
and it is collated nationally as referrals received by provisional diagnosis. The picture 
nationally looks very similar to this study site, with mixed anxiety and depression, 
depressive episode and generalised anxiety disorder being the top three codes, by 
significant margins. (53) The varied level of information does not give a confidence in 
the decision of category of referred problem and is something that would be useful 
for the service to also undertake after assessment, where the standardisation of the 
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assessment would at least provide the assurance of the same framework for 
analysis of information, reducing the effect of quality of information. The recent 
systemic review Firth et al (38) showed that there were issues in a number of studies 
of clarity on diagnostic criteria and relating clear outcomes to specific disorders. 
Clearly there is a need for both practice and research to improve identification and 
categorisation of disorders to be able to effectively relate this to outcome evaluation.  
Gender distribution within the general population nationally and locally is similar, 
49% male and 50% female. For those accessing treatment in this study, 
proportionally there is a consistent average of 37% male, and 63% female, the 
gender distribution is consistent across years, and no significant difference in 
cohorts. Across IAPT services the distribution is very similar with 36% male, 63% 
female and 1% not recorded, (53)  and HSCIC state that this is much “more 
pronounced gender difference than has been seen in secondary mental health care”- 
quoting the 2012/13 Mental Health Bulletin 44% male and 56% female as an 
example. This seems to indicate that at a primary care level women are more likely 
to engage in a talking therapy than men.  
The increase incrementally over the years in the numbers of the younger age groups 
can be explained by a targeted referral recruitment, pathway and treatment by the 
service of “academic wellbeing” with students at the local university. The distribution 
of age and gender (appendices 8,9, 11) shows an interesting pattern where of the 
whole sample, the greatest proportion of women completing treatment is in the 
younger to mid age groups (24-34 – 25.1%, 35-44 – 23.4%) is greater than men.   
However this shifts in the middle age groups, with the largest proportion of men 
completing treatment, 24.9%, occurring in the 45-54 age group. Both the age 
distribution and gender /age proportion corresponds with the national IAPT picture. 
(53) Men are more at risk of depression and suicide, three times more than females, 
with the highest rate of suicide for men in the 40-44 age bracket. (54) What is not clear 
is whether younger men are poorer at engaging in treatment, and older men more 
likely to engage, or are younger men less likely to suffer anxiety or depression, or 
less likely to recognise the problems and seek help? There is a link with other factors 
and older men which increase the risk with significant life events such as 
divorce/separation, other loss, redundancy, unemployment. (55) Therefore it would 
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appear that the accumulativeness of significant life events may make older men 
more likely to exhibit mental health problems that are perhaps more severe that they 
then may access treatment.  
The amount of participants classified as disabled significantly rose from 3-4% in both 
years one and two to just less than 10% in both years 3 and 4. This could be 
attributed to at the same time the service was developing and delivering specific 
treatment to those with long term conditions, of which some may be classed as a 
disability, or may be correlated with other disabling conditions. It would appear that 
there is an interesting proportional difference with more men likely to be registered 
disabled at 9.1%, compared to females at 6.7%. According to the analysis in this 
study there appears to be a rise in middle-aged men and registered disabled 
accessing treatment, therefore developing a long term condition or becoming 
disabled may be one of the significant life events that links with mental ill health 
particularly for men, or it may be they are more willing to access treatment for mental 
health having had to access treatment for physical health problems too. There is 
something of interest here to explore further in terms of outcomes. Although the 
results appear to indicate that gender does not impact on outcome, it may be worth 
exploring the relationship with multiple factors, such as gender, disability, 
employment impact on outcome and whether combined impact on likelihood of 
recovery?   
Another interesting observation is the decrease in entry scores for the older age 
groups, on face value this could imply that this group are not as depressed or 
anxious as younger age groups, or It is possible that the older population are less 
likely to access or be referred to mental health services as they may not be as aware 
of the symptoms of mental health problems, or it is possible that mental ill health 
symptoms are more easily misinterpreted as physical symptoms, for instance 
memory problems through depression compared to natural memory decline with 
age, or shallow breathing common with anxiety, difficult to distinguish from asthma or 
chronic obstructive pulmonary disease (COPD). Alongside the likelihood of a 
physical long term condition increases with age, and the figures here demonstrate 
that this is the case, with the proportion of those registered disabled by age category 
rising in the older age groups to 19.3% of those aged 75 -84, and 40% of those aged 
85-94 (Appendix 15), all may be contributing to an under representation of the older 
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population accessing psychological therapy.  Lastly there is a caution about what the 
data may imply for this age group given the sample size of n=181 in 75-84, and n=35 
in 85-94 across all 4 years and therefore is it generalizable to the whole population in 
this age group, or in this age group with mental health problems, as it is likely that 
there are significantly more older people suffering from anxiety or depression than 
are presenting to this service. Certainly the findings are consistent with the national 
statistics of referrals of 65+ to IAPT services being lower than expected. (56) There is 
a question here regarding the potential reasons for low engagement, and 
implications for service improvement. Is it a cultural generational perception and /or 
misinterpretation of symptoms by patients and professionals that prevents older 
people from accessing psychological treatment, and how can services reach out and 
change those perceptions and misinterpretations, thus removing the barrier to 
engagement? Certainly a recent health survey (57) regarding attitudes to mental 
illness found that attitudes and tolerance varies with age, where “the most prejudiced 
attitudes were held by participants aged 65 and over.” If there is a perception that 
those with a mental illness are ‘weak’ then it is likely that this will also apply to self, 
and that seeking help risks the same judgment from others, then this is likely to be a 
barrier to engaging in seeking and receiving treatment. It is interesting that the 65+ 
groups have good recovery rates and recover better in the allocated model. This 
could be due to a possible preference of face to face treatments, as the step 2 
interventions are more remote and perhaps more technical i.e. telephone, or 
computerised. This could be a barrier to access or recovery for older people, it is 
reasonable to predict that this will change as the more technology comfortable 
generation get older, the current picture  is something for services to consider, given 
the under- representation of the older age group accessing treatment.  
Employment status (Appendix 3) at first session is slightly higher than  the national 
IAPT rate of 46%, (53) and shows the proportion of those employed remains 
consistent at nearly half (47.5% average) across the years, even with a much larger 
number of participants by  year 4. Interestingly for those unemployed there is a 
proportional decrease from 27% year 1 to 18.5% year 4. In terms of this sample, it 
could have been caused by the small increase of students each year, and also a 
larger increase of sick or disabled by year 4 in comparison to year 1 from 6.7% to 
14%. These increases are probably attributed to the Academic wellbeing programme 
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as mentioned previously and the increased targeting of patients with long term 
conditions by the service. However external factors could affect the proportion 
registered as unemployed such as more obtaining work, or changes in benefits, 
therefore not officially registered as unemployed.  Similarly to age, the HSCIC (57) 
health survey of attitudes to mental illness in England found that prejudice, tolerance 
and support for community care was associated with socio-economic factors, such 
as education and employment status, with the lowest incomes, those in most 
deprived areas, no qualifications, unemployed or retired, all had the least positive 
attitudes towards mental illness. Again this will also likely be a self-reflective attitude 
and may impact on accessing or engaging with a talking therapy as treatment, for 
fear of feeling weak or judged by others.  
The information on employment status provided by the participant at the last session 
shows a similar picture to that of the first session, with some very small differences, 
where some participants’ employment or other status has changed during therapy; 
the majority have remained the same. One of the key performance indicators that 
IAPT services are measured on is the number of people that move to employment 
during therapy, with the assumption that their mental health problems are a barrier to 
obtaining employment.  With an average dosage of  6 or 7 sessions (usually weekly) 
in this sample depending on service model, this may be too high an expectation, that 
an unemployed participant will seek and find work in less than 2 months from the 
commencement of therapy.  As there is no national IAPT mandate to obtain specific 
follow up information regarding employment status of all patients sometime after 
treatment completion, it is difficult to link recovery or improvement in mental health 
directly to employment change.  
8.2 Treatment dosage 
As early as 2000, Lovell and Richards (15) argued that some patients get too much 
treatment and some too little, because not enough is known about the optimal 
number of sessions for a type of patient. This study observed a fair consistency 
between cohorts regarding dosage of treatment. This is to be expected with step 2 
interventions as they are prescribed and manualised with a set number of sessions. 
High intensity has much more flexibility, with NICE guidelines advocating 12-20 
sessions depending on disorder. Gyani et al (11) found that “services that offered 
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higher median rates of low intensity and high intensity treatment sessions had overall 
higher recovery rates.” However they do not say what that median is, and whether it 
is within the range of NICE recommended dosage, particularly for high intensity. The 
service has always advocates that therapists follow NICE guidelines but has not 
been prescriptive regarding minimum dosage of step 3, rather the service has 
advocated a collaborative patient/therapist decision regarding treatment completion, 
to allow for idiosyncratic adjustments within the treatment plan. It is an interesting 
result to note that at step 3 only, the average number of sessions is virtually the 
same in each cohort model type, with one session more occurring in the progression 
model across all cohorts. Given the anecdotal concern about the progression model 
in the South area, it could be assumed that more sessions would be delivered, 
however this is not the case.  
With those that have been stepped up, so initially received a step 2 intervention, not 
recovered and thus received a step 3 intervention, the total dosage is more than step 
3 alone, but only by on average 2 sessions. The largest difference appears to be in 
the progression model rather than allocated, and particularly in the North where the 
difference between step 3 only and stepped up total dosage is an average of 3 
sessions, and between allocated and progression stepped up dosage an increase of 
an average 2.5 sessions. Therefore it would appear that either through natural 
treatment end or by drop out, the average step 3 dosages is less than NICE 
guidelines. This could support the notion that perhaps some patients need less 
treatment than guidelines advise. (15) Stepped up results show that patients do not 
receive a much larger dosage of therapy, but on average it increases by 1-2 
sessions. This is still slightly less than the minimum recommended NICE guidelines 
for step 3 of 12 sessions in CBT, however in terms of dosage a combined step 2 and 
3 treatment delivery brings the dosage closer to the recommended guidelines.  This 
study has not calculated the specific difference in numbers regarding increased or 
decreased dosage of treatment at different steps and within models linked to 
outcomes to work out if there is an effect of dosage on outcomes. This could be 
worth further exploration.  
An interesting comparison can be made with this study’s results to the Chan & 
Adams (44) study where the mean dosage in step 3 is higher (8.95) but lower for low 
intensity (3.99) than in this study, and overall they reach a higher recovery rate at 
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52.6%, with a proportional difference of recovery between steps (50% high, 55.3% 
low). It is possible that as suggested by Gyani et al (11) the higher dose at step 3 
effects better recovery rates than have been achieved in this study. However further 
on in time nationally the HSCIC report (53) which collates statistical data on all IAPT 
services reported that the majority of completed treatments had 5 or fewer sessions, 
with the median being 5. This varies in terms of type of disorder, however what is 
interesting is that the mean number sessions for each disorder is consistently less 
than the NICE guidelines recommend.  
It is difficult to compare the discharge reasons with the Chan & Adams (44) study as 
their analysis was based on a much smaller sample (n=100) compared to this study 
(n= 16,723), however proportionally it does appear that the dropout rate in this study 
is higher, the did not attend (DNA) policy and therefore the probable criteria 
distinguishing drop out and the attempts to keep patients engaged appears similar.  
Seekles et al (40) found a higher dropout rate at lower intensity level treatment, and 
Firth et al (38) states that “failure to respond to the initial step may actually discourage 
patients from further engagement across higher steps.” This might be a possibility, 
and is anecdotally one of the concerns raised by clinicians with respect to the 
progression model, however interestingly this study’s results show a reduction 
dropout rate incrementally through the years, with the North area has the larger 
decrease, the South only 1 % difference. This may be indicative of the North having 
2 years to embed the progression model and therefore patient flow through the care 
pathway may be quicker. It would have been useful here to consider waiting times 
for treatment also as a potential influencing factor.  
Regression results of the model type cohorts appear to indicate that in comparison to 
completed treatment the likelihood of dropped out is relatively higher in the 
progression model, however as is the likelihood of completed treatment, so all that 
can be inferred here is that all discharge reasons appear more likely in the 
progression model rather than it meaning that it is more likely to have drop outs, as 
there has not been a specific regression on the discharge reason cohort to test the 
predictability of the model type. Receiving a step 2 intervention in the first instance 
may not be all patients preference of treatment type, however if the treatment is 
received quicker than a step 3 intervention, it may be that shorter waiting time for 
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treatment is the contributing factor to treatment completion. What does not appear to 
be measured in relevant studies is patient preference for specific treatment type 
preferred over receiving treatment quickly, and the relationship to outcome. Not 
enough is known about what characteristics or types of people are suited to different 
types of intervention, and who is more likely to complete treatment and recover. 
“This raises the key dilemma in stepped care systems of balancing the efficient 
distribution and composition of organisational resources across various steps and 
the importance of access to a choice of effective and comprehensive treatments in 
the early steps.” (38) Arguably there is often an assumption that patient choice 
predicts treatment completion and therefore more likely recovery; however this is a 
variable that does not appear to be tested in the literature, in terms of patient choice 
and its relationship with completion and outcome or lack of choice and relationship 
with dropout or outcome. Although this study did not specifically look at the treatment 
type or disorder type and number of sessions, the results do appear consistent with 
the national IAPT picture. Overall there is a question raised around whether the 
number of sessions recommended by NICE guidelines is, in practice, suitable for all, 
the evidence would suggest not.  
8.3 Psychological measures analysis  
Generally the distribution including the mean and standard deviation of first scores 
appears normal, i.e. the spread looks similar across all 3 measures used, providing 
some assumption of validity.  There is an increase from years 1 to 2, in the score 
severity. It is likely that by year 2 referrers and the service alike became more 
familiar with the referring criteria, and from years 2 onwards the severity of referral 
moved to a more settled picture. 
With both the PHQ9 and GAD7 scorings, the detail of change from years 1 to 2 is 
similar, apart from a small change at PHQ9 moderate  level (2.2% decrease), the 
moderate to severe scores in both measures across the years remaining at a static 
level. However the bigger change is a decrease in the volume scoring minimal and 
mild, and a corresponding increase in volume scoring severe in both measures. 
There it appears that there is an increase in severity of scores in terms of the 
patients referred to the service. This may be due to the increase of referrals from a 
wider source, it may be over time referrers increase their understanding and 
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confidence in the service as they become more familiar. What is important is that 
around 50% of those entering treatment score in the moderate to severe range 
which is not the same as the predicted level initially recommended, where it was 
expected that IAPT would treat as a majority mild to moderate presentations. (46) 
The difference in distribution of entry scores in terms of the older age groups has 
already been mentioned, more specifically the norm for GAD7 scores appears to be 
fairly consistent across the age groups, however not for PHQ9 and WSAS, where 
what is noticeable is a norm of less severe scores on both these measures for those 
aged over 65 onwards. Whilst this could infer that older people are less depressed, 
and their problems impact less on their functioning, the HSCIC report (53) shows a 
comparison of IAPT use and specialist mental health services by age distribution 
demonstrating that the numbers using more specialist service significantly rises with 
age. This could of course be affected by cognitive impairment disorders such as 
dementia, and also physical health needs requiring a holistic care co-ordination. 
It is more likely that the lower scores are due to perceptions of older people 
regarding their symptoms and believing them to be symptoms of physical problems 
only or the aging process rather than recognising them as part of a mental health 
condition. As mentioned in section 8.1, older people are more likely to have a 
negative attitude towards mental illness and therefore this could impact on accessing 
and engaging in treatment.  
8.4 Outcomes 
Although the progression model was implemented more robustly in years 3 and 4, it 
would be expected even within this model that some referrals would enter straight 
into step 3, (i.e. re-referrals previously discharged at step 2) and this is why in the 
progression model it is not 100% that enter step 2 first.   
The findings indicate that the proportion of participants that recovery is greater, in the 
progression model than the allocated, there is reduced reliable deterioration with 
progression consistent with all the variations of cohort design. (Table 7, appendix 
31).  
One explanation could be that regardless of model, the service would have naturally 
improved over time, and therefore the apparent effect of the progression model is a 
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coincidence, a cohort effect. Gyani, Shafran, Layard & Clark (11) looked at routine 
data within year 1 of 32 IAPT services in an observational cohort design, exploring 
predictors of variability of outcome. The sample size used is similar to whole dataset 
in this study; however it is comparing 32 sites over the same time period, rather than 
one site’s data over 4 years. Logistical regression is used to test compliance or 
deviation from NICE treatments, controlling for scores. Findings showed reliable 
recovery to be at 40.3% with a range variation of 23.9% to 56.5% (SD = 8%). The 
Improving Access to Psychological Therapies (IAPT) Executive Summary 
September 2015 published by www.hscic.gov.uk” showed a national mean of the 
reliable recovery rate at 43.6% for September 2015. Although there has been some 
small improvement in 3 years, it is still some way from the target of 50% recovery. 
Clearly there will be some services that have improved over time and some that 
have not, or have declined, and this shows that service and therapist increased 
experience does not necessarily directly link with an improvement of recovery rates. 
There are a number of other factors that may also influence either way. Whilst this 
study site’s staffing profile in high intensity has been stable, therefore those 
therapists that were training in the first 2 years have gained more experience by the 
subsequent years. They have not affected the increased recovery outcome, because 
the progression model was implemented, with an increased volume through low 
intensity interventions, where the staffing profile was more changeable and a 
continued level of trainees. This arguably counters any natural service improvement 
through increased experience.  
8.5 High severity needs high intensity? 
One of the questions and perhaps criticisms of the progression model that could be 
levied, and indeed anecdotally clinicians have raised, is that it does not comply with 
NICE guidelines directly, where the recommendations for certain disorders such as 
PTSD, social phobia and severe depression (see stepped care diagram figure 1) are 
to offer high intensity treatment in the first instance, this is stated as typically 
delivered by step 3 services. This however, is confusing as NICE commissioning 
guidance places mild to moderate presentation of these disorders as being treated at 
a step 2 level, and also state “When commissioning services using the stepped care 
model, commissioners should ensure that local systems allow for some flexibility in 
how interventions are provided, with the crucial factors being the patterns of local 
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need.” (9) Therefore it is feasible that this can be open to interpretation and be 
influenced by local capacity, and demand. However to do so, may be open to 
criticism that NICE guidelines may not be followed.  This service has interpreted the 
NICE guidelines to mean a delivery of stepped care, and has taken the definition 
within the literature as a progression stepped care model. What is also perhaps 
confusing for clinicians and service providers reading the evidence regarding 
stepped care is where the definition and the practice differ. For instance one RCT 
study (40) sought to compare the outcomes of patients treated in a stepped care 
model, and those with care as usual. Despite defining stepped care consistent with 
that of other literature, i.e. low intensity first, the study does not follow this principle 
for severe presentations. “Even though there is no clear evidence that patients with 
more severe symptoms of anxiety or depression do not benefit from low intensity 
(self-help) interventions we decided that patients with more severe disorders should 
be referred to more specialised mental health care and /or pharmacotherapy and 
skip the preceding steps.” in addition to this, the stepped care participants were 
randomised to different parts of the stepped care model, to receive different 
treatments. Where participants are randomised to specific steps it could be argued 
that the outcomes simply demonstrate the effectiveness of treatments within that 
step, rather than the effectiveness of a stepped care system. The decision to allocate 
severe presentations straight to the most specialised treatment perpetuates the idea 
that severe must need more intensive therapy. Despite acknowledgement that there 
is no evidence of the ineffectiveness of low intensity, this is an adverse action to the 
principle and definition of stepped care described, and alongside the study being 
underpowered, unfortunately weakens the results.  
 Whilst the discussion here is not questioning the evidence that informs NICE 
regarding the efficacy of step 3 therapies for clinical mental disorders, the efficacy 
has been demonstrated for treatment of depression with low intensity interventions 
(26) and single strand therapies e.g. behaviour activation. (28) However the application 
of this in practice appears sporadic. Although generally the literature may 
acknowledge that the efficacy for low intensity interventions treating specific anxiety 
disorders is less than that of depression, none the less most of studies evaluating 
IAPT treatment or comparing low to high, include those with clinical levels of anxiety, 
and there are still demonstrable benefits, and many patients with anxiety treated at 
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low intensity reaching recovery. (34,44) Although NICE guidelines suggest low intensity 
interventions can be used for some anxiety disorders displaying mild to moderate 
symptoms, it recommends not for PTSD or Social Anxiety. (14) From a pragmatic 
perspective, if a service stringently follows the NICE guidelines to mean moderate to 
severe anxiety disorders can only be treated by step 3 interventions, and this is 
applied to this service where 50% were scoring moderate to severe on both 
measures, it is reasonable to assume that a good proportion of those would meet the 
criteria for the disorders recommended to be treated at step 3 only. Firstly this forces 
a service to provide an allocated, matched care model, secondly it requires a service 
to have enough capacity to meet that clinical demand, which would be at a higher 
financial cost to employ more high intensity staff, to be able to also meet the IAPT 
KPI’s regarding timescale to enter treatment, and more lately the added waiting time 
targets. The difficulty for services perhaps is the volume of patients that are referred, 
and the waiting times for treatment that then occur. To implement this without an 
increase of resources would simply create a very long waiting list, leaving patients 
suffering without support, intervention and potentially at risk. 
Without good evidence of effective low intensity interventions for PTSD or Social 
Anxiety disorders, it is not in question that high intensity should be offered, however 
in routine practice it is highly likely that this will incur a lengthy wait, which could be 
distressing and exacerbate symptoms for patients. Whilst proper resource funding is 
of course a necessity, unfortunately the reality for many services may be the volume 
of demand outweighs the funded capacity. The progression stepped care model 
used properly could ensure that a larger number of other anxiety disorders are 
treated with low intensity, and reserving high intensity for PTSD and Social Anxiety. 
Equally a more generic anxiety low intensity treatment could be offered in the first 
instance to reduce general anxiety symptoms whilst waiting for a high intensity 
treatment, under the premise that something is better than nothing.  Given the key 
areas of research need to explore what works for whom, developing a low intensity 
level treatment for those two disorders may also be a helpful development.  
In reality prior to IAPT, the notion that severity means higher more intensive dose of 
therapy appears to have contributed to long waiting lists,  and certainly within this 
service an allocated model of stepped care has also seen longer waiting lists, which 
defeats the purpose of IAPT – improving access. Pragmatically a progression model 
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offers patients a step 2 psycho-educative intervention as the beginning of treatment 
to increase their understanding of their symptoms, and offer practical strategies to 
reduce symptoms. If this treatment is able to be offered more quickly than a high 
intensity treatment, and those that do not hit recovery at the end of the step 2 
intervention are then stepped up, surely this is a better alternative to patients with 
complexity sitting on a waiting list with no intervention, and no risk management? 
NICE guidelines do not purport to keeping patients on lengthy waiting lists without 
treatment.  
Gyani et al (11) showed that compliance with NICE recommended treatments was 
associated with higher recovery rates, this included low intensity interventions. They 
found that the factors predicting reliable recovery were initial lower severity “patient’s 
initial PHQ9 and GAD 7 scores had a significant effect on reliable recovery” with 
higher scores less likely to reach reliable recovery, however higher scores equalled 
greater reliable improvement. Similarly this study showed that those that score 
moderate to severe are less likely to recover than lower initial scores.  
What is interesting about this study’s results showing that overall the progression 
model achieves an increased recovery rate, this is with a greater proportion receiving 
only lower intensity interventions than in an allocated model and with an 18.3 % 
difference between years 2 and 4 of those receiving a low intensity intervention at 
first session. The results  for the moderate to severe PHQ9 initial scores  where 
recovery is higher in the progression model, not only supports the current NICE 
guidelines for stepped care, but goes further to challenge the notion that severity 
should be offered a higher intensity interventions first. These results appear to 
indicate that in reality even those with higher PHQ9 scores will do well with low 
intensity interventions in the first instance, thus supporting the pure stepped care 
definition and principle of least intrusive intervention first.   
Severe GAD 7 scores also do well in a progression model, and therefore with most 
receiving a low intensity intervention first also supports the challenge that severity 
should mean higher intensity. That they are less likely to reliably improve in a 
progression model than in an allocated model could conversely support that higher 
intensity should be the treatment offered, as it may be that those that recovered did 
so once they were given high intensity. Certainly Gyani et al’s (11) findings suggest 
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that more recovery is achieved through services who have a better step up rate from 
low to high intensity. In this study there is a large proportional difference between 
years 2 and 4 given a low intensity intervention first. The way this service care 
pathway is designed and information collated on the database means that it is a 
single treatment episode that would contain interventions at step 2 and 3, and until 
2015 there was no function on the database to be able to easily identify step up. This 
meant that this study was unable, with such a large dataset to create a variable for 
those that have been stepped up, and therefore unable to measure this potential 
effect.  
It could be that an anomaly of this particular service, the therapists are more skilled 
in treating depression, indeed the majority had received training in Behaviour 
Activation surplus to their low and high intensity courses and this could be 
contributing to the better results with PHQ9 initial scores. However it does not 
explain the model difference. It also does not explain the results showing that severe 
GAD7 scores were more likely to recover in a progression model than allocated. 
What it does highlight is a further research need to better understand the effective 
components of treatment for anxiety disorders, potentially at a low intensity level.  
Although arguably other unmeasured variables may have contributed to this result, it 
is an interesting result that questions the idea that complexity and severity require 
larger doses of therapy than an apparent more simple presentation. These results 
may pose an alternative perspective that a large proportion of those scoring 
moderate to severe will do well with simple structured treatments. Perhaps those 
with extremely complex history and presentation actually may benefit from the 
simplicity, the uncomplicated nature of a step 2 psycho-educative treatment that 
guides to do, rather than risk further rumination?  
Interestingly Vaillancourt et al (58) found that initial scores are not a factor influencing 
whether a service achieves a low or high recovery rate, which indicates that there 
are other factors that do have an influence. Similarly Firth et al (38) systematic review 
found that “patient severity and symptom chronicity varied considerably, and there 
were no clear trends that related chronicity/severity to clinical outcome. This is 
further supported in this study with the outcome of the progression model appearing 
to achieve better recovery and less deterioration than within an allocated model, in 
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that implementing a system that removes the allocation of type of treatment based 
on apparent severity, challenges the notion that severe presentations need higher 
intensity therapy. As discussed in section 4.2, a study Chan et al (44) found no 
difference between low or high intensity treatment groups in the baseline 
psychological measures scores, the high group received more sessions, yet the low 
intensity group achieved a better recovery rate. It is suggested (44) that it is possible 
that clinical assessment information finds presentations are different between the 
groups, with a more complex presentation being allocated a high intensity 
intervention. This could be a similar occurrence in this study, where although the 
progression model means low intensity is offered in the first instance; it could be that 
those that are stepped up are different in clinical presentation. This is not measured 
in either study, and would be worthy of further exploration, to aid understanding of 
what works best for whom.  
8.6 Allocated versus progression model of stepped care 
The major difference between an allocated model and a progression model of 
stepped care is clinical perspective, principle and practicality.  
The allocated model depends on clinician’s opinion as to which treatment and level 
best matches the patient’s presentation, based on a belief that the more complex 
and severe the presentation, the more intensive and complex the therapy needed, 
delivered by a more qualified and skilled therapist. The clinician’s opinion and 
decision is also informed by the content of training, which may depend on the bias of 
curriculum creators. Research appealing to the clinician’s interest, and as discussed 
previously, NICE guidelines are all other elements which may support and 
perpetuate the notion that severity needs high intensity. As also previously 
discussed, service design provides the framework that also informs and supports the 
clinician’s choice. Service design, in particular IAPT is informed by national IAPT 
policy and NICE guidelines which describe a mixed model stepped  care system, 
which although advocating least intrusive intervention first, also supports the notion 
severity means high intensity. The limited research regarding the efficacy of stepped 
care contributes to the problem of an unclear implementation of stepped care in 
practice.  
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Despite apparent agreement in the literature regarding the basic definition of stepped 
care (18, 32, 33, 38, 39), the systematic reviews clearly demonstrate a disparity and 
broadening of definition which contribute to the heterogeneity regarding a wide range 
of different models of ‘stepped’ care, alongside national guidelines (NICE) which 
appear to advocate a mixed model, that arguably must impact on interpretation and 
implication of model in routine practice. Inevitably a continuation custom in routine 
practice, open interpretation of guidelines and a limited body of evidenced based 
literature, has possibly led to the IAPT programme, a reform of service delivery, 
continuing to differ across the country within individual services regarding the 
delivery of stepped care systems. It is likely that there are a good number of IAPT 
sites that have a mixed model, which will include a proportion of allocated/matched 
care.  “A major problem with this model at present is our lack of clear prognostic 
determinants with which to match patients to the available treatments.”(39) Stepped 
care has been purported to be an alternative to matched care (33) and recommended 
as national guidelines and according to van Straten et al (39) “underpins the 
organisational structure” of the IAPT model design. There is an “assumption of 
stepped care is that for most patients the low- intensity  treatment will be sufficient 
and only a few will need a higher intensity treatment, thereby making better use of 
scarce and expensive resources such as therapist time .” (39) However the problem 
with this is the wide interpretation of delivery in routine practice, and indeed in 
research, as demonstrated by a number of studies (32,38,39).  
The structure of a progression model is that it removes the clinician choice of 
intensity of treatment, and requires that all patients will receive a low intensity 
treatment in the first instance, only being stepped up to a higher intensity if needed. 
Patient choice of treatment is retained through a range of low intensity treatments on 
offer included a brief face to face interventions. Whilst method of delivery might 
differ, i.e. computerised, telephone, psycho education group or brief face to face, the 
common themes amongst all in this particular service is that they are manualised 
and standardised treatments, with an emphasis on psycho-education, and motivating 
the patient to apply what they have learnt. The standardised format means there is 
less room for treatment ‘model drift’ which may be a risk with high intensity CBT 
where the complex patient may be presenting with an apparent number of disorders, 
that risks the therapist becoming confused as to which is the best model of CBT to 
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treat with. Clearly the evidence of the efficacy of low intensity interventions for 
depression and the effectiveness of behaviour activation demonstrates that simple is 
effective even with severe presentations.  
The study (32) that compares 4 different sites delivering their own interpretation of 
stepped care, not only showed wide variation of implementation, but interestingly the 
rate of step up from low to high was less than 10% across all sites, which infers that 
there was perhaps not a demonstrable need for those completing at low intensity to 
be stepped up, supporting the efficacy of such interventions, and raising the question 
again that some patients may not actually need high intensity.  
This study demonstrates that within one service, greater proportions of participants 
recover when receiving treatment within a progression model rather than allocated. 
Gyani et al (11) suggest that better use of stepped care produce better outcomes, and 
suggested that IAPT services could improve their recovery rates by improving the 
step up rate. In their review of a number of IAPT services, they found that one of the 
service characteristics that appeared to predict higher recovery rates were “higher 
step up rates among individuals who started with low intensity treatments.” What isn’t 
clear, is which part of the stepped treatment may have contributed the most to the 
recovery, i.e. although the reason for step up will be not recovered at the end of a 
step 2 intervention, what is unknown is whether those participants would have 
equally recovered with a step 3 intervention alone. The inference that can be made 
from the observations in this current study is that greater proportions recover in a 
progression model, with the larger proportion receiving step 2 interventions only.  
The progression model advocates step up based on need. If the majority of patients 
in a service recover with a shorter number of sessions, at a lower intensity level, the 
throughput volume will be greater at the step 2 level, and smaller at the step 3 level, 
thus likely less waiting times.  “Stepped care is a model that seeks to ameliorate 
problems with access through better allocation of scarce psychological therapy 
resources”. (39) Given the volume of step 2 low intensity treatments within a 
progression model, the results could be simply evidencing the efficacy of low 
intensity. The study did not control for this possibility, and could have tested the 
outcomes for intervention type. However given the service development history and 
the issues regarding heterogeneous stepped care definition and delivery, the service 
would perceive the progression model implementation as a necessary mechanism of 
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change in order to increase the effective use of low intensity interventions, which has 
then been demonstrated to effect recovery.  
The results in this study show that drop out proportion was found to be the same for 
low intensity treatment only, comparing model type, and at step 3 only and those 
stepped up were proportionally less in the progression model. There are two 
possibilities that may explain this occurrence. Either this infers that the progression 
model may be a more effective service delivery design, or simply a natural service 
improvement occurred over time. The key component with either possibility could be 
efficiency improvement, simply getting a treatment to a patient quicker may improve 
acceptability, and reduce dropout rate. Treating more patients quicker could be 
achieved either through the system design where treatment more patients with a 
shorter intervention increases the volume of throughput, or performance 
management strategies enable therapists to manage their caseload. However as 
discussed in section 5.4 increasing performance management strategies were in 
place across the whole service from year 2. Yet there was a difference in outcome 
between the two hubs. The change that was in place and subsequently the greatest 
increase in recovery rate occurred afterwards, was when hub B adopted the 
progression model, and thus the whole service was operating with this delivery 
design from the start of year 4. So it would appear that the efficiencies made in 
throughput through the progression model implementation could be linked with the 
improved dropout rate. Unfortunately this study did not test the significance of 
dropout rate, no did it control for acceptability of low or high intensity, or waiting 
times, therefore conclusions still need to remain cautiously optimistic regarding the 
progression model of stepped care.  
8.7 Confounding factors 
Certainly across the development of IAPT the issues would have been similar for 
most services, small numbers of already qualified therapists, large initial recruitment, 
large numbers of trainees, and more lately movement and attrition of qualified staff. 
Within this study site in particular these are some of the factors that may have 
impacted on service improvement and potentially outcomes. As described in section 
4.4 Performance management strategies may also have contributed to the trend of 
increasing recovery. The performance monitoring and management were more 
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refined from years 2 onwards, with strategies developed to help staff understand the 
KPI’s, i.e. why the service was collecting certain information, these strategies 
included the distribution of sharing service monthly performance   results across 
teams, and also scorecard to staff with their individual performance, in order to 
develop a culture of shared understanding and working proactively with performance 
management tools.  
Acknowledging this may have affected outcomes, it is interesting to note is that the 
gains particularly are made in year 4. It is possible that they took some time for effect 
to be demonstrated. As performance management strategies were variables not 
specifically measured in this study, it is perhaps not clear whether the improved use 
of the progression model or performance management affect the increase in 
recovery outcome, or a combination of both. However it is important to note that the 
outcomes remained largely similar for the first 3 years (Table 7), there are very small 
gains between years 2 and 3, despite increasing performance management 
strategies. However there was significant increase in recovery in year 4, when the 
whole service was compliant in delivering the progression model. This suggests that 
the implementation of the progression model was the most influencing factor of the 
improved recovery rates.  
The notion that trainee therapists becoming qualified and then more skilled and 
experienced over time effecting recovery is plausible. Gyani et al’s (11) study 
evaluating first year IAPT sites found that where the greater proportion of sessions 
delivered by staff on pay band 7 or above patients were more likely to reliable 
recover, this may be less to do with the higher intensity therapy and more to do with 
experienced therapists, given that the study period was the first year of IAPT and 
therefore subject to new systems, and a some with a greater proportion of trainees 
paid on band 6 or below.  Therefore where services had a good number of already 
qualified experienced staff may have skewed the results.  
In year 1 of this service delivery, two thirds of the workforce was in training, with one 
third already qualified as therapists at least one year prior to this local IAPT 
commencement, and a small number for longer. This could have contributed to the 
small gains between years 2&3, where new therapists were qualified at end of year 
1, and had a further year of close supervision refining skills. It could be expected that 
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larger gains could have been made at this point, however the service experienced a 
staff attrition rate from year 2 of between 5-10% each year. This attrition was largely 
experienced PWP’s moving on to high intensity trainee places, or the clinical 
doctorate in psychology. A service decision as discussed in section 5.3 was taken to 
replace High Intensity leavers with PWP posts, and a difficulty in recruiting qualified 
PWPs meant that from year 2 onwards the service continued with around 1/3 of the 
workforce as trainees, thus a reduction in caseload capacity and throughput, and 
assumingly smaller recovery rates given the trainee status. This could be a negative 
effect factor, however despite this possibility, the attrition rate and therefore the 
recruitment of trainees remained consistent in year 4, however recovery rates rose 
considerably. “An apparently strong relationship between variables could stem from 
many sources, including the influence of other, currently unmeasured variables .” (59) 
This study did not collate information regarding the qualification, skill or competence 
level of therapists delivering the treatment. “Whether an IV appears particularly 
important in a solution depends on the other IVs in the set.” (59)  It is possible that the 
apparent achievement of the progression model with better outcomes in the latter 
years could be incidental to model type, and may have been influenced by the 
natural increase of service performance as a phenomenon of natural organisational 
maturity, or the unmeasured variable of increased therapist skill and competence, or 
an interaction between all. Indeed a multilevel modelling analysis found that 
“Therapist effects accounted for 6-7% of outcome variance that was moderated by 
greater initial symptoms severity, treatment duration, and non-completion of 
treatment” (38) and also interestingly that “Clinically effective PWPs achieved almost 
double the change per treatment session”, thus supporting both the notion that 
experienced, competent low intensity therapists, and brief interventions are effective. 
Furthermore, a study (60) investigating the relationship between CBT competence and 
patient outcome in routine practice within the IAPT “found little support of a general 
association between CBT competence and patient outcome; however significantly 
more patients of the most competent therapists demonstrated a reliable 
improvement in their symptoms of anxiety than would be expected by chance alone, 
and fewer experienced no reliable change. Conversely, significantly more patients 
treated by the least competent therapists experienced a reliable deterioration in their 
symptoms than would be expected.”  
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Given these findings it would suggest that it is possible that a service with more 
experienced competent PWPs may positively influence the recovery rate, and a 
higher rate of least competent therapists may increase the reliable deterioration rate. 
Consideration does have to be given to the situation in this study where the 
workforce has always had a proportion of trainees, and new staff due to attrition 
rates. The increase in recovery rate target nationally in 2013 (see section 5.1) raised 
the bar for this service at a point it was still refining systems and processes, and 
therefore the continuation of a proportion of workers with assumed less competence, 
and a service in continued development may have an effect on the outcomes in 
either direction.  
A fundamental question regarding the results may be are the results achieved 
through model delivery, or is it evidence of the efficacy of low intensity interventions?  
Clearly as discussed previously a stepped care model in name, and following current 
guidance is more likely to result in an allocated model of care or a mixed model. A 
purely implemented stepped care, or progression model, by default will result in an 
increased throughput of patients receiving step 2 interventions. Van Straten et al (33) 
discussed that the throughput for their brief therapy (broadly equivalent to UK step 2 
guided self-help) was less than predicted, and discussed the potential reluctance for 
therapists to deliver brief therapy to patients with complexity such as personality 
disorders, thus resulting in therapist bias influencing throughput and model delivery. 
However the study demonstrated that the majority of patients regardless of severity, 
or type of disorder do not suffer adverse effects being offered brief therapy. Since 
then, despite the growing evidence for the efficacy of step 2 interventions, given the 
mixed model indicated in guidance, and the continuation of allocated care serviced 
model delivery it would appear that there is a continued belief that severity of 
presentation needs high intensity therapy, both in terms of dosage and complexity.   
8.8 A critique of methodology  
The whole dataset used in this study is large, which on the one hand is good as it 
avoids the risk of small sample bias, and “larger sample sizes increase the ‘power’ of 
statistical tests.”,  making it more likely to detect any existing effect. (61) However, an 
unnecessarily large sample size may risk uncontrolled variables, and may produce 
differences that are not meaningful. Tests are performed on various cohorts which 
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although smaller than the whole dataset are still substantial in size, that there is no 
issue of small sample bias.  
Firstly this study is not a randomised controlled trial (RCT) and therefore by that 
nature is open to bias and the effect of confounding variables, the results occurring 
through factors that have not been controlled or measured in this study. “It is always 
possible that variables unconnected with the independent variable may have 
produced the changes observed in the dependent variable” (61). Within a RCT, the 
experimental design would need to ensure that all participants have exactly the 
same experience, the same treatment delivered in each model to a matched number 
of ‘demographic type’ of patient, with the same number of treatment sessions, etc. 
No information was collected on the type of treatment delivered, and there is a range 
and difference within the steps, for instance computerised cognitive behavioural 
therapy (cCBT) or telephone guided self-help (TGSH) or face to face guided self-
help (FGSH) are delivered very differently, however there does not appear to be a 
difference in outcome whether treatment is delivered face to face or over the 
telephone. (29) Step 3 therapies which are not all CBT informed, IPT and EMDR are 
different modes of therapy to CBT and are only recommended for specific disorders, 
severe depression for IPT and PTSD for EMDR. (Figure 1). However as mentioned 
in section 2 in terms of outcomes for depression, all therapies are just about equal. 
(12,13). Other than the descriptive statistics no further analysis was undertaken on the 
type of problem being treated, it is entirely possible that this could be a confounding 
variable to the results. NICE guidelines which are evidence based recommend 
specific treatments at different levels and dosage, for certain disorders, including 
level of complexity and chronicity. This information was not collated nor measured, 
Comparing types of treatment was not the question concerned in this study, as within 
a stepped care model it is expected there will be a range of treatments, and there is 
already extensive research regarding the comparison of different therapy types, with 
ultimately a meta-analysis of studies comparing therapy for depression showing no 
therapy is particularly more superior than another. (12) Therefore for the basis of the 
question explored it was not felt necessary to control for treatment type.  
Further patient characteristics as well as disorder that could impact on outcomes 
could be personality traits, history of mental health problems, previous treatments 
and response, personal factors that impact on mental health such as housing, 
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relationship issues, family or other support etc. Although the service does collect 
information about previous mental health difficulties and treatments and response, 
and within the content of their treatment and subsequent clinical records there would 
be information of other potential affecting factors, it is not collated or reported on in 
the same manner as the scores and outcomes, and demographic information. 
Therefore any future analysis of these factors would require a systematic information 
collation, either set up through specific research studies exploring specific areas, or 
through further questionnaires’ routinely administered with patients.    
Whilst RCT’s may be deemed as the ‘gold standard’ in terms of evidenced research, 
primarily due to their ability to control variables and demonstrate causation, there 
may be difficulties in translating results and implications into routine practice, thereby 
conversely the ‘artificial nature’ of RCT’s with “ ‘demand characteristics’ may distort 
the procedure and where persons studied are dehumanised.” (61) Observational 
methods explore the ‘real world’, and with this as a design of a study, “the emphasis 
is on observation as the main procedure for data gathering, a non-experiment in 
which records are made of relatively unconstrained behaviour as it occurs.” (61)   
The study was observational in design, looking at data in routine practice. The use of 
an observational study design with retrospective data meant that it was not subject to 
common issues with an observational design, such as bias and influence of 
participants knowing they are being observed, i.e. the Hawthorne effect. (61) There 
are common risks of such a study design regarding selection and information bias 
(62), and there were several elements within the dataset or the design which aims to 
control bias. All participants were treatment completers, using the KPI definition 
rather than therapist perspective, the extraction of data from the electronic database 
which has mandatory fields and the service regularly quality audits meant that there 
was very little missing data, in an extremely large dataset. Outcomes were derived 
from calculated scores meeting a certain point i.e. below caseness for recovery, and 
therefore not withstanding the potential issues regarding reliability of self-reported 
scores, this information should be perceived as accurate. There could be a 
possibility of selection bias, regarding defining the cohort groups in the first cohort 
because there was no exact date where the service completely switched from the 
allocated to progression model. As described in the methodology rationale, although 
communication to the workforce regarding model changeover began at 18 months, 
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consideration of patients who were in the middle of treatment at this point, meant 
that a reasonable timescale for model adjustment would be at the end of year 2. 
Awareness of one of the hubs in the service continuing to largely operate the 
allocate model in year 3, provided an opportunity for this study to have other cohorts 
to compare, and the sensitivity analysis isolating years 2 and 4 attempts to control 
for the variable of systems and procedures being embedded in the service during 
year 1, alongside a greater number of trainees, and impurity of model during year 3, 
as the South hub continued to operate with the allocated model. Therefore despite 
the methodological limitations of an observational study design, it is the method in 
terms of exploring the retrospective data, and based in routine practice. A simple 
analysis of only the whole service data could have been undertaken, however 
recognition of the potential variable effect and a need to attempt to lever some 
control over the confounding variables led to the geographical cohorts, and then 
further refining the sample size with the sensitivity analysis of isolating years 2 and 4.  
As mentioned briefly earlier, sample size of whole dataset is large, and still 
considerable even with the cleaner, smaller sensitivity sample. This leads to a 
potentially good effect size, however the statistical tests used are not without their 
limitations with a large sample.  
Parametric techniques assume that the distribution of scores in the population is 
normal, (51) and there is some argument that even if all the assumptions are not met, 
with a large sample size they are fairly robust and will tolerate minor violations. This 
was the case with the chi square results for some areas, and although given the 
argument about robustness, some data adjustments were made to protect the risk of 
skew, for instance not undertaking parametric tests on the ethnicity variable, and 
removing the age outliers for regression tests.  
Although arguably the ethnicity spread is representative of the local population, the 
values of any category other than White British were so small in comparison that any 
outcome analysis for those categories could not ethically be generalizable.  
Similarly the values of the outliers in the age variable may well have been so small 
that it was tolerable by the regression tests, however the decision was made to 
remove the outliers, to avoid potential skew of the results.  
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Normality of distribution would normally be observed through scatterplots, (51, 61) 
however the sample size was so large visually this was impossible. However through 
the use of boxplots the range and the norm of each factor within the variable could 
be observed.  
The data set met the criteria for the Chi square tests as each value was unique for 
each test, and all values were frequencies, i.e. the number of participants recovered. 
There were some areas where there were low expected frequencies, such as in the 
age variable, and the rule of Cochran (1954) identifies those where there is more of 
the 20% of the expected frequency falling below 5. (61) However there is some debate 
in the statistical literature that 2x2 chi square tests are accurate as long as the total 
sample size is greater than 20. (61) It is on this basis given the dataset in this study is 
extremely large that the Chi square tests were accepted, even where the 
assumptions are not met.  
One of the research questions was to explore the relationship baseline factors may 
have with the outcome. Logistical regression analysis is essentially a set of 
techniques useful to predict or explain if and by how much a set of independent 
variables might affect an outcome, a dependent variable. The specific regression 
technique used will depend on the nature of the outcome variable, the impact of the 
independent variables is explained through odds ratios. (63)   
In this case the outcomes used are reliable recovery, reliable improvement, no 
change and reliable deterioration. These are categorical variables, and as there is 
more than two, multinomial regression was considered however initial model fit tests 
indicated a possible poor fit. Treating the dependant variable, the outcomes as 
ordinal could mean using ordinal regression. Initial assumption tests showed that the 
data was a good fit, however once the independent variables were added, in 
particular the age and employment categories, the dataset failed to meet the 
proportional odds assumption Therefore it was viewed that the most robust method 
of regression with this data was to categorise the dependant variable into 
dichotomous, and run simple binary logistical regression.  
Unlike ordinary linear regression, logistical regression does not require normally 
distributed variables, does not assume linearity of relationship between the 
independent and dependent variables, or homoscedasticity. However the 
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independent variables have to have a linear relationship to the logit of the 
dependent. (63) Outliers may influence logistic regression results (51), in this case, the 
first and last age categories were removed due to extremely low numbers in both.  
The Hosmer-Lemeshow goodness of fit test was undertaken to check that the data 
did not conflict with assumptions made by the regression model. A large p value is 
viewed as indicative of good model fit. However one of the problems with this test is 
that with a small sample size, the test gives a high p value as it may lack power to 
detect mis-specification problems rather than it showing a good fit. This test is 
preferred compared to the classification tables regarding the assessment of model 
fit, and it is considered more robust than the chi-square test particularly if the sample 
size is small. This is not the case with this dataset. There are issues  with the 
Hosmer-Lemeshow test and large data sets however, Kramer & Zimmerman (64) 
undertook replications of the test 1000 times with a number of studies with large 
datasets and found that the larger the sample size the more the more times 
significance was found. This was not the case with this data set, where the majority 
of the regressions showed the data was a good fit for the model, apart from four sets 
of regressions that did not meet the Hosmer-Lemeshow test which were the 
allocated model and reliable improvement outcome, progression model and no 
change outcome and the initial score group PHQ9 moderate/severe with reliable 
improvement, and reliable deterioration outcomes. This does not however invalidate 
results, as there are issues of reliability with the Hosmer–Lemeshow test and 
unfortunately SPSS does not give another option, but other information needs to be 
considered alongside. The sizes of sample, the probabilities, both observed and 
predicted, and adjunct measures of model calibration, for instance are other factors 
to consider with the reliability of regression model fit. (64) 
8.9 Limitations 
Although the dataset is large, with missing data at miniscule levels that do not effect 
results, it is routine practice data, and therefore variables are not as controlled as in 
a RCT. An RCT within routine practice is viewed as a more reliable method of study, 
therefore the findings of an observational study with retrospective data should be 
considered limited. The methodology of the study has attempted to control variables 
and outliers, for example ethnicity as a variable was excluded from logistic 
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regression as the numbers in categories other than White British were not large 
enough for the results to say anything reliable regarding the relationship between 
this baseline factor and outcomes.  
There are limitations with the purity of the cohort design. As described earlier, the 
move from allocated stepped care to a progression model of stepped care did not 
happen with a clean shift from one model to the other, rather it was a gradual change 
impacted by level of adherence to policy and procedure, and culture change issues. 
It could be argued that the as the dividing lines between the allocated and 
progression model, were in reality more blurred than a clear fixed point of absolute 
change, that the model is not a dependent variable. The testing of different cohorts 
was an attempt to control the impact of those environmental variables, and to test 
the reliability of the results of the first cohort design. Further sensitivity analysis tests 
attempted to also provide comparative measures of validity and reliability the first 
cohort results, and used the model type as an independent variable to test the 
predictability. However even with all different cohort designs and sensitivity analysis 
corroborating or improving on the first results, they all are the product of routine 
practice data, tested with an observational study design, and as such are not as 
clean as what might be expected within an RCT, and therefore should be viewed 
with those limitations.  
The results provide some interesting implications for psychological therapies service 
delivery planning, and in particular IAPT services. In terms of cost effectiveness this 
is likely to provide a strong economic rationale for services with limited resources. If 
the outcomes are the same or better using a progression model, the model design 
requires more therapists qualified and able to deliver low intensity interventions 
compared to high, and the current staffing model within IAPT service is that low 
intensity interventions are delivered by lower grade (and therefore salary) than high 
intensity therapists interventions, there is a compelling argument from a simple and 
crude economic perspective for services to reconfigure to a progression model. 
However cost effectiveness would need to be analysed taking other factors into 
account such as treatment dosage, outcomes and referral, and follow up analysis in 
an RCT.  
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There are several factors to consider that may have contributed to the result, not 
least cohort effect; the service over time may simply have got better at delivering 
brief interventions, therapists more experienced over time may have influenced 
better recovery. During year 1 of service delivery two thirds of the workforce were in 
training either as PWPs or high intensity. It could be accepted that during year 2, 
many were still not finished their training and many were consolidating their skills as 
newly qualified therapists. What wasn’t measured in this study was qualification 
status and length of experience of therapist as a potential variable. However this 
may be an impacting variable if indeed the service therapist experience on the whole 
did rise incrementally. In actual reality whilst that may be the case for the high 
intensity staff where since year 1, there has not been a huge attrition rate at this 
level, with high intensity staff remaining within the service. The step 2 workforce 
however has seen a regular attrition rate every year since year 1, where around 10% 
of this workforce has left their posts each year, a very small number have been 
retained within the service as senior PWPs or trainee high intensities, however the 
majority have actually left the service to obtain senior or trainee posts elsewhere or 
to undertake study on the psychology clinical doctorate course.  
The impact of such as turnover has meant that the service has every year had a 
larger number of trainee PWPs to replace qualified staff, reducing capacity and 
presumed skill level. Although these factors have not been measured for the purpose 
of this study, it is likely that incremental experience of staff does not contribute 
greatly to the improved recovery rate in the latter years, as this is likely offset by the 
comparable inexperience and reduced capacity with the regular level of trainee staff.  
Environmental factors may have contributed, for instance IAPT as a concept, as a 
service was new, requiring in some cases quite a radical shift from how mental 
health therapy was delivered previously, and indeed service design of IAPT is 
different from previous primary care or mental health teams. Even collecting 
measures every session was different. As staff adjusted to a new way of working, in 
a new service, with new systems, it is possible that confidence and competence may 
be affected by adjustment, and that by the 3rd and 4th year, the culture of the service, 
and the individual staff were more confident and this impacts positively on 
competence. This was not measured in this study, and arguably may be a limitation 
with the findings.  
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The findings regarding score severity are interesting, and challenge the notion that 
the higher the score should mean a higher intensity treatment. However a further 
limitation to this aspect of the study was that clinically assessed information was not 
included to define severity and it may be that those with higher scores that did not 
recover, or were stepped up had different clinically assessed information, than those 
that did recover.   
Propensity scoring method was originally a considered method in this study. 
Propensity matched scoring is often used  to control the bias potentially found in 
observational studies, compared to in a large RCT randomisation will on average 
balance any bias. However as this method only  estimates an average treatment 
effect and  can only account for variables that are observed, in this particular study it 
would not account for the issues mentioned around environmental factors of cultural 
change, therapist competence etc. therefore would not necessarily have produced 
more reliable results than the tests actually used.  
8.10 Implications for routine practice 
The findings in this study are similar to the national picture (11) where although it 
seems very obvious, completing treatment or being employed gives a patient a 
better chance of recovery. Being unemployed, sick or disabled (but not registered 
disabled) means less of a chance of recovery, and whilst mental health services 
cannot necessarily influence job provision, closer work with employment coaches, 
services or people with awareness and links to training opportunities and 
organisations offering voluntary work could help to tackle those other factors that are 
clearly linked with mental ill health and impact on recovery. Similarly pathways of 
joint working or even collaborative care regarding the dovetail between physical 
health problems and mental health problems may be helpful. Within this service a 
specialised LTC project operates and achieves reasonable recovery rates.  
There is an under- representation of ethnic minorities, and older people accessing 
this service which is consistent with the national picture, and also to a certain extent 
younger men. These are areas which are worthy of exploration regarding promotion 
and engagement to try and increase access.  
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Given the results that are demonstrated, regarding an increase of 4-10% in recovery 
with a progression model, and that recovery is more likely in a progression model, it 
certainly is worthy of consideration for any IAPT service currently delivering a mixed 
or allocated stepped care model. Given the emphasis for any IAPT service to 
balance the apparent competing demands of improving access, whilst achieving a 
minimal target of 50% recovery rate, is clearly a challenge given the average 
national rate is 43%. There are a number of factors that will impact on this, some of 
which will be specific to local services, such as staff numbers, staff attrition rates, 
delivering in higher levels of deprivation which is linked with higher mental health 
problems, to name a few. However if changing from an allocated model to a 
progressive model of stepped care can effect an improvement on volume of patients 
treated, as well at the very least  not negatively impacting on recovery rates, then 
this may be worth a consideration for services seeking to make improvements. This 
study appears to indicate that for those stepped up in a progression model compared 
to step 3 only treatment there would be an increase of 1-2 sessions. However if the 
proportion that receive treatment at step 3 is reduced, through the progression model 
increasing the volume treated at step 2, it is likely that the actual cost is reduced. A 
clinical and cost benefits analysis would be useful here to measure the extent of the 
cost and effect of this. 
A further implication for routine practice is the finding that severity does not do worse 
in a progressive model of stepped care; conversely moderate to severe groups for 
both psychological measures are more likely to recover in a progression model. This 
does challenge what appears to be a clinician bias towards the notion that severity 
should be treated with high intensity. This study can support the growing evidence of 
the efficacy of low intensity interventions, and also add to the research regarding the 
model of stepped care. Crucially, because this study is set in routine practice, the 
findings are of particular value and relevance to IAPT services. Confounding factors 
are controlled in RCT’s, specifically to demonstrate causality; in particular 
participants are carefully selected according to strict criteria to ensure that the results 
that are achieved are not affected by any other factor than the one of interest.   As 
this study is observational using retrospective data, its results are potentially more 
realistic and more applicable to routine practice, where there are naturally issues of 
variance regarding both patient characteristics i.e.co-morbidity, and service based 
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variation in terms of competence and experience of clinician. Therefore the results 
can be seen as realistically demonstrating a relationship between model design and 
outcome, with variance that within routine practice is expected.  
 
8.11 Conclusion and future research recommendations 
This study aimed to review the literature regarding the efficacy of stepped care and 
analyse observed outcomes of two different models of stepped care, 
allocated/matched care and pure/progression stepped care.  
The literature review demonstrates heterogeneity in definition of stepped care and 
inclusion of delivery models, which whilst providing some interesting and challenging 
discussion, potentially hinders rather than helps demonstrate the efficacy of a 
stepped care model. Given the dearth of studies comparing different models of 
stepped care, i.e. matched or allocated versus progression, there is a possibility that 
the studies demonstrating the efficacy of the stepped care model may be more likely 
demonstrating the efficacy of the treatments delivered within the stepped care 
model, rather than the effect of the model design itself. There is an assumption made 
that all IAPTs implement in practice the literature definition of pure stepped care, 
however there is no evidence of this and that it is likely that nationally IAPTs have a 
wide range of service model designs, of allocated/matched care, progressive 
stepped care or a mixture. There is clearly a need in terms of comparing the 
performance of IAPTs around the country, to do so in the context of understanding 
each services model design. The national IAPT programme can provide a further 
research opportunity of numerous services with some of the same components i.e. 
low and high intensity interventions, to survey each service interpretation of stepped 
care delivery, map out each service workforce, in terms of qualification and 
experience of therapists delivering treatment and explore in conjunction with the 
already collated data regarding outcomes.  
Given the limitations discussed, future research would be recommended to build on 
these findings, with staff experience, competence and confidence measured and 
variable impact controlled. Controlling environmental factors could be useful, short of 
setting up two completely new services each with a different model so that 
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experience and confidence can occur over the same length of time, RCT’s within 
routine practice will always have limitations, and always be impacted by outside 
environmental factors. An RCT that sets up an allocated model, and a progression 
model in the same service with the environment the same and staff experience 
evenly distributed, or an RCT based in multiple services that have defined models 
that are either allocated or progression, that can control factors such as staff 
confidence, competence, experience, robustness of systems, could further test out 
the preliminary findings in this study. A cost benefits analysis within such studies 
would greatly enrich the findings.  
In the absence of a fairly radical study design, exploring the impact of some of the 
above mentioned factors through a mixed methods study, collating information about 
clinician competence and experience and adherence to service model, and testing 
whether there is any relationship between these and clinical outcome could prove 
useful.  
The service does need to improve the robustness of diagnostic criteria, and it would 
be useful to test out the relationship between disorders, type of treatment, step 
treated, dosage and clinical outcome. A further study using propensity scoring 
method could be used to match the participants’ characteristics and entry scores to 
control for those variables. Testing the hypotheses that patient choice effects 
treatment completion and outcome should be a future consideration, particularly in 
relation to step and intensity of treatment in the context of understanding better the 
mechanisms needed for efficiency and maximum outcome attainment within a 
stepped care system. Looking at the relationship of therapist qualification and 
competence levels and impact on treatment outcome is another important factor 
worthy of future study.  
Higher score severity was found to not be a negative factor in terms of outcome 
within the progression model. There is a need to explore further added assessment 
information regarding perceived complexity and severity and any relationship with 
treatment step and outcome. An RCT that assessed and recorded clinicians 
recommended treatment and intensity, and then randomised patients of various 
identified complexity and severity to low intensity only, high intensity only and low 
first stepped to high, would be extremely useful to explore the relationship between 
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clinician assessment, treatment type and intensity, actual treatment and intensity and 
outcomes.  
This study has demonstrated that in this particular service increased recovery rates 
were obtained in association with delivering treatment to an increased number of 
participants using a progression model of stepped care. This study has also 
demonstrated that participants with moderate to severe scores do not appear to 
deteriorate; rather there is a larger proportion that recovers whilst being treated 
within a progression model. A higher volume of participants treated at step 2, within 
progression means that in this service there is a higher proportion of therapy delivery 
by NHS pay bands 4 &5, compared to the allocated model. By simple association of 
pay band structure and relatively similar dosage to allocated model for those in step 
3 or have been stepped up, it could be argued that the progression model is more 
efficient and cost effective, as well as achieving better clinical outcomes. A health 
economic analysis would need to be undertaken to explore this further, as is also 
suggested by van Straten et al (39) regarding the cost effectiveness of stepped care 
compared to high intensity alone and matched care.  
Fundamentally the problem with the existing evidence is both in research trials and 
evaluation of routine practice, stepped care has a particular definition but then may 
be implemented in a more stratified matched care manner, either through design or 
clinician bias, or a mixture. This is also supported by a mixed and undetailed 
description of stepped care within the NICE guidelines. There does need to be an 
acceptance in the routine practice world of the robust evidence of low intensity 
interventions, which form the basis of a pure stepped care model. There also needs 
to be further clarity in the guidelines to form a synergy between definition and 
recommended implication.  
The systematic review and meta-analysis of stepped care recommended for future 
research “the ideal test, against true matched care or against high intensity care for 
all patients has not been performed yet.” (39) 
This study cannot claim to be that ideal test, given it is not an RCT, however it has 
taken the unique opportunity that has naturally occurred within the development of a 
particular IAPT service, and explores the impact of a change of service delivery 
model on outcomes adding to a small volume of literature. Not enough is known 
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about the components of treatment or the optimal dosage that work for different 
patients to deliver an effective matched care model that is truly without bias, and 
purely evidenced based to be able to treat the patient’s needs. This study 
demonstrates that there is a significant likelihood of more patients recovered within a 
progression model of stepped care, compared to one that operated more akin to 
matched care, and furthermore those scoring moderate to severe on both 
psychological measures also are significantly more likely to recover in a progression 
model. Add together this, the existing robust evidence for the efficacy of step 2 
interventions for depression, and the demonstration in this study that anxiety 
presentations also recover well in a progression model; perhaps a pure stepped care 
progression model could be viewed, the optimal model in terms of the balance 
between evidenced based effective treatment and efficiency, until further research 
finds the mechanisms of effective treatment with an effective system of matching 
those to the right patient. The implications for clinical practice are a clearer definition 
of the stepped care model and how it should be implemented, evidence of improved 
outcomes within a progression model of stepped care, that can be used to consider, 
influence and improve service design and policy.  
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Appendix 1: Other Database Searches 
15/12/14 other databases through HDAS 
1. PsycINFO; (depression OR depressive OR affective OR "low mood").ti,ab; 258133 
results.  
2. PsycINFO; ATYPICAL DEPRESSION/ OR BECK DEPRESSION INVENTORY/ 
OR "DEPRESSION (EMOTION)"/ OR "LONG-TERM DEPRESSION (NEURONAL)"/ 
OR MAJOR DEPRESSION/ OR POSTPARTUM DEPRESSION/ OR RECURRENT 
DEPRESSION/ OR SPREADING DEPRESSION/ OR TREATMENT RESISTANT 
DEPRESSION/; 116461 results.  
3. PsycINFO; 1 OR 2; 266461 results.  
4. PsycINFO; ("stepped care" OR "collaborative care" OR "stratified care" OR 
"matched care").ti,ab; 1153 results.  
5. PsycINFO; 3 AND 4; 470 results.  
6. PsycINFO; (RCT* OR "randomi* controlled trial*" OR "systematic review*" OR 
"meta analys*").ti,ab; 41147 results.  
7. PsycINFO; 5 AND 6; 133 results.  
8. PsycINFO; (observational OR naturalistic OR "quasi experiment*" OR "natural 
experiment*" OR "before and after study*" OR "service evaluation*").ti,ab; 35451 
results.  
9. PsycINFO; 5 AND 8; 11 results.  
10. PsycINFO; (anxiety OR anxious).ti,ab; 144534 results.  
11. PsycINFO; ANXIETY/ OR ANXIETY DISORDERS/ OR ANXIETY 
MANAGEMENT/; 58540 results.  
12. PsycINFO; 10 OR 11; 149939 results.  
13. PsycINFO; 4 AND 12; 157 results.  
14. PsycINFO; 6 OR 8; 75008 results.  
15. PsycINFO; 13 AND 14; 40 results.  
16. PsycINFO; 5 AND 14; 142 results.  
17. PsycINFO; (("stepped care" OR "stratified care" OR "matched care")).ti,ab; 469 
results.  
18. PsycINFO; 3 AND 17; 152 results.  
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19. PsycINFO; 14 AND 18; 59 results.  
20. PsycINFO; 12 AND 17; 82 results.  
21. PsycINFO; 14 AND 20; 28 results.  
22. MEDLINE; (depression OR depressive OR affective OR "low mood").ti,ab; 
295460 results.  
23. MEDLINE; DEPRESSION/; 82520 results.  
24. MEDLINE; 22 OR 23; 318398 results.  
25. MEDLINE; ("stepped care" OR "stratified care" OR "matched care").ti,ab; 878 
results.  
26. MEDLINE; 24 AND 25; 217 results.  
27. MEDLINE; (RCT* OR "randomi* controlled trial*" OR "systematic review*" OR 
"meta analys*" OR observational OR naturalistic OR "quasi experiment*" OR "natural 
experiment*" OR "before and after study*" OR "service evaluation*").ti,ab; 282400 
results.  
28. MEDLINE; 26 AND 27; 83 results.  
29. MEDLINE; (anxiety OR anxious).ti,ab; 126267 results.  
30. MEDLINE; ANXIETY/ OR ANXIETY DISORDERS/; 79809 results.  
31. MEDLINE; 29 OR 30; 150854 results.  
32. MEDLINE; 25 AND 31; 120 results.  
33. MEDLINE; 27 AND 32; 48 results.  
34. CINAHL; (depression OR depressive OR affective OR "low mood").ti,ab; 51403 
results.  
35. CINAHL; DEPRESSION/ OR DEPRESSION, REACTIVE/; 43592 results.  
36. CINAHL; 34 OR 35; 66300 results.  
37. CINAHL; ("stepped care" OR "stratified care" OR "matched care").ti,ab; 224 
results.  
38. CINAHL; 36 AND 37; 67 results.  
39. CINAHL; (RCT* OR "randomi* controlled trial*" OR "systematic review*" OR 
"meta analys*" OR observational OR naturalistic OR "quasi experiment*" OR "natural 
experiment*" OR "before and after study*" OR "service evaluation*").ti,ab; 72364 
results.  
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40. CINAHL; 38 AND 39; 29 results.  
41. CINAHL; (anxiety OR anxious).ti,ab; 25986 results.  
42. CINAHL; ANXIETY/ OR ANXIETY DISORDERS/; 18694 results.  
43. CINAHL; 41 OR 42; 33143 results.  
44. CINAHL; 37 AND 43; 27 results.  
45. CINAHL; 39 AND 44; 14 results.  
46. EMBASE; (depression OR depressive OR affective OR "low mood").ti,ab; 
352391 results.  
48. EMBASE; ("stepped care" OR "stratified care" OR "matched care").ti,ab; 1039 
results.  
49. EMBASE; (RCT* OR "randomi* controlled trial*" OR "systematic review*" OR 
"meta analys*" OR observational OR naturalistic OR "quasi experiment*" OR "natural 
experiment*" OR "before and after study*" OR "service evaluation*").ti,ab; 346976 
results.  
50. EMBASE; DEPRESSION/ OR LONG TERM DEPRESSION/ OR MAJOR 
DEPRESSION/ OR MIXED ANXIETY AND DEPRESSION/; 281144 results.  
51. EMBASE; 46 OR 50; 447419 results.  
52. EMBASE; 48 AND 51; 291 results.  
53. EMBASE; 49 AND 52; 97 results.  
54. EMBASE; (anxiety OR anxious).ti,ab; 160979 results.  
55. EMBASE; ANXIETY/ OR ANXIETY DISORDER/ OR ANXIETY NEUROSIS/ OR 
MIXED ANXIETY AND DEPRESSION/; 168811 results.  
56. EMBASE; 54 OR 55; 215768 results.  
57. EMBASE; ("stepped care" OR "stratified care" OR "matched care").ti,ab; 1039 
results.  
58. EMBASE; 56 AND 57; 156 results.  
59. EMBASE; (RCT* OR "randomi* controlled trial*" OR "systematic review*" OR 
"meta analys*" OR observational OR naturalistic OR "quasi experiment*" OR "natural 
experiment*" OR "before and after study*" OR "service evaluation*").ti,ab; 346976 
results.  
60. EMBASE; 58 AND 59; 62 results.  
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Appendix 2: Summary of Literature Review Findings 
Authors and date Study design and 
participants 
Findings and limitations 
 
Richards, Bower, 
Pagel, Weaver, Utley, 
Cape, Pilling, Lovell, 
Gilbody, Leibowitz, 
Owens, Paxton, 
Hennessy, 
Simpson,Gallivan, 
Tomson, Vasilakis 
2012 
 
Observational in routine 
practice n=7698 
An observational study using 
data of patients in 4 different 
routine health settings 
operating stepped care 
models, with an analysis of 
the proportion of patients 
accessing treatment, at 
which ‘step’ and the 
transitions between steps.  
Each service developed their 
interpretation of stepped 
care, and data was collected 
and analysed. 
The interpretation of the NICE guidelines for 
stepped care was implemented with large 
variation across all 4 sites, with a particular 
difference with the ratio of low or high intensity 
treatments received by differing proportions of 
patients across all the sites. Findings indicate 
that service model type may have a 
relationship with the volume of patients 
accessing high or low intensity treatment.  
Clinical outcomes data was not present to be 
able to analyse.  
Chan S. W.Y.,  
Adams,M ., 2014 
 Between groups design, 
sample analysis n=100 
This is a small sample study 
comparing low and high 
intensity treatments, 
analysing outcomes and 
dropout rates. 
There is no difference between groups 
regarding dropout rate, a level of % difference 
between groups in terms of recovery rates – 
50% high intensity, 55.3% low intensity, 
however no significant statistical difference.  
Limitations include potential bias In the 
randomisation process as the variable of 
number of contacts was not controlled, and it is 
possible that those with a higher number of 
contacts were more likely to be selected.  
van straten, A.,  Hill,J.,  
Richards,D.,  
Cuijpers,P. 2014 
Systematic review & meta-
analysis of 14 studies 
 (n=5194, 2560 in stepped 
care) of which 10 are used in 
a meta –analysis (n =4580, 
with n= 2243 in stepped 
care). 
7 studies are regarding the delivery of a 
collaborative care model, 6 studies are 
regarding an increasing intensity of stepped 
care with just 2 studies with progressive 
intensity of stepped care.  
The review and meta-analysis finds that there 
is wide heterogeneity amongst design and 
delivery of service models and stepped care 
has a moderate effect on depression with the 
progressive intensity doing significantly worse. 
Limitations include the wide inclusion criteria 
that arguably contribute to heterogeneity, and 
only two studies representing ‘true’ stepped 
care, therefore findings should be viewed 
cautiously.  
 
Firth,N., Barkham,M.,  
kellett,S., 2015 
Systematic review n=14 
studies.  
 9 randomised controlled 
studies, 1 quasi-randomised 
comparison study, and 3 
uncontrolled prospective 
cohort studies. The number 
of patients per study range 
from 18-7859, (mdn = 430). 
 
The review found heterogeneity amongst the 
stepped care systems. Recovery rates for 
depression are between 50%-60% in stepped 
care, and “equivalence to usual care is 
suggested by comparison studies.”, however 
the evidence in some studies suggesting the 
superiority of stepped care, the authors find to 
be inconclusive. Limitations include difficulty in 
comparison and calculating effect due to wide 
variation of stepped care systems and study 
methodology, including two underpowered 
studies.  
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Appendix 3: Demographics by year 
  
Year One Year Two Year Three Year Four Total 
N % N % N % N % N % 
Gender 
Male 702 37.1 1590 37,1 2058 38.2 1867 36.3 6217 37.2 
Female 1191 62.9 2699 62.9 3333 61.8 3278 63.7 10501 62.8 
Not Stated 0 0.0 2 0.0 3 0.1 0 0.0 5 0.0 
Total 1893 11.3 4291 25.7 5394 32.3 5145 30.8 16723 100.0 
Age 
16-17 0 0.0 0 0.0 0 0.0 3 0.1 3 0.0 
18-24 90 4.8 315 7.3 554 10.3 705 13.7 1664 10.0 
25-34 447 23.6 1019 23.7 1256 23.3 1211 23.5 3933 23.5 
35-44 482 25.5 983 22.9 1220 22.6 1180 22.9 3865 23.1 
45-54 435 23.0 991 23.1 1182 21.9 1086 21.1 3694 22.1 
55-64 297 15.7 689 16.1 866 16.1 670 13.0 2522 15.1 
65-74 116 6.1 242 5.6 249 4.6 218 4.2 825 4.9 
75-84 21 1.1 45 1.0 55 1.0 60 1.2 181 1.1 
85-94 5 0.3 7 0.2 12 0.2 11 0.2 35 0.2 
95+ 0 0.0 0 0.0 0 0.0 1 0.0 1 0.0 
Total 1893 11.3 4291 25.7 5394 32.3 5145 30.8 16723 100.0 
Ethnicity  
British 685 36.2 2564 59.8 4741 87.9 4809 93.5 12799 76.5 
Irish 1 0.1 3 0.1 7 0.1 7 0.1 18 0.1 
Other White background 3 0.2 15 0.3 33 0.6 50 1.0 101 0.6 
White & Black Caribbean 2 0.1 1 0.0 13 0.2 7 0.1 23 0.1 
White & Black Af rican 0 0.0 1 0.0 0 0.0 1 0.0 2 0.0 
White & Asian 0 0.0 2 0.0 5 0.1 1 0.0 8 0.0 
Other mixed background 1 0.1 2 0.0 7 0.1 6 0.1 16 0.1 
Indian 2 0.1 10 0.2 18 0.3 14 0.3 44 0.3 
Pakistani 0 0.0 1 0.0 3 0.1 4 0.1 8 0.0 
Bangladeshi 0 0.0 1 0.0 1 0.0 0 0.0 2 0.0 
Other Asian background 0 0.0 3 0.1 8 0.1 7 0.1 18 0.1 
Caribbean 1 0.1 1 0.0 2 0.0 5 0.1 9 0.1 
Af rican 1 0.1 0 0.0 4 0.1 2 0.0 7 0.0 
Other Black background 3 0.2 1 0.0 3 0.1 0 0.0 7 0.0 
Chinese 0 0.0 9 0.2 21 0.4 11 0.2 14 0.1 
Other ethnic group 4 0.0 3 0.1 7 0.1 15 0.3 56 0.3 
Not Stated 1190 62.9 1674 39.0 521 9.7 206 4.0 3591 20.9 
Total 1893 11.3 4291 25.7 5394 32.3 5145 30.8 16723 100.0 
Disability  
Yes 61 3.2 185 4.3 536 9.9 494 9.6 1276 7.6 
No 1832 96.8 4106 95.7 4858 90.1 4651 90.4 15447 92.4 
Total 1893 11.3 4291 25.7 5394 32.3 5145 30.8 16723 100.0 
Ref erred 
Problem 
Mental & Behav ioural 
Disorder due to alcohol use 
1 0.1 1 0.0 4 0.1 3 0.1 9 0.1 
Bipolar Af f ective Disorder 0 0.0 2 0.0 6 0.1 8 0.2 16 0.1 
Depressiv e Episode 437 23.1 939 21.9 1362 25.3 1144 22.2 3882 23.2 
Recurrent Depressiv e 
Episode 
142 7.5 330 7.7 389 7.2 273 5.3 1134 6.8 
Dy sthy mia   0.0   0.0 5 0.1 7 0.1 12 0.1 
Agoraphobia 16 0.8 32 0.7 31 0.6 24 0.5 103 0.6 
Social Phobias 24 1.3 21 0.5 64 1.2 71 1.4 180 1.1 
Specif ic Phobias 26 1.4 33 0.8 65 1.2 49 1.0 173 1.0 
Panic Disorder 38 2.0 195 4.5 293 5.4 229 4.5 755 4.5 
Generalized Anxiety  Disorder 522 27.6 1130 26.3 999 18.5 664 12.9 3315 19.8 
Mixed Anxiety  & Depressiv e 
Disorder 
507 26.8 1310 30.5 1625 30.1 2037 39.6 5479 32.8 
Obsessiv e Compulsiv e 
Disorder 
33 1.7 104 2.4 182 3.4 143 2.8 462 2.8 
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Post Traumatic Stress 
Disorder 
24 1.3 59 1.4 158 2.9 144 2.8 385 2.3 
Adjustment Disorder 1 0.1 3 0.1 35 0.6 40 0.8 79 0.5 
Somatof orm Disorder 1 0.1 1 0.0 22 0.4 25 0.5 49 0.3 
Hy pochondriac Disorder 3 0.2 3 0.1 3 0.1 3 0.1 12 0.1 
Eating Disorder 5 0.3 26 0.6 34 0.6 24 0.5 89 0.5 
Other Mental Disorder 63 3.3 91 2.1 103 1.9 250 4.9 507 3.0 
Disappearance or Death of  
Family  Member 
2 0.1 0 0.0 14 0.3 7 0.1 23 0.1 
Not Stated 48 2.5 11 0.3 0 0.0 0 0.0 59 0.4 
Total 1893 11.3 4291 25.7 5394 32.3 5145 30.8 16723 100.0 
Employ ment 
Status First 
Employ ed 922 48.7 2011 46.9 2548 47.2 2455 47.7 7936 47.5 
Unemploy ed & Seeking Work 511 27.0 1054 24.6 1192 22.1 950 18.5 3707 22.2 
Students Not Seeking Work 92 4.9 269 6.3 361 6.7 378 7.3 1100 6.6 
Sick or Disabled 127 6.7 399 9.3 617 11.4 720 14.0 1863 11.1 
Homemaker 90 4.8 258 6.0 287 5.3 267 5.2 902 5.4 
No Benef its, Not Working or 
Seeking Work 
  0.0 5 0.1 20 0.4 12 0.2 37 0.2 
Voluntary  Work   0.0 1 0.0 3 0.1 3 0.1 7 0.0 
Retired 121 6.4 269 6.3 342 6.3 329 6.4 1061 6.3 
Not Stated 30 1.6 25 0.6 24 0.4 31 0.6 110 0.7 
Total 1893 11.3 4291 25.7 5394 32.3 5145 30.8 16723 100.0 
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Appendix 4: Demographics by locality 
  
North South Total 
  
Allocated Progressiv e Allocated Progressiv e 
N % N % N % N % N % 
Gender 
Male 1316.0 37.2 2218.0 37.7 1808.0 37.2 818.0 35.4 6160.0 37.1 
Female 2217.0 62.7 3665.0 62.3 3053.0 62.8 1490.0 64.6 10425.0 62.8 
Not Stated 1.0 0.0 2.0 0.0 2.0 0.0 0.0 0.0 5.0 0.0 
Total 3534.0 21.3 5885.0 35.5 4863.0 29.3 2308.0 13.9 16590.0 100.0 
Age 
16-17 0.0 0.0 2.0 0.0 0.0 0.0 1.0 0.0 3.0 0.0 
18-24 253.0 7.2 756.0 12.8 361.0 7.4 269.0 11.7 1639.0 9.9 
25-34 869.0 24.6 1412.0 24.0 1098.0 2206.0 529.0 22.9 3908.0 23.6 
35-44 831.0 23.5 1321.0 22.4 1132.0 23.3 553.0 24.0 3837.0 23.1 
45-54 794.0 22.5 1227.0 20.8 1130.0 23.2 516.0 22.4 3667.0 22.1 
55-64 536.0 15.2 841.0 14.3 821.0 16.9 308.0 13.3 2506.0 15.1 
65-74 199.0 5.6 234.0 4.0 273.0 5.6 110.0 4.8 816.0 4.9 
75-84 40.0 1.1 77.0 1.3 43.0 0.9 19.0 0.8 179.0 1.1 
85-94 12.0 0.3 14.0 0.2 5.0 0.1 3.0 0.1 34.0 0.2 
95+ 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 
Total 3534.0 21.3 5885.0 35.5 4863.0 29.3 2308.0 13.9 16590.0 100.0 
Ethnicity  
British 1496.0 42.3 5326.0 90.5 3741.0 76.9 2143.0 92.9 12706.0 76.6 
Irish 3.0 0.1 8.0 0.1 2.0 0.0 5.0 0.2 18.0 0.1 
Other White background 7.0 0.2 62.0 1.1 21.0 0.4 11.0 0.5 101.0 0.6 
White & Black Caribbean 2.0 0.1 9.0 0.2 7.0 0.1 5.0 0.2 23.0 0.1 
White & Black Af rican 1.0 0.0 1.0 0.0   0.0   0.0 2.0 0.0 
White & Asian 1.0 0.0 4.0 0.1 3.0 0.1   0.0 8.0 0.0 
Other mixed background 1.0 0.0 12.0 0.2 2.0 0.0 1.0 0.0 16.0 0.1 
Indian 7.0 0.2 16.0 0.3 12.0 0.2 9.0 0.4 44.0 0.3 
Pakistani 0.0 0.0 4.0 0.1 3.0 0.1 1.0 0.0 8.0 0.0 
Bangladeshi 0.0 0.0   0.0 2.0 0.0   0.0 2.0 0.0 
Other Asian background 0.0 0.0 10.0 0.2 6.0 0.1 2.0 0.1 18.0 0.1 
Caribbean 0.0 0.0 4.0 0.1 4.0 0.1 1.0 0.0 9.0 0.1 
Af rican 0.0 0.0 3.0 0.1 2.0 0.0 2.0 0.1 7.0 0.0 
Other Black background 1.0 0.0   0.0 5.0 0.1   0.0 6.0 0.0 
Chinese 4.0 0.1 7.0 0.1 2.0 0.0   0.0 13.0 0.1 
Other ethnic group 4.0 0.1 27.0 0.5 10.0 0.2 9.0 0.4 50.0 0.3 
Not Stated 2007.0 56.8 392.0 6.7 1041.0 21.4 119.0 5.2 3559.0 21.5 
Total 3534.0 21.3 5885.0 35.5 4863.0 29.3 2308.0 13.9 16590.0 100.0 
Disability  
Yes 123.0 3.5 620.0 10.5 318.0 6.5 205.0 8.9 1266.0 7.6 
No 3411.0 96.5 5265.0 89.5 4545.0 93.5 2103.0 91.1 15324.0 92.4 
Total 3534.0 21.3 5885.0 35.5 4863.0 29.3 2308.0 13.9 16590.0 100.0 
Ref erred 
Problem 
Mental & Behav ioural Disorder 
due to alcohol use 
0.0 0.0 3.0 0.1 3.0 0.1 3.0 0.1 9.0 0.1 
Bipolar Af f ective Disorder 2.0 0.1 11.0 0.2 1.0 0.0 2.0 0.1 16.0 0.1 
Depressiv e Episode 697.0 19.7 1517.0 25.8 1198.0 24.6 437.0 18.9 3849.0 23.2 
Recurrent Depressiv e Episode 328.0 9.3 318.0 5.4 295.0 6.1 187.0 8.1 1128.0 6.8 
Dy sthy mia   0.0 8.0 0.1 1.0 0.0 3.0 0.1 12.0 0.1 
Agoraphobia 25.0 0.7 27.0 0.5 37.0 0.8 14.0 0.6 103.0 0.6 
Social Phobias 24.0 0.7 55.0 0.9 52.0 1.1 45.0 1.9 176.0 1.1 
Specif ic Phobias 29.0 0.8 58.0 1.0 59.0 1.2 26.0 1.1 172.0 1.0 
Panic Disorder 164.0 4.6 259.0 4.4 186.0 3.8 142.0 6.2 751.0 4.5 
Generalized Anxiety  Disorder 984.0 27.8 819.0 13.9 1107.0 22.8 382.0 16.6 3292.0 19.8 
Mixed Anxiety  & Depressiv e 
Disorder 
1061.0 30.0 2327.0 39.5 1408.0 29.0 634.0 27.5 5430.0 32.7 
Obsessiv e Compulsiv e 
Disorder 
73.0 2.1 147.0 2.5 158.0 3.2 81.0 3.5 459.0 2.8 
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Post Traumatic Stress 
Disorder 
29.0 0.9 132.0 2.2 136.0 2.8 84.0 3.6 381.0 2.3 
Adjustment Disorder 1.0 0.0 36.0 0.6 18.0 0.4 24.0 1.0 79.0 0.5 
Somatof orm Disorder 1.0 0.0 22.0 0.4 12.0 0.2 13.0 0.6 48.0 0.3 
Hy pochondriac Disorder 3.0 0.1 5.0 0.1 4.0 0.1   0.0 12.0 0.1 
Eating Disorder 17.0 5.0 24.0 0.4 31.0 0.6 16.0 0.7 88.0 0.5 
Other Mental Disorder 84.0 2.4 101.0 1.7 106.0 2.2 213.0 9.2 504.0 3.0 
Disappearance or Death of  
Family  Member 
1.0 0.0 16.0 0.3 4.0 0.1 2.0 0.1 23.0 0.1 
Not Stated 11.0 0.3 0.0 0.0 47.0 1.0   0.0 58.0 0.3 
Total 3534.0 21.3 5885.0 35.5 4863.0 29.3 2308.0 13.9 16590.0 100.0 
Employ ment 
Status First 
Employ ed 1626.0 46.0 2673.0 45.4 2397.0 49.3 1191.0 51.6 7887.0 47.5 
Unemploy ed & Seeking Work 864.0 24.4 1071.0 18.2 1258.0 25.9 481.0 20.8 3674.0 22.1 
Students Not Seeking Work 260.0 7.4 526.0 8.9 195.0 4.0 100.0 4.3 1081.0 6.5 
Sick or Disabled 353.0 10.0 929.0 15.8 350.0 7.2 217.0 9.4 1849.0 11.1 
Homemaker 169.0 4.8 273.0 4.6 308.0 6.3 148.0 6.4 898.0 5.4 
No Benef its, Not Working or 
Seeking Work 
2.0 0.1 27.0 0.5 5.0 0.1 1.0 0.0 35.0 0.2 
Voluntary  Work 1.0 0.0 6.0 0.1   0.0   0.0 7.0 0.0 
Retired 224.0 6.3 356.0 6.0 316.0 6.5 153.0 6.6 1049.0 6.3 
Not Stated 35.0 1.0 24.0 0.4 34.0 0.7 17.0 0.7 110.0 0.7 
Total 3534.0 21.3 5885.0 35.5 4863.0 29.3 2308.0 13.9 16590.0 100.0 
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Appendix 5: Initial Scores at first session by years 
  
Year One Year Tw o Year Three Year Four Total 
PHQ 
First 
Score 
Minimal 142 7.5% 227 5.3% 287 5.3% 271 5.3% 927 5.5% 
Mild 310 16.4% 554 12.9% 697 12.9% 718 14.0% 2279 13.6% 
Moderate 456 24.1% 959 22.3% 1206 22.4% 1144 22.2% 3765 22.5% 
Moderate to severe 544 28.7% 1163 27.1% 1556 28.8% 1497 29.1% 4760 28.5% 
Severe 441 23.3% 1388 32.3% 1648 30.6% 1515 29.4% 4992 29.9% 
Total 1893 11.3% 4291 25.7% 5394 32.3% 5145 30.8% 16723 100.0% 
GAD 
First 
Score 
Minimal 127 6.7% 220 5.1% 210 3.9% 212 4.1% 769 4.6% 
Mild 366 19.3% 668 15.6% 796 14.8% 848 16.5% 2678 16.0% 
Moderate 547 28.9% 1162 27.1% 1534 28.4% 1454 28.3% 4697 28.1% 
Severe 
852 45.0% 2240 52.2% 2851 52.9% 2625 51.0% 8568 51.2% 
Not Recorded 
1 0.1% 1 0.0% 3 0.1% 6 0.1% 11 0.1% 
Total 
1893 11.3% 4291 25.7% 5394 
32.3% 
5145 
30.8% 16723 100.0% 
W&SAS 
First 
Score 
Mild Functional 
Impairment 
438 23.1% 792 18.5% 978 18.1% 953 18.5% 3161 18.9% 
Moderately Severe 
Functional 
Impairment 
614 32.4% 1471 34.3% 1817 33.7% 1669 32.4% 5571 33.3% 
Severe Functional 
Impairment 
814 43.0% 2020 47.1% 2591 48.0% 2515 48.9% 7940 47.5% 
Not Stated 27 1.4% 8 0.2% 8 0.1% 8 0.2% 51 0.3% 
Total 1893 11.3% 4291 25.7% 5394 32.3% 5145 30.8% 16723 100.0% 
 
 
 
 
 
 
 
 
 
 
 
 
176 
 
Appendix 6: Descriptive statistics for initial scores and outcomes 
  Year One Year Two Year Three Year Four Total 
 Mean SD Mean SD Mean SD Mean SD Mean SD 
PHQ First 14.3 6.4 15.7 6.3 15.6 6.2 15.4 6.2 15.4 6.3 
PHQ Last 9.7 7.4 10.1 7.4 10.0 7.3 9.1 7.1 9.7 7.3 
GAD First 13.1 5.3 13.9 5.1 14.2 5.0 14.0 5.0 13.9 5.1 
GAD Last 8.6 6.3 9.0 6.4 9.0 6.3 8.2 6.1 8.7 6.3 
W&SAS 
First 18.6 9.9 19.7 9.4 20.1 9.5 20.2 9.6 19.8 9.6 
W&SAS 
Last 12.6 10.2 13.6 10.4 14.1 10.5 13.2 10.2 13.5 10.4 
 
  Year One Year Two Year Three Year Four Total 
  Median IR Median IR Median IR Median IR Median IR 
PHQ First 15 9 16 10 16 10 16 9 16 9 
PHQ Last 8 12 9 12 9 12 7 11 8 11 
GAD First 14 9 15 8 15 7 15 7 15 8 
GAD Last 7 11 8 10 8 10 7 10 7 11 
W&SAS 
First 20 16 21 14 20 14 19 15 20 14 
W&SAS 
Last 12 17 12 16 12 16 10 16 12 16 
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Appendix 7: Discharge reason analysis 
By year 
  
Not 
Suitable 
Referred 
On 
Declined Completed 
Dropped 
Out 
Not Known Total 
Year One 72 117 158 990 556 0 1893 
% 3.80% 6.20% 8.30% 52.30% 29.40% 0.00% 100% 
Year Two 139 263 261 2555 930 143 4291 
% 3.20% 6.10% 6.10% 59.50% 21.70% 3.30% 100.00% 
Year Three 126 415 372 3222 1062 197 5394 
% 2.30% 7.70% 6.90% 59.70% 19.70% 3.70% 100.00% 
Year Four 117 251 306 3289 1005 177 5145 
% 2.30% 4.90% 5.90% 63.90% 19.50% 3.40% 100.00% 
 
By Cohort 
    
Not 
Suitable 
Referred 
On 
Declined Completed 
Dropped 
Out 
Not 
Known 
Total 
Model Allocated 211 380 419 3545 1486 143 6184 
  % 3.40% 6.10% 6.80% 57.30% 24.00% 2.30% 100% 
  Progressive 243 666 678 6511 2067 374 10539 
  % 2.30% 6.30% 6.40% 61.80% 19.60% 3.50% 100.00% 
North Allocated 88 203 229 2030 906 78 3534 
  % 2.50% 5.70% 6.50% 57.40% 25.60% 2.20% 100.00% 
  Progressive 155 363 354 3656 1169 188 5885 
  % 2.60% 6.20% 6.00% 62.10% 19.90% 3.20% 100.00% 
South Allocated 157 352 353 2851 995 155 4863 
  % 3.20% 7.20% 7.30% 58.60% 20.50% 3.20% 100.00% 
  Progressive 48 154 154 1437 456 92 2341 
  % 2.10% 6.60% 6.60% 61.40% 19.50% 3.90% 100.00% 
 
By Model & Step 
    
Not 
Suitable 
Referred 
On 
Declined Completed 
Dropped 
Out 
Total 
Allocated 
Step 2 Only 80 157 222 1896 758 3113 
% 2.57% 5.04% 7.13% 60.91% 24.35% 100.00% 
Step 3 Only 74 114 78 879 302 1447 
% 5.11% 7.88% 5.39% 60.75% 20.87% 100.00% 
Stepped Up 32 67 47 378 129 653 
% 4.90% 10.26% 7.20% 57.89% 19.75% 100.00% 
Stepped Down 2 4 7 64 16 93 
% 2.15% 4.30% 7.53% 68.82% 17.20% 100.00% 
Progressive 
Step 2 Only 126 302 484 3844 1482 6238 
% 2.02% 4.84% 7.76% 61.62% 23.76% 100.00% 
Step 3 Only 29 99 45 725 148 1046 
% 2.77% 9.46% 4.30% 69.31% 14.15% 100.00% 
Stepped Up 68 227 96 1568 309 2268 
% 3.00% 10.01% 4.23% 69.14% 13.62% 100.00% 
Stepped Down 1 12 9 106 29 157 
% 0.64% 7.64% 5.73% 67.52% 18.47% 100.00% 
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Appendix 8: Cross tabulation results comparing age against other variables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Age 16-17 18-24 25-34 35-44 45-54 55-64 65-74 75-84 85-94 95+
Male 0.0% 30.9% 32.8% 36.5% 41.9% 41.9% 39.4% 30.9% 48.6% 0.0%
Female 100.0% 69.1% 67.2% 63.5% 58.1% 58.1% 60.6% 69.1% 51.4% 100.0%
Yes 0.0% 3.0% 3.6% 5.4% 9.5% 13.5% 15.9% 19.3% 40.0% 100.0%
No 100.0% 97.0% 96.4% 94.6% 90.5% 86.5% 84.1% 80.7% 60.0% 0.0%
Employed 0.0% 26.3% 53.7% 58.7% 54.2% 41.0% 15.9% 2.2% 0.0% 0.0%
Unemployed 33.3% 24.1% 23.3% 21.6% 24.3% 25.5% 4.8% 0.0% 0.0% 0.0%
Students 66.7% 43.0% 7.7% 1.6% 0.6% 0.0% 0.2% 0.0% 0.0% 0.0%
Sick/Disabled 0.0% 3.3% 7.1% 10.7% 15.9% 19.7% 5.2% 0.0% 0.0% 0.0%
Homemaker 0.0% 3.1% 8.0% 7.0% 4.1% 4.4% 1.3% 0.0% 0.0% 0.0%
No Benefits 0.0% 0.2% 0.1% 0.2% 0.4% 0.3% 0.2% 0.0% 0.0% 0.0%
Voluntary Work 0.0% 0.1% 0.0% 0.1% 0.0% 0.1% 0.0% 0.0% 0.0% 0.0%
Retired 0.0% 0.0% 0.1% 0.1% 0.7% 9.1% 72.3% 97.8% 100.0% 100.0%
Gender
Disability
Employment
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Appendix 9: Cross tabulation results comparing gender against other variables 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gender Male Female
16-17 0.0% 0.0%
18-24 8.3% 11.0%
25-34 20.7% 25.1%
35-44 22.7% 23.4%
45-54 24.9% 20.4%
55-64 17.0% 14.0%
65-74 5.2% 4.8%
75-84 0.9% 1.2%
85-94 0.3% 0.2%
95+ 0.0% 0.0%
Yes 9.1% 6.7%
No 90.9% 93.3%
Employed 46.0% 48.8%
Unemployed 28.0% 19.0%
Students 5.2% 7.5%
Sick/Disabled 13.3% 10.0%
Homemaker 1.3% 7.8%
No Benefits 0.3% 0.2%
Voluntary Work 0.1% 0.0%
Retired 5.9% 6.7%
Age
Disability
Employment
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Appendix 10: Cross tabulation results comparing disability against other variables 
 
 
 
 
 
 
 
 
 
 
 
 
 
Disability Yes No
16-17 0.0% 0.0%
18-24 3.9% 10.4%
25-34 11.2% 24.5%
35-44 16.5% 23.7%
45-54 27.6% 21.6%
55-64 26.6% 14.1%
65-74 10.3% 4.5%
75-84 2.7% 0.9%
85-94 1.1% 0.1%
95+ 0.1% 0.0%
Male 44.5% 36.6%
Female 55.5% 63.4%
Employed 17.0% 50.3%
Unemployed 29.1% 21.8%
Students 2.2% 7.0%
Sick/Disabled 31.6% 9.5%
Homemaker 3.2% 5.6%
No Benefits 0.6% 0.2%
Voluntary Work 0.1% 0.0%
Retired 16.2% 5.6%
Age
Gender
Employment
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Appendix 11: Cross tabulation results – Age v Gender 
 
Male Female
Count 0 3 3
% within age 0.00% 100.00% 100.00%
% within 
gender
0.00% 0.00% 0.00%
Count 514 1150 1664
% within age 30.90% 69.10% 100.00%
% within 
gender
8.30% 11.00% 10.00%
Count 1289 2641 3930
% within age 32.80% 67.20% 100.00%
% within 
gender
20.70% 25.10% 23.50%
Count 1411 2454 3865
% within age 36.50% 63.50% 100.00%
% within 
gender
22.70% 23.40% 23.10%
Count 1549 2145 3694
% within age 41.90% 58.10% 100.00%
% within 
gender
24.90% 20.40% 22.10%
Count 1056 1465 2521
% within age 41.90% 58.10% 100.00%
% within 
gender
17.00% 14.00% 15.10%
Count 325 499 824
% within age 39.40% 60.60% 100.00%
% within 
gender
5.20% 4.80% 4.90%
Count 56 125 181
% within age 30.90% 69.10% 100.00%
% within 
gender
0.90% 1.20% 1.10%
Count 17 18 35
% within age 48.60% 51.40% 100.00%
% within 
gender
0.30% 0.20% 0.20%
Count 0 1 1
% within age 0.00% 100.00% 100.00%
% within 
gender
0.00% 0.00% 0.00%
Count 6217 10501 16718
% within age 37.20% 62.80% 100.00%
% within 
gender
100.00% 100.00% 100.00%
55-64
65-74
75-84
85-94
95+
Total
Crosstab
gender
Total
Age
16-17
18-24
25-34
35-44
45-54
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Appendix 12: Chi Square results - Age v Gender 
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Appendix 13: Cross tabulation results – Age v Employment 
 
Employed
Unemployed 
and Seeking 
Work
FT students or 
part  students 
not seeking 
work
Sick, disabled, 
incapacity ben, 
income support , 
employ & support  
allowance
Homemaker
No benef its not 
working not 
seeking
Voluntary work, 
not working, not 
seeking
Retired
Count 0 1 2 0 0 0 0 0 3
% within age 0.00% 33.30% 66.70% 0.00% 0.00% 0.00% 0.00% 0.00% 100.00%
% within 
Employment Status 
First
0.00% 0.00% 0.20% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Count 435 400 712 55 51 3 1 0 1657
% within age 26.30% 24.10% 43.00% 3.30% 3.10% 0.20% 0.10% 0.00% 100.00%
% within 
Employment Status 
First
5.50% 10.80% 64.70% 3.00% 5.70% 8.10% 14.30% 0.00% 10.00%
Count 2095 908 299 277 312 4 1 3 3899
% within age 53.70% 23.30% 7.70% 7.10% 8.00% 0.10% 0.00% 0.10% 100.00%
% within 
Employment Status 
First
26.40% 24.50% 27.20% 14.90% 34.60% 10.80% 14.30% 0.30% 23.50%
Count 2259 831 61 413 270 7 3 2 3846
% within age 58.70% 21.60% 1.60% 10.70% 7.00% 0.20% 0.10% 0.10% 100.00%
% within 
Employment Status 
First
28.50% 22.40% 5.50% 22.20% 29.90% 18.90% 42.90% 0.20% 23.20%
Count 1987 890 23 582 149 13 0 24 3668
% within age 54.20% 24.30% 0.60% 15.90% 4.10% 0.40% 0.00% 0.70% 100.00%
% within 
Employment Status 
First
25.00% 24.00% 2.10% 31.20% 16.50% 35.10% 0.00% 2.30% 22.10%
Count 1026 638 1 493 109 8 2 227 2504
% within age 41.00% 25.50% 0.00% 19.70% 4.40% 0.30% 0.10% 9.10% 100.00%
% within 
Employment Status 
First
12.90% 17.20% 0.10% 26.50% 12.10% 21.60% 28.60% 21.40% 15.10%
Count 130 39 2 43 11 2 0 593 820
% within age 15.90% 4.80% 0.20% 5.20% 1.30% 0.20% 0.00% 72.30% 100.00%
% within 
Employment Status 
First
1.60% 1.10% 0.20% 2.30% 1.20% 5.40% 0.00% 55.90% 4.90%
Count 4 0 0 0 0 0 0 176 180
% within age 2.20% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 97.80% 100.00%
% within 
Employment Status 
First
0.10% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 16.60% 1.10%
Count 0 0 0 0 0 0 0 35 35
% within age 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 100.00% 100.00%
% within 
Employment Status 
First
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 3.30% 0.20%
Count 0 0 0 0 0 0 0 1 1
% within age 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 100.00% 100.00%
% within 
Employment Status 
First
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.10% 0.00%
Count 7936 3707 1100 1863 902 37 7 1061 16613
% within age 47.80% 22.30% 6.60% 11.20% 5.40% 0.20% 0.00% 6.40% 100.00%
% within 
Employment Status 
First
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
55-64
65-74
75-84
85-94
95+
Total
C rosst ab
Employment Status First
Total
Age
16-17
18-24
25-34
35-44
45-54
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Appendix 14: Chi Square results - Age v Employment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. Sig. 
(2-sided)
Pearson Chi-
Square
14520.994a 63 0
Likelihood 
Ratio
8201.987 63 0
Linear-by-
Linear 
Association
2184.507 1 0
N of Valid 
Cases
16613
Chi-Square Tests
a. 32 cells (40.0%) have expected count less than 5. The 
minimum expected count is .00.
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Appendix 15: Cross tabulation results – Age v Disability 
 
Total
Yes No
Age 16-17 Count 0 3 3
% within age 0.00% 100.00% 100.00%
% within 
disability
0.00% 0.00% 0.00%
18-24 Count 50 1614 1664
% within age 3.00% 97.00% 100.00%
% within 
disability
3.90% 10.40% 10.00%
25-34 Count 143 3790 3933
% within age 3.60% 96.40% 100.00%
% within 
disability
11.20% 24.50% 23.50%
35-44 Count 210 3655 3865
% within age 5.40% 94.60% 100.00%
% within 
disability
16.50% 23.70% 23.10%
45-54 Count 352 3342 3694
% within age 9.50% 90.50% 100.00%
% within 
disability
27.60% 21.60% 22.10%
55-64 Count 340 2182 2522
% within age 13.50% 86.50% 100.00%
% within 
disability
26.60% 14.10% 15.10%
65-74 Count 131 694 825
% within age 15.90% 84.10% 100.00%
% within 
disability
10.30% 4.50% 4.90%
75-84 Count 35 146 181
% within age 19.30% 80.70% 100.00%
% within 
disability
2.70% 0.90% 1.10%
85-94 Count 14 21 35
% within age 40.00% 60.00% 100.00%
% within 
disability
1.10% 0.10% 0.20%
95+ Count 1 0 1
% within age 100.00% 0.00% 100.00%
% within 
disability
0.10% 0.00% 0.00%
Total Count 1276 15447 16723
% within age 7.60% 92.40% 100.00%
% within 
disability
100.00% 100.00% 100.00%
Crosstab
Disability
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Appendix 16: Chi Square Results - Age v Disability 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. Sig. 
(2-sided)
Pearson Chi-
Square
486.636a 9 0
Likelihood 
Ratio
443.304 9 0
Linear-by-
Linear 
Association
438.157 1 0
N of Valid 
Cases
16723
Chi-Square Tests
a. 5 cells (25.0%) have expected count less than 5. The 
minimum expected count is .08.
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Appendix 17: Cross tabulation results – Gender v Disability 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes No
Count 568 5649 6217
% within gender 9.10% 90.90% 100.00%
% within disability 44.50% 36.60% 37.20%
Count 708 9793 10501
% within gender 6.70% 93.30% 100.00%
% within disability 55.50% 63.40% 62.80%
Count 1276 15442 16718
% within gender 7.60% 92.40% 100.00%
% within disability 100.00% 100.00% 100.00%
Total
Crosstab
Disability
Total
Gender
Male
Female
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Appendix 18: Chi Square results – Gender v Disability 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. Sig. 
(2-sided)
Exact Sig. (2-
sided)
Exact Sig. (1-
sided)
Pearson Chi-Square 31.747
a 1 0
Continuity Correction
b 31.408 1 0
Likelihood Ratio 31.1 1 0
Fisher's Exact Test 0 0
Linear-by-Linear Association 31.745 1 0
N of Valid Cases 16718
b. Computed only for a 2x2 table
Chi-Square Tests
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 474.51.
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Appendix 19: Cross tabulation results – Gender v Employment 
 
 
 
 
 
 
 
 
 
 
Male Female
Count 2836 5098 7934
% within Employment Status First 35.70% 64.30% 100.00%
% within gender 46.00% 48.80% 47.80%
Count 1726 1980 3706
% within Employment Status First 46.60% 53.40% 100.00%
% within gender 28.00% 19.00% 22.30%
Count 321 779 1100
% within Employment Status First 29.20% 70.80% 100.00%
% within gender 5.20% 7.50% 6.60%
Count 822 1041 1863
% within Employment Status First 44.10% 55.90% 100.00%
% within gender 13.30% 10.00% 11.20%
Count 83 817 900
% within Employment Status First 9.20% 90.80% 100.00%
% within gender 1.30% 7.80% 5.40%
Count 16 21 37
% within Employment Status First 43.20% 56.80% 100.00%
% within gender 0.30% 0.20% 0.20%
Count 4 3 7
% within Employment Status First 57.10% 42.90% 100.00%
% within gender 0.10% 0.00% 0.00%
Count 362 699 1061
% within Employment Status First 34.10% 65.90% 100.00%
% within gender 5.90% 6.70% 6.40%
Count 6170 10438 16608
% within Employment Status First 37.20% 62.80% 100.00%
% within gender 100.00% 100.00% 100.00%
no benefits not 
working not seeking
vol work not working 
not seeking
retired
Total
Crosstab
Gender
Total
Employment 
Status First
Employed
Unemployed and 
Seeking Work
ft students or part 
students not 
seeking work
sick, disabled, 
incapacity ben, 
income support, 
employ & support 
allowance
homemaker
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Appendix 20: Chi Square results – Gender v Employment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. Sig. 
(2-sided)
Pearson Chi-
Square
522.950
a 7 0
Likelihood 
Ratio
588.207 7 0
Linear-by-
Linear 
Association
29.294 1 0
N of Valid 
Cases
16608
Chi-Square Tests
a. 2 cells (12.5%) have expected count less than 5. The 
minimum expected count is 2.60.
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Appendix 21: Cross tabulation results – Disability v Employment 
 
 
 
 
 
 
Yes No
Count 215 7721 7936
% within Employment 
Status First
2.70% 97.30% 100.00%
% within disability 17.00% 50.30% 47.80%
Count 369 3338 3707
% within Employment 
Status First
10.00% 90.00% 100.00%
% within disability 29.10% 21.80% 22.30%
Count 28 1072 1100
% within Employment 
Status First
2.50% 97.50% 100.00%
% within disability 2.20% 7.00% 6.60%
Count 401 1462 1863
% within Employment 
Status First
21.50% 78.50% 100.00%
% within disability 31.60% 9.50% 11.20%
Count 40 862 902
% within Employment 
Status First
4.40% 95.60% 100.00%
% within disability 3.20% 5.60% 5.40%
Count 8 29 37
% within Employment 
Status First
21.60% 78.40% 100.00%
% within disability 0.60% 0.20% 0.20%
Count 1 6 7
% within Employment 
Status First
14.30% 85.70% 100.00%
% within disability 0.10% 0.00% 0.00%
Count 205 856 1061
% within Employment 
Status First
19.30% 80.70% 100.00%
% within disability 16.20% 5.60% 6.40%
Count 1267 15346 16613
% within Employment 
Status First
7.60% 92.40% 100.00%
% within disability 100.00% 100.00% 100.00%
no benefits not 
working not seeking
vol work not working 
not seeking
retired
Total
Crosstab
disability
Total
Employment 
Status First
Employed
Unemployed and 
Seeking Work
ft students or part 
students not 
seeking work
sick, disabled, 
incapacity ben, 
income support, 
employ & support 
allowance
homemaker
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Appendix 22: Chi Square results – Disability v Employment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. Sig. 
(2-sided)
Pearson Chi-
Square
1081.744
a 7 0
Likelihood 
Ratio
962.826 7 0
Linear-by-
Linear 
544.437 1 0
N of Valid 
Cases
16613
Chi-Square Tests
a. 2 cells (12.5%) have expected count less than 5. The 
minimum expected count is .53.
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Appendix 23: Box plots comparing age against initial scores 
PHQ First Score 
 
GAD First Score 
 
Work and Social Adjustment Scale First Score 
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Appendix 24: Box plots comparing disability against initial scores 
PHQ First Score 
 
GAD First Score 
 
Work and Social Adjustment Scale First Score 
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Appendix 25: Box plots comparing ethnicity against initial scores 
PHQ First Score 
 
GAD First Score 
 
Work and Social Adjustment Scale First Score 
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Appendix 26: Box plots comparing first employment status against initial scores 
PHQ First Score 
 
GAD First Score 
 
Work and Social Adjustment Scale First Score 
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Appendix 27: Box plots comparing age against last scores 
PHQ First Score 
 
GAD First Score 
 
Work and Social Adjustment Scale First Score 
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Appendix 28: Box plots comparing disability against last scores 
PHQ Last Score 
 
 
GAD Last Score 
 
 
Work and Social Adjustment Scale Last Score 
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Appendix 29: Box plots comparing ethnicity against last scores 
PHQ First Score 
 
GAD First Score 
 
Work and Social Adjustment Scale First Score 
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Appendix 30: Box plots comparing first employment status against last scores 
PHQ First Score 
 
 
GAD First Score 
 
 
Work and Social Adjustment Scale First Score 
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Appendix 31: Cross tabulation of model and outcome for whole service 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allocated Progressive
Count 2323 4486 6809
% within 
Model
41.40% 46.10% 44.40%
Count 1401 2360 3761
% within 
Model
25.00% 24.30% 24.50%
Count 1570 2458 4028
% within 
Model
28.00% 25.30% 26.30%
Count 311 426 737
% within 
Model
5.50% 4.40% 4.80%
Count 5605 9730 15335
% within 
Model
100.00% 100.00% 100.00%
Total
Recovery  * Model Crosstabulation
Model
Total
Recovery
Recovered
Reliable 
Improvement
Non 
Recovered
Reliable 
Deterioration
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Appendix 32: Chi square of model and outcome for whole service 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. Sig. 
(2-sided)
Pearson Chi-
Square
38.552
a 3 0
Likelihood 
Ratio
38.44 3 0
Linear-by-
Linear 
Association
37.906 1 0
N of Valid 
Cases
15335
Chi-Square Tests
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Appendix 33: Cross tabulation of model on recovery v non recovery for whole service 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allocated Progressive
Count 2323 4486 6809
% within 
Model
41.40% 46.10% 44.40%
Count 3282 5244 8526
% within 
Model
58.60% 53.90% 55.60%
Count 5605 9730 15335
% within 
Model
100.00% 100.00% 100.00%
Recovery 
Non 
Recovery
Recovered
Non 
Recovered
Total
Recovery Non Recovery * Model Crosstabulation
Model
Total
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Appendix 34: Chi square of model on recovery v non recovery for whole service 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. Sig. 
(2-sided)
Exact Sig. (2-
sided)
Exact Sig. (1-
sided)
Pearson Chi-Square 31.279
a 1 0
Continuity Correction
b 31.091 1 0
Likelihood Ratio 31.353 1 0
Fisher's Exact Test 0 0
Linear-by-Linear 
Association
31.277 1 0
N of Valid Cases 15335
Chi-Square Tests
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Appendix 35: Cross tabulation of model on reliable improvement v non recovery for 
whole service 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allocated Progressive
1401 2360 3761
42.70% 45.00% 44.10%
1881 2884 4765
57.30% 55.00% 55.90%
3282 5244 8526
100.00% 100.00% 100.00%
Total
Count
% within Model
Total
Count
% within Model
Model
Reliable 
Improvement 
Non 
Recovery
Reliable Improvement
Count
% within Model
Non Recovery
Reliable Improvement Non Recovery * Model Crosstabulation
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Appendix 36: Chi square of model on reliable improvement v non recovery for whole 
service 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. Sig. (2-
sided)
Exact Sig. (2-
sided)
Exact Sig. (1-
sided)
Pearson Chi-Square 4.394
a 1 0.036
Continuity Correction
b 4.3 1 0.038
Likelihood Ratio 4.398 1 0.036
Fisher's Exact Test 0.037 0.019
Linear-by-Linear 
Association
4.393 1 0.036
N of Valid Cases 8526
Chi-Square Tests
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Appendix 37: Cross tabulation of model on reliable deterioration v non recovery for 
whole service 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allocated Progressive
Count 311 426 737
% within 
Model
9.50% 8.10% 8.60%
Count 2971 4818 7789
% within 
Model
90.50% 91.90% 91.40%
Count 3282 5244 8526
% within 
Model
100.00% 100.00% 100.00%
Total
RD V Non Recovery * Model Crosstabulation
Model
Total
RD V Non 
Recovery
Reliable 
Deterioration
Non 
Recovery
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Appendix 38: Chi square of model on reliable deterioration v non recovery for whole 
service 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. Sig. 
(2-sided)
Exact Sig. (2-
sided)
Exact Sig. (1-
sided)
Pearson Chi-
Square
4.675
a 1 0.031
Continuity 
Correction
b 4.505 1 0.034
Likelihood 
Ratio
4.629 1 0.031
Fisher's 
Exact Test
0.032 0.017
Linear-by-
Linear 
Association
4.674 1 0.031
N of Valid 
Cases
8526
Chi-Square Tests
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 
283.70.
b. Computed only for a 2x2 table
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Appendix 39: Cross tabulation on PHQ Moderate to Severe/Severe on model v 
outcomes for whole service 
 
 
 
 
 
 
 
 
 
Allocated Progressive
Count 456 924 1380
% within Model 24.90% 29.30% 27.70%
Count 645 1143 1788
% within Model 35.30% 36.20% 35.90%
Count 676 1022 1698
% within Model 37.00% 32.40% 34.10%
Count 51 69 120
% within Model 2.80% 2.20% 2.40%
Count 1828 3158 4986
% within Model 100.00% 100.00% 100.00%
Count 653 1370 2023
% within Model 38.30% 44.90% 42.60%
Count 495 778 1273
% within Model 29.00% 25.50% 26.80%
Count 456 754 1210
% within Model 26.70% 24.70% 25.50%
Count 101 147 248
% within Model 5.90% 4.80% 5.20%
Count 1705 3049 4754
% within Model 100.00% 100.00% 100.00%
Count 1109 2294 3403
% within Model 31.40% 37.00% 34.90%
Count 1140 1921 3061
% within Model 32.30% 30.90% 31.40%
Count 1132 1776 2908
% within Model 32.00% 28.60% 29.90%
Count 152 216 368
% within Model 4.30% 3.50% 3.80%
Count 3533 6207 9740
% within Model 100.00% 100.00% 100.00%
Total
Recovery
Recovered
Reliable 
Improvement
Non Recovered
Reliable 
Deterioration
Total
Total
Moderate 
to Severe
Recovery
Recovered
Reliable 
Improvement
Non Recovered
Reliable 
Deterioration
Total
Crosstab
PHQ Severity
Model
Total
Severe
Recovery
Recovered
Reliable 
Improvement
Non Recovered
Reliable 
Deterioration
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Appendix 40: Chi square on PHQ Moderate to Severe/Severe on model v outcomes 
for whole service 
 
 
 
 
 
 
 
 
Value df
Asymp. Sig. 
(2-sided)
Pearson Chi-
Square
17.063
b 3 0.001
Likelihood 
Ratio
17.066 3 0.001
Linear-by-
Linear 
Association
16.983 1 0
N of Valid 
Cases
4986
Pearson Chi-
Square
20.649
c 3 0
Likelihood 
Ratio
20.714 3 0
Linear-by-
Linear 
Association
14.566 1 0
N of Valid 
Cases
4754
Pearson Chi-
Square
34.118
a 3 0
Likelihood 
Ratio
34.274 3 0
Linear-by-
Linear 
Association
31.926 1 0
N of Valid 
Cases
9740
b. 0 cells (0.0%) have expected count less than 5. The minimum 
expected count is 44.00.
c. 0 cells (0.0%) have expected count less than 5. The minimum 
expected count is 88.94.
Chi-Square Tests
PHQ Severity
Severe
Moderate to 
Severe
Total
a. 0 cells (0.0%) have expected count less than 5. The minimum 
expected count is 133.49.
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Appendix 41: Cross tabulation on GAD Moderate/Severe on model v outcomes for 
whole service 
 
 
 
 
Allocated Progressive
Count 964 1971 2935
% within Model 31.20% 36.00% 34.30%
Count 1064 1827 2891
% within Model 34.40% 33.40% 33.70%
Count 970 1558 2528
% within Model 31.40% 28.50% 29.50%
Count 93 120 213
% within Model 3.00% 2.20% 2.50%
Count 3091 5476 8567
% within Model 100.00% 100.00% 100.00%
Count 854 1666 2520
% within Model 50.00% 55.80% 53.70%
Count 284 474 758
% within Model 16.60% 15.90% 16.10%
Count 440 650 1090
% within Model 25.80% 21.80% 23.20%
Count 130 196 326
% within Model 7.60% 6.60% 6.90%
Count 1708 2986 4694
% within Model 100.00% 100.00% 100.00%
Count 1818 3637 5455
% within Model 37.90% 43.00% 41.10%
Count 1348 2301 3649
% within Model 28.10% 27.20% 27.50%
Count 1410 2208 3618
% within Model 29.40% 26.10% 27.30%
Count 223 316 539
% within Model 4.60% 3.70% 4.10%
Count 4799 8462 13261
% within Model 100.00% 100.00% 100.00%
Total
Recovery
Recovered
Reliable 
Improvement
Non Recovered
Reliable 
Deterioration
Total
Total
Moderate
Recovery
Recovered
Reliable 
Improvement
Non Recovered
Reliable 
Deterioration
Total
Crosstab
GAD Severity
Model
Total
Severe
Recovery
Recovered
Reliable 
Improvement
Non Recovered
Reliable 
Deterioration
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Appendix 42: Chi square on GAD Moderate/Severe on model v outcomes for whole 
service 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. Sig. 
(2-sided)
Pearson Chi-Square 25.034
b 3 0
Likelihood Ratio 25.035 3 0
Linear-by-Linear 
Association
23.534 1 0
N of Valid Cases 8567
Pearson Chi-Square 16.351
c 3 0.001
Likelihood Ratio 16.293 3 0.001
Linear-by-Linear 
Association
15.042 1 0
N of Valid Cases 4694
Pearson Chi-Square 38.647
a 3 0
Likelihood Ratio 38.64 3 0
Linear-by-Linear 
Association
37.846 1 0
N of Valid Cases 13261
b. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 
76.85.
c. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 
118.62.
Chi-Square Tests
GAD Severity
Severe
Moderate
Total
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 
195.06.
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Appendix 43: Cross tabulation for age against model and recovery outcome for 
whole service 
 
 
Allocated Progressive
Count 0 2 2
% w ithin Model 0.00% 0.00% 0.00%
Count 136 488 624
% w ithin Model 5.90% 10.90% 9.20%
Count 517 1011 1528
% w ithin Model 22.30% 22.50% 22.40%
Count 531 1079 1610
% w ithin Model 22.90% 24.10% 23.60%
Count 567 966 1533
% w ithin Model 24.40% 21.50% 22.50%
Count 366 618 984
% w ithin Model 15.80% 13.80% 14.50%
Count 176 253 429
% w ithin Model 7.60% 5.60% 6.30%
Count 24 56 80
% w ithin Model 1.00% 1.20% 1.20%
Count 6 12 18
% w ithin Model 0.30% 0.30% 0.30%
Count 0 1 1
% w ithin Model 0.00% 0.00% 0.00%
Count 2323 4486 6809
% w ithin Model 100.00% 100.00% 100.00%
Count 82 269 351
% w ithin Model 5.90% 11.40% 9.30%
Count 357 624 981
% w ithin Model 25.50% 26.40% 26.10%
Count 337 498 835
% w ithin Model 24.10% 21.10% 22.20%
Count 331 493 824
% w ithin Model 23.60% 20.90% 21.90%
Count 235 380 615
% w ithin Model 16.80% 16.10% 16.40%
Count 50 73 123
% w ithin Model 3.60% 3.10% 3.30%
Count 8 20 28
% w ithin Model 0.60% 0.80% 0.70%
Count 1 3 4
% w ithin Model 0.10% 0.10% 0.10%
Count 1401 2360 3761
% w ithin Model 100.00% 100.00% 100.00%
85-94
Total
Total
Reliable 
Improvement
Age
18-24
25-34
35-44
45-54
55-64
65-74
75-84
45-54
55-64
65-74
75-84
85-94
95+
Recovery
Model
Total
Recovered
Age
16-17
18-24
25-34
35-44
214 
 
 
 
 
 
 
 
 
 
Allocated Progressive
Count 0 1 1
% w ithin Model 0.00% 0.00% 0.00%
Count 123 351 474
% w ithin Model 7.80% 14.30% 11.80%
Count 395 566 961
% w ithin Model 25.20% 23.00% 23.90%
Count 367 549 916
% w ithin Model 23.40% 22.30% 22.70%
Count 360 541 901
% w ithin Model 22.90% 22.00% 22.40%
Count 253 364 617
% w ithin Model 16.10% 14.80% 15.30%
Count 60 68 128
% w ithin Model 3.80% 2.80% 3.20%
Count 11 15 26
% w ithin Model 0.70% 0.60% 0.60%
Count 1 3 4
% w ithin Model 0.10% 0.10% 0.10%
Count 1570 2458 4028
% w ithin Model 100.00% 100.00% 100.00%
Count 22 65 87
% w ithin Model 7.10% 15.30% 11.80%
Count 76 90 166
% w ithin Model 24.40% 21.10% 22.50%
Count 88 102 190
% w ithin Model 28.30% 23.90% 25.80%
Count 65 88 153
% w ithin Model 20.90% 20.70% 20.80%
Count 45 62 107
% w ithin Model 14.50% 14.60% 14.50%
Count 13 19 32
% w ithin Model 4.20% 4.50% 4.30%
Count 2 0 2
% w ithin Model 0.60% 0.00% 0.30%
Count 311 426 737
% w ithin Model 100.00% 100.00% 100.00%
55-64
65-74
75-84
Total
65-74
75-84
85-94
Total
Reliable 
Deterioration
Age
18-24
25-34
35-44
45-54
Non 
Recovered
Age
16-17
18-24
25-34
35-44
45-54
55-64
Recovery
Model
Total
215 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allocated Progressive
Count 0 3 3
% w ithin Model 0.00% 0.00% 0.00%
Count 363 1173 1536
% w ithin Model 6.50% 12.10% 10.00%
Count 1345 2291 3636
% w ithin Model 24.00% 23.50% 23.70%
Count 1323 2228 3551
% w ithin Model 23.60% 22.90% 23.20%
Count 1323 2088 3411
% w ithin Model 23.60% 21.50% 22.20%
Count 899 1424 2323
% w ithin Model 16.00% 14.60% 15.10%
Count 299 413 712
% w ithin Model 5.30% 4.20% 4.60%
Count 45 91 136
% w ithin Model 0.80% 0.90% 0.90%
Count 8 18 26
% w ithin Model 0.10% 0.20% 0.20%
Count 0 1 1
% w ithin Model 0.00% 0.00% 0.00%
Count 5605 9730 15335
% w ithin Model 100.00% 100.00% 100.00%
Total
45-54
55-64
65-74
75-84
85-94
95+
Total
Age
16-17
18-24
25-34
35-44
Recovery
Model
Total
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Appendix 44: Chi square for age against model and recovery outcome for whole 
service 
 
 
 
 
 
 
 
Value df Asymp. Sig. (2-sided)
Pearson Chi-Square 64.164
b 9 0
Likelihood Ratio 68.05 9 0
Linear-by-Linear Association 35.532 1 0
N of Valid Cases 6809
Pearson Chi-Square 37.743
c 7 0
Likelihood Ratio 39.81 7 0
Linear-by-Linear Association 12.139 1 0
N of Valid Cases 3761
Pearson Chi-Square 41.980
d 8 0
Likelihood Ratio 44.197 8 0
Linear-by-Linear Association 15.464 1 0
N of Valid Cases 4028
Pearson Chi-Square 15.174
e 6 0.019
Likelihood Ratio 16.5 6 0.011
Linear-by-Linear Association 2.1 1 0.147
N of Valid Cases 737
Pearson Chi-Square 136.049
a 9 0
Likelihood Ratio 144.774 9 0
Linear-by-Linear Association 59.057 1 0
N of Valid Cases 15335
Reliable 
Deterioration
Total
Chi-Square Tests
Recovery
Recovered
Reliable 
Improvement
Non 
Recovered
217 
 
 
Appendix 45: Cross tabulation for gender against model and recovery outcome for 
whole service 
 
 
 
 
 
 
Allocated Progressive
Count 841 1676 2517
% within Model 36.20% 37.40% 37.00%
Count 1482 2809 4291
% within Model 63.80% 62.60% 63.00%
Count 2323 4485 6808
% within Model 100.00% 100.00% 100.00%
Count 529 853 1382
% within Model 37.80% 36.20% 36.80%
Count 872 1506 2378
% within Model 62.20% 63.80% 63.20%
Count 1401 2359 3760
% within Model 100.00% 100.00% 100.00%
Count 602 939 1541
% within Model 38.40% 38.20% 38.30%
Count 966 1519 2485
% within Model 61.60% 61.80% 61.70%
Count 1568 2458 4026
% within Model 100.00% 100.00% 100.00%
Count 112 144 256
% within Model 36.00% 33.80% 34.70%
Count 199 282 481
% within Model 64.00% 66.20% 65.30%
Count 311 426 737
% within Model 100.00% 100.00% 100.00%
Count 2084 3612 5696
% within Model 37.20% 37.10% 37.20%
Count 3519 6116 9635
% within Model 62.80% 62.90% 62.80%
Count 5603 9728 15331
% within Model 100.00% 100.00% 100.00%
Reliable 
Deterioration
gender
Male
Female
Total
Total
gender
Male
Female
Total
Reliable 
Improvement
gender
Male
Female
Total
Non 
Recovered
gender
Male
Female
Total
Crosstab
Recovery
Model
Total
Recovered
gender
Male
Female
Total
218 
 
Appendix 46: Chi square for gender against model and recovery outcome for whole service 
 
 
 
 
 
 
 
Value df
Asymp. Sig. 
(2-sided)
Exact Sig. (2-
sided)
Exact Sig. (1-
sided)
.893
c 1 0.345
0.843 1 0.358
0.894 1 0.344
0.354 0.179
0.892 1 0.345
6808
.967
d 1 0.325
0.9 1 0.343
0.966 1 0.326
0.328 0.171
0.967 1 0.325
3760
.015
e 1 0.903
0.008 1 0.93
0.015 1 0.903
0.921 0.465
0.015 1 0.903
4026
.387
f 1 0.534
0.296 1 0.586
0.387 1 0.534
0.584 0.293
0.387 1 0.534
737
.006
a 1 0.937
0.004 1 0.95
0.006 1 0.937
0.945 0.475
0.006 1 0.937
15331
Fisher's Exact Test
Linear-by-Linear 
Association
N of Valid Cases
N of Valid Cases
Total
Pearson Chi-Square
Continuity Correction
b
Likelihood Ratio
Reliable 
Deterioration
Pearson Chi-Square
Continuity Correction
b
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear 
Association
Fisher's Exact Test
Linear-by-Linear 
Association
N of Valid Cases
N of Valid Cases
Non 
Recovered
Pearson Chi-Square
Continuity Correction
b
Likelihood Ratio
Reliable 
Improvement
Pearson Chi-Square
Continuity Correction
b
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear 
Association
Fisher's Exact Test
Linear-by-Linear 
Association
N of Valid Cases
Chi-Square Tests
Recovery
Recovered
Pearson Chi-Square
Continuity Correction
b
Likelihood Ratio
219 
 
Appendix 47: Cross tabulation for disability against model and recovery outcome for 
whole service 
 
 
 
 
 
 
 
Allocated Progressive
Count 81 365 446
% within Model 3.50% 8.10% 6.60%
Count 2242 4121 6363
% within Model 96.50% 91.90% 93.40%
Count 2323 4486 6809
% within Model 100.00% 100.00% 100.00%
Count 56 276 332
% within Model 4.00% 11.70% 8.80%
Count 1345 2084 3429
% within Model 96.00% 88.30% 91.20%
Count 1401 2360 3761
% within Model 100.00% 100.00% 100.00%
Count 75 302 377
% within Model 4.80% 12.30% 9.40%
Count 1495 2156 3651
% within Model 95.20% 87.70% 90.60%
Count 1570 2458 4028
% within Model 100.00% 100.00% 100.00%
Count 15 50 65
% within Model 4.80% 11.70% 8.80%
Count 296 376 672
% within Model 95.20% 88.30% 91.20%
Count 311 426 737
% within Model 100.00% 100.00% 100.00%
Count 227 993 1220
% within Model 4.00% 10.20% 8.00%
Count 5378 8737 14115
% within Model 96.00% 89.80% 92.00%
Count 5605 9730 15335
% within Model 100.00% 100.00% 100.00%
Reliable 
Deterioration
Disability
Yes
No
Total
Total
Disability
Yes
No
Total
Reliable 
Improvement
Disability
Yes
No
Total
Non 
Recovered
Disability
Yes
No
Total
Crosstab
Recovery
Model
Total
Recovered
Disability
Yes
No
Total
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Appendix 48: Chi square for disability against model and recovery outcome for whole 
service 
 
 
 
 
 
 
Value df
Asymp. Sig. 
(2-sided)
Exact Sig. (2-
sided)
Exact Sig. (1-
sided)
54.053
c 1 0
53.296 1 0
59.693 1 0
0 0
54.045 1 0
6809
64.726
d 1 0
63.773 1 0
72.21 1 0
0 0
64.709 1 0
3761
63.683
e 1 0
62.801 1 0
69.392 1 0
0 0
63.667 1 0
4028
10.686
f 1 0.001
9.843 1 0.002
11.411 1 0.001
0.001 0.001
10.671 1 0.001
737
184.023
a 1 0
183.183 1 0
202.635 1 0
0 0
184.011 1 0
15335
Fisher's Exact Test
Linear-by-Linear 
Association
N of Valid Cases
N of Valid Cases
Total
Pearson Chi-Square
Continuity Correction
b
Likelihood Ratio
Reliable 
Deterioration
Pearson Chi-Square
Continuity Correction
b
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear 
Association
Fisher's Exact Test
Linear-by-Linear 
Association
N of Valid Cases
N of Valid Cases
Non 
Recovered
Pearson Chi-Square
Continuity Correction
b
Likelihood Ratio
Reliable 
Improvement
Pearson Chi-Square
Continuity Correction
b
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear 
Association
Fisher's Exact Test
Linear-by-Linear 
Association
N of Valid Cases
Chi-Square Tests
Recovery
Recovered
Pearson Chi-Square
Continuity Correction
b
Likelihood Ratio
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Appendix 49: Cross tabulation for first employment status against model and 
recovery outcome for whole service 
 
 
 
Allocated Progressive
Count 1348 2595 3943
% within Model 58.60% 58.00% 58.20%
Count 419 596 1015
% within Model 18.20% 13.30% 15.00%
Count 145 318 463
% within Model 6.30% 7.10% 6.80%
Count 120 386 506
% within Model 5.20% 8.60% 7.50%
Count 107 217 324
% within Model 4.70% 4.90% 4.80%
Count 0 14 14
% within Model 0.00% 0.30% 0.20%
Count 0 1 1
% within Model 0.00% 0.00% 0.00%
Count 162 346 508
% within Model 7.00% 7.70% 7.50%
Count 2301 4473 6774
% within Model 100.00% 100.00% 100.00%
Count 603 950 1553
% within Model 43.30% 40.40% 41.50%
Count 409 619 1028
% within Model 29.40% 26.30% 27.50%
Count 73 157 230
% within Model 5.20% 6.70% 6.10%
Count 164 379 543
% within Model 11.80% 16.10% 14.50%
Count 87 119 206
% within Model 6.20% 5.10% 5.50%
Count 0 9 9
% within Model 0.00% 0.40% 0.20%
Count 0 1 1
% within Model 0.00% 0.00% 0.00%
Count 57 116 173
% within Model 4.10% 4.90% 4.60%
Count 1393 2350 3743
% within Model 100.00% 100.00% 100.00%
Employment 
Status First
ft students or part 
students not seeking 
work
no benefits not working 
not seeking
Reliable 
Improvement
Employment 
Status First
ft students or part 
students not seeking 
work
no benefits not working 
not seeking
vol work not working not 
seeking
retired
Total
Employed
Unemployed and 
Seeking Work
sick, disabled, incapacity 
ben, income support, 
employ & support 
allowance
homemaker
sick, disabled, incapacity 
ben, income support, 
employ & support 
allowance
homemaker
vol work not working not 
seeking
retired
Total
Recovery
Model
Total
Employed
Unemployed and 
Seeking Work
Recovered
222 
 
 
 
 
 
 
 
 
Allocated Progressive
Count 541 835 1376
% within Model 34.80% 34.10% 34.40%
Count 543 710 1253
% within Model 34.90% 29.00% 31.30%
Count 86 178 264
% within Model 5.50% 7.30% 6.60%
Count 194 462 656
% within Model 12.50% 18.90% 16.40%
Count 110 147 257
% within Model 7.10% 6.00% 6.40%
Count 4 9 13
% within Model 0.30% 0.40% 0.30%
Count 1 3 4
% within Model 0.10% 0.10% 0.10%
Count 76 103 179
% within Model 4.90% 4.20% 4.50%
Count 1555 2447 4002
% within Model 100.00% 100.00% 100.00%
Count 107 139 246
% within Model 35.00% 33.10% 33.90%
Count 109 132 241
% within Model 35.60% 31.40% 33.20%
Count 17 29 46
% within Model 5.60% 6.90% 6.30%
Count 39 76 115
% within Model 12.70% 18.10% 15.80%
Count 22 28 50
% within Model 7.20% 6.70% 6.90%
Count 12 16 28
% within Model 3.90% 3.80% 3.90%
Count 306 420 726
% within Model 100.00% 100.00% 100.00%
Total
Reliable 
Deterioration
Employment 
Status First
Employed
Unemployed and 
Seeking Work
ft students or part 
students not seeking 
work
sick, disabled, incapacity 
ben, income support, 
employ & support 
allowance
homemaker
retired
Total
Non 
Recovered
Employment 
Status First
Employed
Unemployed and 
Seeking Work
ft students or part 
students not seeking 
work
sick, disabled, incapacity 
ben, income support, 
employ & support 
allowance
homemaker
no benefits not working 
not seeking
vol work not working not 
seeking
retired
Recovery
Model
Total
223 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allocated Progressive
Count 2599 4519 7118
% within Model 46.80% 46.60% 46.70%
Count 1480 2057 3537
% within Model 26.60% 21.20% 23.20%
Count 321 682 1003
% within Model 5.80% 7.00% 6.60%
Count 517 1303 1820
% within Model 9.30% 13.40% 11.90%
Count 326 511 837
% within Model 5.90% 5.30% 5.50%
Count 4 32 36
% within Model 0.10% 0.30% 0.20%
Count 1 5 6
% within Model 0.00% 0.10% 0.00%
Count 307 581 888
% within Model 5.50% 6.00% 5.80%
Count 5555 9690 15245
% within Model 100.00% 100.00% 100.00%
Total
Total
Employment 
Status First
Employed
Unemployed and 
Seeking Work
ft students or part 
students not seeking 
work
sick, disabled, incapacity 
ben, income support, 
employ & support 
allowance
homemaker
no benefits not working 
not seeking
vol work not working not 
seeking
retired
Recovery
Model
Total
224 
 
Appendix 50: Chi square for first employment status against model and recovery 
outcome for whole service 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. Sig. 
(2-sided)
Pearson Chi-Square 58.270
b 7 0
Likelihood Ratio 63.8 7 0
Linear-by-Linear 
Association
7.697 1 0.006
N of Valid Cases 6774
Pearson Chi-Square 28.512
c 7 0
Likelihood Ratio 32.263 7 0
Linear-by-Linear 
Association
7.451 1 0.006
N of Valid Cases 3743
Pearson Chi-Square 42.227
d 7 0
Likelihood Ratio 43.086 7 0
Linear-by-Linear 
Association
2.35 1 0.125
N of Valid Cases 4002
Pearson Chi-Square 4.904
e 5 0.428
Likelihood Ratio 4.978 5 0.419
Linear-by-Linear 
Association
0.857 1 0.355
N of Valid Cases 726
Pearson Chi-Square 118.435
a 7 0
Likelihood Ratio 121.823 7 0
Linear-by-Linear 
Association
14.268 1 0
N of Valid Cases 15245
Reliable 
Improvement
Non 
Recovered
Reliable 
Deterioration
Total
Chi-Square Tests
Recovery
Recovered
225 
 
Appendix 51: Cross tabulation of model and outcome for north cohort  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allocated Progressive
Count 1387 2571 3958
% within Model 42.80% 46.90% 45.40%
Count 796 1294 2090
% within Model 24.60% 23.60% 23.90%
Count 891 1360 2251
% within Model 27.50% 24.80% 25.80%
Count 168 260 428
% within Model 5.20% 4.70% 4.90%
Count 3242 5485 8727
% within Model 100.00% 100.00% 100.00%
Total
Model
Total
Recovery
Recovered
Reliable 
Improvement
Non Recovered
Reliable 
Deterioration
226 
 
Appendix 52: Chi Square of model and outcome for north cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. Sig. 
(2-sided)
Pearson Chi-Square 14.825
a 3 0.002
Likelihood Ratio 14.829 3 0.002
Linear-by-Linear 
Association
13.32 1 0
N of Valid Cases 8727
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Appendix 53: Cross tabulation of model on recovery v non recovery for north cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allocated Progressive
Count 1387 2571 3958
% within Model 42.80% 46.90% 45.40%
Count 1855 2914 4769
% within Model 57.20% 53.10% 54.60%
Count 3242 5485 8727
% within Model 100.00% 100.00% 100.00%
Recovery Non 
Recovery
Recovered
Non Recovered
Total
Model
Total
228 
 
Appendix 54: Chi square of model on recovery v non recovery for north cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. 
Sig. (2-
Exact Sig. 
(2-sided)
Exact Sig. 
(1-sided)
Pearson Chi-Square 13.760
a 1 0
Continuity Correction
b 13.596 1 0
Likelihood Ratio 13.783 1 0
Fisher's Exact Test 0 0
Linear-by-Linear 
Association
13.759 1 0
N of Valid Cases 8727
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Appendix 55: Cross tabulation of model on reliable improvement v non recovery for 
north cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allocated Progressive
Count 796 1294 2090
% within Model 42.90% 44.40% 43.80%
Count 1059 1620 2679
% within Model 57.10% 55.60% 56.20%
Count 1855 2914 4769
% within Model 100.00% 100.00% 100.00%
Reliable 
Improvement
Non Recovery
Model
Total
Total
Reliable Improvement 
Non Recovery
230 
 
Appendix 56: Chi square of model on reliable improvement v non recovery for north 
cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. Sig. 
(2-sided)
Exact Sig. 
(2-sided)
Exact Sig. 
(1-sided)
Pearson Chi-Square 1.029
a 1 0.31
Continuity Correction
b 0.97 1 0.325
Likelihood Ratio 1.03 1 0.31
Fisher's Exact Test 0.323 0.162
Linear-by-Linear 
Association
1.029 1 0.31
N of Valid Cases 4769
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Appendix 57: Cross tabulation of model on reliable deterioration v non recovery for 
north cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allocated Progressive
Count 168 260 428
% within Model 9.10% 8.90% 9.00%
Count 1687 2654 4341
% within Model 90.90% 91.10% 91.00%
Count 1855 2914 4769
% within Model 100.00% 100.00% 100.00%
Total
Model
Total
RD V Non 
Recovery
Reliable 
Deterioration
Non Recovery
232 
 
Appendix 58: Chi square of model on reliable deterioration v non recovery for north 
cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. Sig. (2-
sided)
Exact Sig. (2-
sided)
Exact Sig. 
(1-sided)
Pearson Chi-Square .025
a 1 0.874
Continuity Correction
b 0.011 1 0.916
Likelihood Ratio 0.025 1 0.874
Fisher's Exact Test 0.876 0.457
Linear-by-Linear Association 0.025 1 0.874
N of Valid Cases 4769
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 166.48.
b. Computed only for a 2x2 table
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Appendix 59: Cross tabulation on PHQ Moderate to Severe/Severe on model v 
outcomes for north cohort 
 
 
 
 
 
 
 
 
Allocated Progressive
Count 271 532 803
% within Model 25.90% 30.60% 28.80%
Count 367 619 986
% within Model 35.10% 35.60% 35.40%
Count 382 547 929
% within Model 36.60% 31.40% 33.40%
Count 25 42 67
% within Model 2.40% 2.40% 2.40%
Count 1045 1740 2785
% within Model 100.00% 100.00% 100.00%
Count 404 804 1208
% within Model 40.20% 46.00% 43.90%
Count 287 430 717
% within Model 28.50% 24.60% 26.00%
Count 262 426 688
% within Model 26.00% 24.40% 25.00%
Count 53 88 141
% within Model 5.30% 5.00% 5.10%
Count 1006 1748 2754
% within Model 100.00% 100.00% 100.00%
Count 675 1336 2011
% within Model 32.90% 38.30% 36.30%
Count 654 1049 1703
% within Model 31.90% 30.10% 30.70%
Count 644 973 1617
% within Model 31.40% 27.90% 29.20%
Count 78 130 208
% within Model 3.80% 3.70% 3.80%
Count 2051 3488 5539
% within Model 100.00% 100.00% 100.00%
Total
Recovery
Recovered
Reliable Improvement
Non Recovered
Reliable Deterioration
Total
Total
Moderate 
to Severe
Recovery
Recovered
Reliable Improvement
Non Recovered
Reliable Deterioration
Total
PHQ Severity
Model
Total
Severe
Recovery
Recovered
Reliable Improvement
Non Recovered
Reliable Deterioration
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Appendix 60: Chi square on PHQ Moderate to Severe/Severe on model v outcomes 
for north cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. 
Sig. (2-
sided)
Pearson Chi-Square 10.045
b 3 0.018
Likelihood Ratio 10.058 3 0.018
Linear-by-Linear 
Association
8.687 1 0.003
N of Valid Cases 2785
Pearson Chi-Square 9.529
c 3 0.023
Likelihood Ratio 9.541 3 0.023
Linear-by-Linear 
Association
4.586 1 0.032
N of Valid Cases 2754
Pearson Chi-Square 17.173
a 3 0.001
Likelihood Ratio 17.258 3 0.001
Linear-by-Linear 
Association
13.128 1 0
N of Valid Cases 5539
b. 0 cells (0.0%) have expected count less than 5. The minimum 
expected count is 25.14.
c. 0 cells (0.0%) have expected count less than 5. The minimum 
expected count is 51.51.
PHQ Severity
Severe
Moderate 
to Severe
Total
a. 0 cells (0.0%) have expected count less than 5. The minimum 
expected count is 77.02.
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Appendix 61: Cross tabulation on GAD Moderate/Severe on model v outcomes for 
north cohort 
 
 
 
 
 
 
 
 
Allocated Progressive
Count 570 1133 1703
% within Model 31.90% 37.00% 35.10%
Count 614 1003 1617
% within Model 34.40% 32.70% 33.30%
Count 551 853 1404
% within Model 30.90% 27.80% 28.90%
Count 51 75 126
% within Model 2.90% 2.40% 2.60%
Count 1786 3064 4850
% within Model 100.00% 100.00% 100.00%
Count 520 945 1465
% within Model 52.80% 55.70% 54.60%
Count 151 260 411
% within Model 15.30% 15.30% 15.30%
Count 246 373 619
% within Model 25.00% 22.00% 23.10%
Count 68 119 187
% within Model 6.90% 7.00% 7.00%
Count 985 1697 2682
% within Model 100.00% 100.00% 100.00%
Count 1090 2078 3168
% within Model 39.30% 43.60% 42.10%
Count 765 1263 2028
% within Model 27.60% 26.50% 26.90%
Count 797 1226 2023
% within Model 28.80% 25.80% 26.90%
Count 119 194 313
% within Model 4.30% 4.10% 4.20%
Count 2771 4761 7532
% within Model 100.00% 100.00% 100.00%
Total
Recovery
Recovered
Reliable Improvement
Non Recovered
Reliable Deterioration
Total
Total
Moderate
Recovery
Recovered
Reliable Improvement
Non Recovered
Reliable Deterioration
Total
GAD Severity
Model
Total
Severe
Recovery
Recovered
Reliable Improvement
Non Recovered
Reliable Deterioration
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Appendix 62: Chi square on GAD Moderate/Severe on model v outcomes for north 
cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. 
Sig. (2-
sided)
Pearson Chi-Square 13.408
b 3 0.004
Likelihood Ratio 13.478 3 0.004
Linear-by-Linear Association 11.976 1 0.001
N of Valid Cases 4850
Pearson Chi-Square 3.388
c 3 0.336
Likelihood Ratio 3.367 3 0.338
Linear-by-Linear Association 1.955 1 0.162
N of Valid Cases 2682
Pearson Chi-Square 14.612
a 3 0.002
Likelihood Ratio 14.627 3 0.002
Linear-by-Linear Association 12.401 1 0
N of Valid Cases 7532
b. 0 cells (0.0%) have expected count less than 5. The minimum expected 
count is 46.40.
c. 0 cells (0.0%) have expected count less than 5. The minimum expected 
count is 68.68.
GAD Severity
Severe
Moderate
Total
a. 0 cells (0.0%) have expected count less than 5. The minimum expected 
count is 115.15.
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Appendix 63: Cross tabulation for age against model and recovery outcome for north 
cohort 
 
Allocated Progressive
Count 0 1 1
% within Model 0.00% 0.00% 0.00%
Count 87 310 397
% within Model 6.30% 12.10% 10.00%
Count 318 588 906
% within Model 22.90% 22.90% 22.90%
Count 316 590 906
% within Model 22.80% 22.90% 22.90%
Count 337 535 872
% within Model 24.30% 20.80% 22.00%
Count 207 360 567
% within Model 14.90% 14.00% 14.30%
Count 98 137 235
% within Model 7.10% 5.30% 5.90%
Count 18 40 58
% within Model 1.30% 1.60% 1.50%
Count 6 9 15
% within Model 0.40% 0.40% 0.40%
Count 0 1 1
% within Model 0.00% 0.00% 0.00%
Count 1387 2571 3958
% within Model 100.00% 100.00% 100.00%
Count 49 156 205
% within Model 6.20% 12.10% 9.80%
Count 205 352 557
% within Model 25.80% 27.20% 26.70%
Count 192 270 462
% within Model 24.10% 20.90% 22.10%
Count 188 264 452
% within Model 23.60% 20.40% 21.60%
Count 128 201 329
% within Model 16.10% 15.50% 15.70%
Count 29 36 65
% within Model 3.60% 2.80% 3.10%
Count 4 13 17
% within Model 0.50% 1.00% 0.80%
Count 1 2 3
% within Model 0.10% 0.20% 0.10%
Count 796 1294 2090
% within Model 100.00% 100.00% 100.00%
85-94
Total
Total
Reliable 
Improvement
Age
18-24
25-34
35-44
45-54
55-64
65-74
75-84
45-54
55-64
65-74
75-84
85-94
95+
Recovery
Model
Total
Recovered
Age
16-17
18-24
25-34
35-44
238 
 
 
 
 
 
 
 
 
Allocated Progressive
Count 0 1 1
% within Model 0.00% 0.10% 0.00%
Count 79 198 277
% within Model 8.90% 14.60% 12.30%
Count 234 333 567
% within Model 26.30% 24.50% 25.20%
Count 207 306 513
% within Model 23.20% 22.50% 22.80%
Count 196 287 483
% within Model 22.00% 21.10% 21.50%
Count 130 191 321
% within Model 14.60% 14.00% 14.30%
Count 38 32 70
% within Model 4.30% 2.40% 3.10%
Count 6 11 17
% within Model 0.70% 0.80% 0.80%
Count 1 1 2
% within Model 0.10% 0.10% 0.10%
Count 891 1360 2251
% within Model 100.00% 100.00% 100.00%
Count 16 44 60
% within Model 9.50% 16.90% 14.00%
Count 41 52 93
% within Model 24.40% 20.00% 21.70%
Count 51 67 118
% within Model 30.40% 25.80% 27.60%
Count 30 55 85
% within Model 17.90% 21.20% 19.90%
Count 24 32 56
% within Model 14.30% 12.30% 13.10%
Count 6 10 16
% within Model 3.60% 3.80% 3.70%
Count 168 260 428
% within Model 100.00% 100.00% 100.00%
55-64
65-74
Total
65-74
75-84
85-94
Total
Reliable 
Deterioration
Age
18-24
25-34
35-44
45-54
Non 
Recovered
Age
16-17
18-24
25-34
35-44
45-54
55-64
Recovery
Model
Total
239 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allocated Progressive
Count 0 2 2
% within Model 0.00% 0.00% 0.00%
Count 231 708 939
% within Model 7.10% 12.90% 10.80%
Count 798 1325 2123
% within Model 24.60% 24.20% 24.30%
Count 766 1233 1999
% within Model 23.60% 22.50% 22.90%
Count 751 1141 1892
% within Model 23.20% 20.80% 21.70%
Count 489 784 1273
% within Model 15.10% 14.30% 14.60%
Count 171 215 386
% within Model 5.30% 3.90% 4.40%
Count 28 64 92
% within Model 0.90% 1.20% 1.10%
Count 8 12 20
% within Model 0.20% 0.20% 0.20%
Count 0 1 1
% within Model 0.00% 0.00% 0.00%
Count 3242 5485 8727
% within Model 100.00% 100.00% 100.00%
55-64
65-74
75-84
85-94
95+
Total
Total
Age
16-17
18-24
25-34
35-44
45-54
Recovery
Model
Total
240 
 
Appendix 64: Chi square for age against model and recovery outcome for north 
cohort 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. 
Sig. (2-
sided)
Pearson Chi-Square 41.811
b 9 0
Likelihood Ratio 44.66 9 0
Linear-by-Linear Association 18.72 1 0
N of Valid Cases 3958
Pearson Chi-Square 25.422
c 7 0.001
Likelihood Ratio 26.674 7 0
Linear-by-Linear Association 8.346 1 0.004
N of Valid Cases 2090
Pearson Chi-Square 22.495
d 8 0.004
Likelihood Ratio 23.292 8 0.003
Linear-by-Linear Association 8.21 1 0.004
N of Valid Cases 2251
Pearson Chi-Square 6.560
e 5 0.255
Likelihood Ratio 6.758 5 0.239
Linear-by-Linear Association 0.582 1 0.446
N of Valid Cases 428
Pearson Chi-Square 82.865
a 9 0
Likelihood Ratio 87.701 9 0
Linear-by-Linear Association 32.376 1 0
N of Valid Cases 8727
Total
Recovery
Recovered
Reliable 
Improvement
Non 
Recovered
Reliable 
Deterioration
241 
 
Appendix 65: Cross tabulation for gender against model and recovery outcome for 
north cohort 
 
 
 
 
 
 
 
Allocated Progressive
Count 505 983 1488
% within Model 36.40% 38.20% 37.60%
Count 882 1588 2470
% within Model 63.60% 61.80% 62.40%
Count 1387 2571 3958
% within Model 100.00% 100.00% 100.00%
Count 303 485 788
% within Model 38.10% 37.50% 37.70%
Count 493 808 1301
% within Model 61.90% 62.50% 62.30%
Count 796 1293 2089
% within Model 100.00% 100.00% 100.00%
Count 346 513 859
% within Model 38.90% 37.70% 38.20%
Count 544 847 1391
% within Model 61.10% 62.30% 61.80%
Count 890 1360 2250
% within Model 100.00% 100.00% 100.00%
Count 58 91 149
% within Model 34.50% 35.00% 34.80%
Count 110 169 279
% within Model 65.50% 65.00% 65.20%
Count 168 260 428
% within Model 100.00% 100.00% 100.00%
Count 1212 2072 3284
% within Model 37.40% 37.80% 37.60%
Count 2029 3412 5441
% within Model 62.60% 62.20% 62.40%
Count 3241 5484 8725
% within Model 100.00% 100.00% 100.00%
Reliable 
Deterioration
Gender
Male
Female
Total
Total
Gender
Male
Female
Total
Reliable 
Improvement
Gender
Male
Female
Total
Non 
Recovered
Gender
Male
Female
Total
Recovery
Model
Total
Recovered
Gender
Male
Female
Total
242 
 
Appendix 66: Chi square for gender against model and recovery outcome for north 
cohort 
 
 
 
 
 
 
 
Value df
Exact Sig. 
(2-sided)
1.279
c 1
1.202 1
1.281 1
0.271
1.278 1
3958
.065
d 1
0.043 1
0.065 1
0.816
0.065 1
2089
.304
e 1
0.257 1
0.304 1
0.595
0.304 1
2250
.010
f 1
0 1
0.01 1
1
0.01 1
428
.130
a 1
0.114 1
0.13 1
0.732
0.13 1
8725
0.368
0.502
0.306
0.417
Exact Sig. (1-sided)
0.136
Fisher's Exact Test
Linear-by-Linear 
Association
0.719
N of Valid Cases
0.92
N of Valid Cases
Total
Pearson Chi-Square 0.719
Continuity Correction
b 0.736
Likelihood Ratio 0.719
Reliable 
Deterioration
Pearson Chi-Square 0.92
Continuity Correction
b 1
Likelihood Ratio 0.92
Fisher's Exact Test
Linear-by-Linear 
Association
Fisher's Exact Test
Linear-by-Linear 
Association
0.581
N of Valid Cases
0.799
N of Valid Cases
Non 
Recovered
Pearson Chi-Square 0.581
Continuity Correction
b 0.612
Likelihood Ratio 0.581
Reliable 
Improvement
Pearson Chi-Square 0.799
Continuity Correction
b 0.835
Likelihood Ratio 0.799
Fisher's Exact Test
Linear-by-Linear 
Association
Fisher's Exact Test
Linear-by-Linear 
Association
0.258
N of Valid Cases
Recovery Asymp. Sig. (2-sided)
Recovered
Pearson Chi-Square 0.258
Continuity Correction
b 0.273
Likelihood Ratio 0.258
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Appendix 67: Cross tabulation for disability against model and recovery outcome for 
north cohort 
 
 
 
 
 
 
 
Allocated Progressive
Count 43 235 278
% within Model 3.10% 9.10% 7.00%
Count 1344 2336 3680
% within Model 96.90% 90.90% 93.00%
Count 1387 2571 3958
% within Model 100.00% 100.00% 100.00%
Count 25 171 196
% within Model 3.10% 13.20% 9.40%
Count 771 1123 1894
% within Model 96.90% 86.80% 90.60%
Count 796 1294 2090
% within Model 100.00% 100.00% 100.00%
Count 41 167 208
% within Model 4.60% 12.30% 9.20%
Count 850 1193 2043
% within Model 95.40% 87.70% 90.80%
Count 891 1360 2251
% within Model 100.00% 100.00% 100.00%
Count 4 26 30
% within Model 2.40% 10.00% 7.00%
Count 164 234 398
% within Model 97.60% 90.00% 93.00%
Count 168 260 428
% within Model 100.00% 100.00% 100.00%
Count 113 599 712
% within Model 3.50% 10.90% 8.20%
Count 3129 4886 8015
% within Model 96.50% 89.10% 91.80%
Count 3242 5485 8727
% within Model 100.00% 100.00% 100.00%
Reliable 
Deterioration
Disability
Yes
No
Total
Total
Disability
Yes
No
Total
Reliable 
Improvement
Disability
Yes
No
Total
Non 
Recovered
Disability
Yes
No
Total
Recovery
Model
Total
Recovered
Disability
Yes
No
Total
244 
 
Appendix 68: Chi square for disability against model and recovery outcome for north 
cohort 
 
 
 
 
 
 
 
Value df
Exact Sig. 
(2-sided)
50.334
c 1
49.414 1
56.982 1
0
50.322 1
3958
58.854
d 1
57.674 1
68.075 1
0
58.825 1
2090
37.839
e 1
36.929 1
41.28 1
0
37.822 1
2251
9.089
f 1
7.958 1
10.473 1
0.003
9.068 1
428
150.333
a 1
149.343 1
169.303 1
0
150.316 1
8727
0
0.001
0
0
Exact Sig. (1-sided)
0
Fisher's Exact Test
Linear-by-Linear 
Association
0
N of Valid Cases
0.003
N of Valid Cases
Total
Pearson Chi-Square 0
Continuity Correction
b 0
Likelihood Ratio 0
Reliable 
Deterioration
Pearson Chi-Square 0.003
Continuity Correction
b 0.005
Likelihood Ratio 0.001
Fisher's Exact Test
Linear-by-Linear 
Association
Fisher's Exact Test
Linear-by-Linear 
Association
0
N of Valid Cases
0
N of Valid Cases
Non 
Recovered
Pearson Chi-Square 0
Continuity Correction
b 0
Likelihood Ratio 0
Reliable 
Improvement
Pearson Chi-Square 0
Continuity Correction
b 0
Likelihood Ratio 0
Fisher's Exact Test
Linear-by-Linear 
Association
Fisher's Exact Test
Linear-by-Linear 
Association
0
N of Valid Cases
Recovery Asymp. Sig. (2-sided)
Recovered
Pearson Chi-Square 0
Continuity Correction
b 0
Likelihood Ratio 0
245 
 
Appendix 69: Cross tabulation for first employment status against model and 
recovery outcome for north cohort 
 
Allocated Progressive
Count 786 1388 2174
% within Model 57.30% 54.20% 55.30%
Count 240 328 568
% within Model 17.50% 12.80% 14.40%
Count 111 235 346
% within Model 8.10% 9.20% 8.80%
Count 80 285 365
% within Model 5.80% 11.10% 9.30%
Count 56 112 168
% within Model 4.10% 4.40% 4.30%
Count 0 12 12
% within Model 0.00% 0.50% 0.30%
Count 0 1 1
% within Model 0.00% 0.00% 0.00%
Count 98 201 299
% within Model 7.10% 7.80% 7.60%
Count 1371 2562 3933
% within Model 100.00% 100.00% 100.00%
Count 331 507 838
% within Model 41.90% 39.30% 40.30%
Count 229 293 522
% within Model 29.00% 22.70% 25.10%
Count 47 105 152
% within Model 5.90% 8.10% 7.30%
Count 110 267 377
% within Model 13.90% 20.70% 18.10%
Count 40 54 94
% within Model 5.10% 4.20% 4.50%
Count 0 7 7
% within Model 0.00% 0.50% 0.30%
Count 0 1 1
% within Model 0.00% 0.10% 0.00%
Count 33 57 90
% within Model 4.20% 4.40% 4.30%
Count 790 1291 2081
% within Model 100.00% 100.00% 100.00%
sick, disabled, 
incapacity ben, 
income support, 
employ & support 
allowance
homemaker
no benefits not 
working not seeking
vol work not working 
not seeking
retired
Total
homemaker
no benefits not 
working not seeking
vol work not working 
not seeking
retired
Total
Reliable 
Improvement
Employment 
Status First
Employed
Unemployed and 
Seeking Work
ft students or part 
students not seeking 
work
Recovery
Model
Total
Recovered
Employment 
Status First
Employed
Unemployed and 
Seeking Work
ft students or part 
students not seeking 
work
sick, disabled, 
incapacity ben, 
income support, 
employ & support 
allowance
246 
 
 
 
 
 
 
Allocated Progressive
Count 290 455 745
% within Model 32.90% 33.60% 33.30%
Count 301 340 641
% within Model 34.10% 25.10% 28.60%
Count 61 124 185
% within Model 6.90% 9.10% 8.30%
Count 133 307 440
% within Model 15.10% 22.60% 19.70%
Count 50 72 122
% within Model 5.70% 5.30% 5.50%
Count 2 8 10
% within Model 0.20% 0.60% 0.40%
Count 1 3 4
% within Model 0.10% 0.20% 0.20%
Count 44 47 91
% within Model 5.00% 3.50% 4.10%
Count 882 1356 2238
% within Model 100.00% 100.00% 100.00%
Count 60 90 150
% within Model 36.40% 34.90% 35.50%
Count 52 69 121
% within Model 31.50% 26.70% 28.60%
Count 14 25 39
% within Model 8.50% 9.70% 9.20%
Count 24 53 77
% within Model 14.50% 20.50% 18.20%
Count 9 13 22
% within Model 5.50% 5.00% 5.20%
Count 6 8 14
% within Model 3.60% 3.10% 3.30%
Count 165 258 423
% within Model 100.00% 100.00% 100.00%
Total
Reliable 
Deterioration
Employment 
Status First
Employed
Unemployed and 
Seeking Work
ft students or part 
students not seeking 
work
sick, disabled, 
incapacity ben, 
income support, 
employ & support 
allowance
homemaker
retired
Total
Non 
Recovered
Employment 
Status First
Employed
Unemployed and 
Seeking Work
ft students or part 
students not seeking 
work
sick, disabled, 
incapacity ben, 
income support, 
employ & support 
allowance
homemaker
no benefits not 
working not seeking
vol work not working 
not seeking
retired
Recovery
Model
Total
247 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allocated Progressive
Count 1467 2440 3907
% within Model 45.70% 44.60% 45.00%
Count 822 1030 1852
% within Model 25.60% 18.80% 21.30%
Count 233 489 722
% within Model 7.30% 8.90% 8.30%
Count 347 912 1259
% within Model 10.80% 16.70% 14.50%
Count 155 251 406
% within Model 4.80% 4.60% 4.70%
Count 2 27 29
% within Model 0.10% 0.50% 0.30%
Count 1 5 6
% within Model 0.00% 0.10% 0.10%
Count 181 313 494
% within Model 5.60% 5.70% 5.70%
Count 3208 5467 8675
% within Model 100.00% 100.00% 100.00%
Total
Total
Employment 
Status First
Employed
Unemployed and 
Seeking Work
ft students or part 
students not seeking 
work
sick, disabled, 
incapacity ben, 
income support, 
employ & support 
allowance
homemaker
no benefits not 
working not seeking
vol work not working 
not seeking
retired
Recovery
Model
Total
248 
 
 
Appendix 70: Chi square for first employment status against model and recovery 
outcome for north cohort 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. 
Sig. (2-
sided)
Pearson Chi-Square 51.080
b 7 0
Likelihood Ratio 57.028 7 0
Linear-by-Linear Association 10.499 1 0.001
N of Valid Cases 3933
Pearson Chi-Square 29.929
c 7 0
Likelihood Ratio 33.079 7 0
Linear-by-Linear Association 6.248 1 0.012
N of Valid Cases 2081
Pearson Chi-Square 39.213
d 7 0
Likelihood Ratio 39.671 7 0
Linear-by-Linear Association 1.299 1 0.254
N of Valid Cases 2238
Pearson Chi-Square 3.131
e 5 0.68
Likelihood Ratio 3.181 5 0.672
Linear-by-Linear Association 0.399 1 0.528
N of Valid Cases 423
Pearson Chi-Square 111.500
a 7 0
Likelihood Ratio 115.996 7 0
Linear-by-Linear Association 15.47 1 0
N of Valid Cases 8675
Total
Recovery
Recovered
Reliable 
Improvement
Non 
Recovered
Reliable 
Deterioration
249 
 
Appendix 71: Cross tabulation of model and outcome for south cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allocated Progressive
Count 1764 1045 2809
% within Model 40.10% 49.70% 43.20%
Count 1153 493 1646
% within Model 26.20% 23.50% 25.30%
Count 1253 488 1741
% within Model 28.50% 23.20% 26.80%
Count 228 76 304
% within Model 5.20% 3.60% 4.70%
Count 4398 2102 6500
% within Model 100.00% 100.00% 100.00%
Total
Model
Total
Recovery
Recovered
Reliable 
Improvement
Non Recovered
Reliable 
Deterioration
250 
 
Appendix 72: Chi square of model and outcome for south cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. 
Sig. (2-
sided)
Pearson Chi-Square 56.904
a 3 0
Likelihood Ratio 56.976 3 0
Linear-by-Linear Association 52.331 1 0
N of Valid Cases 6500
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Appendix 73: Cross tabulation of model on recovery v non recovery for south cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allocated Progressive
Count 1764 1045 2809
% within Model 40.10% 49.70% 43.20%
Count 2634 1057 3691
% within Model 59.90% 50.30% 56.80%
Count 4398 2102 6500
% within Model 100.00% 100.00% 100.00%
Total
Model
Total
Recovery Non Recovery
Recovered
Non 
Recovered
252 
 
 
Appendix 74: Chi square of model on recovery v non recovery for south cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. Sig. 
(2-sided)
Exact Sig. (2-
sided)
Exact Sig. 
(1-sided)
Pearson Chi-Square 53.473
a 1 0
Continuity Correction
b 53.083 1 0
Likelihood Ratio 53.259 1 0
Fisher's Exact Test 0 0
Linear-by-Linear Association 53.465 1 0
N of Valid Cases 6500
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Appendix 75: Cross tabulation of model on reliable improvement v non recovery for 
south cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allocated Progressive
Count 1153 493 1646
% within Model 43.80% 46.60% 44.60%
Count 1481 564 2045
% within Model 56.20% 53.40% 55.40%
Count 2634 1057 3691
% within Model 100.00% 100.00% 100.00%
Total
Total
Reliable Improvement Non 
Recovery
Reliable 
Improvement
Non Recovery
Model
254 
 
Appendix 76: Chi square of model on reliable improvement v non recovery for south 
cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. Sig. 
(2-sided)
Exact Sig. 
(2-sided)
Exact Sig. 
(1-sided)
Pearson Chi-Square 2.511
a 1 0.113
Continuity Correction
b 2.396 1 0.122
Likelihood Ratio 2.507 1 0.113
Fisher's Exact Test 0.115 0.061
Linear-by-Linear Association 2.51 1 0.113
N of Valid Cases 3691
255 
 
Appendix 77: Cross tabulation of model on reliable deterioration v non recovery for 
south cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allocated Progressive
Count 228 76 304
% within Model 8.70% 7.20% 8.20%
Count 2406 981 3387
% within Model 91.30% 92.80% 91.80%
Count 2634 1057 3691
% within Model 100.00% 100.00% 100.00%
Total
Model
Total
RD V Non Recovery
Reliable 
Deterioration
Non 
Recovery
256 
 
Appendix 78: Chi square of model on reliable deterioration v non recovery for south 
cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. Sig. 
(2-sided)
Exact Sig. 
(2-sided)
Exact Sig. 
(1-sided)
Pearson Chi-Square 2.145
a 1 0.143
Continuity Correction
b 1.955 1 0.162
Likelihood Ratio 2.198 1 0.138
Fisher's Exact Test 0.146 0.08
Linear-by-Linear Association 2.144 1 0.143
N of Valid Cases 3691
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 87.06.
b. Computed only for a 2x2 table
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Appendix 79: Cross tabulation on PHQ Moderate to Severe/Severe on model v 
outcomes south cohort 
 
 
 
 
 
 
 
 
Allocated Progressive
Count 349 223 572
% within Model 23.70% 32.10% 26.40%
Count 544 246 790
% within Model 36.90% 35.40% 36.40%
Count 546 208 754
% within Model 37.00% 29.90% 34.80%
Count 35 18 53
% within Model 2.40% 2.60% 2.40%
Count 1474 695 2169
% within Model 100.00% 100.00% 100.00%
Count 485 317 802
% within Model 37.20% 47.80% 40.80%
Count 385 163 548
% within Model 29.50% 24.60% 27.90%
Count 354 156 510
% within Model 27.10% 23.50% 25.90%
Count 80 27 107
% within Model 6.10% 4.10% 5.40%
Count 1304 663 1967
% within Model 100.00% 100.00% 100.00%
Count 834 540 1374
% within Model 30.00% 39.80% 33.20%
Count 929 409 1338
% within Model 33.40% 30.10% 32.40%
Count 900 364 1264
% within Model 32.40% 26.80% 30.60%
Count 115 45 160
% within Model 4.10% 3.30% 3.90%
Count 2778 1358 4136
% within Model 100.00% 100.00% 100.00%
Total
Recovery
Recovered
Reliable 
Improvement
Non 
Recovered
Reliable 
Deterioration
Total
Moderate to 
Severe
Recovery
Recovered
Reliable 
Improvement
Non 
Recovered
Reliable 
Deterioration
Total
PHQ Severity
Model
Total
Severe
Recovery
Recovered
Reliable 
Improvement
Non 
Recovered
Reliable 
Deterioration
Total
258 
 
Appendix 80: Chi square on PHQ Moderate to Severe/Severe on model v outcomes 
for south cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. 
Sig. (2-
sided)
Pearson Chi-Square 19.927
b 3 0
Likelihood Ratio 19.697 3 0
Linear-by-Linear Association 15.552 1 0
N of Valid Cases 2169
Pearson Chi-Square 21.663
c 3 0
Likelihood Ratio 21.651 3 0
Linear-by-Linear Association 16.775 1 0
N of Valid Cases 1967
Pearson Chi-Square 40.122
a 3 0
Likelihood Ratio 39.66 3 0
Linear-by-Linear Association 33.313 1 0
N of Valid Cases 4136
b. 0 cells (0.0%) have expected count less than 5. The minimum expected 
count is 16.98.
c. 0 cells (0.0%) have expected count less than 5. The minimum expected 
count is 36.07.
PHQ Severity
Severe
Moderate 
to Severe
Total
a. 0 cells (0.0%) have expected count less than 5. The minimum expected 
count is 52.53.
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Appendix 81: Cross tabulation on GAD Moderate/Severe on model v outcomes for 
south cohort 
 
 
 
 
 
 
 
Allocated Progressive
Count 751 463 1214
% within Model 30.40% 39.00% 33.20%
Count 861 397 1258
% within Model 34.80% 33.40% 34.40%
Count 791 309 1100
% within Model 32.00% 26.00% 30.10%
Count 68 19 87
% within Model 2.80% 1.60% 2.40%
Count 2471 1188 3659
% within Model 100.00% 100.00% 100.00%
Count 651 391 1042
% within Model 48.50% 61.60% 52.70%
Count 252 86 338
% within Model 18.80% 13.50% 17.10%
Count 338 122 460
% within Model 25.20% 19.20% 23.30%
Count 101 36 137
% within Model 7.50% 5.70% 6.90%
Count 1342 635 1977
% within Model 100.00% 100.00% 100.00%
Count 1402 854 2256
% within Model 36.80% 46.80% 40.00%
Count 1113 483 1596
% within Model 29.20% 26.50% 28.30%
Count 1129 431 1560
% within Model 29.60% 23.60% 27.70%
Count 169 55 224
% within Model 4.40% 3.00% 4.00%
Count 3813 1823 5636
% within Model 100.00% 100.00% 100.00%
Total
Recovery
Recovered
Reliable 
Improvement
Non Recovered
Reliable 
Deterioration
Total
Moderate
Recovery
Recovered
Reliable 
Improvement
Non Recovered
Reliable 
Deterioration
Total
Severe
Recovery
Recovered
Reliable 
Improvement
Non Recovered
Reliable 
Deterioration
Total
GAD Severity
Model
Total
260 
 
Appendix 82: Chi square on GAD Moderate/Severe on model v outcomes for south 
cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. 
Sig. (2-
sided)
Pearson Chi-Square 32.372
b 3 0
Likelihood Ratio 32.474 3 0
Linear-by-Linear Association 31.45 1 0
N of Valid Cases 3659
Pearson Chi-Square 29.624
c 3 0
Likelihood Ratio 29.859 3 0
Linear-by-Linear Association 22.024 1 0
N of Valid Cases 1977
Pearson Chi-Square 56.530
a 3 0
Likelihood Ratio 56.505 3 0
Linear-by-Linear Association 52.664 1 0
N of Valid Cases 5636
b. 0 cells (0.0%) have expected count less than 5. The minimum expected 
count is 28.25.
c. 0 cells (0.0%) have expected count less than 5. The minimum expected 
count is 44.00.
GAD Severity
Severe
Moderate
Total
a. 0 cells (0.0%) have expected count less than 5. The minimum expected 
count is 72.45.
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Appendix 83: Cross tabulation for age against model and recovery outcome for south 
cohort  
 
 
 
Allocated Progressive
Count 0 1 1
% within Model 0.00% 0.10% 0.00%
Count 124 98 222
% within Model 7.00% 9.40% 7.90%
Count 363 250 613
% within Model 20.60% 23.90% 21.80%
Count 441 257 698
% within Model 25.00% 24.60% 24.80%
Count 417 236 653
% within Model 23.60% 22.60% 23.20%
Count 280 130 410
% within Model 15.90% 12.40% 14.60%
Count 127 61 188
% within Model 7.20% 5.80% 6.70%
Count 11 10 21
% within Model 0.60% 1.00% 0.70%
Count 1 2 3
% within Model 0.10% 0.20% 0.10%
Count 1764 1045 2809
% within Model 100.00% 100.00% 100.00%
Count 80 61 141
% within Model 6.90% 12.40% 8.60%
Count 296 126 422
% within Model 25.70% 25.60% 25.60%
Count 257 110 367
% within Model 22.30% 22.30% 22.30%
Count 259 105 364
% within Model 22.50% 21.30% 22.10%
Count 209 73 282
% within Model 18.10% 14.80% 17.10%
Count 42 16 58
% within Model 3.60% 3.20% 3.50%
Count 10 1 11
% within Model 0.90% 0.20% 0.70%
Count 0 1 1
% within Model 0.00% 0.20% 0.10%
Count 1153 493 1646
% within Model 100.00% 100.00% 100.00%
Total
Reliable 
Improvement
Age
18-24
25-34
35-44
45-54
55-64
65-74
75-84
85-94
45-54
55-64
65-74
75-84
85-94
Total
Recovery
Model
Total
Recovered
Age
16-17
18-24
25-34
35-44
262 
 
 
 
 
 
 
 
 
Allocated Progressive
Count 110 81 191
% within Model 8.80% 16.60% 11.00%
Count 293 91 384
% within Model 23.40% 18.60% 22.10%
Count 272 122 394
% within Model 21.70% 25.00% 22.60%
Count 302 110 412
% within Model 24.10% 22.50% 23.70%
Count 229 65 294
% within Model 18.30% 13.30% 16.90%
Count 40 16 56
% within Model 3.20% 3.30% 3.20%
Count 5 3 8
% within Model 0.40% 0.60% 0.50%
Count 2 0 2
% within Model 0.20% 0.00% 0.10%
Count 1253 488 1741
% within Model 100.00% 100.00% 100.00%
Count 16 9 25
% within Model 7.00% 11.80% 8.20%
Count 52 20 72
% within Model 22.80% 26.30% 23.70%
Count 56 16 72
% within Model 24.60% 21.10% 23.70%
Count 51 16 67
% within Model 22.40% 21.10% 22.00%
Count 38 12 50
% within Model 16.70% 15.80% 16.40%
Count 13 3 16
% within Model 5.70% 3.90% 5.30%
Count 2 0 2
% within Model 0.90% 0.00% 0.70%
Count 228 76 304
% within Model 100.00% 100.00% 100.00%
75-84
Total
85-94
Total
Reliable 
Deterioration
Age
18-24
25-34
35-44
45-54
55-64
65-74
Non 
Recovered
Age
18-24
25-34
35-44
45-54
55-64
65-74
75-84
Recovery
Model
Total
263 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allocated Progressive
Count 0 1 1
% within Model 0.00% 0.00% 0.00%
Count 330 249 579
% within Model 7.50% 11.80% 8.90%
Count 1004 487 1491
% within Model 22.80% 23.20% 22.90%
Count 1026 505 1531
% within Model 23.30% 24.00% 23.60%
Count 1029 467 1496
% within Model 23.40% 22.20% 23.00%
Count 756 280 1036
% within Model 17.20% 13.30% 15.90%
Count 222 96 318
% within Model 5.00% 4.60% 4.90%
Count 28 14 42
% within Model 0.60% 0.70% 0.60%
Count 3 3 6
% within Model 0.10% 0.10% 0.10%
Count 4398 2102 6500
% within Model 100.00% 100.00% 100.00%
65-74
75-84
85-94
Total
Total
Age
16-17
18-24
25-34
35-44
45-54
55-64
Recovery
Model
Total
264 
 
Appendix 84: Chi square for age against model and recovery outcome for south 
cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. Sig. 
(2-sided)
Pearson Chi-Square 19.199
b 8 0.014
Likelihood Ratio 19.434 8 0.013
Linear-by-Linear Association 11.27 1 0.001
N of Valid Cases 2809
Pearson Chi-Square 19.117
c 7 0.008
Likelihood Ratio 19.036 7 0.008
Linear-by-Linear Association 8.443 1 0.004
N of Valid Cases 1646
Pearson Chi-Square 31.442
d 7 0
Likelihood Ratio 30.779 7 0
Linear-by-Linear Association 8.993 1 0.003
N of Valid Cases 1741
Pearson Chi-Square 3.277
e 6 0.773
Likelihood Ratio 3.66 6 0.723
Linear-by-Linear Association 1.856 1 0.173
N of Valid Cases 304
Pearson Chi-Square 48.328
a 8 0
Likelihood Ratio 47.507 8 0
Linear-by-Linear Association 26.838 1 0
N of Valid Cases 6500
Recovered
Reliable 
Improvement
Non 
Recovered
Reliable 
Deterioration
Total
Recovery
265 
 
Appendix 85: Cross tabulation for gender against model and recovery outcome for 
south cohort 
 
 
 
 
 
 
 
Allocated Progressive
Count 663 351 1014
% within Model 37.60% 33.60% 36.10%
Count 1100 694 1794
% within Model 62.40% 66.40% 63.90%
Count 1763 1045 2808
% within Model 100.00% 100.00% 100.00%
Count 420 166 586
% within Model 36.40% 33.70% 35.60%
Count 733 327 1060
% within Model 63.60% 66.30% 64.40%
Count 1153 493 1646
% within Model 100.00% 100.00% 100.00%
Count 478 185 663
% within Model 38.20% 37.90% 38.10%
Count 774 303 1077
% within Model 61.80% 62.10% 61.90%
Count 1252 488 1740
% within Model 100.00% 100.00% 100.00%
Count 80 24 104
% within Model 35.10% 31.60% 34.20%
Count 148 52 200
% within Model 64.90% 68.40% 65.80%
Count 228 76 304
% within Model 100.00% 100.00% 100.00%
Count 1641 726 2367
% within Model 37.30% 34.50% 36.40%
Count 2755 1376 4131
% within Model 62.70% 65.50% 63.60%
Count 4396 2102 6498
% within Model 100.00% 100.00% 100.00%
Reliable 
Deteriorati
on
Gender
Male
Female
Total
Total
Gender
Male
Female
Total
Reliable 
Improvem
ent
Gender
Male
Female
Total
Non 
Recovered
Gender
Male
Female
Total
Recovery
Model
Total
Recovered
Gender
Male
Female
Total
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Appendix 86: Chi square for gender against model and recovery outcome for south 
cohort 
 
 
 
 
 
Value df
Asymp. 
Sig. (2-
Exact Sig. 
(2-sided)
Exact Sig. 
(1-sided)
4.591
c 1 0.032
4.418 1 0.036
4.612 1 0.032
0.035 0.018
4.589 1 0.032
2808
1.144
d 1 0.285
1.027 1 0.311
1.149 1 0.284
0.312 0.155
1.143 1 0.285
1646
.011
e 1 0.917
0.002 1 0.961
0.011 1 0.917
0.956 0.481
0.011 1 0.917
1740
.312
f 1 0.577
0.175 1 0.675
0.315 1 0.575
0.676 0.34
0.311 1 0.577
304
4.783
a 1 0.029
4.663 1 0.031
4.803 1 0.028
0.03 0.015
4.782 1 0.029
6498
Fisher's Exact Test
Linear-by-Linear 
Association
N of Valid Cases
N of Valid Cases
Total
Pearson Chi-Square
Continuity Correction
b
Likelihood Ratio
Reliable 
Deterioration
Pearson Chi-Square
Continuity Correction
b
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear 
Association
Fisher's Exact Test
Linear-by-Linear 
Association
N of Valid Cases
N of Valid Cases
Non 
Recovered
Pearson Chi-Square
Continuity Correction
b
Likelihood Ratio
Reliable 
Improvement
Pearson Chi-Square
Continuity Correction
b
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear 
Association
Fisher's Exact Test
Linear-by-Linear 
Association
N of Valid Cases
Recovery
Recovered
Pearson Chi-Square
Continuity Correction
b
Likelihood Ratio
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Appendix 87: Cross tabulation for disability against model and recovery outcome for 
south cohort 
 
 
 
 
 
 
 
Allocated Progressive
Count 87 77 164
% within Model 4.90% 7.40% 5.80%
Count 1677 968 2645
% within Model 95.10% 92.60% 94.20%
Count 1764 1045 2809
% within Model 100.00% 100.00% 100.00%
Count 87 46 133
% within Model 7.50% 9.30% 8.10%
Count 1066 447 1513
% within Model 92.50% 90.70% 91.90%
Count 1153 493 1646
% within Model 100.00% 100.00% 100.00%
Count 106 61 167
% within Model 8.50% 12.50% 9.60%
Count 1147 427 1574
% within Model 91.50% 87.50% 90.40%
Count 1253 488 1741
% within Model 100.00% 100.00% 100.00%
Count 24 11 35
% within Model 10.50% 14.50% 11.50%
Count 204 65 269
% within Model 89.50% 85.50% 88.50%
Count 228 76 304
% within Model 100.00% 100.00% 100.00%
Count 304 195 499
% within Model 6.90% 9.30% 7.70%
Count 4094 1907 6001
% within Model 93.10% 90.70% 92.30%
Count 4398 2102 6500
% within Model 100.00% 100.00% 100.00%
Reliable 
Deterioration
Disability
Yes
No
Total
Total
Disability
Yes
No
Total
Reliable 
Improvement
Disability
Yes
No
Total
Non 
Recovered
Disability
Yes
No
Total
Recovery
Model
Total
Recovered
Disability
Yes
No
Total
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Appendix 88: Chi square for disability against model and recovery outcome for south 
cohort 
 
 
 
 
 
 
 
Value df
Asymp. 
Sig. (2-
Exact Sig. 
(2-sided)
Exact Sig. 
(1-sided)
7.086
c 1 0.008
6.65 1 0.01
6.902 1 0.009
0.01 0.005
7.084 1 0.008
2809
1.482
d 1 0.224
1.251 1 0.263
1.446 1 0.229
0.236 0.132
1.481 1 0.224
1646
6.611
e 1 0.01
6.153 1 0.013
6.307 1 0.012
0.014 0.007
6.607 1 0.01
1741
.872
f 1 0.35
0.527 1 0.468
0.834 1 0.361
0.406 0.23
0.869 1 0.351
304
11.220
a 1 0.001
10.889 1 0.001
10.898 1 0.001
0.001 0.001
11.219 1 0.001
6500
Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases
N of Valid Cases
Total
Pearson Chi-Square
Continuity Correction
b
Likelihood Ratio
Reliable 
Deterioration
Pearson Chi-Square
Continuity Correction
b
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear Association
Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases
N of Valid Cases
Non 
Recovered
Pearson Chi-Square
Continuity Correction
b
Likelihood Ratio
Reliable 
Improvement
Pearson Chi-Square
Continuity Correction
b
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear Association
Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases
Recovery
Recovered
Pearson Chi-Square
Continuity Correction
b
Likelihood Ratio
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Appendix 89: Cross tabulation for first employment status against model and 
recovery outcome for south cohort 
 
 
 
Allocated Progressive
Count 1089 663 1752
% within Model 62.00% 63.60% 62.60%
Count 311 128 439
% within Model 17.70% 12.30% 15.70%
Count 69 43 112
% within Model 3.90% 4.10% 4.00%
Count 72 64 136
% within Model 4.10% 6.10% 4.90%
Count 91 64 155
% within Model 5.20% 6.10% 5.50%
Count 2 0 2
% within Model 0.10% 0.00% 0.10%
Count 123 80 203
% within Model 7.00% 7.70% 7.30%
Count 1757 1042 2799
% within Model 100.00% 100.00% 100.00%
Count 500 208 708
% within Model 43.60% 42.40% 43.20%
Count 350 143 493
% within Model 30.50% 29.20% 30.10%
Count 51 24 75
% within Model 4.40% 4.90% 4.60%
Count 112 53 165
% within Model 9.80% 10.80% 10.10%
Count 76 35 111
% within Model 6.60% 7.10% 6.80%
Count 2 0 2
% within Model 0.20% 0.00% 0.10%
Count 56 27 83
% within Model 4.90% 5.50% 5.10%
Count 1147 490 1637
% within Model 100.00% 100.00% 100.00%
homemaker
no benefits not 
working not seeking
retired
Total
homemaker
no benefits not 
working not seeking
retired
Total
Reliable 
Improvement
Employment 
Status First
Employed
Unemployed and 
Seeking Work
ft students or part 
students not seeking 
work
sick, disabled, 
incapacity ben, 
income support, 
employ & support 
allowance
Recovery
Model
Total
Recovered
Employment 
Status First
Employed
Unemployed and 
Seeking Work
ft students or part 
students not seeking 
work
sick, disabled, 
incapacity ben, 
income support, 
employ & support 
allowance
270 
 
 
 
 
 
 
Allocated Progressive
Count 452 171 623
% within Model 36.40% 35.30% 36.10%
Count 447 156 603
% within Model 36.00% 32.20% 34.90%
Count 50 25 75
% within Model 4.00% 5.20% 4.30%
Count 129 80 209
% within Model 10.40% 16.50% 12.10%
Count 104 29 133
% within Model 8.40% 6.00% 7.70%
Count 1 1 2
% within Model 0.10% 0.20% 0.10%
Count 60 23 83
% within Model 4.80% 4.70% 4.80%
Count 1243 485 1728
% within Model 100.00% 100.00% 100.00%
Count 73 20 93
% within Model 32.60% 27.00% 31.20%
Count 88 31 119
% within Model 39.30% 41.90% 39.90%
Count 5 2 7
% within Model 2.20% 2.70% 2.30%
Count 27 10 37
% within Model 12.10% 13.50% 12.40%
Count 20 8 28
% within Model 8.90% 10.80% 9.40%
Count 11 3 14
% within Model 4.90% 4.10% 4.70%
Count 224 74 298
% within Model 100.00% 100.00% 100.00%
homemaker
retired
Total
homemaker
no benefits not 
working not seeking
retired
Total
Reliable 
Deterioration
Employment 
Status First
Employed
Unemployed and 
Seeking Work
ft students or part 
students not seeking 
work
sick, disabled, 
incapacity ben, 
income support, 
employ & support 
allowance
Non 
Recovered
Employment 
Status First
Employed
Unemployed and 
Seeking Work
ft students or part 
students not seeking 
work
sick, disabled, 
incapacity ben, 
income support, 
employ & support 
allowance
Recovery
Model
Total
271 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allocated Progressive
Count 2114 1062 3176
% within Model 48.40% 50.80% 49.10%
Count 1196 458 1654
% within Model 27.40% 21.90% 25.60%
Count 175 94 269
% within Model 4.00% 4.50% 4.20%
Count 340 207 547
% within Model 7.80% 9.90% 8.50%
Count 291 136 427
% within Model 6.70% 6.50% 6.60%
Count 5 1 6
% within Model 0.10% 0.00% 0.10%
Count 250 133 383
% within Model 5.70% 6.40% 5.90%
Count 4371 2091 6462
% within Model 100.00% 100.00% 100.00%
no benefits not 
working not seeking
retired
Total
Total
Employment 
Status First
Employed
Unemployed and 
Seeking Work
ft students or part 
students not seeking 
work
sick, disabled, 
incapacity ben, 
income support, 
employ & support 
allowance
homemaker
Recovery
Model
Total
272 
 
Appendix 90: Chi square for first employment status against model and recovery 
outcome for south cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. 
Sig. (2-
sided)
Pearson Chi-Square 20.903
b 6 0.002
Likelihood Ratio 21.845 6 0.001
Linear-by-Linear Association 1.375 1 0.241
N of Valid Cases 2799
Pearson Chi-Square 2.092
c 6 0.911
Likelihood Ratio 2.649 6 0.851
Linear-by-Linear Association 0.735 1 0.391
N of Valid Cases 1637
Pearson Chi-Square 16.447
d 6 0.012
Likelihood Ratio 15.878 6 0.014
Linear-by-Linear Association 0.595 1 0.441
N of Valid Cases 1728
Pearson Chi-Square 1.091
e 5 0.955
Likelihood Ratio 1.1 5 0.954
Linear-by-Linear Association 0.16 1 0.689
N of Valid Cases 298
Pearson Chi-Square 28.203
a 6 0
Likelihood Ratio 28.518 6 0
Linear-by-Linear Association 1.178 1 0.278
N of Valid Cases 6462
Total
Recovery
Recovered
Reliable 
Improvement
Non 
Recovered
Reliable 
Deterioration
273 
 
Appendix 91: Cross tabulation of model and outcome for sensitivity analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Year 2 Year 4
Count 1559 2286 3845
% within Embedded Year 39.60% 49.20% 44.80%
Count 1034 1068 2102
% within Embedded Year 26.30% 23.00% 24.50%
Count 1138 1102 2240
% within Embedded Year 28.90% 23.70% 26.10%
Count 201 190 391
% within Embedded Year 5.10% 4.10% 4.60%
Count 3932 4646 8578
% within Embedded Year 100.00% 100.00% 100.00%
Total
Embedded Year
Total
Recovery
Recovered
Reliable 
Improvement
Non Recovered
Reliable 
Deterioration
274 
 
Appendix 92: Chi square of model and outcome for sensitivity analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. 
Sig. (2-
sided)
Pearson Chi-Square 80.021
a 3 0
Likelihood Ratio 80.228 3 0
Linear-by-Linear Association 68.281 1 0
N of Valid Cases 8578
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Appendix 93: Cross tabulation of model on recovery v non recovery for sensitivity 
analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Year 2 Year 4
1559 2286 3845
39.60% 49.20% 44.80%
2373 2360 4733
60.40% 50.80% 55.20%
3932 4646 8578
100.00% 100.00% 100.00%
Total
Total
Count
% within Embedded Year
Non Recovered
Count
% within Embedded Year
Embedded Year
Recovery Non Recovery
Recovered
Count
% within Embedded Year
276 
 
Appendix 94: Chi square of model on recovery v non recovery for sensitivity analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. 
Sig. (2-
sided)
Exact Sig. (2-
sided)
Exact Sig. 
(1-sided)
Pearson Chi-Square 78.608
a 1 0
Continuity Correction
b 78.223 1 0
Likelihood Ratio 78.826 1 0
Fisher's Exact Test 0 0
Linear-by-Linear Association 78.599 1 0
N of Valid Cases 8578
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Appendix 95: Cross tabulation of model on reliable improvement v non recovery for 
sensitivity analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Year 2 Year 4
1034 1068 2102
43.60% 45.30% 44.40%
1339 1292 2631
56.40% 54.70% 55.60%
2373 2360 4733
100.00% 100.00% 100.00%
Total
Total
Count
% within Embedded Year
Non Recovery
Count
% within Embedded Year
Embedded Year
Reliable Improvement 
Non Recovery
Reliable Improvement
Count
% within Embedded Year
278 
 
Appendix 96: Chi square of model on reliable improvement v non recovery for 
sensitivity analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. 
Sig. (2-
sided)
Exact Sig. (2-
sided)
Exact Sig. 
(1-sided)
Pearson Chi-Square 1.354
a 1 0.245
Continuity Correction
b 1.287 1 0.257
Likelihood Ratio 1.354 1 0.245
Fisher's Exact Test 0.254 0.128
Linear-by-Linear Association 1.354 1 0.245
N of Valid Cases 4733
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Appendix 97: Cross tabulation of model on reliable deterioration v non recovery for 
sensitivity analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reliable 
Deterioration
Non 
Recovery
Count 201 2172 2373
% within RD V 
Non Recovery
51.40% 50.00% 50.10%
Count 190 2170 2360
% within RD V 
Non Recovery
48.60% 50.00% 49.90%
Count 391 4342 4733
% within RD V 
Non Recovery
100.00% 100.00% 100.00%
Total
RD V Non Recovery
Total
Embedded 
Year
Year 2
Year 4
280 
 
Appendix 98: Chi square of model on reliable deterioration v non recovery for 
sensitivity analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. 
Sig. (2-
sided)
Exact Sig. 
(2-sided)
Exact Sig. 
(1-sided)
Pearson Chi-Square .275
a 1 0.6
Continuity Correction
b 0.222 1 0.637
Likelihood Ratio 0.275 1 0.6
Fisher's Exact Test 0.635 0.319
Linear-by-Linear Association 0.275 1 0.6
N of Valid Cases 4733
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 194.96.
b. Computed only for a 2x2 table
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Appendix 99: Cross tabulation on PHQ Moderate to Severe/Severe on model v 
outcomes sensitivity analysis  
 
 
 
 
 
 
 
Year 2 Year 4
Count 303 440 743
% within Embedded Year 22.70% 30.50% 26.80%
Count 480 517 997
% within Embedded Year 36.00% 35.90% 35.90%
Count 514 448 962
% within Embedded Year 38.50% 31.10% 34.70%
Count 38 36 74
% within Embedded Year 2.80% 2.50% 2.70%
Count 1335 1441 2776
% within Embedded Year 100.00% 100.00% 100.00%
Count 459 686 1145
% within Embedded Year 37.40% 47.70% 43.00%
Count 359 353 712
% within Embedded Year 29.30% 24.60% 26.70%
Count 334 337 671
% within Embedded Year 27.20% 23.50% 25.20%
Count 75 61 136
% within Embedded Year 6.10% 4.20% 5.10%
Count 1227 1437 2664
% within Embedded Year 100.00% 100.00% 100.00%
Count 762 1126 1888
% within Embedded Year 29.70% 39.10% 34.70%
Count 839 870 1709
% within Embedded Year 32.70% 30.20% 31.40%
Count 848 785 1633
% within Embedded Year 33.10% 27.30% 30.00%
Count 113 97 210
% within Embedded Year 4.40% 3.40% 3.90%
Count 2562 2878 5440
% within Embedded Year 100.00% 100.00% 100.00%
Total
Recovery
Recovered
Reliable 
Improvement
Non 
Recovered
Reliable 
Deterioration
Total
Total
Moderate 
to Severe
Recovery
Recovered
Reliable 
Improvement
Non 
Recovered
Reliable 
Deterioration
Total
PHQ Severity
Embedded Year
Total
Severe
Recovery
Recovered
Reliable 
Improvement
Non 
Recovered
Reliable 
Deterioration
282 
 
Appendix 100: Chi square on PHQ Moderate to Severe/Severe on model v 
outcomes for sensitivity analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. 
Sig. (2-
sided)
Pearson Chi-Square 27.208
b 3 0
Likelihood Ratio 27.317 3 0
Linear-by-Linear Association 25.045 1 0
N of Valid Cases 2776
Pearson Chi-Square 30.142
c 3 0
Likelihood Ratio 30.24 3 0
Linear-by-Linear Association 23.909 1 0
N of Valid Cases 2664
Pearson Chi-Square 56.224
a 3 0
Likelihood Ratio 56.467 3 0
Linear-by-Linear Association 50.568 1 0
N of Valid Cases 5440
b. 0 cells (0.0%) have expected count less than 5. The minimum expected 
count is 35.59.
c. 0 cells (0.0%) have expected count less than 5. The minimum expected 
count is 62.64.
PHQ Severity
Severe
Moderate 
to Severe
Total
a. 0 cells (0.0%) have expected count less than 5. The minimum expected 
count is 98.90.
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Appendix 101: Cross tabulation on GAD Moderate/Severe on model v outcomes for 
sensitivity analysis 
 
 
 
 
 
 
 
 
Year 2 Year 4
Count 668 937 1605
% within Embedded Year 29.40% 37.70% 33.70%
Count 795 815 1610
% within Embedded Year 35.00% 32.80% 33.80%
Count 742 683 1425
% within Embedded Year 32.60% 27.50% 29.90%
Count 68 51 119
% within Embedded Year 3.00% 2.10% 2.50%
Count 2273 2486 4759
% within Embedded Year 100.00% 100.00% 100.00%
Count 575 875 1450
% within Embedded Year 49.60% 59.20% 54.90%
Count 204 223 427
% within Embedded Year 17.60% 15.10% 16.20%
Count 297 301 598
% within Embedded Year 25.60% 20.40% 22.70%
Count 84 80 164
% within Embedded Year 7.20% 5.40% 6.20%
Count 1160 1479 2639
% within Embedded Year 100.00% 100.00% 100.00%
Count 1243 1812 3055
% within Embedded Year 36.20% 45.70% 41.30%
Count 999 1038 2037
% within Embedded Year 29.10% 26.20% 27.50%
Count 1039 984 2023
% within Embedded Year 30.30% 24.80% 27.30%
Count 152 131 283
% within Embedded Year 4.40% 3.30% 3.80%
Count 3433 3965 7398
% within Embedded Year 100.00% 100.00% 100.00%
Total
Recovery
Recovered
Reliable 
Improvement
Non 
Recovered
Reliable 
Deterioration
Total
Total
Moderate
Recovery
Recovered
Reliable 
Improvement
Non 
Recovered
Reliable 
Deterioration
Total
GAD Severity
Embedded Year
Total
Severe
Recovery
Recovered
Reliable 
Improvement
Non 
Recovered
Reliable 
Deterioration
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Appendix 102: Chi square on GAD Moderate/Severe on model v outcomes for 
sensitivity analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. 
Sig. (2-
sided)
Pearson Chi-Square 40.753
b 3 0
Likelihood Ratio 40.891 3 0
Linear-by-Linear Association 37.991 1 0
N of Valid Cases 4759
Pearson Chi-Square 24.841
c 3 0
Likelihood Ratio 24.835 3 0
Linear-by-Linear Association 22.598 1 0
N of Valid Cases 2639
Pearson Chi-Square 71.893
a 3 0
Likelihood Ratio 72.111 3 0
Linear-by-Linear Association 65.053 1 0
N of Valid Cases 7398
b. 0 cells (0.0%) have expected count less than 5. The minimum expected 
count is 56.84.
c. 0 cells (0.0%) have expected count less than 5. The minimum expected 
count is 72.09.
GAD Severity
Severe
Moderate
Total
a. 0 cells (0.0%) have expected count less than 5. The minimum expected 
count is 131.32.
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Appendix 103: Logistical regression on recovered outcome for sensitivity analysis 
 
 
 
 
 
Lower Upper
Model(1) 0.424 0.056 57.075 1 0 1.527 1.368 1.705
Gender(1) -0.024 0.058 0.176 1 0.675 0.976 0.872 1.093
Disability(1) -0.025 0.11 0.053 1 0.818 0.975 0.787 1.209
Age 30.314 5 0
Age(1) 0.089 0.113 0.628 1 0.428 1.093 0.877 1.364
Age(2) 0.227 0.117 3.772 1 0.052 1.255 0.998 1.578
Age(3) 0.287 0.119 5.835 1 0.016 1.332 1.056 1.681
Age(4) 0.176 0.127 1.905 1 0.167 1.192 0.929 1.53
Age(5) 1.01 0.208 23.504 1 0 2.745 1.825 4.129
Employment 160.801 5 0
Employment(1) -0.725 0.073 99.336 1 0 0.485 0.42 0.559
Employment(2) -0.259 0.129 4.06 1 0.044 0.771 0.599 0.993
Employment(3) -0.895 0.091 96.315 1 0 0.409 0.342 0.489
Employment(4) -0.488 0.119 16.762 1 0 0.614 0.486 0.775
Employment(5) -0.73 0.181 16.297 1 0 0.482 0.338 0.687
PHQ 151.663 4 0
PHQ(1) -0.159 0.224 0.502 1 0.479 0.853 0.55 1.324
PHQ(2) -0.661 0.211 9.815 1 0.002 0.516 0.342 0.781
PHQ(3) -1.034 0.21 24.188 1 0 0.356 0.235 0.537
PHQ(4) -1.339 0.213 39.578 1 0 0.262 0.173 0.398
GAD 124.811 3 0
GAD(1) 0.057 0.244 0.055 1 0.815 1.059 0.656 1.709
GAD(2) -0.455 0.236 3.738 1 0.053 0.634 0.4 1.006
GAD(3) -0.914 0.235 15.166 1 0 0.401 0.253 0.635
Discharge 1548.424 5 0
Discharge(1) -2.774 0.085 1061.675 1 0 0.062 0.053 0.074
Discharge(2) -2.434 0.206 138.909 1 0 0.088 0.059 0.131
Discharge(3) -2.122 0.123 300.067 1 0 0.12 0.094 0.152
Discharge(4) -3.434 0.217 251.076 1 0 0.032 0.021 0.049
Discharge(5) -1.329 0.14 89.779 1 0 0.265 0.201 0.349
Constant 2.181 0.328 44.166 1 0 8.853
Step 1
a
a. Variable(s) entered on step 1: Model, Gender, Disability, Age, Employment, PHQ, GAD, Discharge.
B S.E. Wald df Sig. Exp(B)
95% C.I.for EXP(B)
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 104: Logistical regression on recovered outcome for allocated model 
 
 
 
 
 
 
B S.E. Wald df Sig. Exp(B)
Lower Upper
Step 1a Gender(1) -0.07 0.084 0.702 1 0.402 0.932 0.791 1.099
Disability(1) 0.095 0.202 0.221 1 0.638 1.1 0.74 1.634
Age 28.038 5 0
Age(1) -0.027 0.185 0.021 1 0.886 0.974 0.678 1.4
Age(2) 0.241 0.192 1.572 1 0.21 1.273 0.873 1.856
Age(3) 0.283 0.194 2.126 1 0.145 1.327 0.907 1.94
Age(4) 0.248 0.203 1.492 1 0.222 1.281 0.861 1.907
Age(5) 1.271 0.3 17.939 1 0 3.564 1.979 6.416
Employment 83.242 5 0
Employment(1) -0.596 0.101 35.079 1 0 0.551 0.452 0.671
Employment(2) -0.055 0.191 0.083 1 0.773 0.947 0.652 1.375
Employment(3) -1.135 0.154 54.133 1 0 0.321 0.238 0.435
Employment(4) -0.606 0.171 12.65 1 0 0.545 0.39 0.762
Employment(5) -0.975 0.264 13.652 1 0 0.377 0.225 0.633
PHQ 94.405 4 0
PHQ(1) -0.379 0.331 1.31 1 0.252 0.684 0.357 1.31
PHQ(2) -0.779 0.313 6.174 1 0.013 0.459 0.248 0.848
PHQ(3) -1.36 0.313 18.863 1 0 0.257 0.139 0.474
PHQ(4) -1.582 0.316 25.037 1 0 0.206 0.111 0.382
GAD 52.911 3 0
GAD(1) 0.328 0.303 1.172 1 0.279 1.388 0.767 2.514
GAD(2) -0.152 0.288 0.277 1 0.599 0.859 0.488 1.512
GAD(3) -0.593 0.287 4.263 1 0.039 0.553 0.315 0.97
Discharge 592.094 5 0
Discharge(1) -2.401 0.12 403.088 1 0 0.091 0.072 0.115
Discharge(2) -2.578 0.327 62.111 1 0 0.076 0.04 0.144
Discharge(3) -1.637 0.174 88.486 1 0 0.195 0.138 0.274
Discharge(4) -3.08 0.296 108.146 1 0 0.046 0.026 0.082
Discharge(5) -1.475 0.227 42.169 1 0 0.229 0.147 0.357
Constant 2.044 0.451 20.538 1 0 7.719
a. Variable(s) entered on step 1: Gender, Disability, Age, Employment, PHQ, GAD, Discharge.
95% C.I.for EXP(B)
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 105: Logistical regression on reliably improved outcome for allocated 
model 
 
 
 
 
 
B S.E. Wald df Sig. Exp(B)
Lower Upper
Step 1a Gender(1) 0.037 0.081 0.212 1 0.645 1.038 0.886 1.216
Disability(1) -0.064 0.193 0.11 1 0.741 0.938 0.643 1.369
Age 10.827 5 0.055
Age(1) 0.131 0.179 0.535 1 0.464 1.14 0.803 1.618
Age(2) 0.001 0.186 0 1 0.997 1.001 0.696 1.44
Age(3) -0.056 0.188 0.09 1 0.764 0.945 0.654 1.366
Age(4) -0.018 0.197 0.008 1 0.928 0.982 0.668 1.446
Age(5) -0.739 0.317 5.442 1 0.02 0.477 0.256 0.889
Employment 4.543 5 0.474
Employment(1) -0.094 0.096 0.961 1 0.327 0.91 0.755 1.098
Employment(2) -0.089 0.194 0.211 1 0.646 0.915 0.626 1.337
Employment(3) 0.111 0.131 0.727 1 0.394 1.118 0.865 1.444
Employment(4) -0.029 0.163 0.032 1 0.857 0.971 0.705 1.337
Employment(5) 0.376 0.271 1.928 1 0.165 1.456 0.857 2.476
PHQ 79.629 4 0
PHQ(1) 0.587 0.5 1.381 1 0.24 1.799 0.676 4.792
PHQ(2) 0.885 0.477 3.448 1 0.063 2.424 0.952 6.172
PHQ(3) 1.628 0.473 11.865 1 0.001 5.095 2.017 12.867
PHQ(4) 1.69 0.474 12.72 1 0 5.418 2.141 13.714
GAD 91.985 3 0
GAD(1) 1.161 0.74 2.457 1 0.117 3.192 0.748 13.626
GAD(2) 1.837 0.725 6.416 1 0.011 6.275 1.515 25.985
GAD(3) 2.494 0.723 11.896 1 0.001 12.11 2.935 49.964
Discharge 14.942 5 0.011
Discharge(1) 0.262 0.094 7.727 1 0.005 1.3 1.08 1.564
Discharge(2) -0.305 0.216 1.992 1 0.158 0.737 0.482 1.126
Discharge(3) 0.093 0.161 0.333 1 0.564 1.098 0.8 1.506
Discharge(4) -0.203 0.159 1.619 1 0.203 0.816 0.597 1.116
Discharge(5) -0.101 0.215 0.22 1 0.639 0.904 0.593 1.378
Constant -4.681 0.877 28.509 1 0 0.009
a. Variable(s) entered on step 1: Gender, Disability, Age, Employment, PHQ, GAD, Discharge.
95% C.I.for EXP(B)
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 106: Logistical regression on no change outcome for allocated model  
 
 
 
 
 
 
B S.E. Wald df Sig. Exp(B)
Lower Upper
Step 1a Gender(1) 0.086 0.083 1.078 1 0.299 1.09 0.926 1.282
Disability(1) 0.032 0.194 0.027 1 0.869 1.033 0.706 1.511
Age 8.171 5 0.147
Age(1) -0.132 0.171 0.589 1 0.443 0.877 0.627 1.227
Age(2) -0.308 0.179 2.948 1 0.086 0.735 0.517 1.045
Age(3) -0.234 0.181 1.677 1 0.195 0.791 0.555 1.128
Age(4) -0.209 0.192 1.185 1 0.276 0.811 0.557 1.182
Age(5) -0.767 0.317 5.866 1 0.015 0.464 0.25 0.864
Employment 43.155 5 0
Employment(1) 0.494 0.097 25.816 1 0 1.638 1.354 1.982
Employment(2) 0.206 0.191 1.164 1 0.281 1.229 0.845 1.786
Employment(3) 0.63 0.133 22.313 1 0 1.877 1.445 2.437
Employment(4) 0.615 0.161 14.626 1 0 1.85 1.35 2.535
Employment(5) 0.688 0.272 6.411 1 0.011 1.99 1.168 3.391
PHQ 15.966 4 0.003
PHQ(1) 0.075 0.389 0.037 1 0.848 1.077 0.502 2.311
PHQ(2) 0.431 0.366 1.388 1 0.239 1.54 0.751 3.156
PHQ(3) 0.425 0.366 1.354 1 0.245 1.53 0.747 3.133
PHQ(4) 0.686 0.367 3.5 1 0.061 1.986 0.968 4.077
GAD 8.026 3 0.045
GAD(1) -0.568 0.337 2.832 1 0.092 0.567 0.292 1.098
GAD(2) -0.166 0.32 0.269 1 0.604 0.847 0.452 1.586
GAD(3) -0.188 0.319 0.348 1 0.556 0.829 0.444 1.548
Discharge 402.548 5 0
Discharge(1) 1.666 0.095 307.442 1 0 5.293 4.394 6.377
Discharge(2) 1.622 0.188 74.153 1 0 5.065 3.501 7.327
Discharge(3) 1.373 0.149 84.504 1 0 3.946 2.945 5.287
Discharge(4) 1.832 0.146 157.951 1 0 6.249 4.696 8.317
Discharge(5) 1.523 0.194 61.685 1 0 4.586 3.136 6.707
Constant -2.167 0.503 18.53 1 0 0.115
a. Variable(s) entered on step 1: Gender, Disability, Age, Employment, PHQ, GAD, Discharge.
95% C.I.for EXP(B)
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 107:  Logistical regression on reliably deteriorated outcome for allocated 
model 
 
 
 
 
 
 
Lower Upper
Step 1a Gender(1) -0.211 0.165 1.642 1 0.2 0.81 0.586 1.118
Disability(1) 0.182 0.369 0.243 1 0.622 1.2 0.582 2.475
Age 2.37 5 0.796
Age(1) 0.229 0.333 0.471 1 0.493 1.257 0.654 2.415
Age(2) 0.445 0.344 1.671 1 0.196 1.56 0.795 3.063
Age(3) 0.259 0.349 0.551 1 0.458 1.296 0.654 2.571
Age(4) 0.166 0.379 0.192 1 0.661 1.181 0.562 2.481
Age(5) 0.295 0.61 0.234 1 0.629 1.343 0.406 4.439
Employment 24.26 5 0
Employment(1) 0.772 0.192 16.176 1 0 2.165 1.486 3.154
Employment(2) 0.128 0.379 0.114 1 0.735 1.137 0.541 2.39
Employment(3) 0.944 0.251 14.132 1 0 2.571 1.571 4.206
Employment(4) 0.156 0.342 0.208 1 0.648 1.169 0.598 2.286
Employment(5) -0.169 0.586 0.083 1 0.773 0.844 0.268 2.662
PHQ 25.735 4 0
PHQ(1) 0.16 0.585 0.075 1 0.785 1.173 0.373 3.692
PHQ(2) 0.044 0.559 0.006 1 0.937 1.045 0.35 3.124
PHQ(3) -0.21 0.564 0.138 1 0.71 0.811 0.269 2.448
PHQ(4) -1.162 0.589 3.891 1 0.049 0.313 0.099 0.993
GAD 46.822 3 0
GAD(1) -0.426 0.45 0.898 1 0.343 0.653 0.27 1.577
GAD(2) -0.952 0.44 4.676 1 0.031 0.386 0.163 0.915
GAD(3) -1.868 0.451 17.117 1 0 0.154 0.064 0.374
Discharge 130.793 5 0
Discharge(1) 1.58 0.206 58.944 1 0 4.855 3.244 7.267
Discharge(2) 2.771 0.3 85.356 1 0 15.973 8.874 28.753
Discharge(3) 1.708 0.291 34.325 1 0 5.516 3.115 9.766
Discharge(4) 2.379 0.26 83.41 1 0 10.794 6.478 17.984
Discharge(5) 1.34 0.411 10.635 1 0.001 3.82 1.707 8.549
Constant -3.003 0.766 15.376 1 0 0.05
a. Variable(s) entered on step 1: Gender, Disability, Age, Employment, PHQ, GAD, Discharge.
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 108: Logistical regression on recovered outcome for progressive model 
 
 
 
 
 
 
B S.E. Wald df Sig. Exp(B)
Lower Upper
Step 1a Gender(1) 0.01 0.08 0.015 1 0.902 1.01 0.863 1.182
Disability(1) -0.072 0.134 0.287 1 0.592 0.931 0.715 1.211
Age 8.317 5 0.14
Age(1) 0.124 0.147 0.714 1 0.398 1.132 0.849 1.511
Age(2) 0.152 0.151 1.004 1 0.316 1.164 0.865 1.566
Age(3) 0.229 0.155 2.199 1 0.138 1.258 0.929 1.703
Age(4) 0.054 0.17 0.1 1 0.752 1.055 0.757 1.471
Age(5) 0.715 0.305 5.504 1 0.019 2.045 1.125 3.718
Employment 91.161 5 0
Employment(1) -0.878 0.106 69.13 1 0 0.416 0.338 0.511
Employment(2) -0.425 0.177 5.761 1 0.016 0.654 0.462 0.925
Employment(3) -0.802 0.117 47.144 1 0 0.449 0.357 0.564
Employment(4) -0.386 0.17 5.151 1 0.023 0.68 0.487 0.949
Employment(5) -0.533 0.256 4.342 1 0.037 0.587 0.356 0.969
PHQ 64.99 4 0
PHQ(1) 0.044 0.304 0.021 1 0.886 1.044 0.576 1.894
PHQ(2) -0.571 0.284 4.051 1 0.044 0.565 0.324 0.985
PHQ(3) -0.745 0.283 6.941 1 0.008 0.475 0.273 0.826
PHQ(4) -1.123 0.287 15.362 1 0 0.325 0.185 0.57
GAD 75.24 3 0
GAD(1) -0.393 0.419 0.876 1 0.349 0.675 0.297 1.536
GAD(2) -0.947 0.409 5.357 1 0.021 0.388 0.174 0.865
GAD(3) -1.433 0.408 12.331 1 0 0.239 0.107 0.531
Discharge 949.005 5 0
Discharge(1) -3.13 0.123 650.031 1 0 0.044 0.034 0.056
Discharge(2) -2.35 0.271 74.929 1 0 0.095 0.056 0.162
Discharge(3) -2.535 0.173 215.567 1 0 0.079 0.056 0.111
Discharge(4) -3.77 0.319 139.896 1 0 0.023 0.012 0.043
Discharge(5) -1.245 0.182 46.925 1 0 0.288 0.202 0.411
Constant 3.017 0.509 35.133 1 0 20.423
a. Variable(s) entered on step 1: Gender, Disability, Age, Employment, PHQ, GAD, Discharge.
95% C.I.for EXP(B)
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 109: Logistical regression on reliably improved outcome for progressive 
model 
 
 
 
 
 
B S.E. Wald df Sig. Exp(B)
Lower Upper
Step 1a Gender(1) 0 0.079 0 1 0.997 1 0.856 1.168
Disability(1) -0.042 0.128 0.111 1 0.739 0.958 0.746 1.231
Age 21.099 5 0.001
Age(1) 0.246 0.14 3.104 1 0.078 1.279 0.973 1.682
Age(2) -0.122 0.146 0.699 1 0.403 0.885 0.665 1.178
Age(3) -0.106 0.148 0.511 1 0.475 0.899 0.672 1.203
Age(4) 0.195 0.162 1.452 1 0.228 1.215 0.885 1.668
Age(5) -0.423 0.323 1.713 1 0.191 0.655 0.348 1.234
Employment 6.299 5 0.278
Employment(1) 0.213 0.1 4.561 1 0.033 1.238 1.018 1.505
Employment(2) 0.255 0.176 2.107 1 0.147 1.291 0.914 1.822
Employment(3) 0.049 0.112 0.194 1 0.66 1.051 0.843 1.31
Employment(4) 0.036 0.17 0.046 1 0.83 1.037 0.743 1.447
Employment(5) 0.257 0.268 0.925 1 0.336 1.293 0.766 2.185
PHQ 66.157 4 0
PHQ(1) 0.73 0.548 1.777 1 0.182 2.075 0.71 6.068
PHQ(2) 1.326 0.525 6.389 1 0.011 3.767 1.347 10.535
PHQ(3) 1.684 0.521 10.433 1 0.001 5.386 1.939 14.961
PHQ(4) 1.966 0.522 14.183 1 0 7.145 2.568 19.883
GAD 145.298 3 0
GAD(1) -0.153 0.765 0.04 1 0.841 0.858 0.192 3.841
GAD(2) 1.407 0.728 3.731 1 0.053 4.083 0.979 17.019
GAD(3) 2.201 0.726 9.183 1 0.002 9.037 2.176 37.528
Discharge 44.751 5 0
Discharge(1) 0.485 0.091 28.315 1 0 1.624 1.358 1.941
Discharge(2) 0.139 0.237 0.346 1 0.557 1.149 0.723 1.827
Discharge(3) 0.623 0.146 18.208 1 0 1.865 1.401 2.483
Discharge(4) 0.008 0.162 0.003 1 0.959 1.008 0.734 1.385
Discharge(5) -0.241 0.218 1.228 1 0.268 0.786 0.513 1.204
Constant -4.939 0.901 30.083 1 0 0.007
a. Variable(s) entered on step 1: Gender, Disability, Age, Employment, PHQ, GAD, Discharge.
95% C.I.for EXP(B)
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 110: Logistical regression on no change outcome for progressive model 
 
 
 
 
 
 
B S.E. Wald df Sig. Exp(B)
Lower Upper
Step 1a Gender(1) 0.047 0.084 0.307 1 0.579 1.048 0.888 1.237
Disability(1) 0.076 0.134 0.325 1 0.569 1.079 0.83 1.404
Age 11.055 5 0.05
Age(1) -0.325 0.143 5.153 1 0.023 0.722 0.546 0.957
Age(2) 0.003 0.146 0 1 0.984 1.003 0.754 1.334
Age(3) -0.114 0.151 0.571 1 0.45 0.892 0.664 1.199
Age(4) -0.234 0.171 1.877 1 0.171 0.791 0.566 1.106
Age(5) -0.428 0.348 1.511 1 0.219 0.652 0.329 1.29
Employment 35.796 5 0
Employment(1) 0.473 0.106 20.031 1 0 1.605 1.305 1.975
Employment(2) 0.322 0.182 3.118 1 0.077 1.38 0.965 1.972
Employment(3) 0.631 0.119 28.275 1 0 1.879 1.489 2.371
Employment(4) 0.365 0.174 4.378 1 0.036 1.44 1.023 2.027
Employment(5) 0.312 0.301 1.075 1 0.3 1.367 0.757 2.468
PHQ 5.844 4 0.211
PHQ(1) 0.268 0.363 0.544 1 0.461 1.307 0.641 2.664
PHQ(2) 0.518 0.342 2.292 1 0.13 1.679 0.858 3.285
PHQ(3) 0.515 0.341 2.283 1 0.131 1.674 0.858 3.268
PHQ(4) 0.599 0.344 3.022 1 0.082 1.82 0.927 3.574
GAD 4.534 3 0.209
GAD(1) 1.145 0.564 4.114 1 0.043 3.142 1.039 9.498
GAD(2) 1.183 0.557 4.515 1 0.034 3.264 1.096 9.717
GAD(3) 1.15 0.555 4.29 1 0.038 3.159 1.064 9.381
Discharge 694.622 5 0
Discharge(1) 2.287 0.097 557.939 1 0 9.841 8.141 11.898
Discharge(2) 2.191 0.208 111.305 1 0 8.947 5.955 13.442
Discharge(3) 2.029 0.141 207.527 1 0 7.61 5.774 10.03
Discharge(4) 2.491 0.15 275.345 1 0 12.077 8.998 16.208
Discharge(5) 1.839 0.182 101.913 1 0 6.293 4.403 8.994
Constant -4.166 0.66 39.88 1 0 0.016
a. Variable(s) entered on step 1: Gender, Disability, Age, Employment, PHQ, GAD, Discharge.
95% C.I.for EXP(B)
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 111: Logistical regression on reliably deteriorated outcome for progressive 
model 
 
 
 
 
 
B S.E. Wald df Sig. Exp(B)
Lower Upper
Step 1a Gender(1) -0.327 0.178 3.375 1 0.066 0.721 0.509 1.022
Disability(1) 0.144 0.261 0.302 1 0.583 1.154 0.692 1.926
Age 1.187 5 0.946
Age(1) -0.182 0.28 0.423 1 0.515 0.833 0.481 1.443
Age(2) -0.046 0.29 0.025 1 0.874 0.955 0.541 1.686
Age(3) 0.019 0.299 0.004 1 0.949 1.019 0.567 1.831
Age(4) 0.097 0.331 0.087 1 0.768 1.102 0.577 2.107
Age(5) 0.189 0.704 0.072 1 0.788 1.208 0.304 4.803
Employment 27.958 5 0
Employment(1) 0.975 0.214 20.707 1 0 2.651 1.742 4.034
Employment(2) -0.078 0.4 0.038 1 0.846 0.925 0.423 2.025
Employment(3) 0.937 0.248 14.212 1 0 2.551 1.568 4.152
Employment(4) 0.607 0.344 3.122 1 0.077 1.836 0.936 3.6
Employment(5) 0.096 0.66 0.021 1 0.885 1.1 0.302 4.01
PHQ 24.92 4 0
PHQ(1) -1.113 0.451 6.092 1 0.014 0.329 0.136 0.795
PHQ(2) -0.889 0.4 4.95 1 0.026 0.411 0.188 0.9
PHQ(3) -1.347 0.409 10.824 1 0.001 0.26 0.117 0.58
PHQ(4) -1.957 0.446 19.276 1 0 0.141 0.059 0.339
GAD 75.034 3 0
GAD(1) -0.92 0.5 3.379 1 0.066 0.399 0.15 1.063
GAD(2) -1.171 0.487 5.782 1 0.016 0.31 0.119 0.805
GAD(3) -2.777 0.508 29.899 1 0 0.062 0.023 0.168
Discharge 158.628 5 0
Discharge(1) 2.594 0.229 127.976 1 0 13.382 8.538 20.975
Discharge(2) 2.359 0.423 31.064 1 0 10.586 4.617 24.27
Discharge(3) 2.161 0.308 49.314 1 0 8.683 4.75 15.874
Discharge(4) 3.215 0.297 117.237 1 0 24.908 13.918 44.576
Discharge(5) 1.531 0.475 10.395 1 0.001 4.621 1.822 11.717
Constant -2.079 0.663 9.839 1 0.002 0.125
a. Variable(s) entered on step 1: Gender, Disability, Age, Employment, PHQ, GAD, Discharge.
95% C.I.for EXP(B)
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 112: Logistical regression on recovered outcome on PHQ moderate for 
sensitivity analysis 
 
 
 
 
 
 
 
 
MODEL(1) 0.244 0.111 4.85 1 0.028 1.277 1.027 1.587
GENDER(1) -0.06 0.114 0.274 1 0.601 0.942 0.753 1.179
DISABILITY(1) 0.177 0.251 0.5 1 0.48 1.194 0.73 1.953
AGEREGRESSION 8.077 5 0.152
AGEREGRESSION(1) 0.283 0.204 1.928 1 0.165 1.327 0.89 1.98
AGEREGRESSION(2) 0.327 0.215 2.321 1 0.128 1.387 0.91 2.114
AGEREGRESSION(3) 0.384 0.225 2.912 1 0.088 1.469 0.945 2.283
AGEREGRESSION(4) 0.567 0.243 5.455 1 0.02 1.764 1.096 2.839
AGEREGRESSION(5) 1.011 0.41 6.087 1 0.014 2.748 1.231 6.133
EMPLOYMENT 38.569 5 0
EMPLOYMENT(1) -0.509 0.154 10.851 1 0.001 0.601 0.444 0.814
EMPLOYMENT(2) -0.094 0.229 0.166 1 0.683 0.911 0.581 1.428
EMPLOYMENT(3) -1.09 0.205 28.276 1 0 0.336 0.225 0.503
EMPLOYMENT(4) -0.616 0.246 6.292 1 0.012 0.54 0.334 0.874
EMPLOYMENT(5) -0.809 0.354 5.234 1 0.022 0.445 0.223 0.891
GAD 49.18 3 0
GAD(1) -0.208 0.322 0.418 1 0.518 0.812 0.433 1.525
GAD(2) -0.623 0.311 4.012 1 0.045 0.536 0.292 0.987
GAD(3) -1.181 0.314 14.104 1 0 0.307 0.166 0.569
DISCHARGE 407.887 5 0
DISCHARGE(1) -2.732 0.158 297.91 1 0 0.065 0.048 0.089
DISCHARGE(2) -1.754 0.388 20.4 1 0 0.173 0.081 0.37
DISCHARGE(3) -1.91 0.217 77.208 1 0 0.148 0.097 0.227
DISCHARGE(4) -3.216 0.391 67.516 1 0 0.04 0.019 0.086
DISCHARGE(5) -1.781 0.299 35.387 1 0 0.169 0.094 0.303
Constant 1.644 0.363 20.52 1 0 5.174
Step 1
a
a. Variable(s) entered on step 1: MODEL, GENDER, DISABILITY, AGEREGRESSION, EMPLOYMENT, GAD, DISCHARGE.
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 113: Logistical regression on reliably improved outcome on PHQ moderate 
for sensitivity analysis 
 
 
 
 
 
 
 
 
B S.E. Wald df Sig. Exp(B)
Lower Upper
Step 1a MODEL(1) -0.016 0.141 0.012 1 0.912 0.985 0.747 1.298
GENDER(1) -0.234 0.149 2.47 1 0.116 0.791 0.591 1.06
DISABILITY(1) 0.201 0.332 0.365 1 0.546 1.222 0.637 2.345
AGEREGRESSION 4.669 5 0.458
AGEREGRESSION(1) 0.066 0.256 0.067 1 0.796 1.068 0.647 1.764
AGEREGRESSION(2) -0.276 0.28 0.969 1 0.325 0.759 0.438 1.314
AGEREGRESSION(3) 0.07 0.287 0.059 1 0.808 1.072 0.61 1.883
AGEREGRESSION(4) -0.263 0.324 0.657 1 0.418 0.769 0.407 1.452
AGEREGRESSION(5) -0.257 0.556 0.213 1 0.644 0.774 0.26 2.299
EMPLOYMENT 8.005 5 0.156
EMPLOYMENT(1) -0.01 0.197 0.002 1 0.961 0.99 0.673 1.458
EMPLOYMENT(2) 0.043 0.293 0.021 1 0.884 1.044 0.588 1.852
EMPLOYMENT(3) 0.471 0.251 3.521 1 0.061 1.602 0.979 2.622
EMPLOYMENT(4) -0.662 0.363 3.321 1 0.068 0.516 0.253 1.051
EMPLOYMENT(5) 0.38 0.495 0.59 1 0.443 1.463 0.554 3.86
GAD 123.765 3 0
GAD(1) 17.373 4387.093 0 1 0.997 35057651 0 .
GAD(2) 18.954 4387.093 0 1 0.997 1.7E+08 0 .
GAD(3) 20.178 4387.093 0 1 0.996 5.8E+08 0 .
DISCHARGE 35.886 5 0
DISCHARGE(1) 0.882 0.163 29.248 1 0 2.416 1.755 3.327
DISCHARGE(2) -0.414 0.757 0.299 1 0.585 0.661 0.15 2.914
DISCHARGE(3) 0.739 0.279 7.03 1 0.008 2.094 1.213 3.617
DISCHARGE(4) 0.845 0.333 6.458 1 0.011 2.328 1.213 4.467
DISCHARGE(5) 0.032 0.464 0.005 1 0.945 1.033 0.416 2.565
Constant -21.295 4387.093 0 1 0.996 0
95% C.I.for EXP(B)
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 114: Logistical regression on no change outcome on PHQ moderate for 
sensitivity analysis 
 
 
 
 
 
 
 
B S.E. Wald df Sig. Exp(B)
Lower Upper
Step 1a MODEL(1) -0.249 0.121 4.218 1 0.04 0.78 0.615 0.989
GENDER(1) 0.199 0.125 2.537 1 0.111 1.221 0.955 1.56
DISABILITY(1) -0.18 0.3 0.358 1 0.55 0.836 0.464 1.506
AGEREGRESSION 12.069 5 0.034
AGEREGRESSION(1) -0.203 0.204 0.99 1 0.32 0.816 0.547 1.218
AGEREGRESSION(2) -0.1 0.217 0.214 1 0.643 0.904 0.591 1.384
AGEREGRESSION(3) -0.54 0.237 5.21 1 0.022 0.583 0.367 0.927
AGEREGRESSION(4) -0.408 0.257 2.51 1 0.113 0.665 0.402 1.101
AGEREGRESSION(5) -1.306 0.5 6.83 1 0.009 0.271 0.102 0.721
EMPLOYMENT 21.572 5 0.001
EMPLOYMENT(1) 0.134 0.163 0.677 1 0.411 1.143 0.831 1.574
EMPLOYMENT(2) 0.152 0.237 0.409 1 0.523 1.164 0.731 1.853
EMPLOYMENT(3) 0.54 0.221 5.993 1 0.014 1.717 1.114 2.646
EMPLOYMENT(4) 0.907 0.242 14.063 1 0 2.476 1.542 3.978
EMPLOYMENT(5) 0.987 0.414 5.69 1 0.017 2.683 1.192 6.035
GAD 18.234 3 0
GAD(1) 0.483 0.39 1.53 1 0.216 1.62 0.754 3.481
GAD(2) 0.754 0.38 3.929 1 0.047 2.126 1.008 4.48
GAD(3) 0.182 0.388 0.22 1 0.639 1.2 0.561 2.565
DISCHARGE 203.82 5 0
DISCHARGE(1) 1.836 0.141 169.845 1 0 6.274 4.76 8.27
DISCHARGE(2) 0.607 0.447 1.842 1 0.175 1.835 0.764 4.411
DISCHARGE(3) 1.488 0.221 45.386 1 0 4.428 2.872 6.826
DISCHARGE(4) 1.673 0.27 38.508 1 0 5.329 3.141 9.039
DISCHARGE(5) 1.78 0.294 36.668 1 0 5.933 3.334 10.557
Constant -2.396 0.426 31.667 1 0 0.091
a. Variable(s) entered on step 1: MODEL, GENDER, DISABILITY, AGEREGRESSION, EMPLOYMENT, GAD, DISCHARGE.
95% C.I.for EXP(B)
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 115: Logistical regression on reliably deteriorated outcome on PHQ 
moderate for sensitivity analysis 
 
 
 
 
 
 
 
B S.E. Wald df Sig. Exp(B)
Lower Upper
Step 1a MODEL(1) -0.069 0.2 0.119 1 0.731 0.933 0.63 1.382
GENDER(1) 0.075 0.204 0.134 1 0.714 1.078 0.722 1.609
DISABILITY(1) -0.424 0.491 0.746 1 0.388 0.654 0.25 1.713
AGEREGRESSION 3.349 5 0.646
AGEREGRESSION(1) -0.244 0.322 0.571 1 0.45 0.784 0.417 1.474
AGEREGRESSION(2) 0.039 0.339 0.013 1 0.908 1.04 0.535 2.021
AGEREGRESSION(3) 0.151 0.35 0.187 1 0.666 1.163 0.586 2.309
AGEREGRESSION(4) -0.102 0.397 0.067 1 0.797 0.903 0.414 1.966
AGEREGRESSION(5) 0.742 0.725 1.047 1 0.306 2.099 0.507 8.693
EMPLOYMENT 26.654 5 0
EMPLOYMENT(1) 0.992 0.234 18.011 1 0 2.697 1.706 4.266
EMPLOYMENT(2) 0.048 0.44 0.012 1 0.914 1.049 0.443 2.484
EMPLOYMENT(3) 1.035 0.321 10.385 1 0.001 2.814 1.5 5.279
EMPLOYMENT(4) 0.374 0.446 0.705 1 0.401 1.454 0.607 3.481
EMPLOYMENT(5) -0.878 0.832 1.112 1 0.292 0.416 0.081 2.125
GAD 25.35 3 0
GAD(1) -0.689 0.425 2.623 1 0.105 0.502 0.218 1.156
GAD(2) -1.597 0.431 13.725 1 0 0.202 0.087 0.471
GAD(3) -1.527 0.437 12.233 1 0 0.217 0.092 0.511
DISCHARGE 117.161 5 0
DISCHARGE(1) 2.261 0.257 77.524 1 0 9.593 5.799 15.868
DISCHARGE(2) 3.294 0.445 54.784 1 0 26.961 11.269 64.506
DISCHARGE(3) 1.932 0.351 30.334 1 0 6.903 3.471 13.728
DISCHARGE(4) 2.886 0.352 67.109 1 0 17.923 8.985 35.751
DISCHARGE(5) 1.797 0.489 13.475 1 0 6.029 2.31 15.735
Constant -3.019 0.516 34.232 1 0 0.049
a. Variable(s) entered on step 1: MODEL, GENDER, DISABILITY, AGEREGRESSION, EMPLOYMENT, GAD, DISCHARGE.
95% C.I.for EXP(B)
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 116: Logistical regression on recovered outcome on PHQ 
moderate/severe for sensitivity analysis 
 
 
 
 
 
 
 
B S.E. Wald df Sig. Exp(B)
Lower Upper
Step 1a MODEL(1) 0.584 0.098 35.493 1 0 1.794 1.48 2.174
GENDER(1) -0.027 0.101 0.071 1 0.79 0.974 0.799 1.186
DISABILITY(1) -0.104 0.194 0.287 1 0.592 0.901 0.616 1.318
AGEREGRESSION 8.744 5 0.12
AGEREGRESSION(1) 0.344 0.185 3.449 1 0.063 1.411 0.981 2.028
AGEREGRESSION(2) 0.26 0.192 1.83 1 0.176 1.297 0.89 1.892
AGEREGRESSION(3) 0.242 0.197 1.514 1 0.219 1.274 0.866 1.872
AGEREGRESSION(4) 0.145 0.212 0.466 1 0.495 1.156 0.762 1.753
AGEREGRESSION(5) 0.936 0.38 6.063 1 0.014 2.549 1.21 5.367
EMPLOYMENT 33.456 5 0
EMPLOYMENT(1) -0.677 0.125 29.378 1 0 0.508 0.398 0.649
EMPLOYMENT(2) -0.228 0.214 1.14 1 0.286 0.796 0.523 1.21
EMPLOYMENT(3) -0.513 0.153 11.192 1 0.001 0.599 0.443 0.809
EMPLOYMENT(4) -0.201 0.209 0.925 1 0.336 0.818 0.542 1.232
EMPLOYMENT(5) -0.406 0.368 1.222 1 0.269 0.666 0.324 1.369
GAD 19.972 3 0
GAD(1) 0.427 0.468 0.835 1 0.361 1.533 0.613 3.832
GAD(2) -0.013 0.445 0.001 1 0.977 0.987 0.413 2.363
GAD(3) -0.29 0.442 0.431 1 0.511 0.748 0.315 1.779
DISCHARGE 493.006 5 0
DISCHARGE(1) -2.894 0.158 333.671 1 0 0.055 0.041 0.076
DISCHARGE(2) -3.055 0.475 41.389 1 0 0.047 0.019 0.12
DISCHARGE(3) -2.398 0.247 94.013 1 0 0.091 0.056 0.148
DISCHARGE(4) -3.282 0.373 77.359 1 0 0.038 0.018 0.078
DISCHARGE(5) -1.086 0.226 23.159 1 0 0.338 0.217 0.525
Constant 0.401 0.476 0.708 1 0.4 1.493
a. Variable(s) entered on step 1: MODEL, GENDER, DISABILITY, AGEREGRESSION, EMPLOYMENT, GAD, DISCHARGE.
95% C.I.for EXP(B)
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 117: Logistical regression on reliably improved outcome on PHQ 
moderate/severe for sensitivity analysis 
 
 
 
 
 
 
 
B S.E. Wald df Sig. Exp(B)
Lower Upper
Step 1a MODEL(1) -0.346 0.093 13.743 1 0 0.708 0.589 0.85
GENDER(1) 0.037 0.097 0.15 1 0.699 1.038 0.859 1.255
DISABILITY(1) 0.192 0.184 1.095 1 0.295 1.212 0.845 1.737
AGEREGRESSION 5.378 5 0.371
AGEREGRESSION(1) 0.057 0.171 0.111 1 0.739 1.059 0.758 1.479
AGEREGRESSION(2) -0.048 0.179 0.071 1 0.789 0.953 0.672 1.353
AGEREGRESSION(3) -0.142 0.186 0.581 1 0.446 0.868 0.602 1.25
AGEREGRESSION(4) 0.039 0.203 0.036 1 0.849 1.039 0.698 1.547
AGEREGRESSION(5) -0.625 0.397 2.482 1 0.115 0.535 0.246 1.165
EMPLOYMENT 2.593 5 0.762
EMPLOYMENT(1) 0.014 0.116 0.014 1 0.905 1.014 0.807 1.274
EMPLOYMENT(2) -0.004 0.201 0 1 0.984 0.996 0.671 1.478
EMPLOYMENT(3) -0.206 0.15 1.874 1 0.171 0.814 0.606 1.093
EMPLOYMENT(4) -0.138 0.198 0.482 1 0.488 0.871 0.59 1.286
EMPLOYMENT(5) -0.148 0.37 0.16 1 0.689 0.862 0.418 1.781
GAD 68.104 3 0
GAD(1) 1.386 1.04 1.776 1 0.183 3.998 0.521 30.692
GAD(2) 1.801 1.026 3.084 1 0.079 6.056 0.811 45.206
GAD(3) 2.478 1.024 5.858 1 0.016 11.912 1.602 88.566
DISCHARGE 22.649 5 0
DISCHARGE(1) 0.483 0.11 19.157 1 0 1.621 1.306 2.013
DISCHARGE(2) 0.064 0.295 0.047 1 0.828 1.066 0.598 1.899
DISCHARGE(3) 0.397 0.197 4.044 1 0.044 1.487 1.01 2.189
DISCHARGE(4) 0.035 0.214 0.027 1 0.869 1.036 0.682 1.574
DISCHARGE(5) -0.112 0.256 0.192 1 0.661 0.894 0.541 1.477
Constant -3.094 1.037 8.894 1 0.003 0.045
a. Variable(s) entered on step 1: MODEL, GENDER, DISABILITY, AGEREGRESSION, EMPLOYMENT, GAD, DISCHARGE.
95% C.I.for EXP(B)
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 118: Logistical regression on no change outcome on PHQ 
moderate/severe for sensitivity analysis 
 
 
 
 
 
 
 
B S.E. Wald df Sig. Exp(B)
Lower Upper
Step 1a MODEL(1) -0.128 0.105 1.486 1 0.223 0.88 0.717 1.081
GENDER(1) 0.037 0.108 0.116 1 0.733 1.037 0.84 1.282
DISABILITY(1) -0.216 0.204 1.115 1 0.291 0.806 0.54 1.203
AGEREGRESSION 5.733 5 0.333
AGEREGRESSION(1) -0.369 0.185 3.968 1 0.046 0.692 0.481 0.994
AGEREGRESSION(2) -0.261 0.194 1.812 1 0.178 0.77 0.527 1.126
AGEREGRESSION(3) -0.104 0.201 0.271 1 0.603 0.901 0.608 1.335
AGEREGRESSION(4) -0.223 0.226 0.974 1 0.324 0.8 0.514 1.246
AGEREGRESSION(5) -0.407 0.418 0.947 1 0.331 0.666 0.294 1.511
EMPLOYMENT 25.876 5 0
EMPLOYMENT(1) 0.561 0.129 18.852 1 0 1.752 1.36 2.256
EMPLOYMENT(2) 0.323 0.222 2.124 1 0.145 1.381 0.895 2.133
EMPLOYMENT(3) 0.61 0.157 15.075 1 0 1.841 1.353 2.505
EMPLOYMENT(4) 0.441 0.21 4.418 1 0.036 1.554 1.03 2.343
EMPLOYMENT(5) 0.393 0.389 1.023 1 0.312 1.482 0.692 3.176
GAD 6.904 3 0.075
GAD(1) -0.836 0.519 2.588 1 0.108 0.434 0.157 1.2
GAD(2) -0.408 0.495 0.682 1 0.409 0.665 0.252 1.752
GAD(3) -0.599 0.492 1.483 1 0.223 0.549 0.209 1.441
DISCHARGE 363.899 5 0
DISCHARGE(1) 2.064 0.121 289.094 1 0 7.877 6.209 9.993
DISCHARGE(2) 2.175 0.263 68.194 1 0 8.8 5.252 14.746
DISCHARGE(3) 1.916 0.192 100.045 1 0 6.794 4.668 9.89
DISCHARGE(4) 2.17 0.196 122.11 1 0 8.755 5.959 12.865
DISCHARGE(5) 1.527 0.236 41.992 1 0 4.605 2.901 7.308
Constant -1.6 0.526 9.263 1 0.002 0.202
a. Variable(s) entered on step 1: MODEL, GENDER, DISABILITY, AGEREGRESSION, EMPLOYMENT, GAD, DISCHARGE.
95% C.I.for EXP(B)
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 119: Logistical regression on reliably deteriorated outcome on PHQ 
moderate/severe for sensitivity analysis 
 
 
 
 
 
 
 
B S.E. Wald df Sig. Exp(B)
Lower Upper
Step 1a MODEL(1) -0.44 0.205 4.619 1 0.032 0.644 0.431 0.962
GENDER(1) -0.144 0.206 0.488 1 0.485 0.866 0.578 1.297
DISABILITY(1) 0.385 0.329 1.366 1 0.243 1.47 0.771 2.803
AGEREGRESSION 3.938 5 0.558
AGEREGRESSION(1) -0.518 0.388 1.778 1 0.182 0.596 0.278 1.275
AGEREGRESSION(2) -0.068 0.382 0.032 1 0.858 0.934 0.441 1.976
AGEREGRESSION(3) -0.049 0.394 0.015 1 0.902 0.953 0.44 2.062
AGEREGRESSION(4) 0.021 0.429 0.002 1 0.961 1.021 0.44 2.368
AGEREGRESSION(5) -0.292 0.72 0.165 1 0.685 0.746 0.182 3.061
EMPLOYMENT 12.959 5 0.024
EMPLOYMENT(1) 0.689 0.252 7.458 1 0.006 1.991 1.215 3.265
EMPLOYMENT(2) -0.119 0.495 0.058 1 0.81 0.888 0.337 2.342
EMPLOYMENT(3) 0.837 0.288 8.455 1 0.004 2.31 1.314 4.062
EMPLOYMENT(4) 0.13 0.446 0.084 1 0.771 1.138 0.475 2.727
EMPLOYMENT(5) 0.893 0.632 1.995 1 0.158 2.442 0.707 8.427
GAD 54.907 3 0
GAD(1) -0.646 0.66 0.957 1 0.328 0.524 0.144 1.912
GAD(2) -1.205 0.64 3.548 1 0.06 0.3 0.086 1.05
GAD(3) -2.474 0.649 14.512 1 0 0.084 0.024 0.301
DISCHARGE 76.469 5 0
DISCHARGE(1) 1.782 0.261 46.548 1 0 5.943 3.562 9.916
DISCHARGE(2) 2.197 0.418 27.583 1 0 8.994 3.962 20.414
DISCHARGE(3) 1.882 0.357 27.731 1 0 6.565 3.259 13.225
DISCHARGE(4) 2.425 0.326 55.443 1 0 11.3 5.969 21.394
DISCHARGE(5) 1.224 0.518 5.575 1 0.018 3.401 1.231 9.394
Constant -2.446 0.744 10.807 1 0.001 0.087
a. Variable(s) entered on step 1: MODEL, GENDER, DISABILITY, AGEREGRESSION, EMPLOYMENT, GAD, DISCHARGE.
95% C.I.for EXP(B)
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 120: Logistical regression on recovered outcome on PHQ severe for 
sensitivity analysis 
 
 
 
 
 
 
 
 
Lower Upper
Step 1a MODEL(1) 0.474 0.105 20.472 1 0 1.606 1.308 1.972
GENDER(1) -0.068 0.106 0.406 1 0.524 0.935 0.759 1.15
DISABILITY(1) -0.051 0.178 0.082 1 0.774 0.95 0.671 1.346
AGEREGRESSION 25.608 5 0
AGEREGRESSION(1) -0.111 0.257 0.188 1 0.665 0.895 0.541 1.48
AGEREGRESSION(2) 0.247 0.258 0.912 1 0.34 1.28 0.771 2.123
AGEREGRESSION(3) 0.315 0.255 1.534 1 0.216 1.371 0.832 2.258
AGEREGRESSION(4) 0.008 0.269 0.001 1 0.975 1.008 0.595 1.708
AGEREGRESSION(5) 1.333 0.398 11.232 1 0.001 3.793 1.739 8.27
EMPLOYMENT 102.04 5 0
EMPLOYMENT(1) -1 0.129 60.477 1 0 0.368 0.286 0.473
EMPLOYMENT(2) -0.456 0.298 2.335 1 0.126 0.634 0.354 1.137
EMPLOYMENT(3) -1.258 0.153 67.466 1 0 0.284 0.211 0.384
EMPLOYMENT(4) -0.954 0.228 17.473 1 0 0.385 0.246 0.603
EMPLOYMENT(5) -1.193 0.326 13.374 1 0 0.303 0.16 0.575
GAD 39.724 3 0
GAD(1) 0.633 0.782 0.656 1 0.418 1.883 0.407 8.713
GAD(2) 0.132 0.733 0.033 1 0.857 1.142 0.271 4.803
GAD(3) -0.607 0.723 0.706 1 0.401 0.545 0.132 2.247
DISCHARGE 456.046 5 0
DISCHARGE(1) -3.102 0.187 274.258 1 0 0.045 0.031 0.065
DISCHARGE(2) -2.995 0.403 55.157 1 0 0.05 0.023 0.11
DISCHARGE(3) -2.378 0.239 98.817 1 0 0.093 0.058 0.148
DISCHARGE(4) -4.204 0.51 68.004 1 0 0.015 0.005 0.041
DISCHARGE(5) -1.412 0.254 30.992 1 0 0.244 0.148 0.401
Constant 0.773 0.768 1.013 1 0.314 2.167
a. Variable(s) entered on step 1: MODEL, GENDER, DISABILITY, AGEREGRESSION, EMPLOYMENT, GAD, DISCHARGE.
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 121: Logistical regression on reliably improved outcome on PHQ severe 
for sensitivity analysis 
 
 
 
 
 
 
 
 
Lower Upper
Step 1a MODEL(1) -0.054 0.082 0.431 1 0.512 0.948 0.808 1.112
GENDER(1) 0.046 0.083 0.311 1 0.577 1.047 0.89 1.232
DISABILITY(1) -0.196 0.142 1.921 1 0.166 0.822 0.622 1.085
AGEREGRESSION 20.973 5 0.001
AGEREGRESSION(1) 0.226 0.183 1.525 1 0.217 1.254 0.876 1.795
AGEREGRESSION(2) -0.072 0.185 0.151 1 0.697 0.931 0.648 1.337
AGEREGRESSION(3) -0.11 0.184 0.356 1 0.551 0.896 0.625 1.284
AGEREGRESSION(4) 0.135 0.194 0.483 1 0.487 1.144 0.782 1.674
AGEREGRESSION(5) -0.844 0.339 6.187 1 0.013 0.43 0.221 0.836
EMPLOYMENT 7.612 5 0.179
EMPLOYMENT(1) 0.11 0.1 1.203 1 0.273 1.116 0.917 1.359
EMPLOYMENT(2) 0.22 0.23 0.912 1 0.34 1.246 0.793 1.956
EMPLOYMENT(3) 0.208 0.116 3.199 1 0.074 1.231 0.98 1.547
EMPLOYMENT(4) 0.172 0.177 0.945 1 0.331 1.188 0.839 1.682
EMPLOYMENT(5) 0.614 0.271 5.115 1 0.024 1.848 1.085 3.146
GAD 19.882 3 0
GAD(1) -0.571 0.743 0.592 1 0.442 0.565 0.132 2.42
GAD(2) 0.146 0.681 0.046 1 0.83 1.157 0.305 4.395
GAD(3) 0.513 0.672 0.581 1 0.446 1.67 0.447 6.239
DISCHARGE 15.748 5 0.008
DISCHARGE(1) 0.123 0.098 1.563 1 0.211 1.131 0.933 1.371
DISCHARGE(2) -0.255 0.202 1.594 1 0.207 0.775 0.522 1.151
DISCHARGE(3) 0.238 0.151 2.502 1 0.114 1.269 0.945 1.705
DISCHARGE(4) -0.359 0.146 6.022 1 0.014 0.698 0.524 0.93
DISCHARGE(5) -0.254 0.216 1.391 1 0.238 0.775 0.508 1.183
Constant -1.135 0.699 2.636 1 0.104 0.322
a. Variable(s) entered on step 1: MODEL, GENDER, DISABILITY, AGEREGRESSION, EMPLOYMENT, GAD, DISCHARGE.
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 122: Logistical regression on no change outcome on PHQ severe for 
sensitivity analysis 
 
 
 
 
 
 
 
B S.E. Wald df Sig. Exp(B)
Lower Upper
Step 1a MODEL(1) -0.311 0.094 10.886 1 0.001 0.733 0.609 0.882
GENDER(1) 0.04 0.095 0.174 1 0.677 1.041 0.863 1.255
DISABILITY(1) 0.324 0.155 4.376 1 0.036 1.383 1.021 1.873
AGEREGRESSION 2.844 5 0.724
AGEREGRESSION(1) -0.319 0.204 2.453 1 0.117 0.727 0.487 1.084
AGEREGRESSION(2) -0.206 0.203 1.031 1 0.31 0.814 0.546 1.212
AGEREGRESSION(3) -0.18 0.202 0.792 1 0.374 0.835 0.562 1.241
AGEREGRESSION(4) -0.167 0.216 0.598 1 0.439 0.846 0.555 1.292
AGEREGRESSION(5) -0.246 0.377 0.426 1 0.514 0.782 0.373 1.637
EMPLOYMENT 43.71 5 0
EMPLOYMENT(1) 0.666 0.115 33.514 1 0 1.946 1.554 2.439
EMPLOYMENT(2) 0.252 0.264 0.908 1 0.341 1.287 0.766 2.16
EMPLOYMENT(3) 0.71 0.134 28.224 1 0 2.034 1.565 2.644
EMPLOYMENT(4) 0.54 0.205 6.969 1 0.008 1.716 1.149 2.563
EMPLOYMENT(5) 0.257 0.323 0.633 1 0.426 1.293 0.687 2.433
GAD 31.205 3 0
GAD(1) -0.566 0.819 0.477 1 0.49 0.568 0.114 2.829
GAD(2) -0.491 0.749 0.43 1 0.512 0.612 0.141 2.655
GAD(3) 0.282 0.737 0.147 1 0.702 1.326 0.313 5.618
DISCHARGE 452.678 5 0
DISCHARGE(1) 2.085 0.116 323.148 1 0 8.042 6.407 10.094
DISCHARGE(2) 2.187 0.199 120.18 1 0 8.904 6.023 13.163
DISCHARGE(3) 1.85 0.162 129.81 1 0 6.358 4.625 8.741
DISCHARGE(4) 2.453 0.153 255.784 1 0 11.619 8.603 15.694
DISCHARGE(5) 1.864 0.213 76.61 1 0 6.45 4.249 9.792
Constant -2.253 0.77 8.57 1 0.003 0.105
a. Variable(s) entered on step 1: MODEL, GENDER, DISABILITY, AGEREGRESSION, EMPLOYMENT, GAD, DISCHARGE.
95% C.I.for EXP(B)
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 123: Logistical regression on reliably deteriorated outcome on PHQ severe 
for sensitivity analysis 
 
 
 
 
 
 
 
B S.E. Wald df Sig. Exp(B)
Lower Upper
Step 1a MODEL(1) -0.196 0.282 0.485 1 0.486 0.822 0.473 1.427
GENDER(1) -0.494 0.301 2.687 1 0.101 0.61 0.338 1.101
DISABILITY(1) 0.103 0.408 0.064 1 0.8 1.109 0.498 2.469
AGEREGRESSION 3.989 5 0.551
AGEREGRESSION(1) 1.364 0.862 2.502 1 0.114 3.911 0.722 21.198
AGEREGRESSION(2) 1.577 0.872 3.27 1 0.071 4.842 0.876 26.765
AGEREGRESSION(3) 1.241 0.881 1.985 1 0.159 3.459 0.616 19.436
AGEREGRESSION(4) 1.244 0.908 1.877 1 0.171 3.469 0.585 20.565
AGEREGRESSION(5) 0.601 1.652 0.132 1 0.716 1.823 0.072 46.443
EMPLOYMENT 10.133 5 0.072
EMPLOYMENT(1) 1.021 0.383 7.108 1 0.008 2.776 1.311 5.881
EMPLOYMENT(2) 0.432 0.955 0.205 1 0.651 1.541 0.237 10.007
EMPLOYMENT(3) 1.183 0.429 7.612 1 0.006 3.264 1.409 7.563
EMPLOYMENT(4) 1.151 0.557 4.274 1 0.039 3.162 1.062 9.416
EMPLOYMENT(5) 0.261 1.442 0.033 1 0.856 1.298 0.077 21.937
GAD 95.173 3 0
GAD(1) 0.494 1.233 0.161 1 0.688 1.64 0.146 18.387
GAD(2) -0.123 1.172 0.011 1 0.917 0.885 0.089 8.797
GAD(3) -2.81 1.175 5.723 1 0.017 0.06 0.006 0.602
DISCHARGE 41.927 5 0
DISCHARGE(1) 2.237 0.449 24.804 1 0 9.367 3.884 22.593
DISCHARGE(2) 3.029 0.545 30.927 1 0 20.678 7.11 60.137
DISCHARGE(3) 1.798 0.588 9.341 1 0.002 6.036 1.906 19.116
DISCHARGE(4) 2.84 0.495 32.976 1 0 17.11 6.491 45.1
DISCHARGE(5) 1.149 1.106 1.08 1 0.299 3.155 0.361 27.567
Constant -5.504 1.514 13.215 1 0 0.004
a. Variable(s) entered on step 1: MODEL, GENDER, DISABILITY, AGEREGRESSION, EMPLOYMENT, GAD, DISCHARGE.
95% C.I.for EXP(B)
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 124: Logistical regression on recovered outcome on GAD moderate for 
sensitivity analysis 
 
 
 
 
 
 
 
Lower Upper
MODEL(1) 0.4 0.099 16.165 1 0 1.491 1.227 1.812
GENDER(1) 0.146 0.104 1.977 1 0.16 1.157 0.944 1.418
DISABILITY(1) 0.086 0.205 0.177 1 0.674 1.09 0.73 1.629
AGEREGRESSION 16.742 5 0.005
AGEREGRESSION(1) 0.319 0.193 2.729 1 0.099 1.376 0.942 2.008
AGEREGRESSION(2) 0.444 0.204 4.719 1 0.03 1.559 1.044 2.328
AGEREGRESSION(3) 0.509 0.208 5.971 1 0.015 1.664 1.106 2.503
AGEREGRESSION(4) 0.275 0.222 1.531 1 0.216 1.316 0.852 2.033
AGEREGRESSION(5) 1.395 0.392 12.665 1 0 4.036 1.872 8.705
EMPLOYMENT 60.493 5 0
EMPLOYMENT(1) -0.89 0.138 41.855 1 0 0.411 0.314 0.538
EMPLOYMENT(2) -0.3 0.213 1.989 1 0.158 0.741 0.488 1.124
EMPLOYMENT(3) -0.93 0.171 29.481 1 0 0.395 0.282 0.552
EMPLOYMENT(4) -0.477 0.208 5.242 1 0.022 0.621 0.413 0.934
EMPLOYMENT(5) -0.823 0.335 6.047 1 0.014 0.439 0.228 0.846
PHQ 49.312 4 0
PHQ(1) -0.006 0.319 0 1 0.985 0.994 0.532 1.858
PHQ(2) -0.369 0.304 1.469 1 0.225 0.692 0.381 1.256
PHQ(3) -0.895 0.304 8.68 1 0.003 0.408 0.225 0.741
PHQ(4) -0.893 0.32 7.796 1 0.005 0.409 0.219 0.766
DISCHARGE 471.923 5 0
DISCHARGE(1) -2.674 0.141 361.144 1 0 0.069 0.052 0.091
DISCHARGE(2) -2.044 0.324 39.825 1 0 0.13 0.069 0.244
DISCHARGE(3) -1.76 0.2 77.646 1 0 0.172 0.116 0.254
DISCHARGE(4) -3.51 0.434 65.292 1 0 0.03 0.013 0.07
DISCHARGE(5) -1.029 0.26 15.703 1 0 0.358 0.215 0.595
Constant 1.237 0.342 13.052 1 0 3.445
Sig. Exp(B)
95% C.I.for EXP(B)
Step 1
a
a. Variable(s) entered on step 1: MODEL, GENDER, DISABILITY, AGEREGRESSION, EMPLOYMENT, PHQ, DISCHARGE.
B S.E. Wald df
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 125: Logistical regression on reliably improved outcome on GAD moderate 
for sensitivity analysis 
 
 
 
 
 
 
Lower Upper
MODEL(1) -0.25 0.115 4.739 1 0.029 0.778 0.621 0.975
GENDER(1) -0.14 0.121 1.34 1 0.247 0.869 0.685 1.102
DISABILITY(1) 0.004 0.235 0 1 0.987 1.004 0.634 1.59
AGEREGRESSION 7.335 5 0.197
AGEREGRESSION(1) 0.198 0.218 0.825 1 0.364 1.219 0.795 1.871
AGEREGRESSION(2) -0.071 0.234 0.093 1 0.76 0.931 0.589 1.473
AGEREGRESSION(3) -0.03 0.238 0.016 1 0.901 0.971 0.609 1.546
AGEREGRESSION(4) 0.057 0.257 0.049 1 0.824 1.059 0.64 1.751
AGEREGRESSION(5) -0.883 0.519 2.894 1 0.089 0.414 0.15 1.144
EMPLOYMENT 1.624 5 0.898
EMPLOYMENT(1) 0.114 0.153 0.556 1 0.456 1.121 0.831 1.512
EMPLOYMENT(2) 0.03 0.245 0.015 1 0.903 1.03 0.638 1.665
EMPLOYMENT(3) -0.037 0.198 0.036 1 0.85 0.963 0.654 1.42
EMPLOYMENT(4) 0.136 0.234 0.336 1 0.562 1.146 0.724 1.813
EMPLOYMENT(5) 0.379 0.441 0.741 1 0.389 1.461 0.616 3.465
PHQ 89.179 4 0
PHQ(1) 1.18 0.742 2.531 1 0.112 3.254 0.761 13.919
PHQ(2) 1.481 0.727 4.151 1 0.042 4.398 1.058 18.284
PHQ(3) 2.268 0.724 9.824 1 0.002 9.661 2.339 39.902
PHQ(4) 2.716 0.729 13.888 1 0 15.116 3.623 63.058
DISCHARGE 22.741 5 0
DISCHARGE(1) 0.449 0.136 10.861 1 0.001 1.567 1.2 2.046
DISCHARGE(2) -0.628 0.447 1.979 1 0.16 0.534 0.222 1.28
DISCHARGE(3) 0.572 0.218 6.905 1 0.009 1.772 1.156 2.714
DISCHARGE(4) 0.53 0.265 3.997 1 0.046 1.699 1.01 2.857
DISCHARGE(5) -0.459 0.413 1.232 1 0.267 0.632 0.281 1.421
Constant -3.661 0.747 24.002 1 0 0.026
Exp(B)
95% C.I.for EXP(B)
Step 1
a
a. Variable(s) entered on step 1: MODEL, GENDER, DISABILITY, AGEREGRESSION, EMPLOYMENT, PHQ, DISCHARGE.
B S.E. Wald df Sig.
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 126: Logistical regression on no change outcome on GAD moderate for 
sensitivity analysis 
 
 
 
 
 
 
 
B S.E. Wald df Sig. Exp(B)
Lower Upper
Step 1a MODEL(1) -0.258 0.106 5.887 1 0.015 0.773 0.628 0.952
GENDER(1) 0.09 0.11 0.678 1 0.41 1.095 0.883 1.357
DISABILITY(1) 0.021 0.216 0.009 1 0.924 1.021 0.668 1.56
AGEREGRESSION 9.125 5 0.104
AGEREGRESSION(1) -0.488 0.189 6.691 1 0.01 0.614 0.424 0.889
AGEREGRESSION(2) -0.439 0.2 4.836 1 0.028 0.645 0.436 0.953
AGEREGRESSION(3) -0.505 0.207 5.981 1 0.014 0.603 0.403 0.905
AGEREGRESSION(4) -0.375 0.226 2.748 1 0.097 0.688 0.441 1.071
AGEREGRESSION(5) -0.917 0.459 3.992 1 0.046 0.4 0.163 0.983
EMPLOYMENT 15.576 5 0.008
EMPLOYMENT(1) 0.421 0.139 9.124 1 0.003 1.524 1.159 2.003
EMPLOYMENT(2) 0.226 0.213 1.124 1 0.289 1.254 0.825 1.906
EMPLOYMENT(3) 0.568 0.176 10.467 1 0.001 1.766 1.251 2.491
EMPLOYMENT(4) 0.293 0.219 1.789 1 0.181 1.34 0.873 2.057
EMPLOYMENT(5) 0.255 0.413 0.382 1 0.536 1.291 0.575 2.898
PHQ 21.21 4 0
PHQ(1) -0.097 0.374 0.068 1 0.795 0.907 0.436 1.888
PHQ(2) 0.393 0.355 1.225 1 0.268 1.481 0.739 2.97
PHQ(3) 0.331 0.356 0.865 1 0.352 1.392 0.693 2.796
PHQ(4) -0.235 0.375 0.394 1 0.53 0.79 0.379 1.648
DISCHARGE 267.156 5 0
DISCHARGE(1) 1.893 0.122 242.251 1 0 6.637 5.229 8.423
DISCHARGE(2) 1.248 0.288 18.816 1 0 3.482 1.981 6.118
DISCHARGE(3) 1.424 0.197 52.247 1 0 4.153 2.823 6.11
DISCHARGE(4) 1.726 0.236 53.544 1 0 5.616 3.538 8.916
DISCHARGE(5) 1.303 0.274 22.681 1 0 3.679 2.152 6.29
Constant -1.881 0.387 23.615 1 0 0.152
95% C.I.for EXP(B)
a. Variable(s) entered on step 1: MODEL, GENDER, DISABILITY, AGEREGRESSION, EMPLOYMENT, PHQ, DISCHARGE.
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 127: Logistical regression on reliably deteriorated outcome on GAD 
moderate for sensitivity analysis 
 
 
 
 
 
 
 
Lower Upper
MODEL(1) 0.049 0.18 0.075 1 0.784 1.051 0.738 1.496
GENDER(1) -0.472 0.194 5.921 1 0.015 0.624 0.427 0.912
DISABILITY(1) -0.069 0.33 0.043 1 0.835 0.933 0.489 1.783
AGEREGRESSION 2.035 5 0.844
AGEREGRESSION(1) 0.075 0.32 0.054 1 0.816 1.077 0.576 2.016
AGEREGRESSION(2) 0.178 0.338 0.276 1 0.599 1.194 0.616 2.317
AGEREGRESSION(3) 0.114 0.352 0.105 1 0.746 1.121 0.562 2.233
AGEREGRESSION(4) 0.374 0.378 0.979 1 0.323 1.454 0.693 3.053
AGEREGRESSION(5) -0.272 0.737 0.136 1 0.713 0.762 0.18 3.234
EMPLOYMENT 40.242 5 0
EMPLOYMENT(1) 1.3 0.235 30.669 1 0 3.668 2.316 5.811
EMPLOYMENT(2) 0.591 0.39 2.299 1 0.129 1.806 0.841 3.878
EMPLOYMENT(3) 1.432 0.276 26.841 1 0 4.189 2.436 7.201
EMPLOYMENT(4) 0.623 0.361 2.972 1 0.085 1.864 0.918 3.783
EMPLOYMENT(5) 1.36 0.619 4.819 1 0.028 3.896 1.157 13.119
PHQ 11.447 4 0.022
PHQ(1) -0.654 0.517 1.596 1 0.207 0.52 0.189 1.434
PHQ(2) -1.303 0.504 6.682 1 0.01 0.272 0.101 0.73
PHQ(3) -1.236 0.5 6.107 1 0.013 0.291 0.109 0.774
PHQ(4) -1.226 0.522 5.51 1 0.019 0.293 0.105 0.817
DISCHARGE 135.053 5 0
DISCHARGE(1) 2.31 0.239 93.639 1 0 10.079 6.312 16.094
DISCHARGE(2) 3.276 0.347 88.968 1 0 26.482 13.405 52.315
DISCHARGE(3) 1.763 0.35 25.433 1 0 5.832 2.939 11.574
DISCHARGE(4) 2.905 0.339 73.476 1 0 18.259 9.398 35.474
DISCHARGE(5) 1.795 0.48 13.986 1 0 6.017 2.349 15.409
Constant -3.639 0.577 39.746 1 0 0.026
Exp(B)
95% C.I.for EXP(B)
Step 1
a
a. Variable(s) entered on step 1: MODEL, GENDER, DISABILITY, AGEREGRESSION, EMPLOYMENT, PHQ, DISCHARGE.
B S.E. Wald df Sig.
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 128: Logistical regression on recovered outcome on GAD7 severe for 
sensitivity analysis 
 
 
 
 
 
 
 
B S.E. Wald df Sig. Exp(B)
Lower Upper
Step 1a MODEL(1) 0.436 0.076 33.002 1 0 1.546 1.333 1.794
GENDER(1) -0.084 0.078 1.161 1 0.281 0.919 0.788 1.072
DISABILITY(1) -0.064 0.144 0.2 1 0.655 0.938 0.707 1.244
AGEREGRESSION 14.996 5 0.01
AGEREGRESSION(1) -0.011 0.16 0.005 1 0.946 0.989 0.723 1.353
AGEREGRESSION(2) 0.078 0.164 0.225 1 0.635 1.081 0.784 1.49
AGEREGRESSION(3) 0.104 0.166 0.392 1 0.531 1.11 0.801 1.537
AGEREGRESSION(4) -0.009 0.178 0.003 1 0.959 0.991 0.699 1.404
AGEREGRESSION(5) 0.91 0.286 10.158 1 0.001 2.485 1.42 4.349
EMPLOYMENT 99.486 5 0
EMPLOYMENT(1) -0.761 0.096 63.186 1 0 0.467 0.387 0.564
EMPLOYMENT(2) -0.26 0.189 1.898 1 0.168 0.771 0.532 1.116
EMPLOYMENT(3) -0.919 0.119 59.525 1 0 0.399 0.316 0.504
EMPLOYMENT(4) -0.526 0.161 10.645 1 0.001 0.591 0.431 0.811
EMPLOYMENT(5) -0.819 0.249 10.788 1 0.001 0.441 0.27 0.719
PHQ 73.543 4 0
PHQ(1) -0.016 0.42 0.001 1 0.969 0.984 0.432 2.239
PHQ(2) -0.584 0.391 2.233 1 0.135 0.558 0.259 1.2
PHQ(3) -0.799 0.384 4.318 1 0.038 0.45 0.212 0.956
PHQ(4) -1.222 0.384 10.133 1 0.001 0.295 0.139 0.625
DISCHARGE 815.696 5 0
DISCHARGE(1) -3.044 0.134 518.957 1 0 0.048 0.037 0.062
DISCHARGE(2) -2.593 0.309 70.371 1 0 0.075 0.041 0.137
DISCHARGE(3) -2.526 0.201 157.837 1 0 0.08 0.054 0.119
DISCHARGE(4) -3.382 0.299 128.223 1 0 0.034 0.019 0.061
DISCHARGE(5) -1.312 0.183 51.392 1 0 0.269 0.188 0.385
Constant 1.328 0.412 10.376 1 0.001 3.774
a. Variable(s) entered on step 1: MODEL, GENDER, DISABILITY, AGEREGRESSION, EMPLOYMENT, PHQ, DISCHARGE.
95% C.I.for EXP(B)
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 129: Logistical regression on reliable improvement outcome on GAD7 
severe for sensitivity analysis 
 
 
 
 
 
 
 
B S.E. Wald df Sig. Exp(B)
Lower Upper
Step 1a MODEL(1) -0.101 0.064 2.504 1 0.114 0.904 0.798 1.024
GENDER(1) 0.071 0.065 1.176 1 0.278 1.074 0.944 1.221
DISABILITY(1) -0.033 0.12 0.077 1 0.781 0.967 0.764 1.224
AGEREGRESSION 15.81 5 0.007
AGEREGRESSION(1) 0.115 0.129 0.794 1 0.373 1.121 0.872 1.443
AGEREGRESSION(2) -0.097 0.132 0.537 1 0.464 0.908 0.7 1.176
AGEREGRESSION(3) -0.089 0.134 0.439 1 0.507 0.915 0.703 1.191
AGEREGRESSION(4) 0.081 0.144 0.318 1 0.573 1.085 0.818 1.439
AGEREGRESSION(5) -0.581 0.256 5.127 1 0.024 0.56 0.338 0.925
EMPLOYMENT 3.965 5 0.554
EMPLOYMENT(1) 0.062 0.079 0.609 1 0.435 1.064 0.911 1.243
EMPLOYMENT(2) 0.143 0.16 0.799 1 0.371 1.153 0.844 1.577
EMPLOYMENT(3) 0.109 0.096 1.274 1 0.259 1.115 0.923 1.346
EMPLOYMENT(4) -0.036 0.138 0.067 1 0.795 0.965 0.737 1.264
EMPLOYMENT(5) 0.32 0.217 2.175 1 0.14 1.377 0.9 2.107
PHQ 35.131 4 0
PHQ(1) 0.392 0.45 0.76 1 0.383 1.48 0.613 3.574
PHQ(2) 0.776 0.421 3.394 1 0.065 2.173 0.952 4.963
PHQ(3) 0.997 0.416 5.742 1 0.017 2.711 1.199 6.128
PHQ(4) 1.168 0.415 7.903 1 0.005 3.215 1.424 7.257
DISCHARGE 32.798 5 0
DISCHARGE(1) 0.346 0.076 20.68 1 0 1.414 1.218 1.641
DISCHARGE(2) 0.002 0.176 0 1 0.991 1.002 0.71 1.415
DISCHARGE(3) 0.281 0.126 4.952 1 0.026 1.324 1.034 1.696
DISCHARGE(4) -0.216 0.127 2.907 1 0.088 0.806 0.629 1.033
DISCHARGE(5) -0.123 0.169 0.531 1 0.466 0.884 0.635 1.231
Constant -1.796 0.433 17.214 1 0 0.166
a. Variable(s) entered on step 1: MODEL, GENDER, DISABILITY, AGEREGRESSION, EMPLOYMENT, PHQ, DISCHARGE.
95% C.I.for EXP(B)
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 130: Logistical regression on no change outcome on GAD7 severe for 
sensitivity analysis 
 
 
 
 
 
 
 
Lower Upper
MODEL(1) -0.234 0.075 9.672 1 0.002 0.791 0.683 0.917
GENDER(1) 0.002 0.078 0.001 1 0.977 1.002 0.861 1.167
DISABILITY(1) 0.094 0.137 0.465 1 0.495 1.098 0.839 1.438
AGEREGRESSION 2.375 5 0.795
AGEREGRESSION(1) -0.05 0.148 0.112 1 0.738 0.951 0.711 1.273
AGEREGRESSION(2) 0.027 0.152 0.032 1 0.859 1.027 0.763 1.383
AGEREGRESSION(3) 0.058 0.155 0.141 1 0.708 1.06 0.783 1.435
AGEREGRESSION(4) -0.051 0.168 0.091 1 0.763 0.951 0.684 1.321
AGEREGRESSION(5) -0.279 0.304 0.843 1 0.359 0.756 0.417 1.373
EMPLOYMENT 61.077 5 0
EMPLOYMENT(1) 0.577 0.092 39.141 1 0 1.78 1.486 2.133
EMPLOYMENT(2) 0.202 0.194 1.092 1 0.296 1.224 0.838 1.789
EMPLOYMENT(3) 0.712 0.111 41.154 1 0 2.038 1.639 2.533
EMPLOYMENT(4) 0.593 0.155 14.607 1 0 1.809 1.335 2.452
EMPLOYMENT(5) 0.566 0.26 4.738 1 0.03 1.761 1.058 2.931
PHQ 32.612 4 0
PHQ(1) -0.326 0.49 0.445 1 0.505 0.722 0.276 1.883
PHQ(2) -0.108 0.442 0.06 1 0.806 0.897 0.378 2.132
PHQ(3) 0.145 0.433 0.113 1 0.737 1.156 0.495 2.702
PHQ(4) 0.448 0.431 1.081 1 0.298 1.566 0.672 3.645
DISCHARGE 722.887 5 0
DISCHARGE(1) 2.105 0.09 544.448 1 0 8.204 6.875 9.79
DISCHARGE(2) 2.13 0.176 146.545 1 0 8.418 5.962 11.885
DISCHARGE(3) 1.937 0.134 209.925 1 0 6.935 5.337 9.012
DISCHARGE(4) 2.391 0.129 342.927 1 0 10.93 8.486 14.078
DISCHARGE(5) 1.887 0.167 128.165 1 0 6.601 4.761 9.152
Constant -2.599 0.456 32.542 1 0 0.074
Exp(B)
95% C.I.for EXP(B)
Step 1
a
a. Variable(s) entered on step 1: MODEL, GENDER, DISABILITY, AGEREGRESSION, EMPLOYMENT, PHQ, DISCHARGE.
B S.E. Wald df Sig.
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 131: Logistical regression on reliable deterioration outcome on GAD7 
severe for sensitivity analysis 
 
 
 
 
 
 
 
Lower Upper
MODEL(1) -0.532 0.218 5.944 1 0.015 0.587 0.383 0.901
GENDER(1) -0.257 0.228 1.269 1 0.26 0.773 0.494 1.21
DISABILITY(1) 0.471 0.385 1.496 1 0.221 1.601 0.753 3.403
AGEREGRESSION 11.585 5 0.041
AGEREGRESSION(1) -0.674 0.418 2.608 1 0.106 0.509 0.225 1.155
AGEREGRESSION(2) 0.224 0.388 0.335 1 0.563 1.251 0.585 2.675
AGEREGRESSION(3) -0.35 0.428 0.669 1 0.414 0.704 0.304 1.631
AGEREGRESSION(4) 0.083 0.44 0.036 1 0.85 1.087 0.458 2.576
AGEREGRESSION(5) 0.692 0.809 0.732 1 0.392 1.998 0.409 9.76
EMPLOYMENT 16.916 5 0.005
EMPLOYMENT(1) 0.813 0.254 10.232 1 0.001 2.256 1.37 3.713
EMPLOYMENT(2) -0.813 0.777 1.095 1 0.295 0.443 0.097 2.035
EMPLOYMENT(3) 0.411 0.343 1.439 1 0.23 1.509 0.77 2.955
EMPLOYMENT(4) 0.479 0.417 1.318 1 0.251 1.614 0.713 3.657
EMPLOYMENT(5) -1.894 1.172 2.61 1 0.106 0.151 0.015 1.497
PHQ 75.71 4 0
PHQ(1) -0.729 0.792 0.847 1 0.357 0.482 0.102 2.279
PHQ(2) -0.259 0.667 0.151 1 0.698 0.772 0.209 2.853
PHQ(3) -1.406 0.669 4.417 1 0.036 0.245 0.066 0.91
PHQ(4) -2.759 0.687 16.14 1 0 0.063 0.016 0.243
DISCHARGE 66.925 5 0
DISCHARGE(1) 1.868 0.293 40.525 1 0 6.477 3.644 11.513
DISCHARGE(2) 2.204 0.499 19.546 1 0 9.065 3.412 24.089
DISCHARGE(3) 2.264 0.364 38.65 1 0 9.623 4.713 19.647
DISCHARGE(4) 2.559 0.349 53.869 1 0 12.926 6.526 25.601
DISCHARGE(5) -15.917 2794.991 0 1 0.995 0 0 .
Constant -3.439 0.782 19.354 1 0 0.032
Step 1
a
a. Variable(s) entered on step 1: MODEL, GENDER, DISABILITY, AGEREGRESSION, EMPLOYMENT, PHQ, DISCHARGE.
B S.E. Wald df Sig. Exp(B)
95% C.I.for EXP(B)
Key of Variable Reference Categories
Gender Disability Age Employment PHQ GAD Discharge
Reference Female No 18-24 Employed Minimal Minimal Completed
1 Male Yes 25-34 Unemployed Mild Mild Dropped Out
2 35-44 Student Moderate Moderate Not Suitable
3 45-54 SickDisabled Moderate to Severe Severe Declined Treatment
4 55-64 Homemaker Severe Referred On
5 65-74 Retired
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Appendix 132: Cross tabulation on drop out and recovery outcome for whole service 
 
Allocated Progressive
Count 25 37 62
% within Model 12.20% 15.80% 14.10%
Count 48 67 115
% within Model 23.40% 28.60% 26.20%
Count 94 108 202
% within Model 45.90% 46.20% 46.00%
Count 38 22 60
% within Model 18.50% 9.40% 13.70%
Count 205 234 439
% within Model 100.00% 100.00% 100.00%
Count 86 106 192
% within Model 22.80% 16.90% 19.10%
Count 100 182 282
% within Model 26.50% 28.90% 28.00%
Count 155 295 450
% within Model 41.00% 46.90% 44.70%
Count 37 46 83
% within Model 9.80% 7.30% 8.20%
Count 378 629 1007
% within Model 100.00% 100.00% 100.00%
Count 1945 3964 5909
% within Model 61.90% 67.10% 65.30%
Count 708 1247 1955
% within Model 22.50% 21.10% 21.60%
Count 428 614 1042
% within Model 13.60% 10.40% 11.50%
Count 62 86 148
% within Model 2.00% 1.50% 1.60%
Count 3143 5911 9054
% within Model 100.00% 100.00% 100.00%
Count 210 218 428
% within Model 15.20% 11.10% 12.80%
Count 420 635 1055
% within Model 30.40% 32.40% 31.60%
Count 640 933 1573
% within Model 46.30% 47.60% 47.10%
Count 112 174 286
% within Model 8.10% 8.90% 8.60%
Count 1382 1960 3342
% within Model 100.00% 100.00% 100.00%
Count 27 34 61
% within Model 7.40% 5.20% 6.00%
Count 91 159 250
% within Model 24.80% 24.40% 24.50%
Count 195 378 573
% within Model 53.10% 58.00% 56.20%
Count 54 81 135
% within Model 14.70% 12.40% 13.20%
Count 367 652 1019
% within Model 100.00% 100.00% 100.00%
Count 2293 4359 6652
% within Model 41.90% 46.40% 44.80%
Count 1367 2290 3657
% within Model 25.00% 24.40% 24.60%
Count 1512 2328 3840
% within Model 27.60% 24.80% 25.80%
Count 303 409 712
% within Model 5.50% 4.40% 4.80%
Count 5475 9386 14861
% within Model 100.00% 100.00% 100.00%
Total
Recovery
Recovered
Reliable Improvement
Non Recovered
Reliable Deterioration
Total
Referred On
Recovery
Recovered
Reliable Improvement
Non Recovered
Reliable Deterioration
Total
Dropped 
Out of 
Treatment
Recovery
Recovered
Reliable Improvement
Non Recovered
Reliable Deterioration
Total
Completed 
Treatment
Recovery
Recovered
Reliable Improvement
Non Recovered
Reliable Deterioration
Total
Total
Declined 
Treatment
Recovery
Recovered
Reliable Improvement
Non Recovered
Reliable Deterioration
Total
Discharge Reason
Model
Total
Not Suitable
Recovery
Recovered
Reliable Improvement
Non Recovered
Reliable Deterioration
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Appendix 133: Chi square on drop out and recovery outcome for whole service 
 
 
 
 
 
 
 
 
 
 
 
 
Value df
Asymp. Sig. 
(2-sided)
Pearson Chi-Square 8.821
b 3 0.032
Likelihood Ratio 8.864 3 0.031
Linear-by-Linear Association 6.372 1 0.012
N of Valid Cases 439
Pearson Chi-Square 8.419
c 3 0.038
Likelihood Ratio 8.316 3 0.04
Linear-by-Linear Association 1.398 1 0.237
N of Valid Cases 1007
Pearson Chi-Square 32.340
d 3 0
Likelihood Ratio 31.846 3 0
Linear-by-Linear Association 31.643 1 0
N of Valid Cases 9054
Pearson Chi-Square 12.387
e 3 0.006
Likelihood Ratio 12.248 3 0.007
Linear-by-Linear Association 5.717 1 0.017
N of Valid Cases 3342
Pearson Chi-Square 3.725
f 3 0.293
Likelihood Ratio 3.671 3 0.299
Linear-by-Linear Association 0.241 1 0.624
N of Valid Cases 1019
Pearson Chi-Square 37.109
a 3 0
Likelihood Ratio 36.978 3 0
Linear-by-Linear Association 36.804 1 0
N of Valid Cases 14861
Referred On
Total
Discharge Reason
Not Suitable
Declined 
Treatment
Completed 
Treatment
Dropped Out 
of Treatment
316 
 
Appendix 134: Cross tabulation on drop out and recovery outcome for north cohort 
 
Discharge Model Total
Allocated Progressive
Not Suitable Recovery Recovered Count 11 21 32
% within Model 13.10% 14.00% 13.70%
Reliable Improvement Count 20 44 64
% within Model 23.80% 29.30% 27.40%
Non Recovered Count 36 69 105
% within Model 42.90% 46.00% 44.90%
Reliable Deterioration Count 17 16 33
% within Model 20.20% 10.70% 14.10%
Total Count 84 150 234
% within Model 100.00% 100.00% 100.00%
Declined Recovery Recovered Count 51 57 108
% within Model 24.40% 17.30% 20.10%
Reliable Improvement Count 58 89 147
% within Model 27.80% 27.10% 27.30%
Non Recovered Count 84 153 237
% within Model 40.20% 46.50% 44.10%
Reliable Deterioration Count 16 30 46
% within Model 7.70% 9.10% 8.60%
Total Count 209 329 538
% within Model 100.00% 100.00% 100.00%
Completed Recovery Recovered Count 1176 2312 3488
% within Model 64.40% 68.70% 67.20%
Reliable Improvement Count 396 680 1076
% within Model 21.70% 20.20% 20.70%
Non Recovered Count 227 321 548
% within Model 12.40% 9.50% 10.60%
Reliable Deterioration Count 28 50 78
% within Model 1.50% 1.50% 1.50%
Total Count 1827 3363 5190
% within Model 100.00% 100.00% 100.00%
Dropped Recovery Recovered Count 118 98 216
% within Model 13.80% 8.80% 11.00%
Reliable Improvement Count 259 354 613
% within Model 30.30% 31.90% 31.20%
Non Recovered Count 404 553 957
% within Model 47.30% 49.80% 48.70%
Reliable Deterioration Count 73 106 179
% within Model 8.50% 9.50% 9.10%
Total Count 854 1111 1965
% within Model 100.00% 100.00% 100.00%
Referred On Recovery Recovered Count 14 16 30
% within Model 7.10% 4.50% 5.40%
Reliable Improvement Count 45 97 142
% within Model 23.00% 27.10% 25.60%
Non Recovered Count 106 199 305
% within Model 54.10% 55.60% 55.10%
Reliable Deterioration Count 31 46 77
% within Model 15.80% 12.80% 13.90%
Total Count 196 358 554
% within Model 100.00% 100.00% 100.00%
Total Recovery Recovered Count 1370 2504 3874
% within Model 43.20% 47.10% 45.70%
Reliable Improvement Count 778 1264 2042
% within Model 24.50% 23.80% 24.10%
Non Recovered Count 857 1295 2152
% within Model 27.00% 24.40% 25.40%
Reliable Deterioration Count 165 248 413
% within Model 5.20% 4.70% 4.90%
Total Count 3170 5311 8481
% within Model 100.00% 100.00% 100.00%
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Appendix 135: Chi square on drop out and recovery outcome for north cohort 
 
 
 
 
 
 
 
 
 
 
 
 
Discharge 
Reason
Value df
Asymp. Sig. 
(2-sided)
Pearson Chi-Square 4.249b 3 0.236
Likelihood Ratio 4.111 3 0.25
Linear-by-Linear Association 1.923 1 0.166
N of Valid Cases 234
Pearson Chi-Square 4.688c 3 0.196
Likelihood Ratio 4.64 3 0.2
Linear-by-Linear Association 4.169 1 0.041
N of Valid Cases 538
Pearson Chi-Square 13.903d 3 0.003
Likelihood Ratio 13.701 3 0.003
Linear-by-Linear Association 11.631 1 0.001
N of Valid Cases 5190
Pearson Chi-Square 12.457e 3 0.006
Likelihood Ratio 12.339 3 0.006
Linear-by-Linear Association 6.646 1 0.01
N of Valid Cases 1965
Referred On Pearson Chi-Square 3.371f 3 0.338
Likelihood Ratio 3.31 3 0.346
Linear-by-Linear Association 0.069 1 0.792
N of Valid Cases 554
Total Pearson Chi-Square 13.835a 3 0.003
Likelihood Ratio 13.829 3 0.003
Linear-by-Linear Association 12.998 1 0
N of Valid Cases 8481
Not Suitable
Declined 
Treatment
Completed 
Treatment
Dropped Out 
of Treatment
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Appendix 136: Cross tabulation on drop out and recovery outcome for south cohort 
 
Model Total
Allocated Progressive
Not Suitable Recovery Recovered Count 22 8 30
% within Model 14.50% 17.00% 15.10%
Reliable Improvement Count 36 13 49
% within Model 23.70% 27.70% 24.60%
Non Recovered Count 70 23 93
% within Model 46.10% 48.90% 46.70%
Reliable Deterioration Count 24 3 27
% within Model 15.80% 6.40% 13.60%
Total Count 152 47 199
% within Model 100.00% 100.00% 100.00%
Recovery Recovered Count 58 26 84
% within Model 18.20% 18.20% 18.20%
Reliable Improvement Count 83 52 135
% within Model 26.00% 36.40% 29.20%
Non Recovered Count 150 57 207
% within Model 47.00% 39.90% 44.80%
Reliable Deterioration Count 28 8 36
% within Model 8.80% 5.60% 7.80%
Total Count 319 143 462
% within Model 100.00% 100.00% 100.00%
Recovery Recovered Count 1467 915 2382
% within Model 58.20% 71.40% 62.70%
Reliable Improvement Count 619 245 864
% within Model 24.60% 19.10% 22.70%
Non Recovered Count 374 111 485
% within Model 14.80% 8.70% 12.80%
Reliable Deterioration Count 59 11 70
% within Model 2.30% 0.90% 1.80%
Total Count 2519 1282 3801
% within Model 100.00% 100.00% 100.00%
Recovery Recovered Count 156 53 209
% within Model 16.80% 12.40% 15.40%
Reliable Improvement Count 298 140 438
% within Model 32.20% 32.80% 32.40%
Non Recovered Count 405 198 603
% within Model 43.70% 46.40% 44.60%
Reliable Deterioration Count 67 36 103
% within Model 7.20% 8.40% 7.60%
Total Count 926 427 1353
% within Model 100.00% 100.00% 100.00%
Referred On Recovery Recovered Count 23 8 31
% within Model 6.80% 6.70% 6.80%
Reliable Improvement Count 79 26 105
% within Model 23.20% 21.80% 22.90%
Non Recovered Count 195 70 265
% within Model 57.40% 58.80% 57.70%
Reliable Deterioration Count 43 15 58
% within Model 12.60% 12.60% 12.60%
Total Count 340 119 459
% within Model 100.00% 100.00% 100.00%
Total Recovery Recovered Count 1726 1010 2736
% within Model 40.60% 50.00% 43.60%
Reliable Improvement Count 1115 476 1591
% within Model 26.20% 23.60% 25.40%
Non Recovered Count 1194 459 1653
% within Model 28.10% 22.70% 26.30%
Reliable Deterioration Count 221 73 294
% within Model 5.20% 3.60% 4.70%
Total Count 4256 2018 6274
% within Model 100.00% 100.00% 100.00%
Discharge 
Reason
Dropped 
Out of 
Treatment
Completed 
Treatment
Declined 
Treatment
319 
 
Appendix 137: Chi square on drop out and recovery outcome for south cohort 
 
 
 
 
 
 
 
 
 
 
 
 
Discharge 
Reason
Value df
Asymp. Sig. 
(2-sided)
Not Suitable Pearson Chi-Square 2.790b 3 0.425
Likelihood Ratio 3.192 3 0.363
Linear-by-Linear Association 1.496 1 0.221
N of Valid Cases 199
Pearson Chi-Square 6.030c 3 0.11
Likelihood Ratio 5.998 3 0.112
Linear-by-Linear Association 2.362 1 0.124
N of Valid Cases 462
Pearson Chi-Square 70.210d 3 0
Likelihood Ratio 73.207 3 0
Linear-by-Linear Association 68.718 1 0
N of Valid Cases 3801
Pearson Chi-Square 4.757e 3 0.19
Likelihood Ratio 4.895 3 0.18
Linear-by-Linear Association 3.69 1 0.055
N of Valid Cases 1353
Referred On Pearson Chi-Square .107f 3 0.991
Likelihood Ratio 0.108 3 0.991
Linear-by-Linear Association 0.032 1 0.859
N of Valid Cases 459
Total Pearson Chi-Square 53.874a 3 0
Likelihood Ratio 53.992 3 0
Linear-by-Linear Association 50.096 1 0
N of Valid Cases 6274
Declined 
Treatment
Completed 
Treatment
Dropped Out 
of Treatment
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Appendix 138: Cross tabulation on drop out and recovery outcome for sensitivity 
analysis 
 
Discharge Embedded Total
Year 2 Year 4
Not Suitable Recovery Recovered Count 12 22 34
% within 9.20% 18.50% 13.70%
Reliable Improvement Count 30 31 61
% within 23.10% 26.10% 24.50%
Non Recovered Count 71 56 127
% within 54.60% 47.10% 51.00%
Reliable Deterioration Count 17 10 27
% within 13.10% 8.40% 10.80%
Total Count 130 119 249
% within 100.00% 100.00% 100.00%
Declined Recovery Recovered Count 51 42 93
% within 22.00% 13.20% 16.90%
Reliable Improvement Count 61 95 156
% within 26.30% 30.00% 28.40%
Non Recovered Count 97 154 251
% within 41.80% 48.60% 45.70%
Reliable Deterioration Count 23 26 49
% within 9.90% 8.20% 8.90%
Total Count 232 317 549
% within 100.00% 100.00% 100.00%
Completed Recovery Recovered Count 1328 2032 3360
% within 58.70% 71.80% 66.00%
Reliable Improvement Count 552 524 1076
% within 24.40% 18.50% 21.10%
Non Recovered Count 336 246 582
% within 14.90% 8.70% 11.40%
Reliable Deterioration Count 45 30 75
% within 2.00% 1.10% 1.50%
Total Count 2261 2832 5093
% within 100.00% 100.00% 100.00%
Dropped Recovery Recovered Count 124 104 228
% within 13.90% 10.80% 12.30%
Reliable Improvement Count 286 317 603
% within 32.20% 32.90% 32.50%
Non Recovered Count 408 457 865
% within 45.90% 47.40% 46.70%
Reliable Deterioration Count 71 86 157
% within 8.00% 8.90% 8.50%
Total Count 889 964 1853
% within 100.00% 100.00% 100.00%
Referred On Recovery Recovered Count 16 16 32
% within 5.50% 6.30% 5.90%
Reliable Improvement Count 72 71 143
% within 24.60% 28.10% 26.20%
Non Recovered Count 168 134 302
% within 57.30% 53.00% 55.30%
Reliable Deterioration Count 37 32 69
% within 12.60% 12.60% 12.60%
Total Count 293 253 546
% within 100.00% 100.00% 100.00%
Total Recovery Recovered Count 1531 2216 3747
% within 40.20% 49.40% 45.20%
Reliable Improvement Count 1001 1038 2039
% within 26.30% 23.10% 24.60%
Non Recovered Count 1080 1047 2127
% within 28.40% 23.30% 25.70%
Reliable Deterioration Count 193 184 377
% within 5.10% 4.10% 4.50%
Total Count 3805 4485 8290
% within 100.00% 100.00% 100.00%
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Appendix 139: Chi square on drop out and recovery outcome for sensitivity analysis 
 
 
 
 
Discharge 
Reason
Value df
Asymp. Sig. 
(2-sided)
Not Suitable Pearson Chi-Square 6.070b 3 0.108
Likelihood Ratio 6.127 3 0.106
Linear-by-Linear Association 5.787 1 0.016
N of Valid Cases 249
Pearson Chi-Square 8.451c 3 0.038
Likelihood Ratio 8.371 3 0.039
Linear-by-Linear Association 2.547 1 0.111
N of Valid Cases 549
Pearson Chi-Square 102.421d 3 0
Likelihood Ratio 102.174 3 0
Linear-by-Linear Association 98.317 1 0
N of Valid Cases 5093
Pearson Chi-Square 4.529e 3 0.21
Likelihood Ratio 4.527 3 0.21
Linear-by-Linear Association 2.973 1 0.085
N of Valid Cases 1853
Referred On Pearson Chi-Square 1.274f 3 0.735
Likelihood Ratio 1.273 3 0.736
Linear-by-Linear Association 0.655 1 0.418
N of Valid Cases 546
Total Pearson Chi-Square 71.327a 3 0
Likelihood Ratio 71.491 3 0
Linear-by-Linear Association 61.046 1 0
N of Valid Cases 8290
Dropped Out 
of Treatment
Completed 
Treatment
Declined 
Treatment
